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Abstract 
 
Little is known about the long term adverse outcomes following colposcopy. This 
thesis employs a mixed method approach to investigate the long term adverse 
impacts of undergoing this procedure.  
Following a systematic review undertaken to explore the evidence base in terms of 
the potential impacts of colposcopy upon psycho-sexual functioning a two stage 
cohort study using questionnaires was undertaken employing quantitative and 
qualitative data collection tools.  
Of particular interest was whether the level of colposcopic intervention 
(colposcopy, biopsy or loop excision) was associated with more pronounced levels 
of sexual dysfunction, higher levels of anxiety and depression and impaired quality 
of life. 
There were no significant differences observed between women undergoing 
colposcopy, biopsy or loop excision for any of the outcome measures across both 
stages of the study. Age was the only predictor found to be associated with some 
of the outcomes measured. 
The study concludes that the level of colposcopic intervention has no impact upon 
outcomes measured. Factors other than undergoing colposcopy are likely to 
explain any problems observed in this cohort. 
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CHAPTER 1: INTRODUCTION 
 
 
Screening for cancer and other conditions aims to ‘identify preclinical disease by a 
relatively simple test’ and ultimately to reduce mortality and improve patient quality 
of life.1 However, screening has the potential to do harm as well as good.2 A 
National Cervical Screening Programme has been in existence in England and 
Wales since 1988 and aims to provide a cost-effective programme to reduce 
morbidity and mortality rates from cervical cancer. Women between the ages of 25 
and 65 are routinely invited to attend their general practice to undergo a test that 
involves a small brush removing a sample of cells from the transformation zone 
(TZ). This is the area of the cervix where the majority of abnormalities develop. 
The sampled cells are placed in a liquid solution and sent for laboratory 
examination. If mild to moderate abnormalities are identified, a referral is made to 
a colposcopy clinic. 
 
Colpsocopy is an essential part of the NHS Cervical Screening Programme 
(NHSCSP). It is a detailed examination of the cervix (neck of the womb) and is 
performed by a doctor or qualified colposcopist.3 Women are invited for a 
colposcopy following a referral generated via the National Cervical Screening 
Programme requesting further investigation of potential cell abnormalities 
discovered during routine cervical screening. Colposcopy clinics enable the 
diagnosis and treatment of CIN (Cervical Intraepithelial Neoplasia) in an outpatient 
setting.3 There are approximately 406,000 colposcopy appointments each year in 
England and Wales of which 134,000 are new referrals (the remainder being 
follow-up appointments); 78% of these are triggered by screening.4 The success 
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rate for treatment by colposcopy exceeds 90% and although it is a relatively safe 
procedure, there is evidence reported in ‘best practice guidelines’ that some post-
procedure complications can occur - including short-term psychological impacts, 
obstetric effects and an increase in the incidence of cervical stenosis.5,6   
 
Despite colposcopy being a relatively common procedure, little research has 
explored its potential long-term impacts upon psychological well-being, quality of 
life and sexual function. The long-term follow-up of women referred to colposcopy 
has mainly concentrated on establishing the rate of recurrence of CIN (the cell 
changes that can lead to potential abnormalities).7  
 
Studies related to the consequences of an abnormal smear, Human 
Papillomavirus (HPV) testing or colposcopy have not investigated the long-term 
experience of a defined cohort of women having undergone colposcopy stratified 
by level of treatment. Cohort studies have largely focused upon assessing the 
incidence of cervical stenosis;8 the impact of colposcopy on subsequent 
pregnancies or the recurrence of CIN.9-12  
It is timely to investigate how frequently these adverse impacts are experienced 
and to establish whether they have long-term consequences. 
 
Furthermore, most of the existing research on the consequences of colposcopy 
has been based primarily on the use of qualitative methodologies or via small, 
underpowered, studies that focus solely on the time of the abnormal smear or 
colposcopy. None have had sufficient size to differentiate between post-procedure 
effects on women that experienced colposcopy purely for diagnosis and those that 
 3
underwent more ‘invasive’ treatments such as biopsy or loop excision. The need to 
establish the long-term psychological and sexual consequences of colposcopy 
itself has been acknowledged13 and this study aimed to do so. 
 
 
1.2 Aims and objectives 
 
The primary aim of this study was to determine whether undergoing colposcopy 
and treatment for CIN has any long-term adverse psychological or sexual impacts.  
Research question: Are there any long term adverse impacts of undergoing 
colposcopy? 
Study objectives were to:  
 
1. Undertake a systematic review of the available evidence regarding the psycho-
sexual consequences of colposcopy and treatment for CIN. 
 
2. Investigate the long-term effects of colposcopy upon women’s quality of life. 
 
3. Establish whether colposcopy has any long-term effects upon sexual function. 
 
4. Characterise adverse sexual function by level of colposcopic intervention. 
 
5. Determine the potential sociodemographic and/or clinical predictors of adverse 
outcomes following colposcopy i.e level of treatment/intervention, age and 
deprivation. 
Overview of methodology 
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This thesis reports the findings of a cohort study designed to investigate the 
adverse psycho-sexual effects of undergoing colposcopy. Following a systematic 
review of the evidence for psycho-sexual consequences of colposcopy and 
treatment for CIN, the study utilised a two stage questionnaire to provide data to 
ascertain the potential clinical, sociodemographic and lifestyle factors that may 
influence whether or not women experience adverse outcomes following 
colposcopy, and to investigate the nature of any adverse outcomes experienced. 
 
Systematic Review 
A systematic review was undertaken of the available evidence relating to the 
adverse psycho-sexual impacts of undergoing colposcopy and treatment for CIN. 
The purpose of this was two-fold: to provide an overview of the current evidence 
base relating to these outcomes and to provide a reference point for the empirical 
data collected in the subsequent questionnaire element of this study. 
 
Questionnaire 
A cohort of women attending for colposcopy between 1st April 2008 and 31st March 
2009 was identified from the hospital records at five colposcopy units across the 
West Midlands: 
 
 Birmingham Good Hope (Heart of England NHS Foundation Trust) 
 Birmingham Heartlands (Heart of England NHS Foundation Trust) 
 Solihull Hospital (Heart of England NHS Foundation Trust) 
 Birmingham Women’s Hospital (Birmingham Women’s NHS Foundation 
Trust) 
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 Birmingham City Hospital (Sandwell and West Birmingham NHS Trust) 
 
Women who had undergone colposcopy during the time period of interest were 
stratified into equal groups by level of intervention/treatment for both stages of the 
study. The numbers in brackets below indicate the proposed sample size in each 
group (stage one total n=1,050, stage two total n=630). 
 
Stage one:  
1. Colposcopy only – no treatment or investigation (n=350) 
2. Colposcopy with investigation/diagnosis e.g. punch biopsy (n= 350) 
3. Colposcopy and treatment e.g. loop excision (n= 350) 
 
Stage two: 
4. Colposcopy only – no treatment or investigation (n=168) 
5. Colposcopy with investigation/diagnosis i.e. punch biopsy (n= 168) 
6. Colposcopy and treatment i.e. loop excision (n= 168) 
 
The initial study design included a control group, made up of age- and deprivation-
matched women who had never attended for a colposcopy in order to ascertain 
the excess risk of adverse outcomes in the colposcopy group compared with 
controls. These control patients were to be identified from the patient list of a 
general practice in the West Midlands. However, this proved unfeasible due to the 
difficulty of recruiting GP practices to provide details of control patients for 
recruitment to the study (outlined in more detail in Chapter 5). 
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The first questionnaire (Q1) was relatively brief and aimed to establish the 
prevalence of sexual problems and quality of life of respondents. To complement 
quantitative data collection, Q1 also included a qualitative element; a blank page 
was provided within the questionnaire inviting women to note any further, 
unprompted comments about issues related to the topic area. Introducing this 
element enabled exploration of some of the issues that women considered to be 
important, generating qualitative data around women’s experiences of the 
colposcopic procedure(s), adverse events experienced and general comments 
that participants felt were of interest or importance. Respondents to Q1 were 
asked to indicate whether they would be prepared to participate in a second, more 
detailed questionnaire (Q2) designed to collect demographic data alongside data 
related to a range of validated measures of sexual function, depression, anxiety 
and quality of life. Those who indicated a preference to receive the subsequent 
questionnaire were sent this shortly after their responses to Q1 were received.  
 
Analysis of the questionnaire data was undertaken in two stages. Responder bias 
was calculated for both Q1 and Q2. Analysis of questionnaire one included 
calculation of the frequencies of responses to all questions in terms of respondent 
age, socioeconomic status and the treatment type undergone. Chi2 tests were 
performed to investigate relationships between the variables of interest. More 
sophisticated analyses was undertaken for questionnaire two, including bivariate 
analyses of the presence or absence of female sexual dysfunction (FSD), scoring 
‘normal’ or ‘mild and above’ on the depression and anxiety scales, comparison of 
means tests for the scores on the WHOQOL-BREF domains (physical, 
psychological, social and environmental). Bivariate analyses were undertaken for 
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the total scores on the Female Sexual Function Index (FSFI), HADS anxiety and 
depression scores to ascertain the significant predictors of the variance in scores. 
Any significant predictors were entered into a multiple regression model to 
ascertain the ‘best’ predictors of the score variation. 
 
1.3 Structure of thesis 
Chapter two provides the background to the clinical features and epidemiology of 
cervical cancer and an overview of the NHSCSP. It also describes treatments 
available at colposcopy clinics, followed by a discussion of the treatment 
effectiveness and a summary of what is known about the adverse effects of 
cervical screening and colposcopy. Chapter three provides a systematic review of 
the literature pertaining to adverse psycho-sexual outcomes associated with 
colposcopy. Chapter four assesses the debates relating to the use of the 
terminology relating to sexual dysfunction within health research, touching on the 
some of the sociological and psychological issues pertaining to it. Chapter five 
provides an overview of the methodological approach including study design and 
study population. Chapter six presents the results from questionnaire one and 
summary of the findings. Chapter seven presents the results from questionnaire 
two along with a summary of the findings. Chapter eight presents the results from 
the qualitative element of the study and discusses these in the context of the wider 
literature. Chapter nine presents the discussion of the findings and includes study 
limitations along with the strengths of the study. It will also include suggestions for 
service improvement. Finally, chapter ten draws the study conclusions together 
including suggestions for future research. 
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CHAPTER 2: BACKGROUND 
 
 
The following chapter will present the clinical features and epidemiology of cervical 
cancer and describes the treatments available for CIN. It also discusses the 
evidence pertaining to the effectiveness of treatments for CIN and provides a 
summary of what is known in terms of the adverse physical and obstetric effects of 
cervical screening and colposcopy. 
2.1 Prevalence and aetiology 
Around 2,900 women are diagnosed with cervical cancer in the UK each year.  
Overall, 2 out of every 100 cancers diagnosed in women are cervical cancers. It is 
the second most common cancer in women under 35 years old and is most 
frequently diagnosed following cervical screening. Around 4.4 million women are 
invited for screening every year and of these, around 24,000 have a ‘severely’ 
abnormal result (CIN 3).14 
 
Table 2.1 Number of new cases and rates of cervical cancer UK, 200715 
 
 England Wales Scotland N. Ireland UK 
      
Cases 2,276 184 284 84 2,828 
      
Crude rate per 
100,000 population 
8.8 12.1 10.7 9.4 9.1 
      
Age-standardised 
rate (European) per 
100,000 population 
8.0 11.3 9.8 9.3 8.4 
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2.2 Cervical cancer - clinical features and epidemiology 
 
There are two types of cervical cancer, the most common of which is squamous 
cell cervical cancer. This develops from a skin-like cell that covers the cervix and 
accounts for approximately 90-95% of all cervical cancers.16 Much less common is 
adenocarcinoma cervical cancer which develops from a glandular cell (a cell that 
makes mucus) within the cervical canal. The human papillomavirus (HPV) is the 
main cause of cervical cancer and out of the more than 100 known forms of HPV, 
types 16 and 18 are considered ‘high risk’ for cancer of the cervix.17  Persistent or 
frequent infection with HPV type 16 or 18 increases the risk of developing pre-
cancerous cells and cervical cancer and it is estimated that HPV infection 
accounts for over 70% of all cases of cervical cancer detected.17 Some types of 
HPV are passed on through sexual intercourse as well as non-penetrative sexual 
activity and girls aged 12 or 13 are now routinely offered a vaccine against HPV. 
There are other known risk factors for cervical cancer. For example, herpes and 
HPV infection can double the risk of cervical cancer whist infection with Chlamydia 
and HPV can increase the risk by 80%. There is also evidence that smoking can 
increase the risk of developing cervical cancer,18 and women with a weakened 
immune system (women with AIDS or HIV, or women on immunosuppressant 
drugs) have a higher than average risk of developing cervical cancer.19 
Until recently, it was assumed that the link between the oral contraceptive pill and 
cervical cancer was number of sexual partners; the assumption being that women 
on the pill may be more likely to have multiple partners, or less likely to use barrier 
contraceptives. Evidence suggests that women who have used the pill for at least 
five years double their risk of developing cervical cancer.20 This risk drops when 
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the pill is no longer taken. There would also appear to be a link between social 
deprivation and cervical cancer. Women living in more socioeconomically deprived 
areas have been found to have rates of cervical cancer three times higher than 
those living in less deprived areas.21  
 
2.2.1 Clinical Features 
Unlike a number of other cancers, many women with cervical cancer will be 
asymptomatic. This is one of the primary reasons that screening is recommended, 
as screening can detect abnormalities and pre-cancerous cell changes that may 
otherwise take several years to manifest as signs or symptoms of the disease. 
 
However, a number of non-specific symptoms may be an indication of the disease: 
intermenstrual bleeding; post-coital bleeding; postmenopausal bleeding (risk of 
cervical cancer increases with age); blood stained vaginal discharge and pelvic 
pain/dyspareunia. 
 
Symptoms of advanced cervical cancer include renal failure, discomfort, leakage 
of urine or faeces from a fistula, lymph oedema, or severe haemorrhage. 
 
2.3 The National Cervical Screening Programme - an overview 
There has been a cervical screening programme in the UK since 1965. It was not 
until 1988 when a call and recall system was put in place that a systematic NHS 
Cervical Screening Programme (NHSCSP) was launched.22 This system was 
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designed to ensure that maximum numbers of women are invited to attend cervical 
screening depending on their risk status (i.e. age).  
 
The NHSCSP is nationally coordinated and locally managed. The call and recall 
system for each area holds the patient lists for all GP practices and sends these 
lists to each GP who is expected to check the records to ensure patient details 
(such as address and age) are correct. The call and recall system sends out all 
screening invitations and co-ordinates communication of reminders and results.   
Women are invited to attend their first routine screening appointment aged 25. 
Between the ages of 25 to 49, invitations are sent out every three years. Between 
the ages of 50-64, women are invited every five years and aged 65 and beyond, 
only those who have not been screened since the age of 50, or who have received 
recent results showing abnormalities are invited for screening. Women are invited 
five to six weeks prior to the date when the appointment is scheduled. 
 
The GP practice is tasked with undertaking the test, which is sent for laboratory 
analysis. Following this, the laboratory sends the results to the GP, and checks 
that any results showing an abnormality are followed up by the practice. The 
colposcopy service receives referrals directly from the laboratory or primary care 
and undertakes further diagnoses and treatment if required. Following 
investigation and/or treatment, the colposcopy service discharges women back to 
the call and recall system. 
  
The programme operates according to an initial screening invitation age of 25 
following evidence that the incidence of cervical cancer in women under 25 is too 
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rare for screening below this age to be considered cost-effective.23,24 The policy 
was formally reviewed in June 2009, partly due to public interest following the 
death of Jade Goody, a high profile ‘celebrity’ who was diagnosed and died of 
cervical cancer aged 27. Sasieni’s review25 examined the evidence for the efficacy 
of screening women under the age of 25 and concluded that 'cervical screening in 
women aged 20-24 is substantially less effective in preventing cancer (and in 
preventing advanced stage tumours) than is screening in older women.'25 In 
particular, the review concluded that cervical cancer is rare in younger women; 
there is no evidence that cervical screening works in women aged 20-24 because 
the women who developed cancer under the age of 25 were as likely to have been 
screened as unscreened; data available suggests that there is very low 
progression potential in women under the age of 25; there are harms and costs 
associated with screening women aged 20-24, and current evidence suggests that 
the harms outweigh the costs of screening women in this age group.
 
Screening was initially based on the Pap smear, developed in 1943 by George 
Papanicolaou. Following the ‘phasing out’ of the Pap smear, today, cervical 
screening in the UK uses liquid-based cytology. This means that the cells collected 
from the cervix are preserved in a liquid solution, rather than being transferred to a 
slide as was previous practice. This method has a number of advantages over the 
traditional ‘smear test’. Firstly, it simplifies the process for the person taking the 
smear and improves the preservation of the cellular material. It is also takes less 
time for the laboratory to process the sample, so results can be returned to 
patients much sooner. Probably the most important improvement, certainly from a 
patient perspective, is that it reduces the number of inadequate smears. This 
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reduces the burden upon patients who may be unnecessarily recalled to provide a 
further sample. 
 
Despite claims that cervical screening saves lives – over 4,000 in England  
per year,26 it is not a wholly uncontroversial public health policy with concerns that 
is leads to over-treatment and may cause more harm than good. It should be 
noted that the evidence for the effectiveness of this programme has not been 
demonstrated through the means of randomised controlled trial. Raffle et al (1995) 
note that due to the fact that cervical screening is now widely practised, it is too 
late to be able to truly test its efficacy with a randomised control trial, thus ‘we 
must live with the fact that we can never know for certain what contribution 
screening has made’.27 Nevertheless, it would appear that screening for cervical 
cancer has had an impact upon both cervical cancer incidence and mortality rates. 
 
As cervical screening programmes have become formalised within general 
practice and more recently incentivised in primary care through the Quality 
Outcomes Framework, there has been an increase in coverage to approximately 
85%.28 This has resulted in a fall in the incidence of invasive cancer due to early 
diagnosis of pre-cancerous changes and other abnormalities that can be treated 
before disease progression.  
 
2.4 Colposcopy services 
Colpsocopy is an essential part of the NHSCSP. Colposcopy is a detailed 
examination of the cervix (neck of the womb) and is performed by a doctor or 
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qualified colposcopist in an outpatient setting. Women are invited for a colposcopy 
following a referral generated via the National Screening Programme requesting 
further investigation of potential cell abnormalities discovered during routine 
cervical screening. National guidelines for the NHS Cervical Cancer Screening 
Programme published in 2004 require that women who are diagnosed with mild 
cell changes (CIN 1) are referred for colposcopy after three positive tests.  
The most recent NHS guidelines ‘Colposcopy and Programme Management’ have 
been adopted by colposcopic services in England and Wales.30 There are 
approximately 406,000 colposcopy appointments each year of which 134,000 are 
new referrals.4  
There are three reasons for referral to colposcopy:  
 
1. The cervical screening results are not abnormal, but show that the 
laboratory was unable to report results. This may be because there are not 
enough cells to adequately assess whether the cervix is healthy or not. 
 
2. The cervical screening test has found evidence of possible cell 
abnormalities (dyskaryosis). This can serve as a warning that cervical 
cancer may develop in the future. These abnormalities are stratified into 
borderline or mild (CIN 1), moderate (CIN 2), or severe dyskaryosis (CIN 3). 
 
3. Women may be experiencing signs and symptoms related to the health of 
the cervix (abnormal bleeding, pelvic pain, unusually heavy discharge). 
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The subjectivity of judgement in diagnosing a cervical abnormality (exactitude is 
not possible) will mean that many women may undergo colposcopy unnecessarily. 
This should be borne in mind especially in the light of the evidence that 
colposcopy can have negative effects upon women’s health and well-being and 
the fact that little is known of the long term adverse effects of colposcopy upon 
women’s health. This would indicate that there is a need for a study to investigate 
whether there is a reduction in women’s quality of life and in particular whether 
there is an effect upon women’s sex life after colposcopy. 
 
2.4.1 Treatments for CIN 
Treatments for CIN vary depending upon the grade of the neoplasia - namely 
Grade 1, 2 or 3. Figure 2.1 demonstrates the differences between a normal cervix 
compared with low grade and high grade CIN and cervical cancer. With CIN 1 
(also referred to as borderline changes), cells often revert to ‘normal’ without any 
treatment and if this level of abnormality is identified, it is usually monitored by a 
repeat screening test six months later. However, after three borderline samples, 
women will be routinely referred for colposcopy. CIN 2 and 3, referred to as 
moderate or severe dyskaryosis (or carcinoma-in-situ) respectively are routinely 
referred for treatment with the aim of removing the abnormal tissue and cells or 
destroying the cells. 
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Figure 2.1.Cervical abnormalities31 
 
 
 
 
 
Procedures to remove the abnormal area include a cone biopsy; large loop 
excision of the transformation zone (LLETZ) and hysterectomy, although this is not 
commonplace. Cone biopsy is used as a method of diagnosis and treatment 
where the area is of sufficient size. A laser is used to cut away a cone-shaped 
piece of the cervix which will be sent for analysis to determine the grade of CIN 
found in the cervix. 
 
LLETZ is the most common method of treatment but methods employed may 
depend upon the facilities available in a particular NHS Trust as well as the 
clinician’s decision as to what would be most appropriate given the age of the 
patient, or extent of disease. LLETZ is also known as LEEP (Loop electrosurgical 
excision procedure) and is usually performed under local anaesthetic, although 
general anaesthetic may be used if a significant area of tissue requires removal. A 
thin wire loop heated by an electric current enables the colposcopist to cut away 
the area of abnormality and also seals the tissue to minimise post-surgery 
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bleeding. The tissue is sent to the laboratory to ensure that all the abnormal cells 
have been removed. If the edge of the sample cells have no abnormality, no 
further treatment will be required. Otherwise, another colposcopy will be performed 
to ensure removal of the areas of abnormality. 
 
Procedures to destroy the cells in the area of the abnormality include laser 
therapy; cold coagulation and cryotherapy. Laser therapy (also known as laser 
ablation) uses a laser to remove the area of abnormal cells and along with other 
excisional methods (LLETZ) is regarded as a procedure with lower morbidity than 
cold coagulation, which removes cells by heating the area of abnormality using a 
hot probe.32 Cryotherapy, which uses a probe to freeze the abnormal cells, is not 
commonly used as it has a lower success rate than other treatments.  
 
 
2.4.2 Colposcopy procedure 
 
Colposcopy is offered in an out-patient setting. At the colposcopy appointment, the 
nurse records the patient’s medical history, explains the procedure and answers 
any questions the patient may have. The patient lies on a couch that supports the 
legs. The colposcopist warms and lubricates a speculum and places it in the 
vagina, to enable the cervix to be viewed. The colposcope, which works by 
enlarging the image and providing a view of the cervix in 3D, is used to enable a 
closer examination of the cervix (see Figure 2.2). An iodine solution is applied to 
the cervix using a cotton-wool ball and this is used to highlight any abnormal cells 
and enable the colposcopist to make a diagnosis. If no abnormalities are found, no 
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further investigation is required. However, if a diagnosis is made, a punch biopsy 
may be taken or treatment undertaken. 
 
Figure 2.2 The colposcope 
 
 
 
 
2.5 Adverse effects of cervical screening (fear of the smear) 
 
Raffle et al’s Bristol based study27 aimed to analyse the rates of detection of 
cervical abnormalities and investigate the assumptions underpinning screening 
programmes. The assumption that ‘abnormal cells’ would only be found in the 
smears of women ‘destined to die of cervical cancer’ and that surgical treatment 
would prevent this is challenged, as Raffle et al suggest that such an assumption 
may lead to the misdiagnosis of cancer for women who may never go on to 
develop cancer despite the presence of some abnormalities of the cervix (i.e. over-
diagnosis). The authors acknowledge that analysis and interpretation of cervical 
screening tests is not an exact science but ‘a difficult and subjective task, and the 
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distinction between mildly changed and normal cells remains essentially 
arbitrary’.27 It also noted that local treatment of CIN does not ensure the prevention 
of cancer in every case. Further to the issue of over-diagnosis and the 
acknowledged subjectivity of cervical screening, screening has also been argued 
to have a number of negative psychological impacts on women undergoing the 
procedure. 
 
Women’s experiences of cervical screening have been explored by commentators 
and researchers and the potential adverse effects of receiving an abnormal result 
are well described.33-35 Women may have to confront issues around their own 
body image, mortality, self-efficacy and sexuality and receiving a positive result will 
raise the spectre of cancer as well as a fear that they may become stigmatised 
due to associations that have been drawn between cervical cancer and 
promiscuity.36  A 2006 Scottish study of the psychological effects of receiving a 
smear result of a low grade abnormality found levels of anxiety to be consistent 
with levels found in studies of women with high grade abnormalities. This study 
also identified particular sub-groups of women likely to be at higher risk of 
increased anxiety levels; including younger women, women with children, women 
who smoked and women who exercised more.37  
 
Feminist discourse emerged in the 1980’s that challenged the ‘interventionist 
medical model’38 suggesting that the personal costs to individual women in terms 
of the side-effects of the screening procedure itself do not outweigh the public 
health benefits (fear of cancer; the invasive nature of the procedure, physical and 
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emotional trauma). Germaine Greer writing in 1999 stated that ‘screening is many 
times more likely to destroy a woman’s peace of mind than to save her life’.39 
 
In order for a woman to make a fully informed choice about participating in cervical 
screening programmes (or indeed any screening programme), accurate 
information should be provided about the risks as well as the potential benefits.40 
In emphasising only the positive aspects of screening, Raffle states, we are 
ignoring individuals’ autonomy and exacerbating feelings of anger that may be felt 
by patients who feel they have been ‘let down by screening’. Patients may also 
become complacent, disregarding potential symptoms, in the erroneous belief that 
screening will offer full protection. It can also lead to problems for health service 
staff who may be blamed unreasonably for shortcomings that are systemic in the 
screening programme. There is, however, a clear tension that such transparency 
may discourage women to participate in screening. Raffle calls for more ‘clarity at 
national level about the purpose of information about screening’ which should 
enable answers to questions about ‘the kind of information needed to achieve 
informed participation, and about how it should be framed and communicated’. 
 
 
2.6 Effectiveness of treatment in preventing recurrence of CIN 
 
Before summarising the evidence examining the known adverse consequences of 
treatment, this section will outline what is known about the effectiveness of 
colposcopically directed treatment for CIN in terms of its effect upon recurrence 
rates.  
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A systematic review published in 200042 looked at studies assessing the 
effectiveness of a variety of ablative and excisional treatments. The studies 
included did not detect any cases of progression to cervical cancer, but following 
the pooling of results, the median follow-up was 12 months, so conclusions about 
the long-term effectiveness of treatment are limited. 
 
Soutter et al investigated the rate of invasive disease following ablative or 
excisional treatments.41 The authors also assessed the risk of developing cervical 
cancer after treatment, using data from 2,116 women observed over a period of 
eight years  (data combined from five UK studies). They noted that previous 
studies assessing the effectiveness of treatment did not exceed one-year follow-
up. The cumulative rate of invasion eight years after treatment was 5.8 per 1,000 
and the rate of invasive cancer 85 per 100,000 women years (95% CI: 60 to 119). 
They concluded that treatments for CIN reduce the risk of cervical cancer by 95% 
during the first eight years of treatment, but that even with long-term follow-up the 
risk of developing cervical cancer is five times greater than in the general 
population. Careful and systematic follow-up is recommended for this group. 
 
So, there is evidence for the efficacy of treating CIN by colposcopically directed 
interventions, and the case for such intervention is clear. However, to provide a 
balanced view of the effectiveness of treatment, the following section will outline 
the literature that focuses upon the potential adverse effects of undergoing 
treatment.  
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2.7 Literature review: adverse outcomes after colposcopy - what 
is known? 
 
Chapter three provides a systematic review of the available evidence for adverse 
psycho-sexual outcomes after colposcopy. This section provides an overview of 
the evidence for a broader range of adverse outcomes after colposcopy, outlining 
the psychological, physical and obstetric effects. It also summarises the evidence 
for the long-term psychological impacts for patients diagnosed with invasive 
cancer. Some of the studies relating to psycho-sexual function highlighted in this 
section are further explored in Chapter three. 
 
The long-term physical and psychological consequences of invasive cancer are 
well described.43 Psychological well-being scores in patients diagnosed with 
cancer remain lower than those of patients with other chronic illnesses or healthy 
subjects irrespective of age, cancer site or stage of disease, and it has been 
recommended that psychological interventions for patients facing cancer treatment 
should be provided as an integral component of cancer management.44   
 
Longitudinal studies assessing the consequences of hysterectomy in the treatment 
of early stage cervical carcinoma report a persistent negative impact on sexual 
interest.34,45Jensen et al utilised a validated self-assessment questionnaire (the 
Sexual function-Vaginal changes Questionnaire, (SVQ)) and found that radical 
hysterectomy appeared to have a persistent negative impact upon patients’ sexual 
interest.45 There is also evidence that other gynaecological procedures can impact 
negatively upon sexual functioning and concerns about impact on sexual function 
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can be particularly pronounced in younger women.46 Zippe and colleagues 
evaluated sexual dysfunction after radical cystectomy (treatment for bladder 
cancer) and found that all domains of sexual function were affected by the 
intervention.47  
 
Another study focusing upon the impact of hysterectomy upon sexual function also 
found that women experienced a reduction in their sex life following treatment,48 
although Jensen et al found that some of the postoperative problems subsided 
after six months. However, there is a paucity in the literature in relation to sexual 
function after hysterectomy and some of the studies report that sexual function 
may improve after surgery and may be associated with the relief from preoperative 
dyspareunia and dysmenorrhea.49  
 
Treatment for CIN is associated with an excess of adverse obstetric outcomes.8-10  
There is also evidence that women feel anxiety and fear following an abnormal 
smear, attending a colposcopy appointment, or being treated for CIN.33,44,50 
Studies have found that the main reason women may not attend cervical 
screening in the first instance is that they believe it to be a test for cancer and fear 
a positive result.51,52,53  
 
Diagnosis of CIN is also associated with a perceived threat to life and/or women’s 
fertility, feelings of anger and resentment,35,54,55 and effects upon body image and 
sexual functioning. Diagnosis can also have a stigmatising effect,56 which may 
lead women to avoid screening in the future. Sexual health promotion messages 
have advised women that sexual activity at an earlier age can increase the risks 
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of developing CIN. The implications can lead women to fear being labelled as 
promiscuous, and thus avoid screening. 
 
Women who have experienced colposcopy may also report adverse effects upon 
their sexual relationships.3,35,54,55,57-59 McDonald et al’s  longitudinal study followed 
20 patients through diagnosis and treatment with colposcopic biopsy showing 25% 
CIN 1, 45% CIN 2, and 30% CIN 3. After surgery, women reported that they felt 
less attractive and also reported reduced levels of sexual function.60 Gath et al 
studied the emotional reactions of women attending colposcopy in Oxford and 
alongside using validated measures to assess the frequency, nature, severity and 
duration of emotional symptoms (including Present State Examination, General 
Health Questionnaire, Beck depression inventory), semi-structured interviews 
were conducted that found that women’s sexual functioning was impaired following 
colposcopy.61 Posner and Vessey’s study found that 14% of women reported their 
sex life was not ‘back to normal’ 6 to 9 months after colposcopy and 19% of 
women’s sex lives were adversely affected subsequent to treatment.34  
 
Despite qualitative research suggesting the possibility of long-term adverse 
consequences of colposcopy,34 little research has been undertaken to determine 
the generalisability of these findings or to quantify the prevalence of these adverse 
impacts. Quantitative studies have to date been small-scale, underpowered, and 
tend to be restricted to the time of the abnormal smear or colposcopy.60,61 
Furthermore, none have been of sufficient size to differentiate between women 
who underwent colposcopy purely for diagnosis and those who had treatment. The 
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need to establish the long-term psychological consequences of colposcopy has 
been acknowledged,55 and a study of sufficient size and follow-up is required.  
 
In the present study, cases were stratified depending upon whether patients were 
‘treated’ at colposcopy, underwent investigation (biopsy) or had no treatment or 
investigation. This enabled assessment of (for example) whether patients who 
were ‘treated’ experienced an excess of adverse events to a greater extent than 
patients who underwent investigation alone or whether the type of treatment had 
no bearing on the extent of any adverse outcome experienced.  
 
 
2.8 Physical and obstetric impacts of colposcopy and treatment 
for CIN 
 
There is a relatively large body of evidence that has investigated the physical and 
obstetric impacts of undergoing colposcopy and treatment for CIN. Although the 
main focus of this thesis is to investigate the psychological and sexual impacts of 
undergoing colposcopy, in order to provide context and a summary of the clinical 
outcomes associated with the procedure, this section will consider the evidence 
that has explored the physical side-effects, obstetric impacts and incidence of 
cervical stenosis following colposcopy and treatment for CIN.  
 
2.8.1 Obstetric outcomes 
 
The mean age of women undergoing investigation and treatment for CIN is around 
30 years62 and therefore it is important to ensure that treatments minimise any 
adverse obstetric outcomes for future pregnancies. Some studies have reported 
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no association between treatment and adverse obstetric outcomes,62,63 whilst 
others have asserted that such links do exist.64-67  
 
A systematic review and meta-analysis of the obstetric outcomes after treatment 
for CIN published in 2006 provides a useful summary of evidence relating to 
subsequent pregnancies.68 Kyrgiou et al consider the effects of a range of 
conservative treatments for CIN including cold knife conisation, laser ablation, 
laser conisation, LLETZ or studies considering more than one treatment type upon 
obstetric outcomes. The study reviewed the available controlled observational 
studies (due to the nature of CIN and its development, no randomised controlled 
trials (RCTs) are available, nor are ever likely to be). Included studies focused 
upon comparing obstetric outcomes in pregnant women with or without a previous 
treatment intervention for CIN or stage 1 cervical cancer. The outcomes measured 
related to fertility outcomes including conception rates, number of pregnancies and 
time to conception. Maternal outcomes included pre-term births (<37 weeks), 
caesarean section rates, precipitous labour (<2 hours) and preterm spontaneous 
rupture of membranes (pPROM). Foetal outcomes measured included low birth 
weight, perinatal mortality and neonatal intensive care unit admission. All 27 
studies included in the review were retrospective cohort studies. Some of the 
findings were hampered by small sample sizes and the problems inherent in 
retrospective studies. However, this analysis of the best evidence available at the 
time indicated that there are adverse pregnancy related outcomes following 
treatment for CIN. After LLETZ, the most commonly utilised form of excisional 
treatment, there was a significant increased risk of pre-term birth (Relative risk 
1.70; 95% CI: 1.24 to 2.35, 156/1402 [11%] vs. 120/1739 [7%]); low birth-weight 
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(RR 1.82; 95% CI: 1.09 to 3.06, 77/996 [8%] vs. 49/1192 [4%], and pPROM (RR 
2.69; 95% CI:1.62 to 4.46, 48/905 [5%] vs. 22/1038 [2%]). Similar associations 
were also found with cold knife conisation. 
 
No pregnancy related risks were found in relation to ablative treatments (laser 
ablation). None of the included studies that focused upon fertility outcomes found 
any adverse effect on this outcome, although the authors note that the evidence is 
scant. In conclusion, the authors note that the excision of the transformation zone 
has a small but ‘real increase in risk of pregnancy-related morbidity,’ and that 
young women should be informed of this fact. 
 
In 2007, Jakobsson and colleagues’ retrospective cohort study (n=25,827) 
supported the findings of the 2006 meta-analysis and as it is substantially larger, it 
provides yet more evidence for the increased risks of obstetric outcomes for 
women undergoing excisional treatment for CIN.69 
 
Following publication of this and subsequent large population based studies,66,71 
Arbyn and colleagues published a ‘more comprehensive’ review of the evidence 
paying particular attention to more serious outcomes - delivery before 32 weeks, 
birth weight under 2000g and perinatal mortality, for which data had been 
previously unavailable. Cold knife conisation was found to significantly increase 
the risk of perinatal mortality, severe and extreme preterm delivery, and low birth 
weight. Large loop excision, however, was not associated with the more severe 
spectrum of outcomes, although the authors did not rule out the fact that LLETZ 
may be associated with increase risk of pre-term birth.70 The study findings 
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supported those from Kyrgiou et al and Bruinsma et al that ablative techniques are 
less likely to be associated with adverse obstetric outcomes than the more 
commonly utilised excisional treatments. 
 
In 2011, Bruinsma and colleagues published an up to date systematic review and 
meta-analysis, motivated by the number of larger scale studies undertaken since 
the previous review.71 Including data available from these studies provides a more 
comprehensive assessment of the adverse obstetric risks associated with 
treatments for CIN. The review highlights the three main sources of comparison for 
studies investigating the risk of pre-term birth: 
 
 External comparison groups, namely women who gave birth at the same 
time who did not have a diagnosis of precancerous changes to the cervix; 
 
 Internal comparison groups, comparing birth outcomes before treatment 
with births after treatment; 
 
 Comparison of birth outcomes for women who had previous treatment for 
precancerous changes with outcomes for women who had a diagnosis of 
precancerous changes but who had not been treated. 
 
The review investigates the impact of the type of comparison group on any 
association between treatment and subsequent preterm births (pre 37 weeks) and 
to see if the risk varies across treatment types (ablative or excisional). Overall, 
excisional treatments were associated with increased risk of preterm births, when 
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compared with an external (RR 2.19, 95% CI 1.93-2.49) or internal (RR 1.96, 95% 
CI 1.46-2.64) comparison group. In the case of women who were assessed but not 
treated the risk estimate was smaller (RR 1.25, 95% CI 0.98-1.58), suggesting 
intervention and treatment are higher risk factors for adverse obstetric impacts 
than women who underwent assessment alone. 
 
This review adds to the previous debate as it provides evidence that ablative 
treatment may also be associated with an increased risk of preterm birth, albeit  a 
smaller one than excisional treatments. It also highlights the importance of 
considering the types of comparison groups used in a study, noting the importance 
of treating studies with an external comparator separately from studies comparing 
women who have been assessed but not treated for precancerous changes to the 
cervix. 
 
A subsequent Welsh study using a large data linkage method from routine 
healthcare databases was undertaken in 2011 and aimed to describe the risk of 
pre-term birth and low birth weight for women who had been treated for 
precancerous changes to the cervix.72 The study population were aged 20 to 39 
and had attended for screening or referred for colposcopy over a three year period 
(n=157,634 negative smear group; n=8,731 colposcopy group; n=7,735 treatment 
group). The findings from the study indicate that for women undergoing 
colposcopy only and single excisional treatment, risk of pre-term birth (<37 weeks) 
increased significantly (OR 1.54; 95% CI: 1.32 to 1.80; OR 1.77; 95% CI: 1.47 to 
2.13 respectively) when compared with women who had a negative smear test 
result. Rates of low birth weight were higher in women referred to colposcopy than 
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in the negative smear group. The authors found no increased risk of preterm birth 
or low birth weight between colposcopy only and treatment groups. However, 
when confounding factors were taken into account (women referred for colposcopy 
were generally younger at the time of birth, lived in deprived areas, were more 
likely to be smokers and had higher rates of previous obstetric problems), it is 
these factors that may plausibly explain the excess of obstetric problems. 
 
A Finnish study published in 2011 examined the incidence of pregnancy after 
treatment for CIN for which there is little published evidence available. A matched 
cohort study compared pregnancy outcomes and incidence of pregnancy for 
women treated for CIN (n=6,179) and age and area matched women (n=30,436) 
and found that the pregnancy incidence rate was higher in the treated population 
than in the reference population. Despite this, the authors cite the evidence base 
that women treated for CIN are at increased risk of preterm birth, but conclude that 
women should feel reassured by the evidence that treatment for CIN does not 
reduce the incidence of pregnancies amongst this population.73 
 
Kerri et al urge caution when considering the body of evidence investigating long-
term consequences of treatments for CIN and in particular, pre-term birth, arguing 
that the nature of the evidence available e.g. many of the studies are retrospective 
and therefore prone to bias along with the fact that the causes of pre-term birth are 
complex and multi-factorial in nature and not fully understood should be borne in 
mind for practitioners working in the field.74 It is also important to ensure that any 
potential adverse outcome - obstetric or otherwise - should be put in the context of 
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the level of abnormality observed and the likelihood that if left untreated could 
develop into cervical carcinoma. 
 
2.8.2 Physical after-effects 
 
It is known that there are physical side-effects following colposcopy and treatment 
for CIN. Luesley and colleagues (1990) published evidence from a prospective trial 
with six-month follow-up investigating the morbidity associated with treatment for 
CIN, using fine loop diathermy (LLETZ). As may be expected given the nature of 
treatment, mild bleeding occurred in 32% of cases (199/616), moderate bleeding 
in 8% of cases (51/616) and severe bleeding in three cases (3/616), although 59% 
experienced no post operative bleeding. Discomfort levels were relatively low with 
85% of patients reporting no discomfort and only 1% reporting severe pain. 
 
At six-month follow-up (n=557), 24 (4.3%) patients reported excessive bleeding 
(secondary haemorrhage) three weeks post treatment. Vaginal discharge was 
present in most cases post-treatment lasting for two weeks or less in 71% of cases 
(n=398/557). The period of discharge was prolonged in 5.6% of cases (n=31/557), 
lasting for six weeks or longer. Severe cervical stenosis (narrowing of the 
endocervical canal) was noted at follow-up in seven patients (1.3%).75 
 
Bigrigg and colleagues followed 250 women who had been treated with LLETZ, 
three years post-treatment and found no differences in terms of fertility and effect 
upon menstrual cycles when compared with local controls.76 
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2.8.3 Incidence of cervical stenosis (CS) following treatment for CIN 
 
As noted above, cervical stenosis (narrowing of the cervical canal) is one of the 
identified side effects following treatment for CIN. The studies examining the 
incidence of cervical stenosis are heterogeneous in terms of the method of 
treatment assessed, and to some degree, in terms of how cervical stenosis is 
defined.  
 
Delmore et al reported results following 161 patients undergoing laser excision 
and 132 treated with cold knife conisation.77 The study notes that 11% (n=6/132) 
of patients in the cold knife group were diagnosed with cervical stenosis (CS) 
compared to 4% (n=4/161) in the laser group. The authors note that this rate of 
cervical stenosis is higher than a previous study78 reporting 1% and Gilbert et al 
who reported rates of 53%.79 The reason for this variance would be appear to be 
related to the definitional (and clinical) differences in the use of the term ‘cervical 
stenosis.  
Overall, Delmore et al’s study supports the evidence base that there are fewer 
complications with excisional techniques rather than ablative techniques. Baldauf 
and colleagues investigate the frequency of CS in patients treated either by loop 
electrosurgical excision (n=277) or laser conisation (n=255) and define CS as 
narrowing of the cervix to the extent that a 2.5mm dilator cannot be inserted.80  28 
months after treatment, 38 cases of CS were diagnosed (n=26; 10.2% in laser 
group; n=12; 4.3% in the loop group). The study also investigated risk factors for 
CS and found that age (>50 years); location of the lesion (in the endocervical 
canal); height of excision (>20mm) and type of treatment method (laser conisation) 
were all factors associated with an increased risk of cervical stenosis. The authors 
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posit that any decreased risk of CS associated with loop treatment is due to the 
fact that the excision taken under loop is shorter than with laser ablation. 
 
Suh-Burgmann et al’s later study also investigated risk factors for cervical 
stenosis, focusing upon loop electro-surgical excision procedure alone and found 
a correlation between presence of CS and history of undergoing previous loop 
excision and volume of tissue removed (n=164) and the authors recommend that 
women who have previously undergone LEEP would benefit from counselling 
around their increased risk.81 
 
Houlard and colleagues 2002 study focused upon the incidence of cervical 
stenosis after laser cone biopsy.8 This method enables detailed examination and 
diagnosis of cervical abnormalities. The study also assessed the risk factors for 
CS following the procedure. 238 patients were assessed at follow-up (37 +/- 26 
months after surgery) and 40 patients (16.8%) were diagnosed with cervical 
stenosis. This incidence rate is greater than those seen in previous studies and 
authors suggest this may be due to the mean age of patients (36 years - higher 
than previous studies) as well as the varying definitions of cervical stenosis across 
studies. The fact that laser cone biopsy removes tissue at a greater height when 
compared with LEEP may also explain the higher rate of incidence in women 
undergoing cone biopsy.  Risk of CS was found to increase in older patients; when 
excision depth increased; where the lesion was endocervical; when vaginal 
packing was required, and when a continuous laser beam was employed. 
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Despite the varying degrees of incidence cited across these studies, it is clear that 
cervical stenosis is a possible adverse event following investigation and treatment 
for CIN. 
 
 
2.9 Chapter summary 
 
The background to the study presented the rationale for undertaking the thesis 
and outlined what treatments are available. It also discussed the debate around 
the efficacy of the cervical screening programme and the evidence for the 
effectiveness of colposcopically directed treatments for CIN. 
 
Furthermore, it summarised the body of evidence in terms of what is known about 
the adverse psychological, physical and obstetric consequences of undergoing 
colposcopy and colposcopically directed treatment for CIN. There is evidence that 
diagnosis of cervical abnormalities can have adverse psychological consequences 
and it would appear that there are some effects upon psycho-sexual well-being. 
There is evidence that women experience anxiety and fear following a diagnosis of 
a cervical abnormality, and that fear of cancer in particular is a prominent 
experience for these women. Undergoing colposcopy and treatment for CIN can 
also lead to adverse effects upon self-esteem and sexuality. Some studies indicate 
that diagnosis and treatment can lead to reduced libido and pain during sexual 
intercourse. These issues are explored further in Chapter three.  
 
There are physical impacts of colposcopy, particularly post-operatively, and some 
evidence that women may experience a higher incidence of cervical stenosis 
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following treatment. The physical side-effects of undergoing treatment include 
bleeding and discomfort and vaginal discharge. It should be noted that the studies 
assessing the incidence of cervical stenosis were heterogeneous in nature, in 
particular in terms of how cervical stenosis is defined. One study defined CS as 
the narrowing of the cervix to 2.5mm whilst another study used 3mm as the cut off. 
Studies also varied in terms of the kinds of procedure investigated e.g. loop 
excision, laser cone biopsy the later of which found a higher incidence of CS due 
to the degree of tissue removal undertaken for this procedure. 
 
In terms of obstetric outcomes, the most recent systematic review and meta-
analysis of the evidence included the results from the three main comparator 
groups utilised in the included studies. The review focused upon treatment and 
subsequent pre-term birth and found that excisional treatments were associated 
with an increased risk of pre-term births. Overall, studies indicate that there is 
evidence that there are small, but nevertheless real risks in terms of the effect of 
treatment upon obstetric outcomes. However, as highlighted by other studies, 
confounding factors should also be taken into account when explaining any 
increased risks observed. However, it is important that potential risks are 
communicated to women who are considering having children.  
 
Chapter three presents a systematic review of the psycho-sexual impacts of 
colposcopy and undergoing treatment. The findings from this review informed the 
design of the empirical stage of the study. 
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CHAPTER 3: ADVERSE PSYCHO-SEXUAL EFFECTS OF 
COLPOSCOPY AND TREATMENT FOR CIN - 
SYSTEMATIC REVIEW 
 
From the available evidence, what is known about the psycho-sexual impacts of 
undergoing colposcopy and treatment for CIN? 
This chapter outlines the rationale, aim and methodology for conducting a 
systematic review of the literature addressing the adverse psycho-sexual 
consequences of undergoing a colposcopy in order to bring together the body of 
evidence related to these adverse impacts. The results of the review and 
discussion of the findings will be presented. 
 
3.1 Aim of review 
 
Further to the obstetric and physical outcomes following colposcopy discussed in 
Section 2.7, there is evidence that women may feel anxiety and fear following an 
abnormal smear, attending a colposcopy appointment, or being treated for 
CIN.34,50,82 Furthermore, there is evidence that colposcopy itself may be 
associated with sexual dysfunction.3,35,54,13,57 However, little is known about the 
long-term effects of colposcopy upon women’s psychological and sexual health 
and there are no published systematic reviews examining these effects on a 
cohort of women who have undergone colposcopy. Therefore, the primary aim of 
this systematic review was to bring together literature relating to colposcopy and 
its effect upon psychological health and sexual functioning in order to build an 
evidence base regarding the prevalence of adverse psycho-sexual outcomes after 
colposcopy (including anxiety, depression, and sexual functioning). 
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Studies investigating the efficacy of colposcopy for preventing the recurrence or 
progression of cervical intraepithelial neoplasia (CIN) were excluded from the 
review as the aim was not to assess the clinical effectiveness of treatments for 
managing cervical disease - the evidence base for this is well established.32,62,83  
 
Specific objectives of the review were: 
 
1. To ascertain the effect of colposcopy on an exposed group 
2. To consider the prevalence of these effects 
3. To consider whether certain groups of women were more likely to experience 
adverse psycho-sexual outcomes following colposcopy 
 
 
3.2 Methodology 
 
Searches of a number of electronic databases were conducted for studies relating 
to the effect of colposcopy upon psycho-sexual functioning. The following 
databases were searched: 
 
The Cochrane Library, Ovid MEDLINE (1948-2011), PubMed (2001-2011), 
EMBASE (1980-2011), PsycInfo (1967-2011). Citation searches of eligible papers 
were also undertaken to ensure that all relevant literature was included. 
 
The search terms were selected following searches of the relevant literature 
pertaining to ‘colposcopy’ and treatment for CIN, and nomenclature in the field of 
psychological and sexual health; in particular, literature exploring the psychological 
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and sexual impacts of undergoing gynaecological treatment. Discussions with 
clinical practitioners were also undertaken to ensure that the most appropriate 
terminology was included. Search terms related to both the ‘intervention’ i.e. the 
procedures under investigation, and the relevant psycho-sexual outcomes 
measured in the studies returned by the searches. 
 
Table 3.1 Search terms included in the review 
 
Intervention  Outcomes  
Colposcopy  
Conisation  
Laser therapy 
Large  loop 
excision LLETZ  
Loop 
electrosurgical 
excisional 
procedure 
LEEP  
Laser 
conisation 
excision  
Laser 
conisation 
Laser ablation 
Sexual dysfunction Sexual 
function  
Female sexual dysfunction  
Libido  
Desire  
Psycho-sexual Psychological  
Anxiety  
Depression  
Fear of cancer 
Emotional 
 
Painful 
intercourse 
Dyspareunia 
Vaginal 
dryness 
Vaginal 
lubrication 
Body image 
Orgasm 
 
The full search strategy is outlined in Appendix 1. 
 
 
All citations returned by the database searches were downloaded into Reference 
Manager (Version 9). All duplicate citations were removed. Two independent 
reviewers (SF and SD) screened titles and abstracts for eligibility. Full papers were 
obtained for all studies that met eligibility criteria for the review, as well as those 
where consensus could not be reached on inclusion/exclusion criteria from 
title/abstract alone. A further three studies were identified via citation searches. 
 
Data were extracted from eligible papers using a pre-defined data-extraction sheet 
(see Appendix 2) comprising information on study, authors, year and country of 
publication, study design and methods, population, results and conclusions. 
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Following data extraction, all eligible studies were quality assessed using a pre-
specified quality assessment proforma (Appendix 3). All eligible studies were 
assigned a quality assessment score and these scores were used to inform the 
results of the review. All relevant studies were included regardless of the quality 
assessment score they received as the aim of the review was to provide a 
summary of the available evidence to date, and both original qualitative and 
quantitative studies were included.  
 
The review was designed in accordance with the PICO framework:84 
 
Population - women who have undergone colposcopy 
Intervention - colposcopy 
Comparators - women who have not undergone colposcopy/level of colposcopic 
intervention 
Outcomes - Psychological effects including anxiety and depression, sexual 
functioning  
 
Inclusion criteria 
Inclusion Criteria - Study design. 
 Before and after studies using controls 
 Before and after studies without controls 
 Retrospective studies using controls (including historical controls) 
 Retrospective studies without controls 
 Systematic reviews 
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 Studies were included if they compared the effect of alternative treatment 
management options upon psycho-sexual function (e.g. see and treat 
versus surveillance).  
 
 Studies whose purpose it was to measure the effectiveness of a particular 
intervention (e.g. information leaflet) aimed at reducing anxiety were 
included. 
 
 Studies from any country were included in the search terms, so as to obtain 
the broadest overview of research in the field, regardless of geographical 
setting. 
 
Exclusion criteria 
 Studies examining obstetric or physical health outcomes exclusively 
(including incidence of cervical stenosis).  
 Case reports 
 Conference abstracts 
 Correspondence 
 Studies not available in English 
 
For quality assessment (QA) of quantitative and qualitative studies the 
assessment tool presented in Appendix 3 was used as a guideline. Each paper 
was assessed against each criterion. If a paper was deemed to meet that criterion, 
it scored one point. If it did so partially, a score of 0.5 was assigned. If it did not 
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meet the criterion, it scored no points. The QA scores for each paper therefore 
ranged from 1 (very poor quality) to 10 (excellent quality). These are reported in 
Appendix 4.   
 
Table 3.2 Quality assessment - Quantitative studies 
 
 
1. Use of matched control or control (if a cohort study) 
 
2. Sufficient description of the population  
 
3. Whether study is prospective or retrospective (if a cohort study) 
 
4. Sample size 
 
5. Whether study provides sufficiently detailed outcome measures to allow 
conclusions to be made 
 
6. How follow-ups are reported - proportion followed up and length of 
follow-up. 
 
 
 
Although the search strategy sought to include both qualitative and quantitative 
studies, these are considered separately in the elaboration of the findings. 
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Table 3.3 Quality assessment - Qualitative studies85 
 
 
1. Was the theoretical framework of the study and methods used always 
explicit? 
 
2. Was the context of the research clearly described? 
 
3. Was the sampling strategy clearly described and justified? 
 
4. Did the sampling include a diverse range of individuals and settings, if 
appropriate, in order to enhance the generalisability of the analysis? 
 
5. Was the fieldwork clearly described? 
 
6. Were the procedures for analysis clearly described and justified? 
 
7. Can the research material and the procedure for its analysis be inspected by 
an independent investigator? 
 
8. Were triangulated methods used to test the validity of the data and analysis?
 
9. Were the analysis repeated by another researcher to test the reliability of the 
data and the analysis? 
 
10. Was enough of the raw data (e.g. transcripts of interviews) presented in a 
systematic fashion to convince the reader that the interpretation of the 
investigator was based on the evidence and is not impressionistic? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 43
3.3 Results of quantitative studies 
 
The search strategy identified 992 citations that were potentially eligible for 
inclusion in the review and these were transferred to Reference Manager. After 
removal of duplicates (n=332), the remaining 660 titles and abstracts were 
independently screened to determine suitability for inclusion. Disagreements about 
inclusion were resolved by discussion. A further 597 studies were excluded 
following title and abstract screening. 65 studies were deemed suitable for full-text 
assessment. A further three studies were identified via citation searches. Following 
full-text assessment, 45 studies were deemed eligible for inclusion and data 
extraction (Figure 3.1). 
 
20 papers were excluded at the full assessment stage on the following grounds:  
 Study focus on spectroscopy not colposcopy (n=1); discussion paper (n=1);  
 Outcomes were measured prior to colposcopy (n=2) ;  
 Correspondence (n=3) ;  
 Review article (n=2);  
 Not in English language (n=1);  
 Not looking at effect of procedure, rather at risk factors for high state 
anxiety (n=1);  
 Focus of the study HPV (n=1);  
 Focus of study upon PAP smear (n=3);  
 Not focused upon psycho-sexual outcomes (n=1);   
 Focus upon physical effects (n=1);  
 Measuring effect of psychological profile upon disease progression (n=1);  
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 Results reported elsewhere (n=1);  
 Unable to access the full-text article (n=1). 
 
 
Figure 3.1 PRISMA diagram 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.1 Characteristics of included studies 
 
The quality of the studies included varied considerably, as did the study designs, 
study populations and types of measures used (validated/non-validated/mixture of 
both). However, as there are no recent reviews with the aim of investigating 
psycho-sexual outcomes of colposcopy, all studies in the last 70 years that 
focused upon the psychological and/or sexual impacts of undergoing the 
procedure were included. Due to the heterogeneity of the studies included, meta-
analysis and pooling of results was not possible. The approach taken here will first 
Citations from electronic 
databases 
n=992 
Title and abstract 
screening 
n=660 
Full text 
evaluation 
n=63 
Eligible papers 
n=45 
Duplicates removed 
n=332 
Excluded after title and 
abstract screening 
n=597 
Excluded as 
ineligible 
n=20 
Records identified 
from other sources  
n=2 
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describe the characteristics of the studies included before making comparisons 
between studies that to some degree are comparable.  
 
Scope 
All of the studies aimed to measure the psychological and/or sexual impacts of 
either colposcopy or related treatment procedures (LEEP, conisation). Five studies 
were qualitative by design and these will be discussed separately in Section 3.5. 
 
Of the included quantitative studies 19 studies compared psychological and/or 
sexual impacts between two or more types of colposcopically directed 
investigation or treatment.86-88, 93-97,102,105,106,109,111,114,115,54,119,120  
21 studies focused upon colposcopy only or one procedure only (e.g. LLETZ, 
conisation, biopsy).57,58,61, 89-91, 99-101,104,107,108,110,112,60,116-118,121-123  Of these studies, 
two focused upon the development of a questionnaire to use with the population of 
interest - namely women undergoing cervical screening and treatment.89,57 These 
have been included because in order to develop appropriate measures, they 
assessed the impacts of colposcopy upon their study sample. Nine studies also 
explored the influence of coping styles and its effect upon any adverse 
psychological outcomes. 43,54,88,93,106-108,115,116, 
 
Two studies examined the influence of knowledge about the procedure upon 
levels of anxiety and adherence to follow-up91,123 and eight studies assessed the 
effectiveness of interventions in reducing anxiety and one of these also looked at 
the impact of the intervention upon satisfaction levels.114 
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After giving an overview of the characteristics of all included studies, the findings 
of each sub group of studies will be assessed, so that comparable studies are 
considered together. A glossary of acronyms to accompany the studies presented 
can be found in Appendix 5.
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Figure 3.2 Schematic of included studies 
 
 
Qualitative studies 
(n=5) 
 
Beresford 1995 59 
 
Hounsgaard 2007 98 
 
Juraskova 2007 103 
 
Mortensen 2010 113 
 
Posner and Vesey 
1988 34 
Studies comparing 
two or more 
treatment 
modalities (n=19) 
 
Balasubramani 2007 86 
Baldaro 2003 87 
Bell 1996 88 
Cairns 2008 92 
Ferris 2003 93 
Freeman-Wang 2001 94 
Hellsten 2008 95 
Hellsten 2008 96 
Hellsten 2009 97 
Jones 1996 102 
Kitchener 2004 105 
Kola 2009 106 
Le 2006 109 
Little 2009 111 
Naik 2001 114 
Orbell 2004 115 
Palmer 1993 54 
Sharp 2010 119 
Tamburini 1991 120 
Focus on 
influence of 
coping style 
(n=9) 
 
Bell 1996 88 
Ferris 2003 93 
Orbell 2004 115 
Palmer 1993 54 
Kola 2009 106 
Lauver 1999 107 
Lauver 1999 108 
Richardson 1996 
116 
Tahseen 2008 121 
Focus on one 
treatment 
modality (n=21) 
 
Bennets 1995 89 
Boneveski 1998 90 
Brooks 2002 91 
Campion 1988 57 
Doherty 1991 58 
Gath 1995 61 
Howells 1999 99 
Idestrom 2003 100 
Inna 2010 101 
Kikku 1982 104 
Lauver 1999 107 
Lauver 1999 108 
Leman 1991 110 
Marteau 1990 112 
McDonald 1989 60 
Richardson 1996 116 
Rubin 2010 117 
Serati 2010 118 
Tahseen 2008 121 
Valdini 2004 112 
Zeisler 1997 123 
Developing 
questionnaire 
(n=2) 
 
Bennets 1995 4 
 
Campion 1988 9 
INCLUDED 
STUDIES 
n=45
Impact of 
intervention on 
satisfaction (n=1) 
 
Naik 2001 114 
Knowledge about 
procedure – effect 
on anxiety (n=2) 
 
Brooks 2002 7 
 
Zeisler 1997 45 
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3.3.2 Study populations 
 
The characteristics of study populations varied in terms levels of abnormality (grade 
of CIN), and how often patients had attended colposcopy. Some studies emphasised 
the level of abnormality as their main inclusion criteria, others focused upon the time 
of procedure and whether it was a first appointment or follow-up. Others looked at 
disease grade, when women attended, or the type of procedure undertaken. The 
terminology used to describe disease status was not consistent across studies. 
 
One study specified that participants were diagnosed with high grade CIN 86 and two 
others that participants should have a diagnosis of CIN.54,58 Hellsten et al include 
participants with a diagnosis of mild, moderate or severe CIN.96,97,98 One study had 
participants with CIN 2/3, with a comparator group comprised of women with a 
diagnosis of microinvasive cancer.92 Kitchener et al include participants with 
borderline/mild dyskaryosis,105 whereas Bell et al include women with mild/moderate 
dyskaryosis and compare them with those with severe dyskaryosis.88 Freeman-Wang 
et al. specify participants with moderate/severe dyskaryosis.94 
 
Other study populations are described as those who had had an abnormal cytology 
result 61,110,116 mild abnormal smear,102 epithelial abnormality 91, and low grade 
cytology.111,114,118 Lauver et al specify participants having had an abnormal smear 
with no previous history of colposcopy107,108 and Richardson et al define the 
population as having been previously informed of abnormal smear result and 
requiring colposcopy and treatment 34. Campion et al compare four groups including 
those with CIN and those without.57 
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Other studies specify patients with a recent abnormal smear/abnormal cervix result,93 
or having had two abnormal smears100 and Zeisler et al specify participants as having 
a diagnosis of CIN following abnormal Pap and directed biopsy.122 
 
A number of other studies focus their inclusion criteria upon participants who are 
attending their first colposcopy 99,112,115,121 and Bennetts et al compare first attenders 
with those who have had at least one colposcopy.89 Tahseen et al do not specify 
whether participants are attending for the first time, merely that they are attending for 
colposcopy.120 The remaining studies specify participants who underwent LEEP at 
least 3 months previously,101 who underwent conisation,103 underwent colposcopy in 
last 12 months with high grade CIN,106 new colposcopy patients or patients 
undergoing LEEP, having undergone biopsy 6 weeks prior to LEEP, 109 sexually 
active patients who had undergone LEEP for CIN117 or patients attending for 
conisation/Co2.119 
 
 
3.3.3 Outcome measures 
 
25 studies utilised validated measures and 12 used non-validated measures (Table 
3.4). Most studies focused upon anxiety, anxiety and depression, sexual function, 
fear about cancer and other psychological sequelae (see Table 3.5). 
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Table 3.4 Outcomes measured/method of administration 
 
Author and Year Outcomes 
Validated 
Measures 
(Yes/No) 
Administration
Method 
Kilkku et al. 1982 Sexual function, libido No Face-to-face 
 
Campion et al.1988 
 
Sexual Function 
 
No 
 
Face-to face 
McDonald et al. 1989 Self-esteem/body image, sexual function 
 
No Postal 
Marteau et al. 1990 Anxiety Yes Face to face 
Doherty et al. 1991 Anxiety/general Health/ASQ * Yes Unclear 
Lerman et al. 1991 Cancer worries/tension, mood, sexual interest No Telephone 
Tamburini et al. 1991 Depression, sexual function Yes Face-to-face/postal 
Palmer et al. 1993 Anxiety, impact of invents, locus of control 
 
Yes Face-to-face 
Bell et al. 1995 Depression, self-esteem, social adjustment, coping 
 
Yes 
 
Face-to-face 
Bennetts et al. 1995 Beliefs/feelings, worries about infectivity, sexual relationships Yes 
 
Unclear 
Gath et al. 1995 Depression, anxiety, psycho-sexual well-being Yes Face-to-face 
Jones et al. 1996 Anxiety, fear of cancer, libido, relationships 
 
No Unclear 
Richardson et al. 1996 ASQ, Anxiety, General health, POMS**, Evaluation of counselling 
 
Yes 
 
Face-to-face 
Zeisler et al. 1997 Psychological distress No Postal 
 
Bonevski et al. 1998 
 
Anxiety/depression/sexual function 
 
No 
 
Telephone 
 
Campion et al.1988 
 
Sexual Function 
 
No 
 
Face-to-face 
Howells et al. 1999 Anxiety/depression, psycho-sexual  Yes Postal 
Lauver et al. 1999 Uncertainty, coping styles Yes Telephone 
Lauver et al. 1999 Coping styles Yes Telephone 
Naik et al. 2001 Anxiety, satisfaction No Unclear 
Brooks et al. 2002 
Pre-post procedure anxiety, 
knowledge, satisfaction and 
adherence 
 
No 
 
Unclear 
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Author and Year Outcomes 
Validated 
Measures 
(Yes/No) 
Administration
Method 
 
Baldaro et al. 2003 
 
Anxiety and depression Yes 
 
Postal 
Ferris et al. 2003 Depression, health beliefs, coping Yes  Unclear 
Idelstrom et al. 2003 Anxiety, worry No Postal 
Kitchener et al. 2004 
 Anxiety, General Health Yes 
Face-to-
face/postal 
Orbell et al. 2004 
 
Anxiety, emotions 
 Yes Postal 
Valdini et al. 2004 Anxiety/depression (PEAPS-Q***) Yes Face-to-face 
Freeman-Wang et  al. 
2005 Anxiety Yes Unclear 
Le et al. 2006 Anxiety/depression, PEAPS Yes Face-to-face/postal 
 
Balasubramani et al. 
2007 
 
Anxiety 
 
Yes 
 
Postal 
Cairns et al. 2008 Anxiety/depression, POSM Yes Postal 
Hellsten et al. 2008 Sexual functioning Yes Face-to-face 
Hellsten et al. 2008 Anxiety/depression/sexual functioning 
 
Yes Face-to-face 
Tahseen et al. 2008 Worry, personality inventory, impact of leaflet on anxiety  
 
No 
 
Face-to-
face/postal 
Hellsten et al. 2009 Anxiety/depression/sexual functioning Yes Face-to-face 
Kola et al. 2009 Anxiety, worry, distress, coping style, helpfulness of intervention 
 
No 
 
Postal 
Little et al. 2009 Anxiety/depression Yes Postal 
Inna et al. 2010 Sexual function No Face-to-face 
Rubin et al. 2010 Uncertainty, coping, bi-polar profile, body image 
 
Yes Face-to-face 
Serati et al. 2010 Sexual function Yes Face-to-face/postal 
Sharp et al. 2011 Anxiety/depression, POSM, impact of events scale 
 
Yes 
 
Postal 
 
* ASQ - Abnormal Smear Questionnaire 
**POMS - Process Outcome Specific Measure 
*** PEAPS - Q - Psychological Effects of having an Abnormal Pap Smear Questionnaire 
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Table 3.5 - Outcomes measured 
 
 Anxiety Depression Sexual function Libido 
Self-
esteem 
Body 
image 
Cancer/ 
Infectivity 
worries 
Relation
ships Coping  
Mood 
status/em
otions 
Impact 
of 
events 
Satisfact
ion Knowledge 
General 
Health 
Worry/ 
Psycho-
logical 
distress 
 
Balasubramani 
et al 2007 
 
               
 
Baldaro et al 
2003 
 
 
 
 
              
Bell et al1995 
  
 
   
 
    
 
       
Bennetts et al 
1995   
 
    
 
 
 
        
Bonevski et al 
1998 
 
 
 
 
 
         
 
 
 
   
Brooks et al 
2002 
 
               
Cairns et al 
2008 
 
 
 
              
Campion et 
al1998   
 
             
Doherty et al 
1991 
 
             
 
  
Ferris et al 
2003  
 
              
 Freeman-
Wang et al 
2005 
 
               
Gath et al1995   
 
 
 
             
 
Hellsten et al 
2008 
                
 
Hellsten et al 
2008  
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 Anxiety Depression Sexual function Libido 
Self-
esteem 
Body 
image 
Cancer/ 
Infectivity 
worries 
Relation
ships Coping  
Mood 
status/em
otions 
Impact 
of 
events 
Satisfact
ion Knowledge 
General 
Health 
Worry/ 
Psycho-
logical 
distress 
 
Hellsten 2009 
 
 
 
 
 
             
 
Howells et al 
1999 
 
 
 
              
 
Idelstrom et al 
2003 
 
               
 
Inna et al 2010 
 
                
 
Jones et al 
1980 
 
   
 
   
 
 
 
        
Kilkku et al 
1982   
 
 
 
            
 
Kitchener et al 
2004 
 
             
 
  
 
Kola et al 2009 
 
        
 
      
 
 
 
 
Lauver et al 
1999 
                
 
Lauver et al 
1999 
        
 
 
 
      
 
Le et al 2006 
 
 
 
 
              
 
Lerman et al 
1991 
       
 
   
 
      
 
Little et al  
2009 
 
 
 
 
              
 
Marteau et al 
1990 
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 Anxiety Depression Sexual function Libido 
Self-
esteem 
Body 
image 
Cancer/ 
Infectivity 
worries 
Relation
ships Coping  
Mood 
status/em
otions 
Impact 
of 
events 
Satisfact
ion Knowledge 
General 
Health 
Worry/ 
Psycho-
logical 
distress 
 
McDonald et al 
1989 
     
 
 
 
          
 
Naik et al 2001 
 
 
           
 
    
 
Orbell et al 
2004 
 
         
 
 
 
     
 
Palmer et al 
1993 
 
          
 
     
 
Richardson et 
al 1996 
 
             
 
  
 
Rubin et al  
2010 
         
 
       
 
Serati et al 
2010 
                
 
Sharp et al 
2011 
 
 
 
         
 
     
 
Tahseen et al 
2008 
 
              
 
 
 
Tamburini et al 
1991 
   
 
             
 
Valdini et al 
2004 
 
 
 
              
Zeisler et al 
1997               
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The two main methods of administration of the data collection tools were by post or 
face-to-face, although four studies used the telephone.90,107,108,110 Twelve studies 
posted questionnaires to participants60,86,87,92,99,100,106,111,112,118, and eleven used face-
to-face interviews/administration of questionnaires. 34,57,88,95,96,101,102,109,112,116,121, 
Remaining studies used either a mix of both face to face and postal administration or 
it was unclear from the paper how measures had been administered. 54,58,61,89,91, 93,94, 
102,105,114,117,119-121  
 
3.3.4 Follow-up timescales 
A wide range of follow-up time-points (see Table 3.6) were utilised, with most papers 
focusing either on the relatively short-term or the longer term, and a number of 
studies following up at various specific time points. Some studies administered 
measures prior to the procedure in order to provide a base-line measure of 
psychological sequelae. Other studies only partially specify, or did not specify time-
frames.  
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Table 3.6 Follow-up timescales specified 
 
Author and Year Pre/Post follow-up  
Gath et al.1995 4 weeks prior, 4 and 32 weeks post 
Baldaro et al. 2003 2 weeks prior procedure, and 3,6,12 months post 
Bell et al. 1995 1 week pre, 1 week post 
Palmer et al. 1993 6th day after receiving diagnosis, 6th day after treatment 
Author and Year Pre (unspecified) and post follow-up 
Brooks et al. 2002 Pre (unspecified) and 2 weeks post procedure 
Howells et al. 1999 Pre colposcopy (unspecified) 6 months post colposcopy 
Kilkku et al. 1982 Pre procedure, 6 weeks, 6 months, 12 months post procedure 
Richardson et al. 1996 Pre-colposcopy/post colposcopy procedure, 3 and 6 months post treatment 
Freeman-Wang et al. 2005 Pre (unspecified) and post (day of treatment) 
Author and Year Pre (day of procedure) and post follow-up 
Hellsten et al. 2008  Initial (day of procedure), 6 months and 2 years post 
Hellsten et al. 2008 Initial (day of procedure), 6 months and 2 years post 
Hellsten et al. 2009 Initial (day of procedure), 6 months and 2 years post 
Kitchener et al. 2004 Baseline (time of procedure), 6 and 12 months post 
McDonald et al. 1989 First visit, post surgery, 1 week after procedure, 3 weeks after procedure 
Serati et al. 2010 Time of LEEP, 6 months following procedure 
Lauver et al. 1999 After receiving abnormal Pap, day before procedure, day after procedure 
Lauver et al. 1999 After receiving abnormal Pap, day before procedure, day after procedure 
Author and Year Day and post procedure (unspecified) 
Tahseen et al. 2008 Day of colposcopy (pre-procedure), after colposcopy (returned by post - not sure of time frame) 
Author and Year Pre and post follow-up - unspecified  
Bennetts et al. 1995 Pre/post procedure (unspecified) 
Doherty et al. 1991 Pre/post treatment (unspecified) 
Ferris et al. 2003 Pre/post treatment (unspecified) 
Marteau et al. 1990 Pre/post procedure (unspecified) 
Valdini et al. 2004 Pre/post procedure (unspecified) 
Author and Year Post follow-up - multiple time points  
Sharp et al. 2011 6 weeks after last procedure, 12, 18, 24 and 30 months after procedure. 
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Little et al. 2009 6weeks, 3 years post procedure 
Rubin et al.  2010 After Pap result received, time after colposcopy, hearing results of colposcopy, 2-3 weeks, 4 months and 8th month after 
Author and Year Post follow-up - one time point 
Idelstrom et al. 2003 5years after abnormal smear 
Jones et al. 1980 Post (30 months after colposcopy) 
Zeisler et al. 1997 At least 1 year after colposcopy visit 
Campion et al. 1998 Asked to recall about 6 months pre presentation, 6 months post 
Lerman et al. 1991 3 months after Pap result 
Balasubramani et al. 2007 1 week post procedure 
Bonevski et al. 1998 1 week post procedure 
Naik et al. 2001 1 week post procedure 
Orbell et al. 2004 1 week post procedure 
Author and Year Unspecified 
Cairns et al. 2008 Post (unspecified) 
Inna et al. 2010 Post (unspecified) 
Kola et al. 2009 Unspecified 
Le et al. 2006 Before/after procedure (unspecified) 
Tamburini et al. 1991 Post (unspecified) 
 
3.3.5 Sample sizes 
 
The sample size for included studies was variable, ranging from n=20 to n=4,439 
with the mean sample size being n=345. These are presented in Table 3.7. 
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Table 3.7 Sample size 
 
Author and Year 
Total 
sample 
size 
Sub-group  
Little et al. 2009  n=4,439  
Surveillance n= 2,223 
Immediate colposcopy n= 2,216  
Balasubramani et al. 
2007 
 
n=1,085  
ST* n=136, DT** n=949 
To undertake comparison n=136 ST, n=136 DT were 
matched on age, abnormality grade and deprivation 
Orbell et al. 2004 n=1,085  (ST n=136, DD n= 949) 
Sharp et al. 2011  n=989  Immediate  LLETZ n=487, Biopsy and selective recall n=502 
Kitchener et al. 2004 n=476 Choice n=233, No choice n=243  
Ferris et al. 2003 n=413  Colposcopy n=150, Telecolposcopy n=263 
Freeman-Wang et al. 
2005 
Pilot 
n=342  
RCT=93 
Diagnostic colposcopy n=251 
Outpatient treatment n= 60, See and treat n=31 
RCT Leaflet n= 45 Video n=48 
Bennetts et al. 1995 n=350 - 
Jones et al. 1980  n=345  Cytology n= 163, Colposcopy n=182 
Idelstrom et al. 2003 n=242  - 
Lerman et al. 1991 n =224  Normal pap n=118, Abnormal pap n=118 
Richardson et al. 1996 n=219  Counselling plus leaflet n=104   Leaflet only n=115 
Valdini et al. 2004 n=202 - 
Hellsten et al. 2008, 
2008, 2009 n=200  
Cases n=100 LEEP n=46 surveillance n=61 Controls n=100 
pre-smear 
Howells et al. 1999 n=200  Leaflet n=100 Control n=100 
Kola et al. 2009 n=151  Colposcopy n=86, LLETZ n=65 
Bonevski et al. 1998 n=138 - 
Brooks et al. 2002 n=122 - 
Naik et al. 2001 n=118  Cases n=108, Controls n=7 
Campion et al. 1998 n=106 
Women referred for a colposcopy with an abnormal cervical 
smear n=30 Women traced as  sexual partners of men with 
HPV who had evidence of cervical disease n= 26 
As above but no cervical disease n=25  
Traced as partners of men with urethritis and no cervical 
disease n=25 
Gath et al. 1995 n=102 - 
 
Baldaro et al. 2003 
 
n=100  CIN LLETZ n=60, Hysterectomy n= 40 
Inna et al. 2010 n=89 - 
Rubin et al. 2010 n=88 - 
Doherty et al. 1991 
 
 
n=80  
Pre-colposcopy n=25  
Post-colposcopy n=25 Pre-laser n=15  
Post laser n=15 
Lauver et al. 1999 x 2 n=75 - 
Serati et al. 2010 n=67 - 
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Author and Year 
Total 
sample 
size 
Sub-group  
Kilkku et al. 1982 n=64 - 
Tamburini et al. 1991 n=52  Traditional conisation n=25, C02 conisation n=27 
Tahseen et al. 2008 n=50 - 
Cairns et al. 2008 n=44  Microinvasive cancer n=18, CIN 2-3 n=26 
Le et al. 2006 n=41 Colposcopy n=21, LEEP n= 20 
Zeisler et al. 1997 n=40  Reported having insufficient info n=21  Reported having sufficient info n=19 
Palmer et al.1993 n=40  Received news of abnormality n=20, Diagnosed with CIN n=20 
Marteau et al. 1990 n=30 - 
McDonald et al. 1989 n=20 - 
* ST - See and Treat 
** DT - Defer and Treat 
 
 
Table 3.8 gives an overview of the results for included studies. It includes all 
quantitative papers regardless of the type of study, the outcomes being measured or 
the sample size reported. 
 
Table 3.8 (overleaf) Overview of results 
 
 60
Author and Year Results 
Balasubramani et 
al 2007 
See and treat group felt more in control, more relief and less anxiety than defer and treat. See and treat less likely to attend 2nd appt. 
 
Baldaro et al. 
2003 
LLETZ and hysterectomy groups showed significant reduction in anxiety and depression at 3, 6,12 months compared with pre-operation group. 
2 weeks before surgery 8 LLETZ (19.5%) showed anxiety while 10 (24.3%) presented with high levels of anxiety/depression. 
12 months after surgery of women with pre-operative depression, 4 (9.7%) had negative mood status. 
Bell et al. 1995 
Sexual Function - overall the impact of an abnormal smear on sex life was relatively small. Reduced enjoyment was more common in 
colposcopy group and reduced interest in the surveillance group. 
Distress higher among women with abnormal smear. 
Anxiety/depression higher amongst those referred for colposcopy, but distress fell after treatment, but 20% remained highly anxious awaiting 
treatment. In surveillance - adverse psycho sequelae less acute but had more problems with social adjustment.  
Bennetts et al. 
1995 
4 dimensions of distress identified: Experience of medical procedures - beliefs and feelings about abnormality and changes in self-perception/ 
worry about infectivity and effect on sexual relationships. 
Bonevski et al. 
1998 
n=52 - current decline in sexual interest. Of these, 13% indicated their interest had improved following colposcopy; 25% worsened; 62% not 
changed. 
Depression experienced by 11% before colposcopy. Of women reporting depression after colposcopy, n=33 reported that this had not changed 
since appt. 
Of women reporting not anxious following colposcopy, n=98, 23% were so before colposcopy. 
Of women reporting anxiety following colposcopy, n=40, all reported it had either worsened (48%) or not changed (52%). 
Brooks et al. 2002 
Pre colposcopy - fear of cancer 30%; fear of complications 28%; fear of pain 23%; fear of infertility/SF 11% 
50% (n=52/122) returned post-op questionnaire. 
Mean fear score 7.3 (SE2.8, range 1-10); Mean anxiety score 7.8 (SE2.8, range 1-10) 
Cairns et al. 2008 No significant difference in HADS
(a) scores between groups (18% cancer/12% CIN depression scores) 35% anxiety in both groups. 
No significant difference in POSM or concerns of ongoing follow-up. 
Campion et al. 
1998 
Statistically significant adverse psycho-sexual sequelae associated with diagnosis and treatment of pre-invasive cervical intraepithelial disease. 
Doherty et al. 
1991 
68% (n=54) - a little distressed, 21% (n=17) moderately distressed, 8% (n=6) severely distressed on at least 60% of the negative affect items 
with respect to abnormal result. 
Affects of medical procedure  66% (n=53) found it a little distressing, 21% (n=17) moderately distressed, 9% (n-7) very distressed on at least 
60% of 5 negative items 
Ferris et al. 2003 
Mild levels of anxiety/depression in both groups. 
On health belief measure - both groups not excessively concerned about procedure, disease or consequences. 
Significant proportion of telecolposcopy group considered high monitors compared with colposcopy. No significant diff between colposcopy and 
telecolposcopy in proportion of high blunters. 
Colposcopy group less likely to have thoughts or fears about cancer and reported less pain. 
Freeman-Wang et 
al. 2005 
Pilot - see and treat had significantly more anxious than Group 1 or 2. 
RCT - video significantly reduced anxiety of women attending for see and treat 
 61
Author and Year Results 
Gath et al.1995 
In general, psychiatric morbidity was found to be transient and relatively minor. PSE scores not significantly higher than in community sample 
of 520 controls. 
Psycho-sexual function - (A) after receiving abnormal result - 1% increased frequency, 56% no change, 43% decreased frequency; 1% 
increased enjoyment, 63% no change, 36% decreased enjoyment: 24% reported deterioration with sexual relationship, the rest reported no 
change; 3% reported increased interest in sex, 60% no change and 37% reported decreased interest. 
(B) assessment three when asked to compare frequency of intercourse with 2 months before being asked to go to colposcopy clinic -
proportions change considerably - 29% increased frequency, no change 52% and decreased frequency 19%; enjoyment increased for 7%, no 
change 62% and decreased 11%: 22% improved sexual relationship, 74% no change and deterioration 4%; Increased interest in sex 21%, no 
change 71% and reduced interest 8%. 
Hellsten et al. 
2008 
Initial anxiety/depression reduced over time. 
No difference in state anxiety for women treated by LEEP and those not. 
1/3 women still had fear of cancer in spite of lower 2 year state anxiety levels. 
No diff between groups may indicate it is receiving abnormal smear that causes anxiety/depression rather than procedure itself. 
Hellsten et al. 
2008  
Spontaneous interest in sex, frequency of intercourse and sexual arousal all significantly lower at 6 months compared with first visit and at 2 
years spontaneous interest in sex and frequency of intercourse remained low. No difference in sexual function between LEEP and non-LEEP 
group at follow up. 
Hellsten et al. 
2009 
Baseline mean for mental component on all mental health subscales of SF-36 (b) with statistically significant lower than normative data. At 2 
years, scores still significantly lower than normative. 
No difference between LEEP and non-LEEP in general QoL outcomes 
Howells et al. 
1999 
For whole study population on basis of STAI (c) were extremely anxious at initial visit and significantly less so at second visit, although elevated 
compared to population controls. 
TRAIT (d) - did not significantly changes between 2 visits. No significant difference in anxiety between leaflet and controls. 
Second visit anxiety/psycho-sexual scores similar in treated and untreated, although untreated had less spontaneous interest in sex. 
No significantly difference in initial STAI between 67 patients who did not attend follow-up and those who did. 
Psycho-sexual - First visit, leaflet group had more evidence of psycho-sex problems, by second visit, responses were comparable. Only 
significant difference control had problems with lubrication. 
Idelstrom et al. 
2003 
N=184 experienced follow-up in a positive way. 72% considered they understood diagnosis. 
59% experienced worry and anxiety - 30% stating it had affected everyday life from between being informed of pap and further investigation.  
N=20 reported negative effect on sex life after treatment (correlated with less satisfaction at follow-up and negative influence on self-esteem) 
Inna et al. 2010 Changes in frequency of sexual intercourse, dysmenorrhea and dyspareunia not statistically significant. Overall changes in overall satisfaction, vaginal elasticity and orgasmic satisfaction statistically significant. 
Jones et al. 1980 
Invite for colposcopy resulted in increased anxiety, but patients preferred this to surveillance. 
Colposcopy patients higher fear of cancer, resentment of partner and reduced libido. 
Surveillance also raised anxiety 
Kilkku et al. 1982 Significant decrease in no. of patients with dyspareunia. No change in libido, experience of orgasm, coital frequency orgasm, coital frequency, overall satisfaction with sex life. 
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Author and Year Results 
Kitchener et al. 
2004 
No significant diff between arms for GHQ (e) and STAI at 12 months. Significant reduction in psycho-metric morbidity between baseline and 12 
months in both arms.  
Overall rates of default from protocol were same in each arm, but default that led to uncertain ascertainment of cervical pathology was greater 
in no choice. 
Kola et al. 2009 
Reported high level of colposcopy related anxiety/worry. Those who reported fear of cancer, and concerns about fertility, colposcopy itself, 
embarrassment had higher anxiety levels than those not reporting these. 
LLETZ perceived as stressful and more painful than colposcopy. There were associations between women’s perceptions and certain 
interventions. 
Identified to distinct coping styles - ‘blunters’ who preferred idea of distraction based interventions and ‘monitors’ who preferred information 
based interventions 
Lauver et al. 1999 
Uncertainty about abnormal pap smear decreased over time. 
Negative mood scores reflecting psychological distress did not change over time. 
Uncertainty about related positively to the coping strategy of catharsis as well to negative mood scores after receiving news and pre-
colposcopy. 
Catharsis assoc with higher negative mood scores, but acceptance assoc with negative mood scores.  
Helpfulness of relaxation and diversion was assoc with lower negative scores.  
Lauver et al. 1999 Primary concerns involved not understanding pap result; cancer or infertility. Coping strategies most used and rated as most helpful - seeking support and distraction 
Le et al. 2006 
81% colposcopy significant anxiety/depression 
65% LEEP significant anxiety/depression 
Significantly more anxiety/depression in colposcopy group 
LEEP significantly less distressed and scored better than colposcopy on self-belief/cancer concerns and effects on sex life. 
Lerman et al. 
1991 
Pap positive women statistically significant elevated worries about cancer, impaired moods, daily activities, sex interest and sleep. 
Effects of positive result more pronounced among women who did not comply with follow-up. 
Women who had completed follow-up (colposcopy) did not exhibit heightened worry, mood disturbance or sex interest problems compared with 
negative results (pap positive also more likely to be unemployed/less educational attainment) 
Little et al. 2009 Similar proportion of women anxiety/depression in both arms (similar characteristics) 
Marteau et al. 
1990 
Results - high anxiety in group 
Overall women significantly less anxious after procedure 
McDonald et al. 
1989 
Concerns over cancer overrode all other concerns except during post-surgery visit at which time loss of attractiveness was paramount. 
Loss of sexual function high at all visits. 
Self-esteem - lowest and anxiety highest at initial and post visit.  
Positive body image highest at post-surgery 
Naik et al. 2001 
All women in both groups felt anxious at time of clinic visit. After I week, majority of patients managed via one-stop felt slight anxiety and 
controls remained anxious. 
All women said they would prefer one-stop if future abnormalities detected. 
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Author and Year Results 
Orbell et al. 2004 
Diagnosis and cognitive appraisals significantly associated with emotion (accounting for between 3-15% of variance in different emotions. 
Women with CIN 2 or 3 undergoing ST were less anxious, less embarrassed and significantly more relieved compared with matched sample of 
women undergoing DT and perceived their first appt as more motivationally congruent. 
Palmer et al. 1993 20 women interviewed at home 6-7 days after laser treatment reported 60% changes in their feelings about sexual activity. Body and sexual relations suffer after diagnosis (because of CIN’s posited causal relations with STD wart virus) 
Richardson et al. 
1996 
High levels of distress on all measures in both groups pre-colposcopy and significantly post-colposcopy reduction in distress in both groups. 
No significantly diff in psychological functioning between 2 groups post colposcopy assessment. Minor diff at treatment and follow-up but 
following analysis these were interpreted as an artefact of baseline differences. 
Rubin et al. 2010 Relationship between uncertainty and coping strategies was supported in the emotion-focused path, but not in problem-focused path. 
Serati et al. 2010 (9 patients were excluded from  final analysis as only completed sexual function questions before LEEP) In population - data showed overall sexual function was unchanged after LEEP, only ‘desire’ (sexual interest) became significantly worse. 
Sharp et al. 2011 
Over entire follow-up no significant difference between arms in cumulative prevalence or risk of significant depression or anxiety. 
6 weeks post-procedure, distress did not differ between each arm. 
At later time points - 8-11% had significant depression and 14-16% had significant anxiety, but no difference between arms. 
Tahseen et al. 
2008 
Prior to attendance - 36% very worried, 54% slightly worried, 10% not worried. All found leaflet helpful to variable degree. During colposcopy 
30% found video helpful but a significant number (18%) found it increased worry.  
Women with pre-existing high anxiety least satisfied with  
Tamburini et al. 
1991 
Conventional group - 40% hypochondria; 32% on scale of depression; 20% hysteria. 4/25 worsening sex life; 3/25 social life; 4/25 worsening 
partner relationships. 
CO2 14% hysteria/hypochondria 
24% depression; 3/27 worsening social life; 6/27 worsening sex life; 3/27 worsening sex life. 
Prior to attendance - 36% very worried, 54% slightly worried, 10% not worried. All found leaflet helpful to variable degree. During colposcopy 
30% found video helpful but significantly number (18%) found it increased worry.  
Women with pre-existing high anxiety least satisfied with interventions. 
Valdini et al. 2004 Most distress caused - around fear of cancer and worries about miscarriage 
Zeisler et al. 1997 Women with adequate info had less fear of cancer than inadequate info who also had increased distress. Group A - reported follow-up reinforced anxiety in comparison to group B. Compliance for regular attendance of screening significant better in B 
 
(a) HADS - Hospital Anxiety and Depression Scale; (b) SF-36 - Health survey; (c) Spielberger State -Inventory; (d) Spielberger Trait Inventory; (e) GHQ - General 
Health Questionnaire
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3.4 Discussion of quantitative studies 
Although the studies included in this review assess psychological morbidity, sexual 
functioning or a combination of related sequelae, the breadth of methodologies 
adopted, population types and sample sizes across the studies restrict any 
discussions of the findings to a narrative approach. Due to the heterogeneity of the 
studies included, they will be grouped as follows to provide some means of 
comparison and to aid discussion of the results and conclusions. 
 
 Studies measuring and comparing psychological and/or sexual outcomes 
between two or more treatment modalities.  
 Studies measuring psychological and or sexual outcomes with no 
comparison between treatment modalities. It will include studies that are 
assessing impacts at various procedure stages. 
 Studies measuring psychological and or sexual outcomes in terms of disease 
status of participants. 
 Studies focused upon development and validation of a questionnaire to 
measure psychological and or sexual outcomes. 
 
 
3.4.1 Studies comparing two or more treatment modalities 
 
Most commonly, these studies focused upon outcomes based upon surveillance, 
whether by biopsy or colposcopy and treatment,86,95-97,106,109,114,115,119 or via 
cytological surveillance and treatment. 102,105,111 
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One study compared differences between conisation and Co2 treatment,120 between 
hysterectomy and LLETZ,87 telecolposcopy and colposcopy93 and one between 
biopsy, outpatient treatment and see and treat.94 
 
Table 3.9 outlines the nine studies that compared biopsy or colposcopy with 
treatment, including studies that compared ‘immediate treatment’ with excisional or 
ablative methods with deferred treatment or surveillance via biopsy or colposcopy. 
This is followed by a narrative summary of these studies.
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Table 3.9 Studies comparing biopsy/colposcopy versus treatment 
 
First author; 
year; journal 
 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
Balasubramani 
2007 86 
BJOG Do 
women with 
high grade CIN 
prefer see and 
treat option 
 
UK Prospective postal 
questionnaire 
Aim to compare 
experience of see and 
treat LLETZ (ST) and 
defer and treat Biopsy 
(DT). 
Measuring anxiety 
(STAI) and subsequent 
behaviour. 
Questionnaire sent 7 
days after procedure 
Total n=1,085 
(see and treat = 
136; 949=defer 
and treat, but to 
undertake 
comparison 
n=136 ST, n=136 
DT were matched 
on age, 
abnormality grade 
and deprivation). 
High grade CIN 
referred for first 
visit to colposcopy
136=(ST), 
136=(DT) 
ST’s felt more in control, more 
relief and less anxiety than 
DT’s. ST’s less likely to attend 
2nd appointment. 
ST is psychologically
beneficial and may  
be preferred by  
women with CIN 2/3
 
Short term follow 
up – 7 days. 
Issues of over-
treatment? 
9 
Hellsten 2008 
95 
BJOG 
2 year follow-up 
of 
anxiety/depressi
on for 
colposcopy 
Sweden Prospective cohort study
Aim to see if there are 
any long lasting 
elevated anxiety levels 
in women attending 
colposcopy (also 
examines depressive 
mood). 
STAI (at initial visit and 
2yr), MADRS-S at all 
visits. 
Psychological interview 
(not clear when 
completed?) 
n=100 women 
with mild 
moderate, severe 
dyskaryosis 
invited for 
colposcopy. All 
had punch on first 
visit and treated 
either by LEEP 
(n=46), or 6 
monthly 
colposcopy 
(n=61) depending 
on severity. 
Questionnaire 
Initial anxiety/depression 
reduced over time. 
No difference in state anxiety 
for women treated by LEEP 
and those not. 
1/3 women still had fear of 
cancer in spite of lower 2 year 
state anxiety levels. 
No difference between groups 
may indicate it is receiving 
abnormal smear that causes 
anxiety/depression rather than 
procedure itself. 
Referral for 
colposcopy does 
not cause long-
lasting 
anxiety/depression. 
Sub-group with 
initially highest 
depression scores 
at 2 years still had 
significant higher 
depression/anxiety 
scores. 
Small sample, but 
in general a good 
quality study 
8 
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First author; 
year; journal 
 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
completed at 
initial visit, 6 
months and 2 
year follow-up. 
n=100 controls 
(pre-smear) to 
establish 
population 
reference levels 
Hellsten 2008 
96 
BJOG 
Longitudinal 
study of Sexual 
function in 
colposcopy - 2 
year 
Sweden Prospective cohort study 
- as above.  To assess 
levels of psycho-sexual 
problems in women 
referred for colposcopy. 
psycho-sexual 
Questionnaire 
administered at all 3 
visits (based on 
Campion, modified by 
Howells). Study 
compares LEEP and 
non-LEEP 
As above Spontaneous interest in sex, 
frequency of intercourse and 
sexual arousal all significantly 
lower at 6 months compared 
with first visit and at 2 years 
spontaneous interest in sex 
and frequency of intercourse 
remained low. No difference in 
SF between LEEP and non-
LEEP group at follow up. 
2 years after 
referral for 
colposcopy, women 
still had effect on 
SF - less 
spontaneous 
interest and lower 
frequency. 
No relationship 
between treatment 
of CIN by LEEP 
and reduced SF 
Small sample, 
author 
acknowledges 
that maybe be 
difficult to 
determine SF with 
a questionnaire. 
Swedish 
population - may 
have different 
colposcopy 
practices 
8 
Hellsten et al 
2009 97 
Euro J of Obs & 
Gynae & Repro 
Biology 
Longitudinal 
study of QoL - 2 
year 
 
 
Sweden Prospective cohort study 
- Long term follow up 
aim to assess QoL. 
Study design as above. 
Paper reports results 
from the SF-36 which 
includes domain about 
emotional well-being. 
SF-36 has a mental 
component summary 
and is used as a 
compliment to STAI and 
As above 
 
Baseline mean for mental 
component on all MH 
subscales of SF-36 with 
statistically significantly lower 
than normative data. At 2 
years, scores still significant 
lower than normative. 
No diff between LEEP and 
non-LEEP in general QoL. 
Women 
experienced long-
lasting negative 
effects upon mental 
health (but not on 
physical). Although 
no diff between 
LEEP and non-
LEEP (so maybe it 
is the knowledge of 
having an 
abnormality rather 
Small sample, 
author 
acknowledges 
that maybe be 
difficult to 
determine SF with 
a questionnaire. 
Swedish 
population - may 
have different 
colposcopy 
practices 
8 
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First author; 
year; journal 
 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
MADRS-S. SF-36 most 
valued measure of 
subjectively expressed 
mental health whereas 
STAI and MADRS-S are 
symptom oriented 
than procedure 
itself that causes 
distress) 
Kola 2009 106 
Euro J of Obs & 
Gynae & Repro 
Biology 
 
 
Ireland Retrospective postal 
survey 
Aims to compare intra 
procedural stress 
between colposcopy 
and LLETZ and assess 
patient’s perceptions of 
possible non-
pharmocological 
interventions to reduce 
stress. Secondary aim 
to ascertain patients’ 
perceptions of utility of 
possible interventions. 
Measures 
anxiety/worry/distress 
(not validated, but based 
on existing literature). 
Effect of coping style 
upon levels.  
Perceived helpfulness of 
suggested intervention 
(did not undergo, but 
asked to rate 
usefulness). 
Women having 
undergone a 
colposcopy during 
previous 12 
months. 
n=151 (aged 20-
60) with high 
grade CIN. 
n=86 Colposcopy 
n=65 LLETZ 
Reported high level of 
colposcopy related 
anxiety/worry. Those who 
reported fear of cancer, and 
concerns about fertility, 
colposcopy itself, 
embarrassment had higher 
anxiety levels than those not 
reporting these. 
LLETZ perceived as 
distressing and more painful 
than colposcopy. There were 
associations between women’s 
perceptions and certain 
interventions. 
Identified to distinct coping 
styles - ‘blunters’ who 
preferred idea of distraction 
based interventions and 
‘monitors’ who preferred 
information based 
interventions 
Colposcopy elicits 
high level of 
anxiety. See and 
treat LLETZ 
experience greater 
psychological 
consequences than 
colposcopy 
Not sure how long 
after treatment 
Questionnaire 
sent to patients. 
Non-validated 
measures 
6 
Le 2006 109 
Int J of Gynae 
Cancer 
Canada Prospective 
comparing Colposcopy 
vs. LEEP - 
Patients seen for 
new colposcopy 
assessment and 
81% colposcopy significant 
anxiety/depression 
65% LEEP significant 
Recommends face-
to-face education 
and support after 
Small sample size 7 
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First author; 
year; journal 
 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
Psychological 
morbidities prior 
to LLETZ 
anxiety/depression 
levels between groups 
and effectiveness of 
nursing based 
counselling. 
Patients completed 
HADS and PEAPS pre-
procedure. After 
colposcopy, one-to-one 
teaching and clinic 
nurse counselling 
those scheduled 
for colposcopy or 
LEEP offered 
participation. 
LEEP patients 
had previously 
undergone biopsy 
4-6 weeks prior to 
procedure. 
n=21 colposcopy 
n=20 LEEP 
anxiety/depression 
Significantly more 
anxiety/depression in 
colposcopy group 
LEEP significantly less 
distressed and scored better 
than colposcopy on self-
belief/cancer concerns and 
effects on sex life. 
colposcopy may 
reduce subsequent 
distress 
Naik 2001 114 
Euro J of Obs 
and Gynae 
UK Prospective study aims 
to assess feasibility of 
offering one-stop 
colposcopy clinic for low 
grade abnormalities. If 
so, is combination of 
immediate info of biopsy 
result and treatment 
helpful in reducing 
anxiety and improving 
satisfaction levels. 
Self-completed Q (not 
validated) for anxiety 
 
n=108 with low 
grade 
abnormalities 
Control group 
managed by 
standard 
procedure n= 7 
All women in both groups felt 
anxious at time of clinic visit. 
After I week, majority of 
patients managed via 1-stop 
felt slight anxiety and controls 
remained anxious. 
All women said they would 
prefer 1-stop if future 
abnormalities detected. 
One-stop is a 
feasible 
management option 
for women with low-
grade abnormalities 
Main focus is 
feasibility of 1-
stop. 
5 
Orbell 2004 115 
Brit J of Health 
Appraisal theory 
and emotional 
sequelae of first 
visit to 
colposcopy 
following an 
abnormality 
UK Aims to evaluate the 
role of cognitive 
appraisal components in 
explaining reaction to 
colposcopy. Secondly 
comparing psycho 
sequelae of see and 
treat (ST) V diagnose 
and defer (DD). 
n=1,085 attending 
first colposcopy 
(ST=136, 
DD=949) 
Diagnosis and cognitive 
appraisals significantly 
associated with emotion 
(accounting for between 3-
15% of variance in different 
emotions). Women with CIN 2 
or 3 undergoing ST were less 
anxious, less embarrassed 
and significantly more relieved 
Diagnosis, 
motivationally 
congruent 
experiences and 
low emotion-
focused coping 
potential are most 
important 
determinants of 
Well reported 
study 
8 
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First author; 
year; journal 
 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
Questionnaire - STAI; 
Emotions/Appraisals 
assessed derived from 
Smith. Questionnaire 
sent within 7 days of 
colposcopy 
compared with matched 
sample of women undergoing 
DT and perceived their first 
appt as more motivationally 
congruent 
anxiety after 
colposcopy  
ST increased 
motivational 
congruence 
Sharp 2010 119 
J Brit Cancer 
Long-term 
psycho-social 
impact of 
alternative 
management 
policies 
UK RCT - comparing 2 
alternative management 
policies. Baseline - 
depression/anxiety 
scores taken pre-
colposcopy 
HADS, IES completed 6 
weeks after last 
procedure - then 12, 18, 
24, 30 months post 
recruitment - HADS and 
POSM. Prevalence of 
significant depression, 
anxiety and distress and 
medium POSM scores 
compared between 
arms. 
n=989 (age range 
20-59) with low 
grade cytology 
randomised to 
LLETZ n=487) or 
4 punch biopsy 
(with immediate 
recall for LLETZ if 
showed CIN 2/3) 
n=502. 
 
Over entire follow-up no 
significant difference between 
arms in cumulative prevalence 
or risk of significant depression 
or anxiety. 
6 weeks post-procedure, 
distress did not differ between 
each arm. 
At later time points - 8-11% 
had significant depression and 
14-16% had significant 
anxiety, but no difference 
between arms. 
There is no diff in 
long-term or short-
term psycho 
outcomes of 
immediate LLETZ 
vs. punch 
biopsy/selective 
recall. 
Long-term follow 
up 
10 
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Biopsy/colposcopy surveillance versus treatment 
The nine studies focusing upon two treatment modalities (biopsy or colposcopy 
surveillance vs. treatment (or deferred treatment) were of relatively high quality, 
scoring six or above on quality assessment. 86,95,96,97,106,109,114,115,119 Four studies 
were UK based86,114,115,119 and the remainder were from either Europe95,96,97106 or 
Canada.109 
 
Balasubramani et al 86 using the State-Trait Anxiety Index (STAI) found that women 
treated via see and treat (ST) felt more in control, a greater sense of relief and less 
anxiety following the procedure than the defer and treat group (DT) who were 
monitored by biopsy. For this population (women with moderate to severe CIN), the 
authors conclude that ST has better psychological outcomes. As the authors note, 
this could be due to patients feelings that they have a larger stake in decisions being 
about their treatment (women had a choice of whether to have DT or ST). 
Furthermore, immediate treatment may avoid any anxiety based upon fear of 
treatment progression that may have been experienced by the DT group. 
 
The issue of potential over-treatment for those treated immediately, when they may 
have experienced disease regression without treatment is also raised. The authors 
suggest that this is minimised if ST is reserved for those patients with high-grade 
disease. As this study follows women up within a short time frame following the 
procedures, it may be useful in terms of understanding how best to configure 
services for this particular patient group in terms of minimising procedural related 
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stress and anxiety, but its short time frame does not provide evidence of the long 
term impacts of either modality.  
Hellsten et al 95-97 follow the same cohort of 100 women having had biopsy on an 
initial visit and who are treated either by LEEP or 6 monthly colposcopic surveillance 
(dependent upon disease severity). 100 control patients (pre-cytological surveillance) 
are identified to provide reference levels for the treated population. These three two-
year follow-up studies focus upon anxiety and depression levels,95 sexual function 
outcomes,96 and emotional wellbeing.97The studies are well designed and provide 
long-term data when compared with other similar studies. They utilise validated or 
modified measures for data collection. Questionnaires were completed at three time 
points (at initial visit, six months and 12 months after visit). No significant differences 
were found between the LEEP and the non-LEEP group and any initial anxiety or 
depression levels reduced over time. A sub-group of women with the highest initial 
depression scores were found to have significantly higher anxiety and depression 
scores after two years. Study findings suggest that the lack of difference between the 
two treatment modalities cannot account for the anxiety and depression scores 
observed. The authors postulate that initial anxiety levels may be attributed to 
concerns about disease status rather than treatment itself.  
 
Sexual problems appeared to be present at six months following the procedure 
compared to the initial visit, and after two years there remained reduced spontaneous 
interest in sex and frequency of intercourse, which indicated that treatment for or 
diagnosis of CIN does have a longer-term impact upon some domains of sexual 
function. However, there were no differences noted between LEEP and non-LEEP 
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groups.96 In order to measure subjectively expressed mental wellbeing, the SF-36 
was used to compare the LEEP, non-LEEP and population controls.97 The SF-36 is a 
short measure administered to measure the health status of patients. No differences 
were found between LEEP and non-LEEP groups, but mental well-being scores at 
two years were significantly lower in cases than controls. 
 
These studies suggest that it is unlikely that the type of procedure that a woman 
undergoes is itself a predictor of adverse events, although there may be some longer 
term effects upon sexual functioning and emotional well-being. Hellsten et al 
conclude that colposcopy does not seem to result in long-lasting anxiety or 
depression.  
 
Kola et al106 compared see and treat LLETZ with colposcopy for women with high 
grade CIN and aimed to assess levels of anxiety, worry and distress of women 
undergoing the procedure (non-validated measures, but adapted). Questionnaires 
were sent retrospectively, but it is unclear how long after a procedure participants 
returned the questionnaire. It examined patients’ perceptions of the usefulness of 
possible interventions and the effect of particular coping styles upon levels of 
perceived helpfulness of the interventions. It found that participants with higher levels 
of anxiety were more likely to report fear of cancer, fertility concerns, fear of 
colposcopy itself and higher levels of embarrassment.  
 
The study indicates that see and treat LLETZ patients experienced more negative 
psychological outcomes than those undergoing colposcopy surveillance. This is in 
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contrast to the findings of Balasubramani et al. However, Balasubramani et al 
measure state trait anxiety that may subside after a potentially traumatic procedure is 
over. Kola et al. also measure factors such as fear of cancer and concerns about 
future fertility that may remain for a prolonged period after a patient is treated. As 
Kola et al. do not use validated measures and it is unclear when follow-up took place, 
it is difficult to compare across these studies. 
 
Le at al109 compare new colposcopy patients with those scheduled to undergo LEEP 
or colposcopy (who underwent biopsy 4-6 weeks prior to appointment) and uses 
HADS to measure anxiety and depression and PEAPS (to measure psychological 
effects of receiving an abnormal Pap result) before and after the procedure. The 
follow-up questionnaire was accompanied by a one-to-one teaching session and 
nurse counselling. The small sample size limits the generalisability of the findings, 
but the authors found significantly higher levels of anxiety and depression in the 
colposcopy group than the LEEP group (colposcopy 81%, LEEP 65%, p=<0.050). 
The LEEP group also appeared less burdened by fears of cancer and effects upon 
their sex life. The authors argue that one of the reasons for this may be that patients 
attending for LLETZ had had previous support and information provided, which may 
account for reduced levels of anxiety and depression in this group. The fear of the 
unknown in the colposcopy group could be a contributory factor in raising levels for 
these patients. They conclude that providing patients with information and support 
prior to treatment may be psychologically beneficial. 
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Naik et al 34 focus upon women with low-grade abnormalities and compare 
psychological morbidities between women managed by a ‘one-stop’ clinic (underwent 
biopsy and received results of biopsy on same day), and those managed by standard 
practice. It is not entirely clear from the paper what ‘standard procedure’ entails 
although it is plausible that the control group did not receive their biopsy results on 
the day of the clinic appointment. Non-validated anxiety measures were used to 
measure anxiety levels at the time of the clinic visit. One week following ‘one-stop’, 
the majority of patients felt less anxiety than those managed by standard procedure. 
As this study had a further aim to assess the feasibility and acceptability of ‘one-
stop’, they report that all women treated by one-stop as well as those managed by 
standard procedure stated that they would prefer a ‘one-stop’ procedure and 
conclude that for women with low-grade abnormalities, this option appears to reduce 
levels of anxiety. 
 
A well-designed, robust RCT study by Sharp et al 119 uses a similar population to 
Naik et al (focusing on women with low grade abnormality), and compares patients 
randomised to LLETZ (n=487) or to surveillance via four punch biopsies (with recall 
to LLETZ if CIN2/3 is indicated n=502). The study findings were part of a trial to 
assess the benefits and harms of using see and treat, or defer and treat and found 
no differences between both procedures in terms of detection rates for CIN or in their 
cost-effectiveness. The study utilises validated measures (HADS, IES (Impact of 
Event Scale)), POSM (Process Outcome Specific Measure) providing baseline data 
(pre-procedure), 6 weeks, 12, 18, 24, and 30 months post-recruitment to enable short 
and long-term follow-up. 
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Over the entire period of follow-up, the study found no significant differences 
between arms in terms of the risk of significant depression (OR=0.78, 95% CI 0.52-
1.17) or anxiety (OR=0.83, 95% CI 0.57-1.19), although at later time points 8-11% 
had significant depression and 14-16% had significant anxiety levels, with no 
differences found between arms.  
 
The authors conclude that there is no difference in short or long-term psychological 
morbidities between the two approaches. These findings contrast with 
Balasubramani et al, Kola et al, Le at al and Naik et al but these studies all have a 
variety of follow-up time-points and used different scales. Sharp et al ensured that 
the initial six week follow-up would have taken place after both groups had been 
treated unlike in Balasubramani et al when the DT group would not yet have been 
treated.  This study also benefits from the measurements of base-line scores for 
anxiety and depression, and a larger sample size, and its findings seem comparable 
with Hellsten et al. 
 
Although Orbell at al 35 evaluate the role of cognitive appraisal in explaining reaction 
to colposcopy, they also compare psychological outcomes between a matched 
sample of patients undergoing see and treat and diagnose and defer (biopsy) n=136 
in each group. The authors found that women undergoing ST were less anxious, less 
embarrassed and significantly more relieved than those in the DD (diagnose and 
defer) arm (anxiety mean score = 41.08 vs. 43.98; embarrassment mean score = 
1.18 vs 1.28; more relief mean score = 2.68 vs. 2.11). The study seems to support 
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the findings in Le et al and Balasumbramani et al that indicate that women 
undergoing ST are less likely to experience psychological morbidities. 
 
These studies provide data on the potential short/long term impacts of undergoing 
colposcopy and do so by comparing outcomes of women being ‘treated’ and those 
undergoing surveillance. Due to varying follow-up timescales and the variety of 
measures used, it is impossible to draw firm conclusions. However, studies focusing 
upon longer term follow-up 95-97,119 found no differences between outcomes for the 
treatment of surveillance groups. These studies conclude that any adverse outcomes 
are typically short-lived and there are minimal long-term psycho-sexual outcomes 
following colposcopy and treatment for CIN. 
 
Table 3.10 outlines the four studies that compared cytological surveillance and 
colposcopically directed treatment. The table is followed by a narrative summary of 
these studies. 
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Table 3.10 Comparing cytological surveillance v colposcopically directed treatment 
First author; 
year; journal 
Country Study design and methods Population Results Authors 
conclusion 
Comments QA 
Score 
Freeman-Wang 
2001 94 
BJOG 
Anxiety levels in 
women 
attending 
colposcopy 
clinics for 
treatment for 
cervical 
intraepithelial 
neoplasia: a 
randomised trial 
of written and 
video info 
UK Assessing effectiveness of video in 
reducing anxiety using STAI. 
2 stages - Pilot assessing anxiety 
levels in 3 groups - 1 diagnostic 
colposcopy; 2. out-patient treatment; 
3. see and treat clinic. 
Stage 2 - RCT between 
Leaflet or video and leaflet.  
Received prior to their see and treat 
appt. Anxiety measured at 
attendance for see and treat 
Pilot - 3 groups: 
Group 1=251 
Group 2=60; 
Group 3=31 
Women with 
mod/severe 
dyskaryosis. 
RCT - after loss 
to follow-up 
Leaflet n= 45 
Video n= 48  
Pilot - see and treat had 
significant more anxiety than 
Group 1 or 2. 
RCT - video significant 
reduced anxiety of women 
attending for see and treat. 
High degree of 
anxiety in 
patients 
attending 
diagnostic 
colposcopy. 
Video 
successful in 
reducing 
anxiety in see 
and treat. 
Including as 
it provides 
results of 
anxiety in 
women 
attending 
colposcopy, 
although aim 
is to assess 
effectiveness 
of 
intervention 
3 
Jones 1996 102 
J R Soc Med 
The mildly 
abnormal 
cervical smear 
UK Cohort 
Comparing anxiety levels between 
surveillance v colposcopy after first 
smear for women with mild abnormal 
smears. 
At end of study all offered 
colposcopy appt and to complete Q 
to recall previous emotional events 
(30 months post colposcopy) 
Not validated measures, but asking 
about anxiety as well as fear of 
cancer, resentment of partner, loss 
of libido  
n=163 cytology 
surveillance  
n=182 
colposcopy 
 
Invite for colposcopy resulted 
in increased anxiety, but 
patients preferred this to 
surveillance. 
Colposcopy patients higher 
fear of cancer, resentment of 
partner and reduced libido. 
That said, surveillance also 
raised anxiety 
Colposcopy 
increased 
anxiety, but 
was more 
satisfactory 
(maybe due to 
reassurance 
from having 
been treated). 
So 
surveillance 
seems better 
for anxiety. 
Not clear 
about 
measures 
used - not 
validated. 
Recall bias 
as being 
asked to 
think back 
about 
previous 
reactions 
3 
Kitchener 2004 
105 
BJOG 
RCT of 
cytological 
UK RCT of 6 monthly cyto-surveillance  
or to make choice between CS or 
colposcopy in managing mildly 
abnormal smears. 
Followed up for 1 year. 
n=476 women 
with 
borderline/mild 
dyskaryosis. 
Choice=233,  
No significant difference 
between arms for GHQ and 
STAI at 12 months. Significant 
reduction in psycho-metric 
morbidity between baseline 
Choice did not 
impact 
favourably or 
harmfully upon 
psych 
Looking at 
the effect of 
choice upon 
psycho 
outcomes, 
8 
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First author; 
year; journal 
Country Study design and methods Population Results Authors 
conclusion 
Comments QA 
Score 
surveillance V 
patient choice 
and Colp 
No choice - repeat smear at 6/12 
months and if normal returned to 
routine (if abnormal at 6, then LLETZ 
performed). 
Questionnaire in this arm - 
completed baseline, prior to repeat 
smear at 6months, after repeat 
smear at colposcopy, if carried out, 
and at 12 months. 
Choice arm - those choosing CS 
managed as above. Colposcopy 
managed as protocol. Q - taken at 
baseline and after initial colposcopy, 
if chosen before and after 6mth and 
at 12 months. Questionnaire - GHQ, 
STAI (choice arm also questionnaire 
about why made particular choice). 
no-choice=243 and 12 months in both arms.  
Overall rates of default from 
protocol were same in each 
arm, but default that led to 
uncertain ascertainment of 
cervical pathology was greater 
in no choice. 
 
outcomes. If 
patient 
anxious, 
allowing them 
to choose may 
be favourable 
because it will 
reduce default 
rates for this 
group 
but provides 
data of rates 
of caseness 
for STAI and 
GHQ. 
Little  
(Tombola 
Group) 
2009 111 
BMJ 
Cytological 
surveillance 
compared with 
immediate 
referral for colp 
UK Nested RCT. 
Aim- effectiveness of surveillance (6 
monthly n=2,223) V immediate 
referral to colposcopy (n=2,216). 
3 year follow-up 
Main focus - measuring incidence of 
CIN, but also measuring significant 
anxiety/depression (HADS) at 6 
weeks and in 3rd year. 
Women with low 
grade cytology 
(aged 20-59) 
Similar proportion of women 
anxiety/depression in both 
arms (similar characteristics) 
No clear benefit 
immediate  
colposcopy  
compared with 
surveillance in  
terms of  
psychological 
outcomes  
Although the 
main focus of 
study is 
incidence of 
CIN, 
including as 
it also 
focused upon 
psycho 
sequelae.  
10 
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Cytological surveillance vs. colposcopically directed treatment 
In the three studies comparing cytological surveillance and colposcopically directed 
treatment, one was of poor quality102 (quality score=3) and two were of higher 
quality105,111 (QS=8;10). One further study that compared biopsy with outpatient 
treatment and see and treat scored 3 points on the quality score.94 
 
Jones et al 102 focus upon the impact of cytological surveillance versus colposcopy 
after first smear upon anxiety levels. This study uses a relatively large sample size 
(n=163 cytology, n=182 colposcopy) but does not use validated measures. The 
study, which also asks about fears about cancer, libido and sexual relationships, 
found these more likely to be adversely affected in the colposcopy arm. However, 
despite elevated levels of anxiety in the colposcopy arm, these patients found 
immediate colposcopy more satisfactory compared with the surveillance arm. The 
study concludes that in terms of anxiety levels, cytological surveillance is a preferable 
treatment option. However, as is acknowledged by the authors, surveillance also 
raises anxiety. This study is retrospective in design, asking participants to recall 
anxiety levels at the time of colposcopy. This may have resulted in the introduction of 
recall bias as is common with these types of studies.  
 
Kitchener at al 105 compare anxiety levels for patients with mild/borderline dyskaryosis 
undergoing six-monthly cytological surveillance (CS) and patients offered a choice of 
CS or colposcopy. The study concludes that having a choice of management options 
did not impact upon psychological outcomes. A reduction in psychological morbidities 
between base-line and at 12 month follow-up were found and are unsurprising as 
state levels of anxiety are likely to be reduced once treatment has been completed. 
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As well as the study comparing biopsy recall and immediate LLETZ,119 the 
TOMBOLA group report results of an RCT that was partially designed to examine the 
impact of cytological surveillance in primary care compared with immediate referral 
for colposcopic examination upon anxiety and depression. Similar proportions of 
women reported anxiety and depression in both arms and so there would be appear 
to be no psychological benefit from undergoing immediate colposcopy compared with 
cytological surveillance. 
 
Freeman-Wang et al’s 94 two stage study assesses the effectiveness of using a video 
in reducing anxiety by comparing three management options: diagnostic colposcopy; 
outpatient treatment and a see and treat clinic. The first stage measures patients’ 
anxiety levels following their respective appointments and found that women 
attending the see and treat clinic were significantly more anxious than those 
attending alternative management (diagnostic colposcopy p=0.019; outpatient 
treatment p=0.013) despite this group receiving a booklet, information leaflet and 
explanatory letter (diagnostic biopsy group received booklet and those needing 
treatment received booklet and supplementary information leaflet), although the 
numbers across the group are not comparable (Group 1 n=251, Group 2 n=60, 
Group 3 n=31). However, all STAI scores across the three groups indicated high 
levels of anxiety. The study would seem to support the findings of Jones et al102 who 
found higher anxiety levels in the treatment arm. It would also appear that the 
provision of information does little to reduce anxiety for this group. 
 
The larger, well designed studies comparing immediate treatment with deferred 
treatment seem to indicate that it is not the actual procedure per se that is the cause 
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of anxiety and depression with Hellsten et al and Sharp et al finding no differences 
between treatment arms. Of course this is not to say there are no adverse 
psychological affects of undergoing treatment for CIN, but that any adverse effects 
are unlikely to be caused by the ‘wait and see’ and the ‘see and treat’ modalities. 
 
Table 3.11 summarises the data extracted for the remaining three studies included in 
this section. One study compares patient acceptance of and psychological outcomes 
for women experiencing telescolposcopy (for those living in a distant site) and 
colpsoscopy.93 Women were assessed pre- and post-treatment, although different 
measures (non-validated) were administered post-treatment as the focus of the post-
treatment questionnaire was to ascertain acceptance levels of the procedures. The 
study found mild levels of depression and anxiety in both groups pre-treatment 
(validated measure used) and found that the psychological profile of patients 
undergoing alternative treatments were different, with telecolposcopy patients more 
likely to be monitors compared with colposcopy patients. The study concludes that 
each treatment type had similar satisfaction levels (high) and comfort levels. The only 
question on the post-treatment questionnaire to measure any kind of psychological 
impact was in terms of fear of cancer and the colposcopy group were significantly 
less likely to hold such fears. The study adds little in terms of evidence to this review, 
primarily because the main focus is upon acceptability of an alternative treatment 
method. This is reflected in the post-treatment measures that do not address 
psychological impacts other than issues around fear of cancer. 
 
Baldaro et al 87 although comparing psychological reactions to LLETZ to those of 
hysterectomy, provides data on the sequelae pre- and post-treatment of patients 
 83
undergoing LLETZ. The study found elevated levels of anxiety two weeks prior to 
treatment, with a quarter of patients showing high levels of anxiety (n=10), but found 
a significant reduction in anxiety and depression at 3,6, and 12 month follow-up 
indicating that there are no long term psychological impacts of undergoing LLETZ. 
The study is limited by its small sample size (n=60) but would seem to support 
findings from other studies with a long-term follow-up on measures of anxiety and 
depression.95 
 
One study,120 compares psychological and sexual impacts of patients treated with 
either CO2 laser as an outpatient (a relatively new treatment type at the time the 
paper was published) and standard care - inpatient conisation. The study is of poor 
quality, with a small sample (n=52) in total and the results are not well-reported, 
although it concludes that patients treated by the ‘new’ procedure had less anxiety 
about their disease and better quality of life than the conventional group. Although 
findings from these studies are equivocal, there would appear to be little difference in 
terms of impacts irrespective of treatment modalities. 
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Table 3.11 Conisation vs. Co2; hysterectomy vs. LLETZ; telecolposcopy vs. colposcopy 
 
First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
Baldaro 2003 87 
J of Psycho 
Research 
Psychological 
distress of 
conservative 
and non-
conservative 
uterine surgery 
Italy Aim to evaluate 
psychological reaction to 
conisation (its incidence) - 
compares group with 
hysterectomy. 
Pre and post 
Questionnaire - 2 weeks 
prior to op and 3,6,12 
months after. 
Measure - Italian version of 
Symptom Questionnaire 
(SQ) - 4 scales - anxiety, 
depression somatic and 
hostility. 
n=60 with CIN 
undergoing 
LLETZ 
n=40 
hysterectomy 
 
Both LLETZ and hysterectomy 
group showed significant 
reduction in anxiety and 
depression at 3, 6, 12 months 
compared with pre-operation. 
2 weeks before surgery 8 LLETZ 
(19.5%) showed anxiety while 
10 (24.3%) presented with high 
levels of anxiety/depression. 
12 months after surgery of 
women with pre-op depression, 
4 (9.7%) had negative mood 
status. 
LLETZ determines 
good psychological 
prognosis in the  
short/long term 
Short and 
long term 
follow-up. 
Validated 
measures 
5 
Ferris 2003 93 
J Am Board 
Fam Pract 
Patient 
acceptance and 
the 
psychological 
effects of 
women 
experiencing 
telecolposcopy 
and colposcopy 
USA Comparing telecolposcopy 
and colposcopy on 
psychological outcomes. 
Measures completed 
before colposcopy (or 
telecolposcopy) - PRIME-
MD (anxiety); CES-D 
(depression); MBSS 
(coping styles - monitoring 
or blunting) 
12 item health beliefs and 
concerns. 
Post colposcopy (or 
telecolposcopy) completed 
23-item - including 
satisfaction, cancer 
concerns etc. 
 
Colposcopy n= 
150 
Telecolposcopy 
n= 263  
Recent abnormal 
smear/abnormal 
appearance on 
cervix/returning 
for surgery or 
follow-up 
Mild levels of anxiety/depression 
in both groups. 
On health belief measure - both 
groups not excessively 
concerned about procedure, 
disease or consequences. 
Significant proportion of 
telecolposcopy group 
considered high monitors 
compared with colposcopy. No 
significant difference between 
colposcopy and telecolposcopy 
in proportion of high blunters. 
Colposcopy patients less likely 
to have thoughts or fears about 
cancer and reported less pain. 
Main conclusion is 
around the efficacy 
of using 
telecolposcopy as 
an alternative to 
colposcopy - 
satisfactory and 
time/money saving. 
How long 
before/after 
colposcopy 
were 
measures 
taken? 
Not same 
measures 
used after 
procedure as 
before. 
7 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
Tamburini 
1991 120  
The Cervix and 
the lower genital 
female tract 
Psychological 
aspects of 
conization 
 
Italy Aim- evaluate QoL 
(including psychological/ 
sexual) of patients treated 
with CO2 laser conisation 
(out-patient) compared 
with QoL observed in 
previous study in patients 
treated with conventional 
conisation (in-patient). 
Measures -Questionnaire 
on social and sexual 
relationships; Minnesota 
Multiphasic Personality 
Inventory. Completed 
immediately after follow-up 
visit. 
Co2 group at time of 
interview had been treated 
min 3 months/max of 12 
months previously, 
Conventional group - had 
been treated minimum 
12months/maximum 18 
 
n=25 patients 
who had 
undergone 
traditional 
conisation for CIN 
III in 1979 
completed Q on a 
follow-up visit. All 
these patients 
completed and 
returned 
Questionnaire 
n=27 patients 
who had 
undergone CO2 
conisation 
between 1989-
1991returned 
completed 
Questionnaire, 
although only 21 
participants 
completed MMPI 
section. 
Conventional group - 40% 
hypochondria; 32% on scale of 
depression; 20% hysteria. 4/25 
worsening sex life; 3/25 social 
life; 4/25 worsening partner 
relationships. 
CO2 14% hysteria/hypochondria 
24% depression; 3/27 worsening 
social life; 6/27 worsening sex 
life; 3/27 worsening sex life 
No significant 
difference in sex 
life, social life, 
partner relationship, 
but CO2 patients 
appear to have less 
anxiety about their 
disease and had 
better QoL than 
conventional group 
Old study - 
1979 
Conisation 
not 
performed 
today. 
Poorly 
reported 
results. 
3 
 86
3.4.2 Studies focusing upon one cohort 
 
This section will focus upon studies that focus only on one cohort or treatment 
modality (n=17). Table 3.12 outlines the data extracted for each of these studies. 
Again, the studies vary in terms of follow-up time scales, disease stage, method of 
administration and types of measure and study quality. 11 studies scored five or 
below on quality assessment. 60,90,91,100,104,107,112,117,121-123 Six studies were of 
relatively higher quality (scoring 6 or above). 54,61,99,101,108,118 Five studies were UK 
based 99,100,112,116,121 two from Australia,90,123 two from Europe104,118 and six from the 
USA.91,107,108,60,117,122  
 
Boneveski et al 90 use non-validated measures to determine the short term effects 
(anxiety, depression and sexual function) experienced by 138 women attending 
colposcopy, following women up within a week of colposcopy with a telephone 
interview. As well being asked about anxiety and depression following colposcopy 
they were asked how they rated their levels prior to colposcopy. 
 
Participants were asked whether anxiety, depression and reduced sexual interest 
were present before colposcopy, better since colposcopy or worse since colposcopy. 
The presentation of results is unclear, but seems to indicate that anxiety and 
disinterest in sex had either worsened or remained the same since colposcopy. 
Depression was less marked prior to colposcopy, and for those experiencing 
depressive symptoms pre-colposcopy, there were no changes after colposcopy. The 
study is poorly designed and reported, and given its short-time frame for follow-up 
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and lack of validated measures, it is difficult to draw satisfactory conclusions in terms 
of any long term effects of colposcopy. It would seem plausible that depression levels 
remain unchanged in those who were depressed prior to the procedure as 
depressive symptoms can be enduring. One would expect elevated levels of anxiety 
prior to colposcopy, but may expect these to reduce post procedure. A reduction in 
sexual interest in the short-term after undergoing an invasive procedure may also be 
expected. 
 
Brooks et al 91 measure pre-visit anxiety and found that 30% of their sample (30/122) 
experienced fear of cancer, 28% fear of complications, and 23% fear of alteration of 
sexual function. However, this study’s main aim was to measure the association 
between levels of anxiety pre-colposcopy with knowledge, satisfaction and 
adherence to follow-up. Interestingly, the authors found a correlation between higher 
levels of pre-visit knowledge and higher levels of fear, although those who had more 
knowledge pre-procedure were also less likely to default from follow-up. It may be 
argued that for some women, knowing more about the nature of their diagnosis and 
potential treatment may raise anxiety levels, giving greater opportunity to ruminate on 
potential adverse experiences or outcomes. However, to improve default rates, which 
can be marked in follow-up patients, access to better information may reduce poor 
adherence with follow-up. 
 
Gath et al 61 observed psychiatric morbidity in a cohort of 102 patients assessing 
rates four weeks prior to colposcopy assessment (they had received results 
indicating an abnormality) following them up 4 and 34 weeks post colposcopy. The 
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study used validated measures and community controls to measure PSE (Present 
State Examination) scores. The study demonstrates that overall any psychological or 
sexual morbidities are relatively transient. Sexual problems were more pronounced 
prior to treatment which may be explained by concerns about engaging in intercourse 
prior to colposcopy. The study would seem to support the view that any adverse 
psychological or sexual effects diminish over time. 
 
Howells at al’s 99 before and after study measured state-trait anxiety and psycho-
sexual functioning (validated and modified measures) pre-colposcopy and six months 
post procedure. As seen in other studies, pre-colposcopy levels of state anxiety were 
elevated at the initial visit although significantly reduced at follow-up. Trait anxiety 
was not found to be significantly different at either visit. The authors found that those 
treated at colposcopy experienced less spontaneous interest in sex than those who 
were not treated. The study’s main aim was to assess the usefulness of a leaflet 
designed to reduce anxiety, with 100 women receiving the leaflet and 100 controls 
who did not. As observed in Brooks et al, the leaflet appeared to increase psycho-
sexual problems at the first visit, supporting the theory that information provision can 
lead to increased adverse psychological outcomes. However, by the second visit, 
both groups were similar. The authors conclude that sending a leaflet in isolation (i.e. 
without further counselling) is not of benefit in the population.  
 
A five year follow-up study focusing upon the experiences of women with abnormal 
Pap smears who had also undergone subsequent treatment,100 found that 72% 
experienced follow-up in a positive way. Fifty nine percent had experienced worry 
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and anxiety, and 20% reported that treatment had had a negative effect upon their 
sex life. The study is limited by the fact that it asked women to recall their reactions at 
the time of an event that took place a number of years previously, rather than 
whether they had any current psycho-sexual problems. This may have resulted in 
recall bias. 
 
Inna et al 101 examine the effect of LEEP upon sexual function (using a non-validated 
measure) in 89 women who had undergone LEEP three months previously. Although 
administered at one time point, women were asked to recall pre-procedure sexual 
function as well as post-procedure function. As the authors found statistically 
significant changes in overall sexual satisfaction, orgasmic satisfaction and vaginal 
elasticity, rather than predominantly physiological changes (dyspareunia, 
dysmenorrhea, frequency of intercourse), they posit that any adverse effects from the 
procedure are likely to be psychological in origin. The emphasis of this study would 
seem to be largely upon clinical gynaecological effects that may lead to poor sexual 
function, however due to the nature of female sexual dysfunction, it is difficult to 
disentangle the physical from the psychological. 
 
The earliest study included in the review (1982), investigating the effect of conisation 
upon sexual function is poorly designed and reported.104 The study interviews women 
before procedure (it is not clear if this is on the day of procedure) and 6 weeks, 6 and 
12 months post-operation and finds little difference in libido, orgasm, frequency or 
satisfaction before and after procedure. There is scant detail of the measures used 
(although they appear to be non-validated), and there is no control to measure levels 
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of sexual problems in the general population, so it is difficult to ascertain whether pre-
procedure scores for cases were representative. 
 
Two studies by Lauver et al 107,108 focus upon understanding women’s concerns 
about smear abnormality,108 to identify coping strategies to manage concerns.107 
Participants were telephoned pre-procedure and completed a questionnaire before 
colposcopy and post colposcopy. These studies use a small sample with 75 patients 
undergoing a telephone interview and 40 completing a pre-colposcopy questionnaire 
and 35 completing a post-colposcopy questionnaire. Primary concerns were found to 
relate to cancer, fertility and not understanding the nature of the abnormal result.  
The authors found that dependent upon particular coping styles, some women may 
benefit from seeking social support, or engaging in displacement activities to reduce 
procedural anxiety.  
 
A further study with a similar scope121, aimed at finding a correlation between levels 
of anxiety and the perceived helpfulness of interventions to reduce anxiety, rather 
unsurprisingly found that women prone to higher levels of anxiety were less satisfied 
with interventions offered. Zeisler et al 123 compared levels of distress between 
women who perceived that they had received adequate information regarding their 
diagnosis and those who felt they had not. In this small study (n=40) women who felt 
they were inadequately informed had significantly increased levels of distress than 
the group who felt they had been better informed. 
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Rubin et al 117 also looked at coping strategies in a cohort of women with low grade 
abnormality (n=88) and relationships between this and uncertainty about illness and 
knowledge and adaption in reaction to smear result and subsequent investigations. 
The authors conclude that uncertainty about illness exists for women undergoing the 
cervical screening and treatment pathway. It is likely that such uncertainty may result 
in increased anxiety, although it is not reported by the authors.  
 
Marteau et al’s112 study would seem to support the evidence that levels of anxiety are 
high in women when measured immediately prior to colposcopy, but are significantly 
less so immediately after procedure. This study is poorly designed and reported, and 
although it utilised a validated measure (STAI), the small sample size (n=30) means 
that the results are far from robust, despite its conclusions appealing to common-
sense. There are also no normative data reported to account for pre-colposcopy 
anxiety levels. 
 
McDonald et al 60 sample 20 women attending colposcopy, and used 4 time-points for 
data collection (initial visit - biopsy; one week later - results of biopsy; third visit - 
before surgery; three weeks after surgery). Non-validated measures were used and 
focused upon cancer fears, which was found to be pronounced at all visits aside from 
post-surgery; sexual function problems that were high at all visits; self-esteem was 
lowest and anxiety highest at initial and post-surgery visits. The findings of the study 
are limited again by sample size, but it provides an interesting picture of the 
psychological fluctuations that may accompany the pathway from diagnosis to post 
treatment.  
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Richardson et al’s116 primary aim is to focus upon the effectiveness of interventions 
(information and counselling) by randomising 219 patients to receive either leaflet 
(n=104) or leaflet plus counselling (n=115). However, the study also provides data 
using a psychological measure (validated) over a six-month follow-up period. As 
seen in Marteau et al, high levels of distress were found in both groups pre-
procedure which were significantly reduced post-procedure. The study found no 
incremental benefit in offering cognitive behavioural counselling over and above the 
benefit found in the information group alone.  
 
Serati et al 118 is the only study in the review to utilise the Female Sexual Function 
Index (FSFI) to compare sexual function at time of LEEP and six months post 
procedure. A relatively small sample (n=67) and lack of control make results difficult 
to generalise, although the results indicate that overall, sexual function was 
unchanged at six months aside from sexual desire, which became significantly worse 
(p=0.02) which seem to support findings in Gath et al. 
 
Valdini et al 122 used PEAPS to explore the factors associated with distress in a 
population of 202 women undergoing colposcopy and main concerns focused upon 
worry about getting cancer and fear of death.89,91  
 
Conclusions from higher quality studies appear to indicate that any psycho-sexual 
morbidities following colposcopy are relatively transient in nature. 
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Table 3.12 Studies focusing upon one cohort 
First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
Boneveski 
1998 90 
J of Obs abnd 
Gynae 
Women's 
experience of 
having a 
colposcopy 
examination 
Australia Cohort 
Aim - assess satisfaction 
levels, unmet needs and 
consequences of 
colposcopy. 
Measures - short-term 
consequences including 
anxiety, depression, 
sexual function 
Also looking at 
satisfaction with care 
received. Computer 
aided telephone 
interview. Measures 
‘derived from validated 
measures’. 
n=138 attending 
for colposcopy 
contacted within 
a week of clinic 
visit to complete 
telephone 
interview 
n=52 - current decline in sexual 
interest. Of these, 13% indicated 
their interest had improved 
following colposcopy; 25% 
worsened; 62% not changed. 
Depression experienced by 11% 
pre-colposcopy. Of women 
reporting depression after 
colposcopy, n=33 reported that 
this had not changed since appt. 
Of women not anxious following 
colposcopy, n=98 (23%) were so 
before colposcopy. Of women 
reporting anxiety following 
colposcopy (n=40,) all reported it 
worsened (48%) or not changed 
(52%). 
Anxiety, disinterest in 
sex had worsened or 
not improved after 
colposcopy 
Only taken 1 
week after 
procedure - 
short-term. 
Non-
validated 
measures 
utilised 
4 
Brooks 2002 91 
J of Lower 
Genital Tract 
Disease 
Association of 
knowledge 
anxiety and fear 
with adherence 
to follow-up for 
colposcopy. 
USA Aim-evaluate association 
of pre-visit anxiety and 
post-visit knowledge, 
satisfaction and 
adherence to follow-up. 
Questionnaire 
administered prior to appt 
and 2 weeks after 
appointment for 
colposcopy. 
Questionnaire not 
validated - based on 
‘literature and judgments’ 
from focus group. 
n=122 
presenting for 
colposcopy with 
epithelial 
abnormality. 
98% 
participated in 
self-admin 
questionnaire. 
Follow up, only 
50% returned 
post-op 
questionnaire. 
(83% African 
American) 
 
Pre colposcopy - fear of cancer 
30%; fear of complications 28%; 
fear of pain 23%; fear of 
infertility/sexual function 11% 
50% (n=52/122) returned post-
operative Questionnaire. 
Mean fear score 7.3 (SE2.8, 
range 1-10) 
Mean anxiety score 7.8 (SE2.8, 
range 1-10) 
 
Higher pre-visit 
knowledge 
associated with 
greater fear as well 
as adherence to 
follow-up. 
Recommends - 
acknowledgment of 
role of 
anxiety/baseline 
knowledge, logistical 
concerns may 
reduce anxiety, 
promote adherence.  
 
Poor quality - 
non-validated 
measures. 
Confused 
about aims. 
5 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
Gath et al 
1995 61 
Journal of 
Epidem and 
Comm Health 
Emotional 
reactions in 
women 
attending a UK 
colposcopy 
clinic 
 
 
 
UK Observation study 
Women underwent a 
psych assessment at 3 
time points - 4 weeks 
before clinic appt, 4 
weeks after and 32 
weeks after apt. 
Measures - Standard 
psychiatric interview; 
present state 
examination; 4 self rated 
mood scales - Beck 
depression scale, Leeds 
depression scale and 
Leeds anxiety scale. 
Psycho-sexual 
functioning was 
measured by asking 
about frequency of 
intercourse, enjoyment of 
intercourse, interest in 
sex, any changes 
following treatment. 
n=102 New 
attenders to a 
colposcopy 
clinic over a 12 
month period. 
Women had 
been found to 
have a 
abnormal smear 
at routine 
screening, or at 
follow up of 
previously 
inconclusive 
smear. 
In general, psychiatric morbidity 
was found to be transient and 
relatively minor. PSE scores not 
significantly higher than in 
community sample of 520 
controls. 
Psycho-sexual function - (A) after 
receiving abnormal result - 1% 
increased frequency, 56% no 
change, 43% decreased 
frequency; 1% increased 
enjoyment, 63% no change, 36% 
decreased enjoyment: 24% 
reported deterioration with sexual 
relationship, the rest reported no 
change; 3% reported increased 
interest in sex, 60% no change 
and 37% reported decreased 
interest. 
(B) assessment three when asked 
to compare frequency of 
intercourse with 2 months before 
being asked to go to colposcopy 
clinic -proportions change 
considerably - 29% increased 
frequency, no change 52% and 
decreased frequency 19%; 
enjoyment increased for 7%, no 
change 62% and decreased 11%: 
22% improved sexual 
relationship, 74% no change and 
deterioration 4%; Increased 
interest in sex 21%, no change 
71% and reduced interest 8%. 
 
In terms of SF - 
women reported 
increased sex 
problems at time of 
being informed of 
abnormal smear - not 
surprising as would 
have felt more 
anxious. However, 
by final assessment, 
levels of SF return to 
normal levels. 
After abnormal 
smear, investigation 
by colposcopy 
generally associated 
with low levels of 
anxiety/depression 
Relatively 
small sample 
- follow up 
only 32 
weeks 
6 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
Howells 1999 99
BJOG 
Is provision of  
info leaflet 
before colp 
beneficial? 
UK Prospective randomised 
study. 
Assessing usefulness of 
leaflet before colposcopy, 
designed to reduce 
anxiety/psycho-sexual 
morbidity. 
Measures - STAI/TRAI 
and psycho-sexual Q 
(Campion modified) 
completed before 
colposcopy and 6 months 
after colposcopy (leaflet 
group completed further 
questionnaire about the 
leaflet) 
n=200 
undergoing 
colposcopy for 
first time, 
abnormality no 
greater than 
moderate 
dyskaryosis. 
n=100 leaflet 
n=100 control 
For whole study population on 
basis of STAI were extremely 
anxiety at initial visit and 
significantly less so at second 
visit, although elevated compared 
to normal women(?). 
TRAI - did not significantly 
changes between 2 visits. No 
difference in anxiety between 
leaflet and controls. Second visit 
anxiety/psycho-sexual scores 
similar in treated and untreated, 
although untreated had less 
spontaneous interest in sex. 
No significant difference in initial 
STAI between 67 patients who did 
not attend follow-up and those 
who did. 
Psycho-sexual - First visit, leaflet 
group had more evidence of 
psycho-sex problems, by second 
visit, responses were comparable. 
Controls had lubrication problems.
Sending leaflet is not 
of benefit I isolation, 
but of benefit in 
reducing psycho-
sexual function. 
It may in fact 
cause 
anxiety - see 
leaflet group 
increased 
psycho-
sexual 
dysfunction. 
6 
Idestrom 2003 
100 
Acta Obstet 
Gynecol Scand 
Women's 
experience of 
coping with a 
positive Pap 
smear 
Sweden Prospective cohort  
Aim to evaluate women 
with repeated CIN1 by 
describing their 
experiences as well as 
evaluating how 
examinations, treatment 
and follow-up affected 
them. 
Questionnaire 
administered 5 years 
after first abnormal 
n=242 having 
had 2 abnormal 
pap smears and 
who had 
undergone 
colposcopy/ 
biopsy 
n=184 experienced follow-up in a 
positive way. 72% considered 
they understood diagnosis. 
59% experienced worry and 
anxiety - 30% stating it had 
affected everyday life from 
between being informed of pap 
and further investigation.  
n=20 reported negative effect on 
sex life after treatment (correlated 
with less satisfaction at follow-up 
and negative influence on self-
Feeling vulnerable 
when undergoing 
investigation, but no 
influence on follow-
up. 
Diagnosis created 
worry and negative 
experiences, may be 
improved if more 
education at time of 
screening. 
No remaining anxiety 
Not clear 
about data 
collection 
methods. 
Non-
validated 
survey. 
Recall bias 
5 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
smear. 
Questionnaire not 
validated - based upon 
‘knowledge from previous 
studies and reference 
literature.’ 
esteem). after 5 years, but 8% 
reported remaining 
negative influence on 
sex life 
Inna 2010 101 
J Sex Med 
Sexual function 
after LLETZ 
Thailand Aim - to examine effect of 
LEEP on overall sexual 
satisfaction and other 
specific aspects of sexual 
function in women with 
dysplasia. 
Questionnaire 
administered at one time 
point (after procedure) 
and asked about pre and 
post procedural sexual 
function. 
1. Questions about freq 
of sexual intercourse, 
dysmenorrhea, 
dyspareunia, post-coital 
bleeding 
2. Overall satisfaction 
with sex intercourse, 
sexual desire, vaginal 
lubrication/elasticity, 
orgasmic satisfaction, 
patient/partner 
satisfaction, anxiety - 
rated on 6 point Likert 
scale.  
Not validated - but 
designed by research 
team to suit population. 
n=89  women 
who had 
undergone 
LEEP at least 3 
months 
previously 
Changes in frequency of sexual 
intercourse, dysmenorrhea and 
dyspareunia not statistically 
significant Overall changes in 
overall satisfaction, vaginal 
elasticity and orgasmic 
satisfaction statistically significant. 
Authors conclude 
that unlikely that 
LEEP caused 
problems as any of 
the statistically 
significant 
differences relate 
more to 
psychological rather 
than physiological 
aspects 
Different to 
Hellsten 
which 
measured 
psychological 
aspects of 
sexual 
function. Inna 
main focus is 
on 
physiological 
aspects. 
Recall bias 
Asian pop - 
not 
generalisable
? 
7 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
Kilkku 1982 104 
Gynae Oncol 
Sexual function 
after conisation 
Finland Women undergoing 
conisation interviewed - 
about libido and sexual 
function. 
Methods not clearly 
explained. 
64 patients who 
had conisation 
during 6 month 
period. 
Interviewed 
before op, 6wks, 
6mnths and 12 
months post-op. 
Found significant decrease in no. 
of patients with dyspareunia. No 
change in libido, experience of 
orgasm, coital frequency orgasm, 
coital frequency, overall 
satisfaction with sex life. 
Seems to be saying 
sex problems no 
worse pre-op than 
post-op 
Very poor 
quality - 
crude non-
validated 
measures.  
 
1 
Lauver 1999 107 
J of Women’s 
Health and 
Gender-based 
medicine. 
Women's 
uncertainties, 
coping and 
moods 
regarding 
abnormal pap 
USA Aims - understand 
women’s coping process 
with abnormal smear and 
colposcopy. 
Examining influence of 
coping processes upon 
how individuals deal with 
stress/reaction to 
screening results. 
Problem-
focused/acceptance=ass
ociated with positive 
experiences, but 
emotion-focused or 
avoidance has also 
helped reduce anxiety for 
women with abnormal 
pap smears. 
Initial telephone interview 
(n=75), 
Follow-up Q before 
colposcopy (n=40) and 
n=35 completed post 
colposcopy Q. 
Measure - Uncertainty in 
Illness Scale - 17 items 
out of 23 (6 excluded as 
Women with 
abnormal smear 
requiring 
colposcopy, no 
previous history 
of colposcopy.  
Initial telephone 
interview (n=75),
Follow-up 
Questionnaire 
before 
colposcopy 
(n=40) and 
(n=35) 
completed post 
colposcopy 
Questionnaire. 
Uncertainty about abnormal pap 
smear decreased over time. 
Negative mood scores reflecting 
psychological distress did not 
change over time. 
Uncertainty about related 
positively to the coping strategy of 
catharsis as well to negative 
mood scores after receiving news 
and pre-colposcopy. 
Catharsis associated with higher 
negative mood scores, but 
acceptance associated with 
negative mood scores.  
Helpfulness of relaxation and 
diversion was assoc with lower 
negative scores.  
Clinical interventions 
can address 
women’s uncertainty 
and promote coping 
strategies to reduce 
psychological 
distress among 
women with 
abnormal cervical 
screening results. 
Small sample 
size. 
Focus upon 
coping 
styles. 
4 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
not deemed appropriate). 
Further 7 items used in 
prior studies related to 
abnormal smear. 
Coping processes 
assessed - patients 
reporting their use of 
coping strategies. 
Lauver 1999 108 
JOGNN 
Women's 
experiences in 
coping with 
abnormal 
Papanicolaou 
results and 
follow-up 
colposcopy 
USA Longitudinal descriptive 
study - telephone 
interviews after pap result 
and Questionnaire day 
before and after day after 
colposcopy 
Aim to delineate primary 
concerns women 
associate with abnormal 
pap results and 
colposcopy and to 
identify coping strategies. 
Telephone interview - 
open-ended questions re 
coping style (used in 
previous research). 
Questionnaire - asked 
again to think about main 
issues that troubled them 
n=75 with 
abnormal pap 
needing 
colposcopy 
completed 
telephone 
interview; n=40 
pre colposcopy 
Questionnaire; 
n=35 - post 
colposcopy 
Questionnaire 
No previous 
history of 
colposcopy 
Primary concerns involved not 
understanding pap result; cancer 
or infertility. 
Coping strategies most used and 
rated as most helpful - seeking 
support and distraction 
Nursing interventions 
should be considered 
to improve women’s 
understanding of 
meaning of pap, and 
encourage women to 
seek social support 
and distraction while 
awaiting colposcopy 
Non-
validated 
measures. 
Focus upon 
coping 
strategies 
rather than 
measuring 
specific 
adverse 
sequelae. 
6 
Marteau 1990 
112 
BJOG 
Anxieties in 
women 
undergoing colp 
UK Aim to measure level of 
distress in women 
referred for colposcopy 
and examine contributing 
factors to anxiety. 
Questionnaire 
administered before and 
after appt. 
n=30 (age range 
20-53) attending 
for first 
colposcopy 
Results - high anxiety in group 
Overall women significant less 
anxious after procedure 
 Poorly 
reported/desi
gned. Not 
clear about 
results. 
Nor sure how 
long after 
procedure 
1 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
STAI, and asked about 
specific anxieties in 
relation to 1. colposcopy 
itself, 2. what may be 
found, 3. perceived 
seriousness of problem. 
the survey 
was 
administered.
McDonald 1989 
60 
Gynae Oncol 
Impact of CIN 
diagnosis and 
treatment on 
body image and 
self-esteem 
USA Longitudinal study. 
Baseline data on self-
esteem and body image 
from fist visit and post 
surgery 
Questionnaire on 4 visits 
Initial visit (biopsy) 
1 week later (results of 
biopsy) 
Colposcopy/treatment 
3 weeks after surgery 
Questionnaire - 3 
sections 
1- demographics 
2- rate concerns with 
cancer, loss of SF, loss 
of reproduction, loss of 
attractiveness, medical 
procedure, partner 
rejection, STI’s 
3 - 7 items - adjective 
generation technique - 
self, body, medical 
condition, feelings 
towards partner, 
perception of how partner 
feels about her and her 
body. 
Not validated 
n=20 (age range 
15-40) attending 
colposcopy 
clinic 
Concerns over cancer overrode 
all other concerns except during 
post-surgery visit at which time 
loss of attractiveness was 
paramount. 
Loss of sexual function high at all 
visits. 
Self-esteem - lowest and anxiety 
highest at initial and post visit.  
Positive body image highest at 
post-surgery 
Psychological 
problems associated 
with CIN are present 
even prior to 
diagnosis 
Small sample
Short-term 
follow-up 
Non-
validated 
measures 
Baseline 
anxiety likely 
to be raised 
at first visit, 
so not a true 
baseline -  
No controls 
5 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
Richardson 
1996 116 
British Journal 
of Health 
Psychology 
Evaluation of 
cog-behavioural 
for distress 
associated with 
abnormal smear 
 
UK Prospective RCT looking 
at effect of provision of 
info and cog behavioural 
counselling on 
psychological 
adjustment. 
Measures - ASQ STAI, 
GHQ, POMS 
administered pre-
colposcopy, post-
colposcopy, pre-
treatment, post-treatment 
and 3 and 6 month 
follow-up. Also a 
counselling evaluation 
Survey after colposcopy. 
Women who 
had previously 
been informed 
of abnormal 
cervical smear 
result and 
subsequently 
required 
colposcopy and 
treatment. 
219 randomized 
into either 
counselling plus 
leaflet (n=104) 
or leaflet only 
n=115). 
High levels of distress on all 
measures in both groups pre-
colposcopy and significant post-
colposcopy reduction in distress 
in both groups. 
No significant diff in psychological 
functioning between 2 groups 
post colposcopy assessment. 
Minor difference at treatment and 
follow-up but following analysis 
these were interpreted as an 
artefact of baseline difference. 
Cognitive-
behavioural 
counselling plus info 
does not appear to 
have any incremental 
benefit over provision 
of information alone. 
 6 
Rubin 2010 117 
J of Lower 
Genital Tract 
Perceived 
uncertainty. 
Coping 
strategies 
 
USA Correlational study 
Aims to investigate 
relationships among 
uncertainty, knowledge, 
coping strategies and 
adaptation in young 
women having an 
abnormal pap and 
determine changes over 
time - i.e. on receiving 
news of pap; after 
colposcopy; receiving 
results of colposcopy; 4th 
month follow-up pap; 8th 
month follow-up 
colposcopy. 
Measured uncertainty at 
all time points and study 
also designed to 
88 non-pregnant 
women who had 
HPV on a mildly 
abnormal pap 
Relationship between uncertainty 
and coping strategies was 
supported in the emotion-focused 
path, but not in problem-focused 
path. 
Presence of 
uncertainty over time 
was established in 
this pop. Statistically 
significant 
relationships were 
confirmed among 
uncertainty, emotion 
focused coping 
strategies and 
adaption in this 
group. 
Concerned 
with 
relationships 
between 
psychological 
states rather 
than psycho 
outcomes 
per se. 
5 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
determine relationships 
between previous 
knowledge; uncertainty; 
coping strategies 
(emotion and problem 
focused) and adaption 
(body attitude, moods, 
promptness of follow-up). 
Mishall Uncertainty in 
Illness Scale; Ways of 
Coping checklist; Bipolar 
profile of Mood States; 
My Body Right Now 
Questionnaire. 
Serati  
2010 118 
J Sex Med 
Impact of Loop 
on FSF 
 
 
 
Italy Questionnaire study  
FSFI utilised at time of 
the LEEP and 6 months 
after. Comparisons 
drawn between pre and 
post LEEP questionnaire. 
n=67 sexually 
active women 
undergoing 
LEEP for CIN 
lesions 
(9 patients were excluded from  
final analysis as only completed 
sexual function questions before 
LEEP). 
In population - data showed 
overall sexual function was 
unchanged after LEEP, only 
‘desire’ (sexual interest) became 
significantly worse. 
LEEP does not affect 
women’s sexuality, 
when compared to 
before LEEP. 
Women’s SF 
may have 
been 
affected by 
diagnosis. 
Need base-
line that pre-
dated 
diagnosis - 
control group 
required.  
Small sample 
6 
Tahseen 2008 
121 
Euro J of Obs 
and Gynae and 
Reproduction 
Psychological 
distress 
associated with 
colp 
UK Prospective study 
Aims to understand 
factors associated with 
anxiety in relation to 
colposcopy and seek 
opinion on interventions 
designed to reduce such 
risks. 
Anxiety levels recorded 
n=50 first 
colposcopy 
appointment 
Prior to attendance - 36% very 
worried, 54% slightly worried, 
10% not worried. All found leaflet 
helpful to variable degree. During 
colposcopy 30% found video 
helpful but significant number 
(18%) found it increased worry.  
Women with pre-existing high 
anxiety least satisfied with 
Higher the index of 
anxiety - less likely 
they are to find 
interventions helpful. 
Research should 
focus upon very 
anxiety women 
No 
information 
on measures 
used. 
No control 
group 
4 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments Quality 
Score 
upon arrival at clinic and 
given Questionnaire to 
complete after 
colposcopy (- not sure 
how long after they were 
expected to return 
questionnaire. 
interventions. 
Valdini 2004 122 
J of Lower 
Genital Treat 
Disease 
Measurement of 
colp-assocaited 
distress 
USA Aim to illicit factors 
associated with distress 
in Latina pop. 
PEAPS-Q administered 
in 2 parts - before and 
after procedure (doesn’t 
state how long) 
202 Caribbean 
Latino 
colposcopy 
patients 
Most distress caused - around 
fear of cancer and worries about 
miscarriage 
Fear of cancer and 
dying 
 3 
Zeisler 1997 123 
Oncology 
Reports 
Psychological 
burden of 
women with 
mild CIN 
Austria Aim to evaluate the 
psychological distress of 
women after receiving 
abnormal pap. 
Questionnaire sent to 
women at least one year 
after their last colposcopy 
visit. 
Questionnaire - short - 
non-validated 
n=40 attending 
colposcopy 
clinic with CIN I 
(having had 
abnormal pap 
and directed 
biopsy). 
Divided into 
Group A (n=21) 
women who 
reported they 
hadn’t received 
sufficient 
information 
Group B -(n=19) 
had sufficient 
information 
Women with adequate info had 
less fear of cancer than 
inadequate information who also 
had increased distress. Group A - 
reported follow-up reinforced 
anxiety in comparison to group B. 
Compliance for regular 
attendance of screening 
significantly better in B 
Women should have 
adequate info as it 
improves 
psychological 
outcomes and 
improves compliance 
What is 
sufficient to 
one person 
may be 
insufficient to 
another. 
Poorly 
designed 
study. 
3 
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3.4.3 Comparing populations in terms of disease status 
 
This section will discuss those studies that report adverse psycho-sexual 
consequences in terms of disease status, (n=5). Table 3.13 outlines the data 
extracted for these studies. 
 
Five studies compared psychological outcomes between women with varying stages 
of disease progression, or who were disease free. Two studies scored five or below 
on quality assessment 57,110 with the remaining three studies of higher quality (scoring 
six or above). 54,88,92 Four studies were undertaken in the UK 57,88,92,117 and one study 
was from the USA.110 
 
Bell et al 88 compared women with mild/moderate dyskaryosis (under cytological 
surveillance, Group 1 n=75); women with severe dyskaryosis (first abnormal smear - 
referred for colposcopy, Group 2 n=75) and women with negative cytology (Group 3 
n=73) using validated measures. These were administered face-to-face on one 
occasion (Group 1 and 3) where administration took place one week before and one 
week after colposcopy. It is not clear at what time point Group 2 questionnaires were 
administered. The study found that overall, the impact of abnormal smear upon 
patients’ sex life was relatively small, although those undergoing colposcopy were 
more likely to experience reduced enjoyment. Distress was higher in women with an 
abnormality when compared with controls. Anxiety and depression levels were higher 
amongst those referred for colposcopy presenting with severe dyskaryosis, but fell 
following treatment, and the surveillance group in general had fewer psychological 
problems than the colposcopy group. Although this study focuses upon women in 
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terms of abnormality, it is not clear whether it is the level of abnormality that may 
cause adverse effects or the treatment modality. It does seem to indicate that 
receiving an abnormal result has some adverse psychological outcomes. Unlike 
studies that suggest that surveillance can have greater negative psychological 
consequences,86 this study seems to suggest that the treated group were at greater 
risk of such outcomes. 
 
Cairns et al 92 compare women treated for CIN 2/3 with women being treated for 
micro invasive cancer using validated measures and matched on age and year of 
treatment. It is not clear how long after treatment women were followed up. They 
found no significant differences on the HADS or POSM scores. Anxiety levels were 
the same in each group - 35% with a score greater than or equal to eight. This study 
provides reassurance for those undergoing treatment for micro invasive cancer, but 
as there is no control for the CIN group, the results in terms of the CIN group are 
more difficult to interpret. 
 
Campion et al 57 assess six aspects of sexual behaviour in four patient groups 
undergoing colposcopy that demonstrated varying levels of disease status. The two 
stage assessment took place via interview at initial appointment. At this stage, a 
detailed history was taken and patients were asked to explore six aspects of their 
sexual life in the preceding six months. Follow-up took place after patients had 
received the ‘all-clear’ and they returned five to six months after baseline. They were 
asked to complete the same questionnaire with reference to the preceding 5 to 6 
months. The authors found significant adverse psycho-sexual sequelae associated 
with diagnosis and treatment for CIN (Hellsten et al), which given the relatively long-
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term follow-up, indicates that such effects can be more enduring than found in other 
studies.61 
 
Lerman et al 110 compare women with a normal Pap result (n=106) and those with an 
abnormality requiring colposcopy (n=118) and found that the latter group had 
significantly elevated worries about cancer, impaired moods and effects upon their 
sex life and these were more pronounced in women who defaulted from initial follow-
up. 
 
Palmer et al 54 used validated measures to investigate the psychological effects of 
treatment for CIN, administering a questionnaire and interview with 20 women who 
had received news of abnormality and 20 women diagnosed with CIN. The study 
employed a short term follow-up (6 to 7 days post treatment or in the case the first 
group, 6 to 7 days after receiving result of abnormality). Women in the CIN group 
reported higher levels of psychological sequelae than the control group. It is unclear 
whether these impacts arose from the diagnosis itself or treatment or both, although 
the authors posit that given the data from the post-treatment interview, issues around 
the impact of diagnosis were pronounced. 
 
It is difficult to draw satisfactory conclusions from these studies about the nature or 
severity of psycho-sexual impacts. Where elevated worries are observed, it is 
uncertain if these arise from being diagnosed with an abnormality or whether adverse 
impacts can be attributed to treatment itself. 
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Table 3.13 Comparing populations in terms of disease status 
First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Total 
Bell et al 88 
1995 
Preventative 
Medicine 
Psychological 
response to 
cervical 
screening 
 
 
Scotland, 
UK 
Cross sectional - cohort 
Women interviewed at 
home and psychological 
adjustment was 
assessed Structured 
sociological interview 
covering 
sociodemographic 
information - past 
experiences etc 
1. HADS 
2. Self esteem 
measure 
3. Maudsley 
personality 
inventory 
4. Social 
adjustment  
5. Coping 
strategies 
Sexual function 
1. n=75 women 
with mild or 
moderate 
dyskaryotic 
smears, under 
cytological 
surveillance for up 
to 9 months 
(interviewed  on 
one occasion?); 
2. n=75 women 
referred for 
Colposcopy after 
first ever abnormal 
smear showing 
severe dyskaryosis 
(interviewed on 2 
occasions - 1week 
before, 1 week 
after colp);  
3. n=73 controls 
with negative 
cytology 
(interviewed  on 
one occasion?). 
SF - overall the impact of an abnormal 
smear on sex life was relatively small. 
Reduced enjoyment was more 
common in colposcopy group and 
reduced interest in the surveillance 
group. 
Distress higher among women with 
abnormal smear than controls. 
Anxiety/depression higher amongst 
those referred for colposcopy, but 
distress fell after treatment, but 20% 
remained highly anxious awaiting 
treatment. In surveillance - adverse 
psycho sequelae less acute but had 
more problems with social adjustment.  
Positive smear 
maybe 
psychologically  
traumatic for a 
significant 
minority, 
irrespective of 
management 
style. 
 
In contrast to 
Campion et al this 
study suggests 
less marked 
impact upon sex 
life, although this 
is a younger 
group and 
changes they 
found were 
evident only after 
biopsy/ LEEP 
No base line 
data. Cross-
sectional, so 
not long 
term. 
Short term 
follow up. 
Not clear 
when group 
1 and 3 
interviewed. 
6 
Cairns 2008 92 
Int J Gynecol 
Cancer 
Impact of 
microinvasive 
cancer of 
cervix on 
women 
UK Comparing concerns of 
women with 
microinvasive cancer 
and those with high 
grade CIN (CIN2/3). 
Population based, case-
control. 
Postal Q using HADS 
18 with micro-
invasive cancer vs. 
26 CIN 2/3 (age 
and year of 
treatment 
matched) 
diagnosed 
between 2000-
No significant difference in HADS 
scores between groups (18% 
cancer/12% CIN depression scores) 
35% anxiety in both groups. 
No significant difference in POSM or 
concerns of ongoing follow-up 
No difference is 
treatment of 
cancer vs. CIN. 
Comparators 
are cancer 
and CIN. To 
identify 
cancer 
patients had 
to go back to 
2000 were 
7 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Total 
 and POSM - not sure 
how long after procedure 
questionnaire sent 
 
2006. some may be 
6 years post 
diagnosis, so 
adverse 
effects may 
well have 
subsided.  
Campion et al 
1988 57 
Br J Obstet 
Gynaecol 
 
 
 
 
 
UK Before and after 
questionnaire assessing 
6 aspects of sexual 
behaviour before 
presentation and 6 
months after treatment 
n= 30 women 
referred for a 
colposcopy with an 
abnormal cervical 
smear; n=26 
women traced as  
sexual partners of 
men with HPV who 
had evidence of 
cervical disease, 
n=25 as above but 
no cervical disease 
n=25 partners of 
men with urethritis 
and no cervical 
disease) 
Statistically significant adverse psycho-
sexual sequelae associated with 
diagnosis and treatment of pre-
invasive cervical intraepithelial 
disease. 
Need for 
supportive 
counselling to 
help reduce 
anxiety 
Small sample 
size 
4 
Lerman 1991 
110 
Adverse 
psychological 
consequences 
of positive 
cytologic 
screening 
USA Aim to explore 
relationship of cervical 
cancer screening, 
positive and negative 
pap results and 
psychological status. 
3 months after Pap 
smear result  - 10 minute  
structured telephone 
interview. 
Measures - adapted from 
either Mental Health 
n=106 women with 
normal pap result 
compared with 
n=118 requiring 
colposcopy due to 
abnormality. 
Population - lower-
income minority  
 
Pap positive women statistically 
significant elevated worries about 
cancer, impaired moods, daily 
activities, sex interest and sleep. 
Effects of positive result more 
pronounced among women who did 
not comply with follow-up. 
Women who had completed follow-up 
(colposcopy) did not exhibit heightened 
worry, mod disturbance or sex interest 
problems compared with negative 
results. (Pap positive also more likely 
Health education 
targeted to 
psychologically 
vulnerable may 
reduce 
psychological 
distress. 
Recall bias 
Only one 
time-point 
Younger, 
black 
population 
5 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Total 
Inventory and previous 
work - non validated. 
Data gathered on socio-
demo status, screening 
history etc. 
Psychological variables - 
frequency of worry about 
cervical cancer; 
impairment of daily 
activities, tension and 
mood in past month; 
sexual interest; sleep. 
to be unemployed/less educational 
attainment) 
Palmer et al 
1993 54 
Br J Clinical 
Psychol 
Understanding 
women's 
responses to 
treatment for 
cervical intra-
epithelial 
neoplasia. 
 
 
 
 
UK Cohort - questionnaire 
Includes Qualitative 
semi-structured 
Interviews with women. 
Aim to investigate 
emotional effect of 
treatment for CIN using a 
control group (diagnosis 
only). 
Measured - anger, health 
locus of control, impact 
of events. 
Visited at home 6th day 
after receiving diagnosis 
and 7th day after 
treatment. 
Validated measures - 
Impact of events scale, 
STAI, Locus of control 
scale 
Total n=40. Group 
1 n=20 women 
who had received 
news of cervical 
abnormality 
Group 2 n=20 
diagnosed with 
CIN. 
To examine effects 
of treatment group 
2 compared on 2 
occasions - after 
diagnosis and after 
laser treatment 
20 women interviewed at home 6-7 
days after laser treatment reported 
60% changes in their feelings about 
sexual activity. 
Body and sexual relations suffer after 
diagnosis (because of CIN’s posited 
causal relations with STD wart virus) 
Women 
experience 
psychological and 
psycho-sexual 
problems after 
diagnosis and 
treatment for CIN 
Small 
sample, 
short-term 
follow up, so 
answer 
received may 
be related to 
impact of 
treatment 
rather than 
long lasting 
effect of 
diagnosis 
upon 
sexuality, 
qualitative 
6 
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3.4.4 Studies focusing upon the development and validation of a 
questionnaire 
 
Two studies89,58 focus upon the development of a questionnaire to measure the 
psychological effects of receiving an abnormal smear result and subsequent 
treatment and both were found to be reliable for use with this population. Table 3.14 
outlines the data extracted from these studies. 
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Table 3.14 Studies focusing upon the development and validation of a questionnaire 
First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Total 
Bennetts 1995 
89 
J Clin Epidem 
PEAPS-Q: a 
questionnaire to 
measure the 
psychosocial 
effects of having 
an abnormal 
pap smear 
Australia Outlines the development 
and validation of 
Questionnaire to measure 
psycho effects of abnormal 
pap. 
 
2 groups - 1. Received 
notification of abnormal pap 
attending 1st colposcopy. 
2. Had been followed up by 
at least one colposcopy. 
PEAPS-Q administered 
before colposcopy (except 
for Q about experience of 
colposcopy - completed 
post-procedure). 
GHQ administered also for 
validation of PEAPS-Q. 
Group 1, n=93 
Group 2, n=257 - this 
group was divided into 
first follow-up group 
(6mths) and second 
women having other 
than first follow-up. 
 
 
Four dimensions of distress 
identified -  
Experience of medical 
procedures - /beliefs and 
feelings about abnormality 
and changes in self-
perception/ worry about 
infectivity and effect on 
sexual relationships. 
 
PEAPS-Q is 
a valid 
measure of 
psychological 
morbidity 
Main focus on 
validation of Q, 
but does give 
results for 
domains of 
distress. 
8 
Doherty 1991 58 
J Psychosom, 
Obstet. 
Gynaecol 
Assessment of 
the 
psychological 
effects of an 
abnormal 
cervical smear 
result and 
subsequent 
medical 
procedures 
UK Uses Q - Abnormal Smears 
Q - to examine affective and 
cog reactions to abnormal 
smear and subsequent 
procedures. 
4 groups 
Measures -  
STAI, GHQ, ASQ 
 
 
n=80 attending 
colposcopy clinic or 
outpatient theatre for 
laser. Had been 
previously informed of 
abnormal smear and 
diagnosed with CIN. 
4 groups - pre-
colposcopy (n=25) 
Post colposcopy 
(n=25), 
Pre-laser (n=15), post 
laser (n=15) 
68% (n=54) - a little 
distressed, 21% (n=17) 
moderately distressed, 8% 
(n=6) severely distressed 
on at least 60% of the 
negative effect items with 
respect to abnormal result. 
Medical procedure - 66% 
(n=53) found it a little 
distressing, 21% (n=17) 
moderately distressed, 9% 
(n=7) very distressed on at 
least 60% of 5 negative 
items 
ASQ is 
useful 
standardised 
tool for 
assessing 
degree of 
distress  
Not clear when 
followed up. 
Main focus 
validation of 
ASQ 
3 
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3.4.5 Summary - Quantitative studies 
 
The first section of the systematic review focused upon the quantitative studies that 
looked at the psychological and/or sexual impacts of undergoing colposcopy or 
treatment for CIN. Due to the heterogeneity of the study designs, follow-up 
timescales and populations, the studies were grouped to enable a more coherent 
overview of the findings. The over-arching finding from the studies comparing 
biopsy/colposcopy surveillance with treatment was that there were no differences in 
outcomes between these groups. The higher quality studies concluded that any 
adverse outcomes were short lived in nature. Similar findings were observed with the 
studies comparing cytological surveillance and colposcopically directed treatment.  
 
Studies focusing upon one cohort, rather than comparing across intervention 
modalities also indicated that any psycho-sexual morbidities were transient in nature. 
Studies that compared populations in terms of disease stage/status were less 
equivocal in their findings as it was difficult to disentangle the impact of receiving a 
diagnosis of an abnormality from the treatment itself. The main findings are 
discussed in more detail in Section 3.6. 
 
3.5 Qualitative results 
The next section will present the findings from the five qualitative studies included in 
the review. The data extracted from these qualitative studies are presented in Table 
3.15.
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Table 3.15 Qualitative studies 
 
First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
Beresford 1986 
59 
Colp and Gynae 
Laser Surgery 
The emotional 
impact of 
abnormal pap 
smears on 
patients referred 
for colposcopy 
Canada Qualitative interviews after 
colposcopy (undertaken by 
clinical psychologist) 
including some Likert 
questions to rate concerns. 
Open-ended questions 
‘what was it like for you?’ 
using experiential 
humanistic theory. 
Lasting 30 minutes 
n=50 with CIN 
(various grades) 
referred for 
colposcopy 
directed biopsies 
following 
abnormal pap 
smear. 
Four major areas of concern 
identified 
Fear of cancer - 100% of patients 
(70% severe intensity); 
Fear of reproductive loss/sexual 
function (68%) 
Fear of procedure itself (65%) 
Fear of bodily betrayal (62%) 
 
Suggestions for 
improvements  - 
physicians 
inform of result 
directly; 
descriptions of 
pap smears; 
written 
information 
Poorly 
reported. 
Vague 
methodology 
given for 
data 
gathering 
and reporting 
results. 
2 
Hounsgaard 
2007 98 
Euro J of Oncol 
Nursing 
Facing possible 
illness detected 
through 
screening 
Denmark Qualitative study - to gain 
knowledge about women’s 
perceptions of illness - 
based upon detected 
abnormal screen. 
Observation/Interviews + 
fieldwork. 
Theoretical underpinning - 
Ricoeur theory of ‘critical 
interpretation. 
Participants followed over 
2 year period at various 
stages in their treatment. 
n=12 with 
diagnosis of 
potential illness 
n=7 required 
treatment 
n= no treatment 
(monitored by 
pap) 
Main themes identified - feeling 
healthy/being healthy + potentially ill 
at the same time. 
Being a patient and suffering. 
Diagnosis of abnormality caused 
participants to feel anxious. Anxiety 
subsided 6 months after treatment. 
Non-treated group anxiety flared at 
check-up times. 
Biomedical 
model 
juxtaposed with 
patients 
experience - 
patients feeling 
they have early 
stage cancer 
despite (pre-
stage Vs actual 
cancer  
Fits in with 
Quant 
studies 
comparing 
impact of 
different 
treatments, 
giving a 
useful 
theoretical 
overview 
6 
Juraskova 
2007 103 
Psycho-
Oncology 
What does it 
mean - 
uncertainty, 
trust, 
communication 
Australia Qualitative 
Semi-structured telephone 
interviews (Grounded 
theory). 
Aim to identify factors that 
influence women’s 
experience of diagnosis 
and treatment and whether 
these continue long term. 
Follow-up - immediately 
n=21 (aged 24-
54) women with 
CIN who had 
LLETZ (varying 
degrees of CIN) 
Main themes identified 
Pre-treatment - shock, fear anxiety 
exacerbated by feelings of 
uncertainty. 
Post-treatment - negative replaced 
by positive - relief, empowered, 
main concerns - risk of developing 
cancer/reproductive probs. Feeling 
loss of trust in body. 
Communication - Attitudes towards 
So, initial relief, 
but still fear of 
cancer. Study 
suggests 
negative 
impacts can be 
enduring 
Fits in with 
literature r.e. 
cancer fears  
 
6 
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First author; 
year; journal 
Country Study design and 
methods 
Population Results Authors 
conclusion 
Comments QA 
Score 
post-treatment 
8 months post-treatment 
partner - positive and negative. 
Doctor communication - easier to 
cope if positive experience with 
Doctor 
Mortensen 
2010 113 
J Public Health 
Qual study of 
women's 
anxiety and info 
needs 
Denmark Focus groups and 
individual interviews 
12 women with 
diagnosis of 
cervical dysplasia 
within last 3 
months of having 
had conical 
section in last 6 
months. 
Age range 25-35 
Participants considered CD to be a 
highly distressing condition and 
experienced monitoring as a 
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Four of the included qualitative studies were identified following the search strategy 
outlined in Section 3.4.59,98,103,113 One further study was identified via a citation 
search for relevant studies.34 Two studies were of poor quality, scoring five or below 
on quality assessment59,34 with the remaining three scoring six or above. ,98,103,113Two 
Danish studies were included,98,113 and one study from Australia, Canada and the UK 
respectively. 103,59,34 
 
Beresford el al’s 59 study aims to explore the particular emotional concerns that may 
arise following diagnosis of cervical abnormality. The authors interviewed 50 women 
with a diverse range of CIN disease grades. The participants were relatively young, 
with 58% being under 30 years of age. The quality of the study is hampered by a lack 
of explanation or detail in terms of the sampling strategy, description of data 
collection, analysis and discussion of the findings. The main results are expounded 
with the use of quotations, although these were limited and this hampered the 
authors’ ability to demonstrate fully the conclusions being drawn. Four main themes 
are described by the authors, identifying the main areas of concern to be: 
 
 Fear of cancer (100%) 
 Fear of reproductive problems (68%) 
 Fear of the procedure itself (65%) 
 A sense of body betrayal (62%) 
 
The first three themes have been routinely identified in the quantitative literature as 
well as the other qualitative studies. The notion of ‘body betrayal’ is attributed to the 
feelings that women, especially younger, ostensibly healthy women, may experience 
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in learning that they have an illness. Fear of reproductive problems could also be a 
particular concern in the age demographic where many women will not have had 
children and good reproductive health will be of considerable importance to them. 
However, there is scant discussion of these findings, diminishing the impact of the 
study. The authors suggest a number of service improvements, but do not justify 
these recommendations in the light of their results. 
 
Hounsgaard et al’s 98 study is comparatively well designed and provides a clearer 
methodology and exploration of their findings. Their aim is not to focus upon 
providing a framework for a general understanding of illness, but rather to understand 
the perceptions of illness for those women involved in the study. The study is 
longitudinal in design following women over a period of months and again the sample 
is relatively young (mean age 32 years) with no history of serious illness, with a 
diagnosis of moderate to severe cervical abnormality. The theoretical framework 
(phenomenological), study design, context, methodology and analysis plan are well 
described. The design is such to explore the progression and changes in participants’ 
experience of illness over a period of time, taking into account the various stages of 
pre-treatment, treatment and post-treatment. Three main themes arose from data 
analysis:  
  
 Notions of being healthy and potentially ill  
 Being ‘a patient’ and suffering 
 Being unable to work and suffering 
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These themes are presented in the context of the wider literature and the authors 
conclude that receiving an abnormal smear result is a significant event that raises 
worries about mortality, but such events may also be seen as opportunities for 
personal growth. The authors discuss these themes in the context of the biomedical 
model versus the patient/lay model of illness. Many women undergoing cervical 
screening are under the misapprehension that cervical screening is a test for cancer. 
Health care professionals need to take into account the lay person’s knowledge and 
understanding of the kinds of treatment they are undergoing. This study provides a 
useful thematic overview of the kind of concerns this population have - fear of cancer 
and of painful treatments and as identified in Beresford et al, the unsettling position of 
feeling well, whilst being diagnosed with an illness. 
 
Juraskova et al 103 have a slightly different focus in that they aim to identify factors 
that may influence how women experience diagnosis and treatment and to see if 
these continue in the long-term. Women were recruited at various time-points 
(immediate post-treatment up to eight months post-treatment) and with a range of 
abnormalities. The interviews were conducted via telephone, as patients lived within 
a wide geographical area. The context and methodology are adequately described 
and a grounded theory approach is used to aid analysis. Results are presented 
clearly and quotations are used to illustrate the themes that emerge and these are 
discussed in the context of pre- treatment and post-treatment: 
 
 Uncertainty  
 Trust in the body 
 Communication 
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During the pre-treatment phase, the overriding feelings are of shock, fear and anxiety 
bought about by a sense of uncertainty. Following treatment, women experience a 
sense of relief and empowerment, although concerns persist about having/getting 
cancer, and worries about future fertility. A sense of feeling a loss of trust in one’s 
body is a prominent theme, and women’s experiences are ameliorated by a positive 
relationship with the doctor performing the procedure. 
 
Mortensen et al 113 used a focus group and interview approach for data collection to 
examine the experiences of women (aged 25 to 35) with varying disease status and 
those treated by conisation and those who were not. The authors also investigated 
whether knowledge of human papillomavirus as the cause of dysplasia had any 
bearing on women’s perception of disease. The context, methods and results are 
well presented and analysis was undertaken using a discourse theoretical approach. 
The main themes identified were as follows: 
 
1. Discrepancy between severity of dysplasia and level of anxiety experienced. 
For some women with lower grade disease who had not been conised, levels 
of anxiety were more pronounced when compared to those with higher grade 
disease who had been treated. This may indicate that the mere diagnosis of 
dysplasia is of concern irrespective of severity. As seen in Balasubramani et 
al,86 Naik et al 114 and Orbell et al 115 being treated at the outset can have 
more positive psychological outcomes. 
2. This notion is reinforced by the fact that those who were treated felt a sense of 
reassurance. These women had also received more information than the 
untreated group which was also found to be reassuring. This is in contrast with 
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other quantitative studies that do not to support the notion that greater levels 
of information and knowledge have a bearing upon positive psychological 
outcomes (Freeman-Wang et al,94 Howells et al 99). 
3. Effect of information about the role HPV role as a cause of dysplasia. Women 
who did not know about HPV were concerned about getting cancer, whereas 
those who had learned about its role in cancer did not feel stigmatised or 
overly concerned about the fact that it was a sexually transmitted disease. 
4. As seen in Juraskova et al, women’s levels of concern were dependent upon 
the rapport with the medical professional and the amount of information they 
had received. The contrast between the medical and lay language model were 
highlighted (Hounsgaard et al) with women’s anxiety levels being exacerbated 
by the use of terminology to describe their disease - ‘precursor to cancer,’ and 
‘precancerous legion’. 
 
In conclusion, the authors highlight the importance of realising the fears that women 
experience regardless of disease stage and the need to ensure that adequate 
information is provided and that health care professionals have the ability and 
interpersonal skills to communicate effectively with patients. 
 
Posner and Vesey’s large qualitative study34 investigating the psychological, psycho-
sexual and physical impacts of undergoing cervical screening and subsequent 
treatment was the first of its kind to explore women’s experiences.  They used ‘semi-
structured’ interviews with 153 colposcopy patients and although the aim of the study 
is to explore experiences, the study is limited by the nature of data collection as the 
interviews are underpinned by a list of prescriptive questions that may introduce 
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concepts and issues that may not have arisen had the questions not been phrased in 
such a manner, leading to the possibility of researcher bias. Nevertheless, the study 
is important as it is a thorough exposition of women’s responses and raises a number 
of important aspects of the experience of diagnosis and treatment for CIN as well 
making a number of recommendations for treatment providers. 
 
Women’s emotional upset on receiving an abnormal smear result was found to be a 
recurring theme and knowledge deficit around the nature of their diagnosis and fear 
of cancer were contributing factors to this upset. The study presented previously 
unreported experiences of the pain associated with treatment of the cervix that 
hitherto, had been poorly recognised in the field of gynaecological medicine. The 
sense of relief that can follow treatment is also raised as positive aspect of women’s 
experiences. Information accompanying treatment also helped move women away 
from feelings of fear and distress. 
 
The findings from the qualitative studies all seem to suggest that fear of cancer and 
fears around future fertility are prominent issues for women. Five of the studies 
interview younger women,34,59,98,103,113 and therefore, concerns about reproductive 
health are unsurprising. Fear of cancer is a recurring theme through most of the 
studies cited in this review (quantitative and qualitative) and the contrast between lay 
and medical language around diagnosis of cervical abnormality appears to be a 
cause of confusion for patients who mistakenly conflate CIN and cancer.  
 
Feelings of body betrayal also feature in the qualitative literature and such feelings 
are likely to be compounded by the largely asymptomatic nature of cervical disease. 
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Unlike other serious illnesses, there is often little or no warning of the fact that 
women are living with a cervical abnormality. This clearly has a disarming effect upon 
how women relate to their own bodies.  
 
As we see with many interactions between patients and health care professionals, a 
great deal of importance is placed upon the ability of the professional to show 
compassion and care towards a patient as well as the importance of providing the 
patient with adequate and timely information that can help patients feel more at ease 
and less anxious. As commented previously, some of the quantitative literature is 
less than conclusive with regards to the benefits of having adequate information and 
its effect upon anxiety and levels of worry with two studies reporting that it may have 
the opposite effect 94,99 and other studies highlighting that adequate information can 
reduce anxiety levels.91,123 
 
3.6 Discussion 
 
3.6.1 Summary of the main findings 
 
The purpose of this review was to provide an overview of the studies measuring the 
potential adverse impacts upon psychological and psycho-sexual well-being following 
screening and/or treatment for CIN. As outlined, study aims and design, methodology 
and follow-up time-frames are insufficiently homogeneous to enable a meaningful 
meta-analysis of the results to be drawn. The quality of the studies included range 
from the poorly designed to higher quality, robustly designed studies. 
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It is difficult to draw over-arching conclusions, but it is clear that there are a number 
of potential adverse effects that may arise from undergoing colposcopy. The main 
areas of interest would appear to be how enduring these are; whether they are 
dependent upon the management style offered to women and whether participant’s 
psychological profile has any influence upon outcomes. 
 
The studies focusing upon comparing two treatment modalities concluded that either 
see and treat was preferable to defer and treat, or defer and treat was preferable to 
see and treat. The studies concluding there were no significant differences between 
either management approach tended to be of better quality and in the main had a 
longer period of follow-up. In cases where see and treat was deemed to be 
preferable, the reasons given were that patients felt more in control and that anxiety 
was reduced due to the fact that they felt that their abnormality had been treated.  
 
Studies indicating that surveillance may cause lower levels of psychological burden 
found that patients treated immediately may experience more anxiety relating to 
future fertility and effects of treatment upon sexual performance. The studies that 
found no significant differences between treatment and surveillance groups 
acknowledged that women do experience adverse effects including loss of libido and 
higher anxiety and depression scores in the short term, but that these are largely 
transient. The lack of difference between the groups is more likely to be explained by 
the fact that it is the nature of the diagnosis and feelings about ‘body betrayal’ that 
account for psychological sequelae, rather than the treatment itself. 
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Studies focusing upon one treatment employed either long-term or short-term follow-
up. The more robust studies looking at long-term follow-up found that any increased 
psychological morbidities tended to be transient in nature. Studies asking women 
about particular fears and anxieties associated with colposcopy found that fear of 
cancer and fear about future fertility featured prominently as found in the qualitative 
literature. 
 
Overall, it would appear that diagnosis of cervical abnormalities and follow-up 
treatment (whether immediate or deferred) can cause elevated levels of anxiety and 
problems with sexual functioning to a greater or lesser degree, but in general, these 
are unlikely to persist in the long-term.  
 
In general, anxiety levels would appear to be largely transient, being raised post-
diagnosis and pre-treatment but subsiding once treatment is complete. Sexual 
functioning problems appear to be more enduring, although in general, long term 
studies suggest that these too dissipate over time. Further, it would seem important 
to consider the influence of the particular psychological and coping profiles upon how 
a patient experiences diagnosis and treatment. Studies that take into account the 
psychological profile of participants importantly acknowledge that how individual 
women respond to diagnosis and treatment will be largely dependent upon any pre-
morbid psychological or psycho-sexual difficulties they may have as well as how they 
typically manage health-related problems. 
 
It would seem that a balance between benefits and harms needs to be struck. Being 
able to predict which women are likely to experience less adverse events depending 
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upon the treatment type offered is likely to be dependent upon a number of factors 
that it may be difficult to control for - personality types, coping style and stage of 
disease. 
The evidence related to the psychosexual impacts of undergoing colposcopy or 
treatment for CIN is heterogeneous in nature. There are adverse impacts identified 
from the literature, but overall, such impacts are relatively transient in nature. 
 
 
3.6.2 Limitations of this review 
 
Although the aim of this review was to investigate the adverse psychological and 
psycho-sexual sequelae associated with diagnosis of and/or treatment for CIN, the 
heterogeneity of included studies in terms of sample size, study design, follow-up 
time points and use of measures means that the generalisability of the results is 
difficult to establish. Furthermore, a number of studies were undertaken outside of 
the UK and therefore the extent to which the findings are applicable to the UK is 
limited. 
 
Treatment options available for the diagnosis of cervical abnormalities/management 
of CIN have changed over the years. It is plausible that newer management 
techniques reduce the extent of adverse events for women undergoing surveillance 
of treatment. As the year of publication for included studies ranges between 1988 
and 2010, this fact needs to be borne in mind when interpreting the findings and 
recommendations for future service provision outlined in earlier studies. 
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3.6.3 Conclusions 
 
The current evidence available examining the potential adverse psycho-sexual 
outcomes of treatment for CIN are heterogeneous in scope, design, setting, 
population and quality. These facets of the evidence limit the ability to draw 
unequivocal conclusions about the extent of adverse events associated with 
colposcopy and treatment for CIN. This review has confirmed the need to undertake 
a well-designed and sufficiently powered study to investigate any potential long-term 
adverse effects arising from colposcopically directed investigation and treatment.  
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CHAPTER 4: FEMALE SEXUAL DYSFUNCTION - A 
CONTESTED NOTION 
 
 
What are the current debates related to the existence of female sexual dysfunction? 
 
One of the primary aims of this study was to ascertain the effects of undergoing 
colposcopy or treatment for CIN upon women’s sex life. As the measure employed to 
explore ‘sexual function’ seeks to categorise women with or without ‘sexual 
dysfunction,’ it is important to highlight the potential pitfalls of categorising sexual 
problems as a ‘dysfunction’. This chapter will focus upon the development of female 
sexual dysfunction (FSD) as a clinical diagnostic tool and will outline some of the 
arguments that both support and challenge its use within medicine.  
 
Female sexual dysfunction is a contested concept. Some commentators argue that 
medicalisation and the ‘need to treat’ female sexual function is a misguided 
standpoint. The motivation to ‘treat’ FSD became prominent following the ‘treatment’ 
of erectile dysfunction with pharmaceuticals (Sildenafil). This led to the growth of 
interest in the area of ‘treating’ ‘female arousal disorders.’ It is argued that this a 
problematic proposition, not least because female (and male) sexuality are complex 
and multi-faceted phenomena. Sexuality may be considered in physiological terms 
but the psychological and emotional aspects of the phenomena are also integral to 
‘sexuality’. Furthermore, there are also important cultural and political aspects of 
sexuality. 
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‘Dysfunction’ is a value laden term and carries with it the sense that a person’s 
sexual behaviours or desires are somehow malfunctioning. The literature pertaining 
to the creation of the concept of FSD and the arguments that challenge the 
‘reductionist’ model of how best to understand human sexuality will be described. 
The first characterisation of the ‘female sexual response’ cycle was posited by 
Masters and Johnson in 1966.124 It was classified as consisting of four phases - 
excitement, plateau, orgasm and resolution. In 1979, Kaplan125  proposed a three 
phase model (desire, arousal and orgasm) and this later became the basis for the 
Diagnostic and Statistical Manual of Mental Disorders (4th edition).126  
 
Laumann and colleagues’ work in the late 1990’s 127 focused upon sexual dysfunction 
(SD) in men and women and characterised it by ‘disturbances in sexual desire and in 
psycho-physiological changes associated with sexual response cycle of men and 
women’. Laumann et al acknowledged that epidemiological data is scant, but noted 
that the recent interest was sparked by two main areas of ‘progress’: increased 
understanding of neurovascular mechanisms of sexual response, and the availability 
of new drugs. These factors led to more people requesting help and Laumann et al 
realised the potential benefit of providing epidemiological data to explore the 
prevalence and predictors of SD. They postulated that such data would help to 
develop the kinds of services required and how best to deliver these. 
 
The authors also argued that the ‘changing cultural values’ and ‘demographic shifts’ 
have influenced an increase in ‘sexual concerns’. Laumann et al’s paper analysed 
data from the National Health and Social Life Survey 1992 (NHSLS)140 to address 
these issues. This survey collected data on aspects of sexual behaviour including 
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problems and dysfunctions, health and lifestyle variables and socio-cultural 
predictors. The NHSLS analysed interviews with 1,410 men and 1,749 women (age 
range 18 to 59 years). Findings were presented according to seven dichotomous 
response items, looking at symptoms in past 12 months relating to: 
 
 Lacking sexual desire 
 Arousal difficulties (erection/lubrication) 
 Inability to climax 
 Anxiety about sexual performance 
 Premature climax 
 Pain during intercourse 
 Not finding sex pleasurable 
 
The main outcome measures were the risk of experiencing SD as well as other 
negative concomitant outcomes. The prevalence rates of SD for women were 43%. 
SD was found to be associated with age and educational attainment, with those 
achieving high levels of attainment half as likely to experience sexual problems. It 
was noted that women of different racial groups experienced different levels of SD - 
for example, black women experienced lower levels of sexual desire, whereas 
Hispanic women experienced a lower rate of problems with sexual desire. SD was 
also found to be more common among men and women who had poor 
physical/psychological/emotional health and those who had had negative 
experiences within particular sexual relationships. The authors concluded that SD is 
a real and important public health concern and they acknowledged the role that 
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emotional/psychological problems may contribute to the experience of such 
problems. 
 
Jennifer Berman, professor of urology at the University of California, along with Laura 
Berman and Irwin Goldstein,128 published a paper outlining the classifications and 
definitions of FSD agreed at the 1998 AFUD (American Foundation of Urologic 
Disease) consensus panel. The paper also outlined the aetiologies of FSD before 
considering some of the treatments available. Berman’s approach explores sexual 
(dys)function from a predominantly medical perspective focusing upon hormonal and 
physiological changes. However, in conclusion she also acknowledges the 
importance of ‘psychosocial’ evaluations of sexual dysfunctions as well as the 
importance of a collaborative approach between therapists and physicians. She also 
makes clear that FSD is distinct from male dysfunction. This is an important 
acknowledgment, although the tone of the article is largely devoted to approaching 
female sexuality from a medical/physiological angle. 
 
Moynihan’s paper129 questions the motivations behind defining a disorder - namely 
Female Sexual Dysfunction (FSD), presenting the arguments in the debate from the 
pro-medical to the non-medical end of the spectrum. He indicates that in order to 
market similar drugs for women, a ‘clearly defined medical diagnosis’ is required 
before clinical trials for potential medications could go ahead. 
 
The ‘milestone paper’ ‘Sexual dysfunction in the United States: prevalence and 
predictors’ (Lauman et al) estimated prevalence of FSD for women between 18 to 59  
as 43% although concerns were raised - if women answered yes to only one of the 
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seven questions they were characterised as having FSD. Sandra Leiblum believed 
FSD to be far less prevalent and has argued that the figure of 43% has contributed to 
the over-medicalisation of women’s sexual dysfunction. Similar concerns were raised 
by Dr John Bancroft, director of the Kinsey institute, who believed the term 
‘dysfunction’ to be highly misleading. He noted that inhibition of sexual desire may be 
healthy and appropriate in many circumstances.131  
 
Moynihan explains that the focus of male sexual dysfunction was upon erectile 
dysfunction, a physically measurable condition. To be able to ‘measure’ female 
dysfunction in order to ‘treat’ it, researchers like Goldstein were cited as developing 
animal modes of ‘vaginal engorgement insufficiency’. Goldstein used data from other 
studies concerned with comparing testosterone levels of ‘normal’ women with those 
of his patients and reported at a Pfizer sponsored conference (December 2002) that 
women with FSD might have ‘specific defect in steroid synthesis’. Goldstein cites the 
43% prevalence of FSD and is steadfast in his belief that it represents ‘dysfunction’ 
rather than ‘difficulties’ as suggested by Liebman and other commentators. 
Furthermore, Goldstein vociferously defends the importance of the collaboration 
between the pharmaceutical industry and medicine in ‘treating’ ‘this new disorder.  
 
In contrast to Goldstein, Moynihan sited the work of Tiefer et al in promoting a 
‘women-centered definition of sexual problems: ‘discontent or dissatisfaction with any 
emotional, physical, or relational aspect of sexual experience,’ with sociocultural, 
political/economic, psychological or medical causes. Tiefer aruged that sex cannot be 
defined in the context of the medical model that looks at health and sickness. To do 
so is to commit a category error. In conclusion, Moynihan indicated that there are 
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some benefits of the medical model of FSD in the sense that it humanises the 
doctor/patient relationship, leads to effective/safe drugs, and increases public and 
research attention about the complexity of FSD.  
John Bancroft’s 2002 paper further urged caution in the ‘treatment’ of sexual function 
in women.130 He contextualises the ‘Viagra phenomenon’ and how it has become 
relevant to women’s sexuality. He argues that although Viagra has enabled millions 
of men to improve erectile function, and this may be a positive for many women, 
there may be some women for whom this is not such a cause for celebration. 
Furthermore, he charts the brief history of how female sexuality has, at times 
throughout history, been suppressed. The Victorian era in particular conflated female 
sexual enjoyment with malady and madness. Following this period, the phenomenon 
has been largely ignored until the permissive era of the 1960’s when women’s 
burgeoning sexual freedoms were realised with the introduction of the oral 
contraceptive. More recently, there has been increased attention paid to not only the 
potential harms caused by steroidal contraceptives, but also to the impact of 
procedures like hysterectomies upon female sexual health. 
 
Bancroft urges caution in terms of how we conceive sexual function, initially citing the 
differences in male and female sexuality. He notes that male and female sexuality 
have become more similar of late (sexual freedom) but that whereas men’s sexuality 
has been largely ‘directed  and shaped but not suppressed by social determinants’ 
women’s sexual expression should be viewed more profoundly through the prism of 
socio-cultural changes. Male sexuality is more clearly understood in relation to 
hormone levels, whereas female sexuality and desire would appear to be multi-
factorial or less predictable in terms of hormonal levels and physiological factors. The 
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connection between orgasm and reproductive function is fundamental for men, but 
not so for women. Bancroft discusses the sexual response cycle as the underpinning 
theory for much of the recent sex therapy. This theory has been widely criticised by 
feminists as it would seem to equate the male and female response to sex as well as 
suggesting that a ‘normal’ sexual response for a women would be characterised by 
achieving orgasm through intercourse. It seems to ignore the fact that for women, 
this may be only one aspect of their sexuality. Furthermore the underlying 
assumption that men and women have an ‘equal’ relationship may not be a reflection 
of certain societal norms where gender equality may not be a reality. Sex therapy, he 
suggests, also seems ‘in the dark’ when it comes to understanding the interface 
between the ‘psychological processes and the physiological mechanisms involved in 
sexual response.’  
 
Bancroft’s final point focuses upon the use of ‘sexual dysfunction’ as an appropriate 
description for phenomena that may be better described as a ‘sexual problem.’ It is 
important to contextualise and understand that a diminished female sexual response 
maybe due to the relationship a women has and the fact that it just does not excite 
her. It seems curious to describe such a response as a dysfunction. Bancroft 
acknowledges that there are women for whom a pharmacological intervention will be 
appropriate, but it is important that these interventions are not the default setting for 
managing sexual problems. 
 
In 2003, Bancroft published the results of a study whose aim was to assess the 
prevalence of distress about sexuality amongst women and examine the predictors of 
such distress. Notably, his use of the term ‘distress’ is a move away from the 
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medicalised language of ‘dysfunction’.131A telephone survey was conducted in the 
USA with 987 white/Black African women (aged 20 to 65) who had been living for at 
least six months in a heterosexual relationship. A quarter of women reported ‘marked 
distress’ about their relationships or sexuality and the best predictors of this were 
their sense of general emotional well-being and emotional relationship with their 
partner during sexual activity. Bancroft suggested that these predictors do not fit well 
with the DSM-IV criteria for SD in women. Furthermore, he posited that the data 
discussed by Laumann et al was gathered using a very crude tool that does not 
explore responses beyond a yes/no categorisation. Surely women may interpret the 
questions differently and without looking at what is behind the responses it is difficult 
to assign a ‘diagnosis.’  
 
Cynthia Graham, an academic who like Bancroft and Moynihan, is cautious of the 
use of pharmaceuticals to treat female sexual problems, also comments about the 
concern felt by her and other commentators about the utility of the term ‘female 
sexual dysfunction’.132 In response to the increasing concern about the 
medicalisation of female sexual function she notes that recent research has focused 
upon challenging the medical model’s focus upon ‘correct genital performance,’ and 
instead positing the importance of relationships and the emotional responses to 
sexual situations. Like Bancroft, she challenges the 43% prevalence rate of SD as it 
is based upon responses to very limiting questions. She notes that it is important to 
be able to distinguish between ‘transient’ sexual difficulties that may be the result of 
situational stresses (adaptive rather than dysfunctional) and longer term dysfunctions 
that may arise from illness, physical trauma or the effects of medications. 
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Unlike Laumann, Graham is uncomfortable with the close associations between 
sexologists and the pharmaceutical industry and sees the need for wider outcome 
research to evaluate the effectiveness of psychological interventions to treat sexual 
problems.  
 
This chapter highlights the debates around the notion of female sexual dysfunction. 
The aim of the study reported in this thesis was to establish whether undergoing a 
colposcopy, or being treated for CIN carries with it an excess risk of female sexual 
dysfunction. Commentators have questioned the utility in attempting to ‘diagnose’ 
female sexual dysfunction when female sexuality is such a complex issue involving 
the interplay between various psychological, social, cultural, environmental and 
physical factors. It is important that this is borne in mind when drawing conclusions 
about how many women in this cohort have FSD. Although the Female Sexual 
Function Index (FSFI) is the ‘best’ yet measure of female sexual problems, the 
limitations of its use in this study are outlined in Chapter 5.  
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CHAPTER 5: STUDY METHODOLOGY 
 
5.1 Study design - an overview 
 
What methods were employed to investigate the long term impacts of undergoing 
colposcopy or treatment for CIN? 
 
This chapter will outline the methods used in the cohort study reported in this thesis 
and will include details of the study design, population, and details of recruitment. 
 
Following the systematic review, which assessed the existing evidence base of the 
adverse psycho-sexual impacts of colposcopy, the main element of primary data 
collection for this research was the undertaking of a cohort study, with women who 
had undergone colposcopy within a defined period (stratified by level of intervention) 
in order to assess the impact of colposcopic interventions on psychological health 
and sexual functioning.  
 
Data were collected via a two stage questionnaire survey administered by post. Data 
on a number of sociodemographic variables (age, deprivation, ethnicity) were 
obtained, in addition to information relating to the quality of life and sexual function 
derived from a number of validated measures incorporated into the questionnaires 
used. 
 
Women who underwent colposcopy between 31st March 2008 and 1st April 2009 
were identified from the records of participating hospitals in the West Midlands. The 
main outcome measures utilised were HADS (Hospital Anxiety and Depression 
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Scale) to measure anxiety and depression;133 FSFI (Female Sexual Function Index) 
to measure sexual function134 and WHOQOL-BREF (World Health Organisation 
Quality of Life - brief version) to measure quality of life.135 Results were analysed by 
linear and logistic regression (using SPSS) in order to assess the best predictors of 
experiencing problems. 
 
Ethical approval for the study was obtained from The Black Country Research Ethics 
Committee on 15th March 2010. REC reference number: 10/H1202/9. 
 
5.2 Quantitative data collection using questionnaires 
 
The study utilised postal questionnaires to collect both quantitative and qualitative 
data. Questionnaires enable statistical information to be calculated from the data 
collected and allow investigation of any associations between the variables being 
studied.136 In this study, the primary associations of interest were whether the level of 
treatment, age or socioeconomic status had any significant association with sexual 
function, psychological health and quality of life outcomes.  
 
Questionnaire one collected basic data around sexual function, satisfaction with 
relationships, and general physical and psychological health. This questionnaire also 
included an open comment section to enable participants to provide other information 
or comments about the topic area that do not readily emerge from closed questions. 
Questionnaire two was sent to women who had agreed to participate in the second 
stage of the survey and collected more detailed information of outcomes and the 
predictors of adverse outcomes following colposcopy.  
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5.3 Study Population 
 
5.3.1 Colposcopy unit selection 
 
The initial study design outlined recruitment from five colposcopy units - three from 
within the West Midlands (Birmingham Women’s Hospital, Good Hope Hospital and 
City Hospital); one unit in Oxford (John Radcliffe) and one unit in Wales (Wrexham). 
However, it was estimated (given the assumptions about the response rate) that 
sufficient numbers of patients could be recruited from five units in the West Midlands. 
These units cover a wide geographical area providing a mix of more affluent and 
socioeconomically deprived populations, adding to the representativeness of study 
participants. The five participating units were as follows:  
 
 Birmingham Good Hope (Heart of England NHS Foundation Trust) 
 Birmingham Heartlands (Heart of England NHS Foundation Trust) 
 Solihull Hospital (Heart of England NHS Foundation Trust) 
 Birmingham Women’s Hospital (Birmingham Women’s NHS Foundation Trust) 
 Birmingham City Hospital (Sandwell and West Birmingham NHS Trust) 
 
5.3.2 Population profiles of participating colposcopy units 
 
Sandwell and West Birmingham 
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City Hospital is run by Sandwell and West Birmingham Primary Care Trust (PCT) and 
is situated in and serves an ethnically diverse population. Its patients are drawn from 
relatively deprived areas across West Birmingham. 
 
 
Birmingham Women’s Hospital 
Birmingham Women’s hospital is a centre for excellence providing care and 
treatment for women and their families across the West Midlands. As such, it 
provides services for women across a wide range of ethnicities and women from both 
affluent and deprived areas. 
 
Heart of England NHS Foundation Trust  
Heart of England NHSFT is one of the largest trusts in England and serves a diverse 
population across the West Midlands. Three of the participating colposcopy units 
form part of HEFT: 
 
1. Good Hope hospital serves North Birmingham including the more affluent area 
of Sutton Coldfield alongside parts of east Staffordshire. It has a catchment 
population of 450,000. 
2. Heartlands hospital serves a diverse, multi-ethnic inner city community and is 
the flag ship hospital of the Trust. 
3. Solihull hospital serves the relatively affluent area of Solihull, alongside the 
more deprived area of North Solihull. 
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5.4 Recruitment 
 
5.4.1 Inclusion criteria 
 
Women aged 25 to 65 who had undergone colposcopy at least 12 months previously 
(April 2008 to March 2009), recruited from the five participating centres outlined in 
Section 5.3, stratified by level of intervention: 
1. Low risk group - colposcopy only: no treatment or investigation (n=350) 
2. Medium risk - colposcopy with investigation/diagnosis i.e. punch biopsy 
(n=350)  
3. High risk - colposcopy and treatment i.e. loop excision, or cone biopsy (n=350) 
 
The study initially sought to include a control group of women aged 25 to 65 who had 
never undergone colposcopy (n=1,050). These controls would have been age and 
deprivation score matched to the cases (1:1 ratio) (IMD 2007 used as a proxy 
measure for deprivation).137 This proved impossible, given a number of limitations 
that are outlined in Section 5.4.6. 
 
5.4.2 Exclusion criteria 
 
Cases: Women who had undergone treatment that was not colposcopically directed 
(e.g. women who may have been treated by hysterectomy). Excluding these women 
maximised the probability that any observed adverse effects following a colposcopy 
would be due to the colposcopy itself and not attributable to other procedures. 
 
In order to access the study population of interest, contact was made with the lead 
consultants at the colposcopy units via letter and e-mail. The study protocol and 
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study details were included in order to describe the project and its aims. Meetings 
were arranged with each lead consultant to discuss the project in more detail, 
including matters of case identification. The following data were obtained for each 
patient, either by SF, where this was permitted by the terms of the Trust R&D 
approvals, or by an appropriate member of the clinical team. 
 
Patient name 
Hospital number 
Address (including post-code to identify IMD) 
Age  
Date of first referral  
Date of colposcopy 
Diagnosis 
Intervention type 
 Colposcopy and no investigation/treatment 
 Colposcopy and investigation (i.e. punch biopsy)  
 Colposcopy and treatment (i.e. cone biopsy/LEEP/LOOP excision) 
 
An Excel spreadsheet was created populated with the required fields, with each 
potential patient assigned a unique university identifier. Due to differences in patient 
record maintenance and access regulations at each participating Trust, the 
recruitment procedure and process for facilitating patient mailings differed slightly at 
each Trust. The procedures for identifying patients and inviting them to participate in 
the study in each Trust are outlined in Section 5.4.3. 
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5.4.3 Recruitment of patients - Birmingham Women’s NHSFT 
 
Despite R&D approval being granted for the study, the R&D department had some 
concerns about granting a research passport or letter of access to enable SF to work 
on site under the direction of the clinical team to facilitate patient mailings directly. 
Therefore, to enable case identification to take place and to allow the mail outs of 
questionnaire one to potential participants, Birmingham Women’s NHSFT provided 
the support of a research midwife (RM) to undertake this role, who was given a 
spreadsheet pre-populated with the relevant fields for which data were required. The 
RM interrogated the hospital record systems to identify eligible patients, and 
recorded the patient details on the Excel spreadsheet (proforma presented in 
Appendix 6). Each patient’s record was assigned a unique university identifier to 
ensure that the correct patient could be identified throughout the study. Study packs 
were provided to the RM so that the mailings could be directly facilitated from the 
Trust site. These comprised the following items: 
 
1. Letter of invitation. The letter of invitation displaying the trust logo and an 
electronic signature from the lead consultant (Appendix 7) 
2. Patient information sheet (Appendix 8)  
3. Questionnaire 1 - with assigned patient ID number (Appendix 9) 
4. Pre-paid envelope for return of questionnaire by respondent 
5. Envelope to send pack to patient 
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Mailings were undertaken in a series of batches over a period of seven months. As 
the mail-outs were undertaken, the RM sent a copy of the spreadsheet with all 
columns completed, but with identifiable information (name, address and date of birth 
details) removed so that progress with mailings could be monitored whilst 
maintaining anonymity and confidentiality. A postcode was provided to enable an 
IMD quartile to be assigned for each patient. The age for each patient was also 
provided. Study responders returned the questionnaire directly to the University of 
Birmingham, providing their contact details if they wished to receive the follow-up 
questionnaire (Q2) (Appendix 10). All non-responders to the initial mailing of 
questionnaire one received a reminder after three weeks. 
 
5.4.4 Recruitment of Patients - Sandwell and West Birmingham NHST 
 
R&D approvals and a letter of access were provided by SWBNHST and permission 
was granted by the lead consultant to provide onsite administrative support to 
undertake mail-outs for patients of City hospital. All patient identification was 
undertaken by the colposcopy secretary who selected patients using the criteria 
outlined above. SF printed and posted the study packs from the unit and a copy of 
the spreadsheet (with identifiable data removed) was taken back to the University on 
an encrypted memory stick. 
 
5.4.5 Recruitment of patients - Heart of England NHSFT 
 
R & D permissions were granted along with a research passport to enable case 
identification and mail-outs to be undertaken directly by SF. Patient lists were 
provided on behalf of the lead Consultant by a nurse colposcopist listing all eligible 
patients for the three participating hospitals within the trust - Good Hope Hospital, 
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Heartlands Hospital and Solihull Hospital. Some delays were encountered in terms of 
IT access to patient records, but as per R&D permissions from Heart of England 
NHSFT, all patient identification - accessing patient names and addresses from the 
lists provided - was completed by SF.  
 
 
 
 
 
 
 
Table 5.1 Time-line for approvals and recruitment 
 
  
Timeline for Ethics/R&D approvals and patient 
identification 
 
9th September 
2009 
Contact made with SWB R&D informing of forthcoming 
project and requesting permission to name them as lead 
R&D site. 
8th January 2010 Ethics application submitted 
1st February 2010 Ethics Meeting 
15th March 2010 Ethical approval granted 
15th March 2010 Informed SWB R&D of ethical approval decision. 
16th March 2010 Research Passport signed off by University of 
Birmingham. 
22nd March 2010 Contact made with relevant R&D departments to inquire 
about relevant information required for R&D permission 
at each site. 
End April 2010 Responses received from all sites outlining information 
required. Delay occurred due to late responses from a 
number of R&D sites. 
End April 2010 All relevant information sent to each R&D site. 
May-July 2010 Further delays due to absence and sickness of R&D 
staff. 
July 2010 R&D approval granted - Heart of England, Sandwell and 
West Birmingham, Coventry and Warwickshire. 
September 2010 Approvals granted BWH, Worcestershire PCT. 
September 2010 Recruitment of Worcestershire general practices 
commenced (see Section 5.4.6). 
October 2010 - 
end date 
Patient recruitment commenced - BWH (all patient 
identification undertaken by Research Nurse at the unit, 
as BWH R&D would not allow SF to access identifiable 
data. All mail-outs had to be undertaken when RN had 
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availability to do so). 
November 2010 Patient recruitment commenced City Hospital (difficulties 
in arranging on-site meetings with consultants and 
limited access to appropriate IT resources to undertake 
mail-outs).  
March 2011 Patient recruitment commenced - Good Hope and 
Solihull  
April 2011 Patient recruitment commenced - Heartlands 
 
 
The original aim was to identify 1,050 women from across the five participating 
hospitals’ information systems; 350 women from each risk group (low, medium, high). 
 
It was envisaged that 70 women would be required per risk group per hospital, so 
that each unit would provide 210 women in total. However, due to the poor response 
rates observed in the early stages of the questionnaire mailing, a larger number of 
women were mailed in each group to increase the study sample size (colposcopy 
only n=864; biopsy n=592; loop excision n=626). The final numbers of respondents 
are outlined in Chapter six.  
 
5.4.6 General Practice Selection and Recruitment - study limitation 
 
As described in Section 1.2, the initial aim for the study was to access an age and 
deprivation matched control group of women who had never attended colposcopy. 
This was planned in order to ascertain the degree of sexual dysfunction in the 
general population and to assess whether there was any excess risk of sexual 
dysfunction in the population that had undergone colposcopy or other investigations. 
 
In order to recruit control participants for the study, general practices were 
approached within Worcestershire PCT. Potential practices were identified via the 
Midlands Research Practices Consortium (MidReC). This service consists of a 
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network of over 600 general practices, covering a representative population of over 
four million residents of the West Midlands.138 68 GP practices in Worcestershire 
PCT were identified from the MidReC database. 14 practices were originally 
contacted by letter and a provided with a one-page summary of the protocol, 
introducing the aims and background to the study. It also outlined the research 
methods and the role that the practice would be asked to perform for the research. A 
reply slip and Freepost envelope were included, enabling practices to communicate 
their willingness to participate, decline participation or request further information 
about the study. Practices not wishing to participate were not contacted again. Non-
responding practices received one reminder. 
 
Practice involvement was outlined as follows: 
1. To provide a list of all women on the practice list aged 25 to 65 years (name, 
address and date of birth) who had never attended for colposcopy 
2. To check this list so that women who it would be inappropriate to approach 
could be excluded (e.g. if the GP felt that inclusion may cause distress, or if a 
patient was considered to lack the mental capacity needed to enter the 
research study). Women who have had previous gynaecological malignancy 
were also excluded 
3. Provide a practice letterhead to enable the questionnaire to be accompanied 
by a covering letter from a GP in the practice 
Financial reimbursement for practice time was available for performing these tasks. 
One general practice in Redditch responded to the invitation to participate as a 
recruitment centre and following a meeting with one of the general practitioners and a 
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research nurse attached to the practice, they agreed to assist in accessing control 
patients from their list. Exploratory searches were performed using the practice data 
system to see if the required number of practice patients would be eligible to 
participate in the study. These searches suggested that around 3,890 patients were 
potentially eligible from the practice list. 
Unfortunately, despite initial agreement to act as a patient identification site, and 
despite receiving full ethical approval for the questionnaires to be sent to general 
practice patients, the practice decided that it would be inappropriate to mail the 
questionnaire to patients without undertaking in-depth checks to also exclude women 
who may have been the victim of a sex crime. It seemed that the motivation for this 
was that receiving such a questionnaire may have impaired the patient/practitioner 
relationship. The limiting implications of this are discussed in further detail in chapter 
nine.  
Following this, Research and Development (R&D) permissions were sought to 
facilitate access to practices within other Birmingham-based PCTs. Expression of 
interest letters were sent to six ‘research friendly’ practices in Birmingham. Despite 
attempts to fast track approvals, the study timescale was such that it became 
unfeasible to undertake recruitment of a control population for the study, taking into 
account the practice time required to identify patients, to match each case with a 
suitable control and to undertake the mail-outs and reminders to potential 
participants. 
Concerns over response rates were also factored into the decision not to recruit 
controls. Response rates for the case population were well below the original 
forecast. Questionnaires had been sent to double the original number of colposcopy 
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patients anticipated to maximise the response rate. It was anticipated that in order to 
recruit an adequate number of age and deprivation matched control group patients, 
questionnaires would have to be mailed to at least three times the original number 
proposed - largely due to the fact that women who had never undergone colposcopy 
may have not seen the value in completing a questionnaire measuring quality of life, 
and particularly questions of a sexual nature. The decision was made that the study 
would continue, recruiting only women who had undergone colposcopy or treatment 
for CIN, and with normative published data acting as a proxy for control patients.  
 
5.5 Sample Size 
 
Each year, the five collaborating colposcopy units have 12,400 colposcopy 
appointments. 6,693 individuals were estimated to be eligible for inclusion within this 
study (i.e. excluding follow-up, non-attendance, cancellation). Eligible women 
comprised those treated (11.5%), not requiring treatment (65%) and those having 
investigation (e.g. biopsy) but no further treatment (23.5%). Data were based upon 
colposcopy records of three participating colposcopy units. The mean age at 
colposcopy is 38 years (range 17 to 82) and the background (no colposcopy) 
prevalence of FSD (female sexual dysfunction) was assumed to be 15%.139 
 
To estimate a doubling in the risk of FSD, from 15 to 30%, 160 participants were 
required in each group (90% power, 5% significance). The smallest group (high risk) 
comprises 730 women per annum. Conservatively assuming a questionnaire 
response rate of 50%, 350 in each group would be approached. Due to the lower 
than anticipated response rate for the study, the final sample of responders to Q2 
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(which was used to calculate the prevalence of FSD) was as follows: colposcopy only 
n=119; biopsy n=76; loop excision n=84. Given these figures, it was estimated that 
rather than estimating a doubling of FSD risk it would be possible to estimate 2.6 
times the risk of FSD (from 15-39%) for the cohort (at 90% power and 5% 
significance). The limiting aspect of the sample size is discussed in chapters nine. 
 
 
5.6 Data collection tools 
 
The questionnaires used in the study were designed to establish: 
 
1. The prevalence of sexual problems amongst women who have undergone 
colposcopy, in order to ascertain if colposcopy has an adverse effect upon 
women’s sexual life (sexual functioning).  
 
2. The prevalence of physical and psychological health problems amongst 
women who have undergone colposcopy. Again, this enables us to ascertain if 
colposcopy has an adverse effect upon women’s physical and psychological 
health. 
 
3. Demographic details as potential confounders/predictors of psycho-sexual and 
physical outcomes. 
 
5.6.1 Questionnaire one (Q1) 
 
Questionnaire one was relatively brief and aimed to establish the prevalence of 
sexual problems using six questions used in the National Survey of Sexual Attitudes 
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and Lifestyles 2000140 that relate to sexual functioning and Quality of Life (QoL) 
scores. It also contained an open question with space provided for participants to 
provide any further comments about issues raised on the questionnaire. Participants 
were also invited to consent to take part in the second survey.  
 
The focus of Q1 was to measure patients’ perceptions about aspects of their 
physical, emotional, sexual well-being and satisfaction levels in terms of their current 
relationships. Physical, emotional and social well-being are routinely used as the 
focus of quality of life assessment. Although the questionnaire did not use stand 
alone validated measures, it used adapted questions from the SF36, a short and 
multi-purpose measure of health outcomes.141  
 
Consideration was given to utilising the EQ-5D (EUROQOL Group 1990) as a 
measure of five dimensions: mobility, self-care, usual activity, pain and discomfort, 
anxiety and depression.142 However, despite EUROQOL providing a short 
standardised measure of health related outcomes, it has been criticised due to the 
low response rates that it can yield in a number of populations and is highly skewed 
and relatively insensitive.143-146 Furthermore, issues around mobility and self-care 
were unlikely to be relevant to the population age range from which this sample was 
drawn (most attenders at colposcopy are aged 30-40).  
 
Questions relating to general physical and emotional health were adapted from the 
SF-36 and are presented in Figure 5.1. 
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Figure 5.1 Questions relating to physical and emotional health  
 
 
1.  In general, would you say that your health is (Please circle one option) 
 
Excellent 
 
Very Good Good Fair Poor 
 
 
2.  In the past 12 months, have you had any of the following problems with your work or other regular 
daily activities as a result of your physical health? (Please tick one box) 
 
Felt less able to carry out normal tasks  Yes             No  
  
Were limited in the kind of work or other activities you have 
undertaken 
 
Yes             No  
 
 
 
3.  During the past 12 months, have you had any of the following problems with your regular activities 
as a result of any emotional problems (such as feeling depressed or anxious)? (Please tick one 
box)  
 
Accomplished less than you would like Yes              No  
  
Didn’t do work or other activities as you usually would do 
 
Yes              No  
 
 
 
4.  During the past 12 months, how much of the time have your physical OR emotional problems 
interfered with your social activities (like visiting friends, relatives, etc.)? (Please circle one option) 
 
All of the time 
 
Most of the time Some of the time A little of the time None of the time 
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The SF-36 is a reliable measure which has been demonstrated to be more sensitive 
to lower morbidity rates,141 but as it had 36 items, it would not have been appropriate 
for inclusion in the first questionnaire. The first question asks participants to consider 
how they would rate their general health and from the wording, the expectation was 
that they would be rating their perceptions on the day of questionnaire completion. 
Participants were asked to consider whether in the past 12 months they had 
experienced any problems undertaking regular activities (i.e. carrying out normal 
tasks/limited in the work or activities undertaken) as a result of their physical health. 
Similarly, the survey asked if their regular activities had been impeded by their 
emotional health. The next questions focus upon the impact of physical or emotional 
health upon respondents’ social activities, again using a 12-month timeframe. The 
SF-36 also asks people to rate their health in the past four weeks. As this study 
aimed to explore the longer term adverse outcomes of colposcopy, it was deemed 
more appropriate to ask participants to give an overview of the previous 12 month 
period. This was thought to avoid the likelihood that respondents would report 
relatively recent or transient problems. 
 
Six questions from the National Survey of Sexual Attitudes and Lifestyle (Natsal)140 
were employed to measure psycho-sexual problems including physiological 
problems. Natsal is a UK based scientific study of sexual behaviour, originally 
established in the context of the HIV/AIDS epidemic, to gather information about 
sexual lifestyles. It is the largest scientific study of its kind since the 1940’s and 
1950’s.  
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The Natsal questions cover a broad range of sexual problems identified from the 
literature124,147 and cover the main domains of female sexual problems - desire, 
arousal, orgasm, pain, distress. Natsal report that just over half of women (53.8%) 
reported at least one of these problems lasting at least one month; most commonly a 
lack of sexual interest.139 It is acknowledged that a dichotomous format to answer 
questions of this nature does not provide an adequate level of sensitivity, and it does 
not provide a measure of female sexual dysfunction (FSD). This was measured in the 
second study questionnaire (Q2). Furthermore, women were not asked if they had a 
current partner at the time of completing questionnaire one which would have 
excluded responders from completing this section of the questionnaire. It does, 
however, provide a measure of whether participants who were sexually active felt 
they had a problem. As shown in Figure 5.2, it asks women to consider the previous 
three months or longer. As there is no consensus upon how long a difficulty should 
last before it becomes a ‘problem’, three months was  considered to be a reasonable 
balance between avoiding capturing transient difficulties, and short enough to avoid 
missing severe, but relatively short-lived episodes. 
 
Figure 5.2 Questions related to sex life 
 
8.  In the past year have you experienced any of the following for three months or longer? 
(Please tick the box that applies most to you) 
 Yes No 
Lacked interest in having sex? 
 
  
Felt anxious just before having sex about your ability to perform 
sexually? 
 
  
Were unable to come to a climax (experience an orgasm)? 
 
  
Have come to a climax (experienced an orgasm) too quickly? 
 
  
Experienced physical pain during intercourse or sexual activity? 
 
  
Have had trouble lubricating? 
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Two Likert scales were also used to measure overall satisfaction with sexual life and 
overall satisfaction with relationships measured at the time of questionnaire 
completion (see Figure 5.3). These were employed as a broader measure of sexual 
satisfaction. Responses here provided a more impressionistic view of a participant’s 
perception of their sexual life and can add context with which to aid interpretation of 
the six preceding questions. 
 
 
Figure 5.3 Satisfaction with sex life and relationship 
 
9.  On a scale of one to ten, with 1 being most dissatisfied and 10 being most satisfied, how would 
you rate your satisfaction with your sexual life?  (Please circle the number that applies most to 
you) 
 
1 2 3 4 5 6 7 8 9 10 
 
Most 
dis-
satisfied 
    
Neither 
satisfied 
nor 
dis-
satisfied 
     
Most 
satisfied 
 
 
 
10.  On a scale of one to ten, with 1 being most dissatisfied and 10 being most satisfied, how would 
you rate your satisfaction with your relationship?  (Please circle the number that applies most to 
you) 
 
1 2 3 4 5 6 7 8 9 10 
 
Most 
dis-
satisfied 
    
Neither 
satisfied 
nor 
dis-
satisfied 
     
Most 
satisfied 
 
 
 
The final section of the questionnaire provided participants with the opportunity to 
raise any other issues that they feel are relevant or important to them. The results 
from this are analysed in Chapter 8. 
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The second questionnaire described in section 5.6.2 included questions designed to 
elicit demographic data - age, social/educational level, ethnicity, lifestyle factors and 
health related factors. It collected more detailed information on outcomes and the 
predictors of adverse outcomes using a number of validated measures. 
 
5.6.2 Questionnaire two (Q2)  
 
Q2 collected detailed demographic information and details of outcomes and the 
predictors of adverse outcomes shown in Table 5.2. The purpose of the second 
questionnaire was to collect a range of data including ethnicity, level of educational 
attainment, smoking status, problematic licit and illicit substance use, sexual 
orientation, relationship status, method of contraception (if applicable), number of 
children, history of obstetric problems, history of gynaecological problems (e.g. 
dysmenorrhea), history of sexually transmitted infection, long term health problems, 
and frequency of visits to the general practitioner. Alongside these data, three 
validated measures were employed to measure female sexual dysfunction, anxiety 
and depression levels and quality of life. 
 
Table 5.2 Outcomes and predictors 
 
Outcomes Quality of Life, sexual functioning, anxiety and 
depression 
Exposures Colposcopy 
Modifiers Level of Colposcopic intervention: low/medium/high 
risk, age and deprivation137 
Other 
sociodemographic/health 
related factors of interest  
Sociodemographic factors: Ethnicity,148 relationships, 
education 
Lifestyle factors: smoking, alcohol, problem drug use 
Health-related factors: obstetric history, history of 
sexually transmitted disease, number of visits to GP, 
physical health problems 
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The following validated measures were used to measure sexual function, levels of 
anxiety and depression and quality of life:  
 
1. Female Sexual Function Index (FSFI) which provides information about women’s 
sexual functioning.134 
2. The Hospital Anxiety and Depression (HADS) scale to assess levels of anxiety 
and depression. HADS has been found to perform well in assessing the symptom 
severity and caseness of anxiety disorders and depression in both somatic, 
psychiatric and primary care patients and in the general population.133 
 
3. Quality of life was measured using the WHOQOL-BREF incorporating physical 
health, psychological health, social relationships and environmental factors.135 
 
Each of these three scales are described in greater detail in the forthcoming sections. 
 
The Hospital Anxiety and Depression Scale is a relatively short well-validated scale 
that has been demonstrated to perform well in a general population as well as a 
hospital setting. It comprises 14 statements pertaining to generalised anxiety (n=7) 
and depression (n=7), see Figure 5.4. The outcomes indicate anxiety/depression 
levels with a range of ‘normal’, ‘mild’, ‘moderate’ and ‘severe.’ A lower score indicates 
that responders are in the ‘normal’ range in terms of anxiety and depression. 
 
Although widely utilised and validated for the general population, much of the 
literature pertaining to prevalence rates of anxiety and depression investigate rates 
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from a population exposed to a particular disease or disorder. HADS was originally 
designed for use with patients who are physically ill. In the absence of matched 
control data to provide the prevalence rates of anxiety and depression in the general 
population, normative prevalence data will be referenced to provide context to the 
findings from the current study.  
 
Figure 5.4 Anxiety and depression questions 
 
 
Please consider the following statements and tick the box which most applies to you. There are no 
right or wrong answers. Do not spend too much time on any one statement but give the answer which 
best describes your present feeling. (Please tick one box only for each question). 
 
 All of 
the time 
Most of 
the time 
Some of 
the time 
Hardly 
ever 
Never 
25. I feel tense and wound up      
  
26. I still enjoy the things I used to enjoy      
  
27. I get a sort of frightened feeling as if 
something awful is about to happen      
  
28. I can laugh and see the funny side of 
things      
  
29. Worrying thoughts go through my mind       
  
30. I feel cheerful      
  
31. I can sit at ease and feel relaxed      
  
32. I feel as if I am slowed down      
  
33. I get sort of frightened feeling like 
butterflies in the stomach      
  
34. I have lost interest in my appearance      
  
35. I feel restless as if I have to be on the 
move      
  
36. I look forward with enjoyment to things      
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37. I get sudden feelings of panic      
  
38. I can enjoy a good book or radio or TV 
programme      
 
 
 
The maximum score for both the anxiety and depression domains is 21, with the 
following ranges: normal 0 to 7; mild 8 to 10; moderate 11 to 15, and severe 16 to 21.  
 
The Female Sexual Function Index (FSFI) is a brief multidimensional scale (19 items) 
for assessing sexual function in women, and has six domains relating to desire, 
arousal, lubrication, orgasm, satisfaction and pain. It is based upon activity in the 
past four weeks (see Figure 5.5). A score of between one and five was assigned to 
the domain question relating to desire (a score of one indicating no problems and a 
score of five indicating the highest degree of problem in this area). The remaining 
domains were scored in the same manner, although a score of zero was applied if 
responders were not engaged in sexual activity. A score < 26.55 indicates the 
presence of FSD. Total scores of < 26.55 indicate the presence of sexual 
dysfunction. When analysis of the results from the FSFI was undertaken, a sensitivity 
analysis was completed removing women who had reported no sexual activity. The 
purpose of this was to ensure that ‘no sexual activity’ was not treated as a sign of 
‘dysfunction’ of women in the cohort. This limitation of the measure is discussed in 
more detail in chapter 9. 
Chapter four discusses the literature pertaining to FSD in greater detail, but the 
available population prevalence data of FSD are outlined below. There is little 
consensus in terms of the prevalence rate of FSD in the general population. The 
heterogeneity of measures used, the use of inconsistent definitions of ‘sexual 
dysfunction’, differing population age ranges, gender, and timescales that the 
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measures ask participants to rate the length of time over which they have had 
difficulties (one week, one month, three month, six months) have all influenced this 
lack of precision. 
 
Mercer at al139 undertook a survey exploring the sexual function problems of a large 
sample (n=11,161) of men and women aged 16 to 44. The study measured the main 
dimensions of sexual dysfunction as defined by the ICD-10 and utilised by National 
Health and Social Life Survey147 in the USA including sexual desire, lack of 
enjoyment/interest, genital response problems, orgasmic dysfunction, painful sex and 
excessive sexual drive. The study found that 15.6% of women had experienced 
persistent sexual problems in the previous year (persistent defined as lasting for at 
least six months). 
 
A more recent study150 sampled 1,489 women in the UK (aged 18 to 85) and utilised 
the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale 
(FSDS) to assess symptom severity and degree of distress. The study found that 
5.8% of women reported recent sexual dysfunction and 15.5% lifelong sexual 
dysfunction. The later finding would seem to support the findings from Mercer et al, 
although Mercer et al reported ‘persistent’ problems as those experienced in the 
previous six months. Furthermore, the authors report that the most common 
independent predictor of FSD (lifelong or recent) was relationship dissatisfaction (OR 
1.2 to 4.5). When focusing upon lifelong FSD, the authors found that experience of 
abuse, increased anxiety and obsessive compulsive behaviour were the most 
common predictors. These findings support the notion that female sexual dysfunction 
should be interpreted in the context of emotional and social factors and goes some 
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way to support the idea whether a diagnosis of a ‘dysfunction’ can be applied to a 
problem that is multifaceted - relating to partnership status, emotional health as well 
as physiological concerns. 
 
The NHSLS study reports FSD rates of 43% in a sample of 1,749 US women aged 
18 to 59 measuring the presence of a ‘problem’ in the previous 12 months. This study 
also found associations between age and educational attainment. Sexual problems 
were found to decrease with age except for those reporting problems with vaginal 
lubrication. The authors speculate that younger women are more likely to have 
multiple partners, longer periods of inactivity and inexperience all of which may 
contribute to increased anxiety around sex. Women educated to a higher level were 
less likely to experience sexual problems. 
 
Figure 5.5 The Female Sexual Function Index 
 
In the first questionnaire we asked you some questions relating to your sexual feeling and responses 
during the last 3 months. We would like to ask some more questions that are a little more detailed. We 
realise that this is a particularly sensitive and private matter. Your responses will be treated in the 
strictest confidence.  
 
In answering these questions the following definitions apply: 
Sexual activity can include caressing, foreplay, masturbation and vaginal intercourse. 
Sexual intercourse is defined as penile penetration (entry) of the vagina. 
Sexual stimulation includes situations like foreplay with a partner, self-stimulation (masturbation), or 
sexual fantasy. 
Sexual desire or interest is a feeling that includes wanting to have a sexual experience, feeling 
receptive to a partner's sexual initiation, and thinking or fantasizing about having sex. 
 
 
Over the past 4 weeks, (Please tick one box) 
39.  How often did you feel sexual desire or interest?
 Almost always or always 
Most times 
(more than 
half the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never 
or never 
      
      
 
40. How would you rate your level (degree) of sexual desire or interest? 
 Very high High Moderate Low Very low or 
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Sexual arousal is a feeling that includes both physical and mental aspects of sexual excitement. It may 
include feelings of warmth or tingling in the genitals, lubrication (wetness), or muscle contractions. 
 
Over the past 4 weeks; 
 
43.  How confident were you about becoming sexually aroused during sexual activity or intercourse? 
No sexual 
activity 
Very high 
confidence  
High 
confidence 
Moderate 
confidence 
Low 
confidence 
 
Very low or no 
confidence 
      
44. How often have you been satisfied with your arousal (excitement) during sexual activity or 
intercourse? 
No sexual 
activity 
Almost always 
or always 
Most times 
(more than 
half the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never 
or never 
      
45.  How often did you become lubricated ("wet") during sexual activity or intercourse? 
 
No sexual 
activity 
Almost always 
or always 
Most times 
(more than 
half the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never 
or never 
      
  
46.  How difficult was it to become lubricated ("wet") during sexual activity or intercourse? 
 
No sexual 
activity 
Extremely 
difficult or 
impossible 
Very difficult Difficult Slightly difficult Not difficult 
      
none at all 
      
      
41.  How often did you feel sexually aroused ("turned on") during sexual activity or intercourse?
No sexual 
activity 
Almost always 
or always 
Most times 
(more than 
half the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never 
or never 
      
      
 
42.  How would you rate your level of sexual arousal ("turn on") during sexual activity or intercourse? 
No sexual 
activity Very high High Moderate Low 
Very low or 
none at all 
      
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47. How often did you maintain your lubrication ("wetness") until completion of sexual activity or 
intercourse? 
No sexual 
activity 
Almost always 
or always 
Most times 
(more than 
half the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never 
or never 
      
48.  How difficult was it to maintain your lubrication ("wetness") until completion of sexual activity or 
intercourse? 
No sexual 
activity 
Extremely 
difficult or 
impossible 
Very difficult Difficult Slightly difficult Not difficult 
      
49. When you had sexual stimulation or intercourse, how often did you reach orgasm (climax)? 
No sexual 
activity 
Almost always 
or always 
Most times 
(more than 
half the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never 
or never 
      
50.  When you had sexual stimulation or intercourse, how difficult was it for you to reach orgasm 
(climax)? 
No sexual 
activity 
Extremely 
difficult or 
impossible 
Very difficult Difficult Slightly difficult Not difficult 
      
51. How satisfied were you with your ability to reach orgasm (climax) during sexual activity or 
intercourse? 
No sexual 
activity Very satisfied 
Moderately 
satisfied 
About equally 
satisfied and 
dissatisfied 
Moderately 
dissatisfied 
Very 
dissatisfied 
      
52.  How satisfied have you been with the amount of emotional closeness during sexual activity 
between you and your partner? 
No sexual 
activity Very satisfied 
Moderately 
satisfied 
About equally 
satisfied and 
dissatisfied 
Moderately 
dissatisfied 
Very 
dissatisfied 
      
53. How satisfied have you been with your sexual relationship with your partner? 
 
No sexual 
activity Very satisfied 
Moderately 
satisfied 
About equally 
satisfied and 
dissatisfied 
Moderately 
dissatisfied 
Very 
dissatisfied 
      
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The WHOQOL-BREF is a shortened version of the WHOQOL-100 that has been 
validated for use across 15 countries and provides ‘insights into the nature of disease 
by assessing how disease impairs the subjective well being of a person across a 
whole range of areas (see Figure 5.6). The four domains - physical, psychological, 
social and environmental can provide useful assessment of an individuals’ perception 
of their overall well-being. The first two questions refer to the respondents’ overall 
perception of their health. Raw scores for each domain are computed and 
transformed to give a possible score out of 100 for each domain. Domain scores are 
scaled in a positive direction with higher scores denoting a higher quality of life. The 
mean score of the items in each domain is used to calculate the domain score. The 
mean scores for each domain are then multiplied by four to make domain scores 
comparable with the scores used in WHOQOL-100.  
 
Figure 5.6 WHOQOL-BREF 
 
Please choose the answer that appears the most appropriate. If you are unsure about which response 
to give to a question, the first one you give is usually the best one. (Please circle one answer) 
 
We ask you to think about your life in the last four weeks. 
 
58. How would you rate your 
quality of life? Very Poor Poor 
Neither 
poor Nor 
good 
Good Very Good 
  
59. How satisfied are you with 
your health? 
 
Very 
dissatisfied Dissatisfied
Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very Satisfied 
 
 
The following questions ask about how much you have experienced certain things in the last four 
weeks. 
 
60. To what extent do you feel 
that physical pain prevents you 
from doing what you need to 
do? 
Not at all A little A moderate amount Very much 
An extreme 
amount 
      
61. How much do you need any 
medical treatment to function in 
your daily life? 
Not at all A little A moderate amount Very much 
An extreme 
amount 
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62. How much do you enjoy 
your life? Not at all A little 
A moderate 
amount Very much 
An extreme 
amount 
 
63. To what extent do you feel 
your life to be meaningful? Not at all A little 
A moderate 
amount Very much 
An extreme 
amount 
  
64. How well are you able to 
concentrate? Not at all A little 
A moderate 
amount Very much 
An extreme 
amount 
      
65. How safe do you feel in 
your daily life? Not at all A little 
A moderate 
amount Very much 
An extreme 
amount 
      
66. How healthy is your 
physical environment? Not at all A little 
A moderate 
amount Very much 
An extreme 
amount 
 
The following questions ask about how completely you experience or were able to do certain things in 
the last four weeks. 
 
67. Do you have enough 
energy for everyday life? Not at all A little Moderately Mostly Completely
      
68. Are you able to accept your 
bodily appearance? Not at all A little Moderately Mostly Completely
      
69. Do you have enough 
money to meet your needs? Not at all A little Moderately Mostly Completely
      
70. How available to you is the 
information that you need in 
your day-to-day life? 
Not at all A little Moderately Mostly Completely
      
71. To what extent do you have 
the opportunity for leisure 
activity? 
Not at all A little Moderately Mostly Completely
      
72. How well are you able to 
get around? Not at all A little Moderately Mostly Completely
      
73. How satisfied are you with 
your sleep? 
 
Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very Satisfied 
      
74. How satisfied are you with 
your ability to perform your 
daily living activities? 
Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very Satisfied 
      
75. How satisfied are you with 
your capacity for work? Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very Satisfied 
      
76. How satisfied are you with 
yourself? Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very Satisfied 
      
77. How satisfied are you with Very Dissatisfied Neither Satisfied Very 
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your personal relationships? dissatisfied satisfied 
nor 
dissatisfied 
Satisfied 
      
78. How satisfied are you with 
your sex life? Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very Satisfied 
      
79. How satisfied are you with 
the support you get from your 
friends? 
Very 
dissatisfied Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied Very Satisfied 
80. How satisfied are you with 
the conditions of your living 
place? 
Very 
dissatisfied Dissatisfied 
Neither 
satisfied nor 
dissatisfied 
Satisfied Very Satisfied 
      
81. How satisfied are you with 
your access to health 
services? 
Very 
dissatisfied Dissatisfied 
Neither 
satisfied nor 
dissatisfied 
Satisfied Very Satisfied 
      
82. How satisfied are you with 
your transport? Very dissatisfied Dissatisfied 
Neither 
satisfied nor 
dissatisfied 
Satisfied Very Satisfied 
 
The following question refers to how often you have felt or experienced certain things in the last four 
weeks. 
 
83. How often do you have 
negative feelings such as low 
mood, despair, anxiety, 
depression? 
Never Seldom Quite often Very often Always 
 
 
 
5.7 Data analysis 
 
Analysis was undertaken in two stages - with data from questionnaire one and 
questionnaire two analysed separately. Non-responder bias was assessed for each 
questionnaire in terms of where treatment was undertaken, age socioeconomic 
status and treatment type and is reported in Chapter 6.  
 
5.7.1 Analysis questionnaire one (Q1) 
 
Analysis of questionnaire one included calculation of the frequencies of responses to 
all questions in terms of age, socioeconomic status and treatment type.  Chi2 tests 
were performed to investigate the relationships between age, socioeconomic status 
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and treatment type and the physical, emotional and sexual function measures 
included in the questionnaire. In terms of the questions related to sexual function, a 
bivariate analysis each factor was investigated individually using the three variables 
on interest - treatment type, age and socioeconomic status. Following this, a 
multivariate analysis was undertaken to ascertain, the ‘best’ if any predictors of 
reporting problems of a sexual nature. 
For the two questions related to problems with social activities and general health, 
analysis was undertaken by dichotomising the possible responses to. The question 
related to problems with to social activities grouped ‘little of the time’ and ‘none of the 
time’ responses and compared then with ‘some of the time’, ‘’most of the time’ and 
‘all of the time’, the later three indicating more pronounced problems, The questions 
related to best describing general health grouped ‘good’, ‘very good’ and ‘excellent’ 
and compared this with the responses ‘poor’ and ‘fair’. Again, the later responses 
indicating poorer patient rated health.  Frequencies of responses for the measures 
relating to social activities, satisfaction with sex life and partner satisfaction were also 
investigated utilising non-parametric testing (Kruskall-Wallis).  
 
 
5.7.2 Analysis Questionnaire two (Q2) 
 
Analysis of questionnaire two was undertaken in six stages.  
 
Stage one reported the proportion of responses to each question relating to 
demographic details, lifestyle, health status, partner status, gynaecological and 
sexual issues.  
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Stage two analysed the association between treatment type and all factors.  
 
Stage three reported the scores calculated for the validated measures for each 
respondent FSD, HADS anxiety, HADS depression and WHOQOL-BREF domain 
scores.  
 
Stage four investigated the presence of FSD and HADS anxiety and HADS 
depression scores of ‘normal’ or ‘mild and above’ in association with the three main 
potential predictors of interest - treatment type, deprivation and age.  
 
Stage five utilised bivariate analyses of the presence of FSD and scores of ‘normal’ 
or ‘mild or above’ for HADS anxiety/depression were undertaken for the three 
potential predictors of interest.  
 
Stage six comprised logistic regression modelling to ascertain the significant 
predictors of the presence or absence of FSD and scores of ‘normal’ or ‘mild and 
above’ on the anxiety/depression scale. In terms of the WHOQOL-BREF domains, a 
comparison of means test (ANOVA) was undertaken for the scores from each 
domain in terms of treatment type, age and deprivation. 
 
 
 
5.8 Summary of methods 
 
This chapter has outlined the methodology used for the study, providing an overview 
of the study methodology; justification for the use of questionnaires to collect the 
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quantitative and qualitative data; an outline of the study population including 
description and recruitment of the study centres, inclusion and exclusion criteria, and 
the logistics of how the data was collected. Following this, the sample size was 
described and justified and the penultimate section focused upon the data collection 
tools employed (including a description of the validated and non-validated measures 
used). The final section gave a brief overview of the analysis undertaken for the 
study.  
 
Chapter 6 will report the recruitment results for both stages of the study and the 
results from the analysis of the first stage (Q1) of the study.  
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CHAPTER 6: RESULTS - QUESTIONNAIRE ONE (Q1) 
 
6.1 Introduction 
This chapter reports the analysis and results of the first stage of the study, 
Questionnaire one (Q1). Section 6.2 will outline details of the study recruitment for 
both phases. Section 6.3 will report details of responder bias for both phases of the 
study (Q1 and Q2). Section 6.4 begins with the results from the analysis stage of the 
study, firstly by outlining the characteristics of responders to Q1 and presenting the 
factors studied and potential predictors. Section 6.5 presents the frequency of 
responses to the questions for all respondents before focusing upon the 
characteristics of responders in terms of level of intervention, socioeconomic status 
and age and responses to the questions. Section 6.6 presents the summary of the 
findings from Q1, and Section 6.7 presents a short discussion of the limitations of this 
stage of the study. 
 
6.2 Study recruitment  
 
Women who attended for colposcopy between 1st April 2008 and 31st March 2009 
were invited to participate in the first stage of the study.  
 
Women who had experienced colposcopy during the time period were stratified by 
level of intervention for both stages of the study (stage one total n=560, stage two 
total n=279); 
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Questionnaire one:  
 Colposcopy only – no treatment or investigation (n=251) 
 Colposcopy with investigation/diagnosis i.e. punch biopsy (n= 151) 
 Colposcopy and treatment i.e. loop excision (n= 158) 
 
Questionnaire two: 
Due to the lower than anticipated response rate for the study, the final sample of 
responders to Q2 (where presence of FSD is calculated from) was as follows -  
 
 Colposcopy only – no treatment or investigation (n=119) 
 Colposcopy with investigation/diagnosis i.e. punch biopsy (n= 76)  
 Colposcopy and treatment i.e. loop excision (n= 84) 
 
Given these figures, it was estimated that rather than a doubling of risk it was 
possible to estimate 2.6 times the risk of FSD (from 15-39%) for the cohort (at 90% 
power and 5% significance). 
 
The overall number of patients recruited to the study are shown in Figure 6.1. 
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Figure 6.1 Study recruitment figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total non-
responders 
n=1,515 (73%) 
Total number 
invited 
n=2,078 
Responders 
Q1 
n=560 (27%) 
Biopsy 
responders Q1 
n=151 (27%) 
Q2 non-
responders 
n=41 (26%) 
Q2 
responders 
n=119 (74%) 
Q2 
responders 
n=76 (66%) 
Q2 non-
responders 
n=39 (34%) 
Q2 
responders 
n=84 (66%) 
Q2 non-
responders 
n=44 (34%) 
Colposcopy 
responders Q1 
n=251 (45%) 
Loop excision 
responders Q1 
n=158 (28%) 
Declined Q2 
n=91 (36%) 
 
Declined Q2 
n=36 (24%) 
Declined Q2 
n=30 (19%) 
 170
6.3 Responders/non-responders Q1, Q2  
 
Prior to the presentation of non-responder bias for Q1 and Q2, the proportion of 
those who responded to the invitation to participate for both stage of the study are 
presented in tables 6.1 and 6.2.  
Table 6.1 Responders Q1 
Characteristic Total 
number 
invited  
Number of 
responders (%) 
Number of non-
responders 
    
Colposcopy unit    
Women’s 1023 328 (32.1) 695 (67.9) 
City 356 74 (20.7) 282 (79.3) 
Solihull 401 87 (22.0) 314 (78.0) 
Heartlands 100 19 (19.0) 81 (81.0) 
Good Hope 198 52 (26.3) 146 (73.7) 
    
Age range    
19-29 531 122 (30.0) 409 (70.0) 
30-39 799 220 (27.5) 579 (72.5) 
40-49 488 142 (29.1) 346 (70.9) 
50+ 248 76 (30.6) 172 (69.4) 
    
Deprivation *    
Most Affluent (Q1) 202 34 (17.0) 168 (83.0) 
Less Affluent (Q2) 308 125 (40.2) 184 (59.8) 
Less Deprived (Q3) 528 170 (32.2) 358 (67.8) 
Most Deprived (Q4) 984 984 (23.0) 762 (77.0) 
    
Treatment type    
Colposcopy only 862 251 (29.1) 611 (69.9) 
Biopsy 151 151 (26.0) 439 (74.0) 
Loop Excision 158 158 (25.2) 468 (74.8) 
 
* Deprivation quartile derived from 2007 Index of Multiple Deprivation137 
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Table 6.2. Responders Q2 
Characteristic Total 
number 
invited  
Number of 
responders (%) 
Number of non-
responders 
    
Colposcopy unit    
Women’s 221 167 (75.6) 54 (24.4) 
City 57 36 (63.1) 21 (36.9) 
Solihull 68 38 (56.0) 30 (44.0) 
Heartlands 17 13 (76.5) 4 (23.5) 
Good Hope 40 25 (62.5) 15 (37.5) 
    
Age range    
19-29 100 80 (80.0) 20 (20.0) 
30-39 161 95 (61.0) 63 (39.0) 
40-49 95 70 (74.0) 25 (26.0) 
50+ 47 31 (66.0) 16 (34.0) 
    
Deprivation *    
Most Affluent (Q1) 40 28 (70.0) 12 (30.0) 
Less Affluent (Q2) 76 51 (67.0) 25 (33.0) 
Less Deprived (Q3) 107 78 (73.0) 29 (27.0) 
Most Deprived (Q4) 170 114 (67.0) 56 (33.0) 
    
Treatment type    
Colposcopy only 160 119 (74.0) 41 (26.0) 
Biopsy 115 76 (66.0) 39 (34.0) 
Loop Excision 128 84 (66.0) 44 (34.0) 
 
* Deprivation quartile derived from 2007 Index of Multiple Deprivation137 
 
 
 
The characteristics of responders and non-responders for Q1 were compared to 
assess potential responder bias on the basis of where colposcopy was undertaken, 
patient age, type of treatment, and deprivation quartile of those invited to participate 
in the study (see Table 6.3). This was also completed for Q2 results shown in Table 
6.4. 
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Table 6.3 Non-responders bias Q1 
 
Characteristic Responders 
(%) 
Non-responders 
(%) 
Non-responder bias 
    
Colposcopy unit    
Women’s 328 (58.6) 695 (45.8)  
City 74 (13.2) 282 (18.6) X2=29.43; p=<0.0001 
Solihull 87 (15.5) 314 (20.7)  
Heartlands 19 (3.4) 81 (5.3)  
Good Hope 52 (9.3) 146 (9.6)  
    
Age range    
19-29 122 (21.8) 409 (27.2)  
30-39 220 (39.3) 579 (38.4) X2=7.21; p=0.0655 
40-49 142 (25.4) 346 (23.0)  
50+ 76 (13.6) 172 (11.4)  
    
Deprivation *    
Most Affluent (Q1) 34 (6.2) 168 (11.4) X2=54.85;  
Less Affluent (Q2) 124 (22.5) 184 (12.5) p=<0.0001 
Less Deprived (Q3) 170 (30.9) 358 (24.3)  
Most Deprived (Q4) 222 (40.4) 762 (51.8)  
    
Treatment type    
Colposcopy only 251 (44.8) 611 (40.3)  
Biopsy 151 (27.0) 439 (28.9) X2=3.54; p=0.1703 
Loop Excision 158 (28.2) 468 (30.8)  
 
* Deprivation quartile derived from 2007 Index of Multiple Deprivation137 
 
 
There was a significant difference between the proportion of responders and non-
responders on the basis of the colposcopy units from which patients were invited 
(X2=29.43; p=<0.0001). There were fewer than expected numbers of responders 
from Good Hope, Heartlands, City and Solihull, and higher than expected numbers of 
women responding from the Women’s hospital (i.e. the numbers of respondents that 
would be expected to respond at each unit if responses were equally distributed 
across groups).  
 
This may be explained by the fact that women attending City and Heartlands 
hospitals may have been less likely to respond given the ethnic make up of their 
populations. Both of these hospitals serve areas of ethnic diversity and have some of 
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the highest number of women from South Asian populations in the West Midlands. 
Given some of the cultural norms for these groups (women may be less likely to be 
able to read or write English; the head of the household is male and may open the 
post; the sensitive nature of questions around satisfaction with sexual life may not be 
amenable for these women), this may go some way to explaining the lower than 
expected responses from these hospitals. However, higher than expected numbers 
of non-responders were found in the hospitals situated in generally more affluent and 
less ethnically diverse areas (Good Hope and Solihull). It is difficult to draw 
conclusions about reasons for this; data on the ethnicity of women who either 
responded or did not respond to Q1 were not available. 
 
Differences between the proportion of responders and non-responders were found in 
terms of age (X2=7.21; p=0.0655), with higher than expected numbers of patients 
responding from the 30 to 39, 40 to 49 and the 50+ age groups. The lowest 
proportion of responders was found in the 19 to 29 group. This may be because 
younger women may feel less inclined to participate in health related research.151 
They may also be less likely to experience poor health outcomes due to their age.  
 
The level of deprivation was found to be significantly associated with the likelihood of 
responding to Q1 (X2=54.85; p=<0.0001) with higher than expected numbers of 
responders from the less affluent and less deprived groups (quartiles 2 and 3) and 
higher than expected numbers of non-responders in the most affluent and most 
deprived groups (quartiles 1 and 4). Although a lower response rate may be 
expected from women in the most deprived quartile, as these women may have 
poorer literacy rates; less inclination to participate in research or perceived barriers to 
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participation, the lower than expected response rate in the most affluent group was 
somewhat surprising given the perception that more affluent groups are more likely to 
participate in research.  
 
No significant differences in the proportion of responders and non-responders were 
found on the basis of treatment type (X2=3.54; p=0.1703).  
 
Table 6.4 Responders/non-responders Q2 
Responders Responders 
(%) 
Non-responders 
(%) 
Non-responder bias 
Colposcopy unit    
Women’s 167 (59.9) 54 (43.5)  
City 36 (12.9) 21 (16.9)  
Solihull 38 (13.6) 30 (24.2) X2=12.11; p=0.0166 
Heartlands 13 (4.7) 4 (3.2)  
Good Hope 25 (9.0) 15 (12.1)  
Age range    
19-29 80 (28.7) 20 (16.1)  
30-39 98 (35.1) 63 (50.8)  
40-49 70 (25.1) 25 (20.2) X2=11.85; p=0.0079 
50+ 31 (11.1) 16 (12.9)  
Deprivation quartile*    
Most Affluent (Q1) 28 (10.3) 12 (9.8)  
Less Affluent (Q2) 51 (18.8) 25 (20.5) X2=1.2; p=0.753 
Less Deprived (Q3) 78 (28.8) 29 (23.8)  
Most Deprived (Q4) 114 (42.1) 56 (45.9)  
Treatment type    
Colposcopy Only 119 (42.7) 41 (33.1)  
Biopsy 76 (27.2) 39 (31.5) X2=3.3; p=0.0192 
Loop Excision 84 (30.1) 44 (35.5)  
* Deprivation quartile derived from 2007 Index of Multiple Deprivation 137 
 
The characteristics of responders and non-responders to Q2 were compared to 
explore potential responder bias on the basis of where colposcopy was undertaken, 
treatment type, age and deprivation quartile, for those invited to participate in the 
study. There was a significant difference between the proportion of responders and 
non-responders on the basis of the colposcopy units from which patients were invited 
(X2=12.11; p=0.0166). As for Q1, there was a lower than expected number of 
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responders from Good Hope, City and Solihull. Higher than anticipated numbers of 
women responded from both the Women’s and Heartlands hospitals. 
 
Significant differences between the proportion of responders and non-responders 
were found with regard to age group (X2=11.85; p=0.0079), with higher than 
expected numbers of patients responding from the 19 to 29 and 40 to 49 groups. 
Lower than expected numbers of responses were received from women in the 30 to 
39 and 50+ age groups. 
 
Significant differences were also found in the proportion of responders and non-
responders on the basis of treatment type (X2=3.3; p=0.0192) with proportionally 
larger numbers in the colposcopy group responding to Q2 and significantly lower 
than expected responses from individuals in the biopsy or loop excision groups.  
 
The level of deprivation was not found to be significantly associated with the 
likelihood of responding to Q2.  
 
6.4 Results of Analysis - Q1   
Questionnaire one was designed to ascertain participants’ perception of their general 
health; physical and emotional health; sexual life and partner satisfaction and social 
life. Responder characteristics are presented in Table 6.5. 
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Table 6.5 Characteristics of responders Q1 
 
Characteristic n(%) 
  
Colposcopy unit  
Women’s 328 (58.6) 
City 74 (13.2) 
Solihull 87 (15.5) 
Heartlands 19 (3.4) 
Good Hope 
52 (9.3) 
  
Age range  
19-29 121 (21.7) 
30-39 219 (39.3) 
40-49 141 (25.3) 
50+ 76 (13.6) 
  
Deprivation quartile *  
Most Affluent (Q1) 34 (6.2) 
Less Affluent (Q2) 124 (22.5) 
Less Deprived (Q3) 170 (30.9) 
Most Deprived (Q4) 222 (40.4) 
  
Treatment type  
Colposcopy only 251 (44.8) 
Biopsy 151 (27.0) 
Loop Excision 158 (28.2) 
  
* Deprivation quartile derived from 2007 Index of Multiple Deprivation 137 
 
 
Nearly two thirds of patients were treated at the Women’s hospital (n=328; 58.6%). In 
terms of age range, the 30 to 39 group accounted for the largest proportion of the 
sample (n=219; 39.3%). The 40 to 49 group and the 19 to 29 group were similar in 
their proportion of responders (n=141; 25.3% and n=121; 21.7% respectively). The 
lowest proportion of the sample were from the 50 group (n=76; 13.6%) The majority 
of the sample were from the most deprived quartiles (n=328; 58.69%). In terms of 
treatment type, women undergoing colposcopy accounted for almost half of the 
sample (n=251; 44.8%); with the remaining patients split fairly evenly between the 
biopsy and loop groups (n=151; 27.0%, n=158; 28.2% respectively). 
 
The following questions were considered when analysing Q1: 
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 Is age associated with women experiencing physical, emotional, social or 
sexual problems?  
 
 Is there a relationship between quality of life scores and levels of deprivation 
and/or age? 
 
 Is there a relationship between treatment type and physical/emotional/sexual 
health (e.g. are women who have undergone loop excision more likely to 
experience sexual problems due to the invasive nature of the procedure when 
compared with the biopsy/colposcopy only groups)? 
 
The results are presented below - including graphical representation of response 
frequencies and an investigation of the association between age, deprivation and 
treatment type and responses to the questions.  
 
Chi2 tests were performed to investigate the relationships between age stratified by 
range, deprivation stratified by level of deprivation and treatment type and the 
outcome measures relating to physical, emotional and sexual function. Frequency 
tables of responses for problems with social activities, satisfaction with sex life and 
satisfaction with partner are also presented. 
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Table 6.6 Factors studied and potential predictors (Q1) 
 
Factor Potential Predictors 
  
General Health Quality Level of treatment, deprivation quartile, age 
  
Physical Health affecting:  
 Ability to carry out normal 
tasks 
 Kind of work/activities 
undertaken 
 
 
Level of treatment, deprivation quartile, age 
Emotional Health 
 Accomplishing less than 
would like 
 Not doing work or other 
activities 
 
Level of treatment, deprivation quartile, age 
  
Sexual Health 
 Lacking interest in having 
sex 
 Anxious about ability to 
perform 
 Unable to come to climax 
 Climaxing too quickly 
 Pain during intercourse 
 Problems lubricating 
 
 
 
 
Level of treatment, deprivation quartile, age 
Problems with social activities Level of treatment, deprivation quartile, age 
  
Overall satisfaction with sex life Level of treatment, deprivation quartile, age 
  
Overall satisfaction with partner Level of treatment, deprivation quartile, age 
 
 
6.5 Analysis of results - Q1 
 
Analysis of questionnaire one presents the overall frequency of responses for all 
respondents to the questions relating to physical, emotional and sexual health before 
presenting analysis of the characteristics of responders in relation to the range of 
responses given to questions about physical, emotional and sexual health. This 
analysis was repeated for the questions relating to general health, social activities, 
satisfaction with sex life and satisfaction with partner. In terms of the six questions 
related to sexual function, bivariate analysis was undertaken for each question using 
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the three predictor variables - treatment type, deprivation and age. The purpose of 
the analysis of responder characteristics was to ascertain if there were any 
statistically significant relationships between variables, and thus whether clinical or 
sociodemographic predictors of these factors could be found. 
 
The characteristics considered in the analysis were - level of intervention (colposcopy 
vs. biopsy vs. loop excision) level of deprivation and patient age. Further analysis 
was undertaken comparing the colposcopy group (to act as a proxy in the absence of 
a matched control group – see Section 5.4.6) with those undergoing biopsy or loop 
excision. It was hypothesised that women undergoing biopsy or loop excision were at 
greatest risk of experiencing adverse events - such as impaired physical and 
emotional health or reduced sexual functioning following the procedure, as these 
procedures could be considered more ‘invasive’ than colposcopy alone. Similarly, 
analysis was undertaken by collapsing the four deprivation quartiles into a 
dichotomous variable representing ‘affluent’ and ‘deprived’. Significant results from 
this stage of analysis are reported. 
 
6.5.1 Physical, emotional and sexual health 
 
This section presents the analysis for the questions relating to physical, emotional 
and sexual health, presenting the total responses followed by analysis of the 
characteristics of responders in relation to these questions. Women were asked to 
consider the last 12 months and respond with ‘yes’ or ‘no’ to two questions relating to 
their physical health and two questions relating to their emotional health. They were 
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asked to consider the last three months and respond with a ‘yes’ or ‘no’ answer to six 
questions relating to their sexual well-being (Table 6.7). 
 
 
Table 6.7 Frequency of response (all respondents) to questions on physical, 
emotional and sexual health 
 
 
         
 Yes 
n 
 
(%) 
No 
n 
 
(%) 
Missing
n 
 
(%) 
Total 
n 
 
(%) 
Physical/Emotional 
Health 
 
        
Physical Health 1- less 
able to carry out normal 
tasks 
 
111 (19.8) 437 (78.0) 12 (2.1) 560 100 
Physical Health 2  - 
limiting kind of 
work/activities 
undertaken 
 
111 (19.8) 433 (77.3) 16 (2.9) 560 100 
Emotional Health 1 - 
accomplished less than 
would like 
 
166 (29.6) 385 (68.8) 9 (1.6) 560 100 
Emotional Health 2 - 
Didn’t do work or other 
activities 
 
135 (24.1) 408 (72.9) 17 (3.0) 560 100 
Sexual Health 
 
        
Lacked interest in 
having sex 
 
199 (35.5) 338 (60.4) 23 (4.1) 560 100 
Anxious about ability to 
perform 
127 (22.7) 400 (71.4) 33 (5.9) 560 100 
 
Unable to come to 
climax 
 
 
134 
 
(23.9)
 
389 
 
(69.5) 
 
37 
 
(6.6) 
 
560 
 
100 
Come to climax too 
quickly 
 
37 (6.6) 479 (85.5) 44 (7.9) 560 100 
Experienced pain during 
intercourse 
 
192 (34.3) 334 (59.6) 34 (6.1) 560 100 
Experienced problems 
lubricating 
 
143 (25.5) 381 (68.0) 36 (6.4) 560 100 
 
 
 181
Just under one fifth of responders reported that their physical health meant that they 
were less able to carry out normal tasks (n=111; 19.8%), or that it limited work or 
other activities normally undertaken (n=111; 19.8%). Just under one third of 
responders found that their emotional health meant that they accomplished less than 
they would like to (n=166; 29.6%) around a quarter found that their emotional health 
impacted upon work and other activities (n=135; 24.1%). With regard to sexual 
health, around one third of respondents reported lacking interest in sex (n=199; 
35.3%) and experiencing pain during intercourse (n=192; 34.3%). The least common 
sexual problem related to coming to a climax too quickly, with 6.6% (n=37) of 
respondents reporting problems in this area.  
 
 
Table 6.8 presents the results of the analysis relating to physical, emotional and 
sexual health in terms of treatment type.
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Table 6.8 Physical/emotional/sexual heath - responses categorised by treatment type 
 
 Colposcopy  Biopsy  Loop Excision   
 Yes No  Total Yes No  Total Yes No  Total  
Physical/Emotional Health 
 
n (%) n (%)   n (%) n (%)   n (%) n (%)    
Physical Health 1- less able 
to carry out normal tasks 
 
59 (23.8) 189 (76.2) 
  
 
 
248 
27 (18.2) 121 (81.8)  148 25 (16.4) 127 (83.6)  152 X
2=3.65 
p=0.1612 
Physical Health 2  - limiting 
kind of work/activities 
undertaken 
 
58 (23.6) 188 (76.4) 
 
 
246 29 (19.9) 117 (80.1)  146 24 (15.8) 128 (84.2)  152 X
2=3.54 
p=0.1703 
Emotional Health 1 - 
accomplished less than 
would like 
 
85 (43.1) 164 (65.9) 
 
 
249 42 (28.4) 106 (71.6)  148 39 (25.3) 115 (74.7)  154 X
2=3.8 
p=0.1496 
Emotional Health 2 - Didn’t 
do work or other activities 
 
68 (27.7) 178 (72.4)  246 37 (25.7) 107 (74.3)  144 30 (19.6) 123 (80.4)  153 X
2=3.33 
p=0.1892 
Sexual Health 
 
       
Lacked interest in having 
Sex 
 
87 (37.2) 147 62.8)  234 54 (36.0) 96 (64.0)  150 58 (37.9) 95 (62.1)  153 X
2=0.12 
p=0.9418 
Anxious about ability to 
perform 
54 (23.3) 178 (76.7)  232 34 (23.6) 110 (76.4)  144 39 (25.8) 112 (74.2)  151 X
2=0.35 
p=0.8395 
Unable to come to climax 
 
63 (27.4) 167 (72.6)  230 35 (24.1) 110 (75.9)  145 36 (24.3) 112 (75.7)  148 X
2=0.68 
p=0.7118 
Come to climax too quickly 
 
15 (6.6) 213 (93.4)  228 8 (5.6) 134 (94.4)  142 14 (9.6) 132 (90.4)  146 X
2=1.91 
p=0.3848 
Experienced pain during 
intercourse 
 
94 (40.5) 138 (59.5)  232 50 (34.5) 95 (65.5)  145 48 (32.2) 101 (67.8)  149 X
2=3.05 
p=0.2176 
Experienced problems 
lubricating 
 
69 (29.6) 164 (70.4)  233 33 (23.1) 110 (76.9)  143 41 (27.7) 107 (72.3)  148 X
2=1.93 
p=0.381 
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No significant differences were found between respondents to questions relating to 
whether physical health impacted upon ability to carry out normal tasks or limited the 
kind of work or activities undertaken (X2=3.65, p=0.1612; X2= 3.54, p=0.1703). 
Around a quarter of the respondents in the treatment group reported problems with 
physical health in terms of its impact on carrying out normal tasks and limiting work or 
activities compared with 18.2% (n=27) and 19.9% (n=29) in the biopsy group and 
16.4% (n=25) and 15.8% (n=24) in the loop excision group. Similarly, no significant 
differences were found in relation to the impact of emotional health upon ability to 
accomplish what respondents would like to or upon undertaking work or other 
activities (X2=3.8, p=0.1496; X2=3.33, p=0.1892).  
 
Treatment type was not significantly associated with an  impact upon sexual health - 
lacking interest in having sex (X2=012, p=0.9418); being anxious about ability to 
perform (X2=0.35, p=0.8395); being unable to come to a climax (X2=0.68, p=0.7118), 
coming to climax too quickly (X2=1.91, p=0.3848); experiencing pain during 
intercourse (X2=3.05, p=0.2176), or experiencing problems lubricating (X2=1.93, 
p=0.381). A similar proportion of responders across all treatment groups reported 
‘lacking interest in sex’ - colposcopy 37.2% (n=87); biopsy 36.0% (n=54) and loop 
excision 37.9% (n=58). The least problematic area in terms of sexual health was 
respondents climaxing too quickly. Similar proportions of responses were observed 
across treatment types - colposcopy 6.6% (n=15); biopsy 5.6% (n=8) and loop 
excision 9.6% (n=14). 
 
Table 6.9 presents results relating to physical, emotional and sexual health in terms 
of treatment type using colposcopy as a proxy for a ‘control’ group.
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Table 6.9 Physical/emotional/sexual health - responses categorised by 
undergoing colposcopy only, or biopsy/loop excision 
 
 
 
The premise of comparing the colposcopy group to a combined biopsy/loop groups is 
that colposcopy can be considered less ‘invasive’ than the other treatment types and 
therefore may be associated with fewer problems. Biopsy and loop excision groups 
were analysed together and compared with colposcopy patients, and although no 
 Colposcopy  Biopsy/Loop   
 Yes No  Total Yes No  Total  
Physical/Emotion
al Health 
 
  n (%)         n (%)    n (%)          n (%)   
Physical Health 1- 
less able to carry 
out normal tasks 
 
59 (23.8) 189 (76.2) 
  
 
248 52 (17.3) 248 (82.7)  300 Pearson 
X2=3.5 
p=0.0614 
Physical Health 2  - 
limiting kind of 
work/activities 
undertaken 
 
58 (23.6) 188 (76.4) 
 
 
246 53 (17.8) 245 (82.2)  298 Pearson 
X2=2.78 
p=0.0954 
Emotional Health 1 
- accomplished 
less than would 
like 
 
85 (43.1) 164 (65.9) 
 
 
249 81 (26.8) 221 (73.2)  302 Pearson 
X2=3.47 
p=0.0625 
Emotional Health 2 
- Didn’t do work or 
other activities 
 
68 (27.7) 178 (72.4)  246 67 (22.6) 230 (77.4)  297 Pearson 
X2=1.86 
p=0.1726 
Sexual Health 
 
     
Lacked interest in 
having sex 
 
87 (37.2) 147 (62.8)  234 112 (37.0) 191 (63.0)  303 Pearson 
X2=0 p=1 
Anxious about 
ability to perform 
54 (23.3) 178 (76.7)  232 73 (25.0) 222 (75.0)  295 Pearson 
X2=0.15 
p=0.6985 
Unable to come to 
climax 
 
63 (27.4) 167 (72.6)  230 71 (24.2) 222 (75.8)  293 Pearson 
X2=0.67 
p=0.4131 
Come to climax too 
quickly 
 
15 (6.6) 213 (93.4)  228 22 (7.7) 266 (92.3)  288 Pearson 
X2=0.21 
p=0.6468 
Experienced pain 
during intercourse 
 
94 (40.5) 138 (59.5)  232 98 (33.0) 196 (67.0)  294 Pearson 
X2=2.89 
p=0.0891 
Experienced 
problems 
lubricating 
 
69 (29.6) 164 (70.4)  233 74 (25.0) 217 (75.0)  291 Pearson 
X2=1.14 
p=0.2857 
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statistically significant differences were found, the degree of difference between 
factors following Chi2 analysis was higher than that found during analysis undertaken 
with the three groups considered separately.  
 
A higher than expected number in the colposcopy group answered ‘yes’ to questions 
relating to physical health - being less able to carry out normal tasks and limiting 
work activities undertaken and a lower than expected number from the biopsy/loop 
excision group agreed with these statements (X2=3.5, p=0.0614; X2=2.78, p=0.0954). 
Similarly, higher than expected numbers in the colposcopy group answered ‘yes’ to 
questions relating to emotional health - accomplishing less than they would like and 
noting an effect upon ability to undertaken work or other activities. A lower than 
expected number from the biopsy or loop excision group responded ‘yes’ to these 
statements (X2=3.47, p=0.0625; X2=1.86, p=0.1726). In this analysis, intervention 
level was not significantly associated with any impact upon sexual health for any of 
the questions within these ‘domains’. These findings show that level of intervention is 
not a significant indicator of physical, emotional or sexual problems following 
colposcopy. 
 
The following tables present the analysis of the association between physical, 
emotional and sexual health and levels of deprivation. Deprivation was analysed in 
two stages - first with deprivation categorised into four quartiles (most affluent, less 
affluent, less deprived and most deprived) (Table 6.10) and secondly dichotomised 
between affluent and deprived, with Q1 and Q2 indicating ‘affluence’ and Q3 and Q4 
indicating ‘deprived’ individuals. As no significant results were found in this stage of 
analysis, these results are not reported.  
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Table 6.10 Physical/emotional/sexual health - responses categorised by deprivation quartile  
 
 Most Affluent  Less Affluent  Less Deprived  Most Deprived   
 Yes 
 
n (%)  
No 
 
n (%)   
Total Yes No 
 
n          (%) n          (%)  
Total Yes No 
 
n           (%) n           (%)  
Total Yes No 
 
n         (%) n         (%)  
Total p value* 
Physical/Emotional Health         
Physical Health 1- less 
able to carry out 
normal tasks 
3  (8.8) 31 (91.2)  34 28 (23.3) 92 (76.7)  120 32  (18.9) 137 (81.1)  169 44 (20.5) 171 (79.5)  215  
X2=3.65 
P=0.3018 
 
Physical Health 2  - 
limiting kind of 
work/activities 
undertaken 
5  (15.2) 28 (84.8)  33 27 (22.7) 92 (77.3)  119 30  (18.0) 137 (82.0)  167 46 (21.4) 169 (78.6)  215 
X2=1.69 
P=0.06392 
 
Emotional Health 1 - 
accomplished less 
than would like 
7  (21.2) 26 (78.2)) 
     
33 30 (25.0) 90 (75.0)  120 45 (26.8) 123 (73.2)  168 81 (36.8) 139 (63.2)  220 
X2=8.31 
P=0.04 
 
Emotional Health 2 - 
Didn’t do work or other 
activities 
4  (12.1) 29 (87.9)  33 30 (35.0) 90 (75.0)  120 35  (20.7) 134 (79.3)  169 63 (29.9) 148 (70.1)  211 
X2=7.26 
P=0.0641 
Sexual Health          
 
Lacked interest in 
having sex 
14  (41.2) 20 (58.8)  34 40 (34.2) 77 (65.8)  117 65  (38.9) 102 (61.1)  167 77 (36.8) 132 (63.2)  209 
X2=0.91 
P=0.823 
 
Anxious about ability to 
perform 
8   (23.5) 26  (76.5)  34 29 (24.8) 88 (75.2)  117 34 (21.0) 124 (79.0)  162 53 (26.0) 151 (74.0)  204 
X2=1 
P=0.8013 
 
Unable to come to 
climax 
8 (23.5) 26 (76.5)  34 29 (25.2) 86 (74.8)  115 35  (21.6) 125 (78.1)  160 61 (29.9) 143 (70.1)  204 
X2=3.8 
P=0.3647 
 
Come to climax too 
quickly 
3 (9.1)  30 (90.9)  33 7 (6.3) 105 (93.8)  112 12 (7.5)  147 (92.5)  159 14 (6.9) 188 (93.1)  202 
 X2=0.38 
P=0.9443 
 
Experienced pain 
during intercourse 
9 (26.5)  25 (73.5)  34 45 (38.8) 71 (61.2)  116 66  (41.0) 95 (59.0)  160 67 (32.7) 138 (67.3)  205 
X2=4.43 
P=0.2186 
 
Experienced problems 
lubricating 
9  (26.5) 25  (73.5)  34 35 (30.2) 81 (69.8)  116 48 (30.0) 112 (70.0)  160 49 (24.0) 155 (76.0)  204 
X2=2.18 
P=0.5359 
 
* Statistically significant results are shown in bold text 
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As shown in Table 6.10, no statistically significant differences were found in the 
proportion of participants answering ‘yes’ to questions relating to physical health 
impact upon carrying out normal tasks (X2=3.65, p=0.3018). 
 
Physical health limiting the kind of work or activities undertaken although not 
statistically significant, was of higher significance (X2=1.69, p=0.06392) than other 
responses. A lower number of most affluent participants responded ‘yes’ to this 
question - 8.8% (n=3), compared to 23.3% (n=28) in the less affluent quartile; 18.9% 
(n=32) in the less deprived quartile and 20.5% (n=44) in the most deprived quartile. 
Similar levels of significance were found in relation to the impact of emotional health 
upon ability to do work and other activities (X2=7.26, p=0.0641) with a lower number 
of most affluent respondents answering yes to this statement  and a higher number 
of most deprived respondents also answering yes to this statement. 
 
Statistically significant differences were found in responses regarding the effect of 
emotional health upon ability to accomplish what respondents would like. 
Respondents in the ‘most affluent’ group were less likely to answer ‘yes’ to this 
statement and responders in the ‘most deprived’ group were more likely to respond 
with a “yes” to this statement (X2=8.31, p=0.04). This would appear to support the 
theory that an individual’s level of deprivation can be associated with impairments in 
some aspects of emotional well-being, but given that analysis categorised by 
treatment type did not demonstrate any significant associations, and can therefore 
not be assumed to be due to their clinical treatment these differences are likely to be 
independent of whether an individual had undergone colposcopy/biopsy or loop 
excision. 
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Deprivation levels were not significantly associated with an impact upon sexual 
health - lacking interest in having sex; being anxious about ability to perform; being 
unable to come to a climax; coming to climax too quickly; experiencing pain during 
intercourse and experiencing problems lubricating. 
 
Overall, these results suggest that socioeconomic deprivation does not have a 
significant association with respondents’ perceptions of their physical, emotional or 
sexual well-being. This is a surprising finding as there is a body of evidence that 
supports the notion that those living in more deprived areas experience more 
pronounced health problems. However, these findings should be placed in context. 
The IMD deprivation quartiles may be considered as a fairly crude instrument in 
assigning deprivation or affluence to a particular individual.  
 
 
Table 6.11 presents the analysis of the association between physical, emotional and 
sexual health and patient age. Responses were categorised into four age groups: 19 
to 29, 30 to 39, 40 to 49 and 50+. 
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Table 6.11 Physical/emotional/sexual health - responses categorised by age group 
 19 to 29  30 to 39  40 to 49  50+   
 Yes No  Total Yes No  Total Yes No  Total Yes No  Total  
Physical/ 
Emotional Health 
 
   n          (%)         n       (%)     n           (%)        n          (%)        n             (%)        n           (%)        n        (%)        n        (%)   
Physical Health 1- 
less able to carry 
out normal tasks 
10  (8.3)  110 (91.7)  120 37 (17.1) 180 (82.9)  217 36  (26.5)  100 (73.5)  136 28 (38.9)  44 (61.1)  72 
X2=30.54 
Cramer=0.2367 
p=<0.001 
 
Physical Health 2  
- limiting work / 
activities 
 
 
12  (10.1) 107 (89.9)  
 
119 
 
36 (16.7) 180 (83.3)  
 
216 
 
36  (26.9)  98 (73.1)  
 
134 
 
27 (37.5) 45  (62.5)  
 
72 
 
X2=25.95 
Cramer=0.219 
p=0.001 
Emotional Health 1 
accomplished less 
than would like to 
31 (25.6)  90 (74.4)  121 57 (26.3) 160 (73.7)  217 45  (33.1)  91 (66.9)  136 33 (44.6)  41 (55.4)  74 
X2=10.59 
Cramer=0.139 
p=0.0142 
 
Emotional Health 2 
- Didn’t do work or 
other activities 
 
25  (20.8)  95 (79.2)  
 
120 
 
53 (24.4) 164 (75.6)  
 
217 
 
35  (26.1)  99 (73.9)  
 
134 
 
22 (31.9)  47 (68.1)  
 
69 
 
X2=2.98 
Cramer=0.0743 
p=0.3947 
 
Sexual Health 
 
         
Lacked interest in 
having sex 40  (36.6)  79 (66.4)  119 75  (35.0) 139 (65.0)  214 53  (39.3)  82 (60.7)  135 31 (47.0) 35 (53.0)  66 
X2=4.02 
Cramer=0.0868 
p=0.2593 
 
Anxious about 
ability to perform 
 
 
32  (27.1)  86 (72.9)  
 
118 
 
48  (22.4) 166 (77.6)  
 
214 
 
30  (23.4)  98 (76.6)  
 
128 
 
17 (26.6) 47 (73.4)  
 
64 
 
X2=1.15 
Cramer=0.0468 
p=0.765 
 
Unable to come to 
climax 
 
 
32  (27.4)  85 (72.6)  
 
117 
 
45  (21.2) 167 (78.8)  
 
212 
 
37 (28.7)  92 (71.3)  
 
129 
 
20 (32.3) 42 (67.7)  
 
62 
 
X2=4.38 
Cramer=0.0918 
p=0.2232 
 
Come to climax 
too quickly 
 
 
8  (6.8)  109 (93.2)  
 
117 
 
14  (6.7)  194 (93.3)  
 
208 
 
11  (8.6)  117 (91.4)  
 
128 
 
4  (6.7)  56 (93.3)  
 
60 
 
X2=0.49 
Cramer=0.0309 
p=0.9211 
Experienced pain 
during intercourse 
 
54  (45.4) 65 (54.6)  119 78 (36.4) 136 (63.6)  214 42  (33.1)  85 (66.9)  127 17  (27.0) 46 (73.0)  63 
X2=7.15 
Cramer=0.1169 
p=0.0673 
Experienced 
problems 
lubricating 29  (24.6) 89 (75.4)  118 54 (25.2) 160 (74.8)  214 35  (28.2)  89 (71.8)  124 25 (38.5) 40 (61.5)  65 
 
X2=5.01 
Cramer=0.0981 
p=0.1711 
Statistically significant results are shown in bold text 
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A significant difference between age groups was observed in responses to the 
question regarding the effect physical health had upon individuals’ ability to carry out 
normal tasks. Participants aged 50 and over were significantly more likely to answer 
‘yes’ to this statement (X2=30.54; p=<0.001) and the 19 to 29 age group less likely to 
answer agree with this statement than those in the other age groups.  Similarly, there 
was a significant difference in responses to the statement regarding the effect of 
physical health limiting the kind of work or activities undertaken. Again, the older age 
group were significantly more likely to answer ‘yes’ and the younger group more 
likely to answer ‘no’ (X2=25.95, p=<0.001). 
 
A significant difference was also observed in responses to the question regarding the 
impact of emotional health upon accomplishing what individuals would like to, with 
the older group more likely to answer ‘yes’ to this question and the younger group 
less likely to answer “no” to this statement (X2=10.59, p=0.0142). 
 
Age group did not appear to be significantly associated with responses to questions 
relating to sexual health, lacking interest in having sex; being anxious about ability to 
perform; being unable to come to a climax; coming to climax too quickly; and 
experiencing problems lubricating. However, although not statistically significant 
(X2=7.15, p=0.0673), younger women were more likely to report having experienced 
pain during intercourse than those in the 50+ age group. 
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Bivariate analysis of questions related to sexual function 
 
This section will present the results from the bivariate analysis of the questions 
related to sexual function utilising the three predictors of interest - treatment,  
deprivation and age. The results are shown in tables 6.12 to table 6.17 All responses 
relate to problems experienced for three months or longer. 
Table 6.12 Bivariate analysis of predictor variables in relation ‘lacking interest 
in having sex’ 
 
Lacked interest in 
having sex 
 Bivariate OR 
(95% CI) 
p value  
 Yes No 
   
  
    
Treatment type    
Colposcopy Only 87 (37.2) 147 (62.8)  0.97 (0.6 - 1.5) 0.86 
Biopsy 54 (36.0) 96 (64.0)  0.92 (0.6 - 1.5 0.73 
Loop Excision 58 (37.9) 95 (62.1)  Reference Reference 
    
Deprivation quartile    
Most Affluent (Q1) 14 (41.2) 20 (58.8)  1.20 (0.5 - 2.5) 0.62 
Less Affluent (Q2) 40 (34.2) 77 (65.8)  0.89 (0.5 - 1.4) 0.63 
Less Deprived (Q3) 
Most Deprived (Q4) 
65 (38.9) 102 (61.1) 
77 (36.8) 132 (63.2)  
1.09 (0.7 - 1.6) 
Reference 
0.79 
    
Age group    
19 to 29 40 (36.6) 79 (66.4)  0.57 (0.3 - 1.0) 0.07 
30 to 39 75 (35.0) 139 (65.0)  0.60 (0.3 - 1.0) 0.08 
40 to 49 
50+ 
53 (39.3) 82 (60.7) 
31 (47.0) 36 (53.0)  
0.73 (0.4 - 1.3) 
Reference 
0.29 
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Table 6.13 Bivariate analysis of predictor variables in relation to ‘feeling 
anxious before having sex’ 
 
Felt anxious about 
having sex 
 Bivariate OR 
(95% CI) 
p value  
 Yes No 
   
  
    
Treatment type    
Colposcopy Only 54 (23.3) 178 (76.7   0.87 (0.5 - 1.4) 0.56 
Biopsy 34 (23.6) 110 (76.4)  0.88 (0.5 - 1.5) 0.65 
Loop Excision 39 (25.8) 112 (74.2)  Reference  
    
Deprivation quartile    
Most Affluent (Q1) 8 (23.5) 26 (76.5)  0.87 (0.3 - 2.0) 0.76 
Less Affluent (Q2) 29 (24.8) 88 (75.2)  0.93 (0.5 - 1.5) 0.81 
Less Deprived (Q3) 
Most Deprived (Q4) 
34 (21.0) 124 (79.0) 
53 (26.0) 151 (74.0)  
0.75 (0.4 - 1.2) 
Reference 
0.26 
    
Age group    
19 to 29 32 (27.1) 86 (72.9)  1.02 (0.5 - 2.0) 0.93 
30 to 39 48 (22.4) 166 (77.6)  0.79 (0.4 - 1.5) 0.49 
40 to 49 
50+ 
30 (23.4) 98 (76.6) 
17 (26.6) 47 (73.4)  
0.84 )0.4 - 1.6) 
Reference 
0.63 
    
 
Table 6.14 Bivariate analysis of predictor variables in relation to being ‘unable 
to come to a climax 
Unable to come to a 
climax 
 Bivariate OR 
(95% CI) 
p value  
 Yes No 
   
  
    
Treatment type    
Colposcopy Only 63 (27.4) 167 (72.6  1.17 (0.7 - 1.8) 0.50 
Biopsy 35 (24.1) 110 (75.9)  0.97 (0.5 - 1.6) 0.99 
Loop Excision 36 (24.3) 112 (75.7)  Reference Reference 
    
Deprivation quartile    
Most Affluent (Q1) 8 (23.5) 26 (76.5)  0.72 (0.3 - 1.6) 0.45 
Less Affluent (Q2) 29 (25.2) 86 (74.8)  0.79 (0.4 - 1.5) 0.37 
Less Deprived (Q3) 
Most Deprived (Q4) 
35 (21.6) 125 (78.1) 
61 (29.9) 143 (70.1)  
0.65 (0.4 - 1.0) 
Reference 
0.08 
    
Age group    
19 to 29 32 (27.4) 85 (72.6)  0.79 (0.4 - 1.5) 0.49 
30 to 39 45 (21.1) 167 (78.8)  0.56 (0.3 - 1.0) 0.07 
40 to 49 
50+ 
37 (28.7) 92 (71.3) 
20 (32.3) 42 (67.7)  
0.84 (0.4 - 1.6) 
Reference 
0.61 
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Table 6.15 Bivariate analysis of predictor variables in relation to ‘coming to a 
climax to quickly’ 
Climax too quickly  Bivariate OR 
(95% CI) 
p value  
 Yes No 
   
  
    
Treatment type    
Colposcopy Only 15 (6.6) 213 (93.4  0.64 (0.3 - 1.4) 0.29 
Biopsy 8 (5.6) 134 (94.4)  0.56 (0.2 - 1.3) 0.56 
Loop Excision 14 (9.6) 132 (90.4)  Reference  
    
Deprivation quartile    
Most Affluent (Q1) 3 (9.1) 30 (90.9)  1.34 (0.3 - 4.9) 0.65 
Less Affluent (Q2) 7 (6.3) 105 (93.8)  0.89 (0.3 - 2.2) 0.81 
Less Deprived (Q3) 
Most Deprived (Q4) 
12 (7.5) 147 (92.5) 
14 (6.9) 188 (93.1)  
0.82 (0.4 - 2.4) 
Reference 
1.09 
    
Age group    
19 to 29 8 (6.8) 109 (93.2)  1.02 (0.2 - 3.5) 0.96 
30 to 39 14 (6.7) 194 (93.3)  1.01 (0.2 - 3.1) 0.98 
40 to 49 
50+ 
11 (8.6) 117 (91.4) 
4 (6.7) 56 (93.3)  
1.31 (0.4 - 4.3) 
Reference 
0.65 
    
 
Table 6.16 Bivariate analysis of predictor variables in relation to ‘experiencing 
pain during sex’ 
Pain during sex  Bivariate OR 
(95% CI) 
p value  
 Yes No 
   
  
    
Treatment type    
Colposcopy Only 94 (40.5) 138 (59.5)  1.43 (0.9 - 2.2) 0.10 
Biopsy 50 (34.5) 95 65.5)  1.10 (0.6 - 1.7) 0.68 
Loop Excision 48 (32.2) 101 (67.8)  Reference  
    
Deprivation quartile    
Most Affluent (Q1) 9 (26.5) 25 (73.5)  0.74 (0.3 - 1.6) 0.47 
Less Affluent (Q2) 45 (38.8) 71 (61.2)  1.30 (0.8 - 2.0) 0.27 
Less Deprived (Q3) 
Most Deprived (Q4) 
66 (41.0) 95 (59.0) 
67 (32.7) 138 (67.3)  
1.43 (0.9 - 2.1) 
Reference 
0.10 
    
Age group    
19 to 29 54 (45.4) 65 (54.6  2.24 (1.1 - 4.3) 0.01 
30 to 39 78 (36.4) 136 (63.6)  1.55 (0.8 - 2.8) 0.16 
40 to 49 
50+ 
42 (33.1) 85 (66.9) 
17 (27.0) 46 (73.0)  
1.55 (0.8 - 2.8) 
Reference 
0.39 
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Table 6.17 Bivariate analysis of predictor variables in relation to ‘problems 
lubricating’ 
Problems lubricating  Bivariate OR 
(95% CI) 
p value  
 Yes No 
   
  
    
Treatment type    
Colposcopy Only 69 (29.6) 164 (70.4  1.0 (0.6 - 1.7) 0.68 
Biopsy 33 (23.1) 110 (76.9)  0.7 (0.4 - 1.3) 0.36 
Loop Excision 41 (27.7) 107 (72.3)  Reference  
    
Deprivation quartile    
Most Affluent (Q1) 9 (26.5) 25 (73.5)  1.13 (0.4 - 2.6) 0.75 
Less Affluent (Q2) 35 (30.2) 81 (69.8)  1.36 (0.8 - 2.2) 0.23 
Less Deprived (Q3) 
Most Deprived (Q4) 
48 (30.0) 112 (70.0) 
49 (24.0) 155 (76.0)  
1.35 (0.8 - 2.1) 
Reference 
0.20 
    
19 to 29 29 (24.6) 89 (75.4)  0.52 (0.2 - 1.0) 0.05 
30 to 39 54 (25.2) 160 (74.8)  0.54 (0.3 - 0.9) 0.04 
40 to 49 
50+ 
35 (28.2) 89 (71.8) 
25 (38.5) 40 (61.5)  
0.62 (0.3 - 1.1) 
Reference 
0.15 
    
 
 
Following bivariate analysis of the responses to the six questions relating to sexual 
function, the only significant predictors of experiencing problems with sexual function 
were observed in terms of experiencing pain during sexual intercourse and problems 
with lubrication. Younger women (aged 19-29) were over twice as likely to report 
experiencing pain during sex compared with women over 50 years of age (OR: 2.24; 
CI 1.1 to 4.3). Women aged 19-29 were also half as likely to report problems with 
lubrication (OR: 0.52; 0.2 to 1.0) compared to women over 50. 
Multivariate analysis of questions related to sexual function 
 
This section will present the results from the multivariate regression undertaken to 
establish which, if any, of the three factors of interest might be significant predictors 
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of experiencing problems across the 6 six domain questions, when all other factors 
are controlled for in the model. 
Table 6.18 Multivariate analysis of predictor variables in relation to ‘lacking 
interest in having sex’ 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
-0.75 (0.225) 
 
0.73 
 
0.927  
 
(0.5 - 1.4) 
 
Treatment type 2 
(biopsy) 
 
0.004 (0.253) 
 
0.98 
 
1.004 (0.6 - 1.6) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
0.208 (0.388) 
 
0.59 
 
1.231 (0.5 - 2.6) 
 
IMD 2 (Q2) 
 
-0.109 (0.255) 
 
0.67 
 
0.897 (0.5 - 1.4) 
 
IMD 3 (Q3) 
 
0.077 (0.219) 
 
0.72 
 
1.080 (0.7 - 1.6) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
-0.555 (0.317) 
 
0.80 
 
0.564 (0.3 - 1.0) 
 
Age 2 (29-39) 
 
-0.499 (0.289) 
 
0.84 
 
0.607 (0.3 - 1.0) 
 
Age 3 (40-49) 
 
-0.328 (0.307) 
 
0.28 
 
0.720 (0.3 - 1.3) 
 
Note: Model X2 =4.753 (p=0.784); Hosmer and Lemeshow = 8.871 (p=3.53); Cox & Snell R2=0.09; 
Nagelkerke R2 = 0.012 
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Table 6.19 Multivariate analysis of predictor variables in relation to ‘feeling 
anxious before having sex’ 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
 
-0.233 (0.254) 
 
 
0.35 
 
 
0.792 
 
 
(0.4 - 1.3) 
 
Treatment type 2 
(biopsy) 
 
-0.143 (0.287) 
 
0.61 
 
0.866 (0.4 - 1.5) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
-0.123 (0.445) 
 
0.78 
 
0.884 (0.3 - 2.1) 
 
IMD 2 (Q2) 
 
-0.054 (0.281) 
 
0.84 
 
0.948 (0.5 - 1.6) 
 
IMD 3 (Q3) 
 
-0.317 (0.256) 
 
0.21 
 
0.72 (0.4 - 1.2) 
 
Age range 
 
 
 
 
 
 
 
Age 1 (19-29) 
 
0.015 (0.355) 
 
0.96 
 
1.015 (0.5 - 2.0) 
 
Age 2 (29-39) 
 
-0.242 (0.332) 
 
0.46 
 
0.785 (0.4 - 1.5) 
 
Age 3 (40-49) 
 
-0.209 (0.357) 
 
0.55 
 
0.812 (0.4 - 1.6) 
Note: Model X2 =3.481 (p=0.901); Hosmer and Lemeshow = 2.110 (p=0.977); Cox & Snell R2=0.007; 
Nagelkerke R2 = 0.010 
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Table 6.20 Multivariate analysis of predictor variables in relation to being 
‘unable to come to a climax 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
0.069 (0.254) 
 
0.78 
 
1.071 
 
(0.6 - 1.7) 
 
Treatment type 2 
(biopsy) 
 
-0.017 (0.290) 
 
0.95 
 
0.983 (0.5 - 1.7) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
-0.255 (0.442) 
 
0.56 
 
0.775 (0.3 - 1.8) 
 
IMD 2 (Q2) 
 
-0.163 (0.278) 
 
0.55 
 
0.849 (0.4 - 1.4) 
 
IMD 3 (Q3) 
 
-0.394 (0.250) 
 
0.166 
 
0.675 (0.4 - 1.1) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
-0.189 (0.346) 
 
0.58 
 
0.828 (0.4 - 1.6) 
 
Age 2 (29-39) 
 
-0.496 (0.324) 
 
0.21 
 
0.609 (0.3 - 1.1) 
 
Age 3 (40-49) 
 
-0.111 (0.339) 
 
0.073 
 
0.529 (0.4 - 1.7) 
Note: Model X2 =7.054 (p=0.531); Hosmer and Lemeshow = 5.018 (p=0.756); Cox & Snell R2=0.014; 
Nagelkerke R2 = 0.020 
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Table 6.21 Multivariate analysis of predictor variables in relation to ‘coming to a 
climax to quickly’ 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
-0.493 (0.408) 
 
0.22 
 
0.611 
 
(0.2 - 1.3) 
 
Treatment type 2 
(biopsy) 
 
-0.557 (0.482) 
 
0.24 
 
0.573 (0.2 - 1.4) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
0.168 (0.681) 
 
0.80 
 
1.183 (0.3 - 4.4) 
 
IMD 2 (Q2) 
 
-0.052 (0.501) 
 
0.91 
 
0.949 (0.3 - 2.5) 
 
IMD 3 (Q3) 
 
-0.005 (0.419) 
 
0.99 
 
0.995 (0.4 - 2.2) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
-0.013 (0.641) 
 
0.98 
 
0.987 (0.2 - 3.4) 
 
Age 2 (29-39) 
 
-0.014 (0.594) 
 
0.98 
 
0.987 (0.3 - 3.1) 
 
Age 3 (40-49) 
 
0.173 (0/618) 
 
0.77 
 
1.189 (0.3 - 3.9) 
Note: Model X2 =2.489 (p=0.962); Hosmer and Lemeshow = 4.179 (p=0.841); Cox & Snell R2=0.005; 
Nagelkerke R2 = 0.012 
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Table 6.22 Multivariate analysis of predictor variables in relation to 
‘experiencing pain during sex’ 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
0.503 (0.234) 
 
0.03 
 
1.654 
 
(1.0 - 2.6) 
 
Treatment type 2 
(biopsy) 
 
0.027 (0.267) 
 
0.92 
 
1.027 (0.6 - 1.7) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
-0.84 (0.429) 
 
0.84 
 
0.920 (0.3 - 2.1) 
 
IMD 2 (Q2) 
 
0.419 (0.258) 
 
0.10 
 
1.520 (0.9 - 2.5) 
 
IMD 3 (Q3) 
 
0.480 (0.227) 
 
0.03 
 
1.615 (1.0 - 2.5) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
0.884 (0.346) 
 
0.01 
 
2.421 (1.2 - 4.7) 
 
Age 2 (29-39) 
 
0.500 (0.325) 
 
0.12 
 
1.648 (0.8) - 3.1) 
 
Age 3 (40-49) 
 
0.320 (0.348) 
 
0.35 
 
1.376 (0.6 - 2.7) 
Note: Model X2 =17.414 (p=0.026); Hosmer and Lemeshow = 3.154 (p=0.924); Cox & Snell R2=0.033; 
Nagelkerke R2 = 0.046 
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Table 6.23 Multivariate analysis of predictor variables in relation to ‘problems 
lubricating’ 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
0.20 (0.245) 
 
0.93 
 
1.021 
 
(0.6 - 1.6) 
 
Treatment type 2 
(biopsy) 
 
-0.333 (0.288) 
 
0.248 
 
0.717 (0.4 - 1.2) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
0.159 (0.433) 
 
0.71 
 
1.172 (0.5 - 2.7) 
 
IMD 2 (Q2) 
 
0.479 (0.276) 
 
0.08 
 
1.614 (0.9 - 2.7) 
 
IMD 3 (Q3) 
 
0.336 (0.245) 
 
0.16 
 
1.400 (0.8 - 2.8) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
-0.620 (0.388) 
 
0.06 
 
0.538 (0.2 - 1.0) 
 
Age 2 (29-39) 
 
-0.623 (0.306) 
 
0.42 
 
0.536 (0.2 - 0.7) 
 
Age 3 (40-49) 
 
-0.457 (0.329) 
 
0.16 
 
0.633 (0.3 - 1.2) 
Note: Model X2 =9.384 (p=0.311); Hosmer and Lemeshow = 4.196(p=0.839); Cox & Snell R2=0.018; 
Nagelkerke R2 = 0.026 
 
Following multivariate analysis, none of the three potential predictors were found to 
be significantly associated with experiencing sexual problems except in the response 
to the question relating to experiencing pain during sex. 
After controlling for all factors in the model, three significant predictors of 
experiencing pain during sex were identified. Women aged between 19 and 29 were 
almost two and a half times as likely to experience pain during sex compared with 
women over 50 (p=0.001). Women who had undergone colposcopy were half as 
likely to experience pain during sex compared with women who had undergone loop 
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excision (p= 0.03). Finally, women in the less deprived quartile were half as likely to 
undergo pain during sex compared with women in the most deprived quartile. 
Caution is required when interpreting these results as the amount of variation 
explained by these variables is between 3.0 and 4.6 percent. 
 
6.5.2 General health  
 
The following section presents the analysis for the question relating to general health, 
presenting the aggregate responses for all respondents, followed by an analysis of 
the characteristics of responders in relation to these questions.  
 
Women were asked which response best described their general health from the 
following options: ‘excellent’, ‘very good’, ‘good’, ‘fair’ or ‘poor.’ The total responses 
for each of the domains of interest are presented in Table 6.24 and illustrated 
graphically in Figure 6.2. 
 
 
Table 6.24 General health - total responses 
 
General Health n   (%) 
Excellent 84 (15.0) 
Very Good 210 (37.5) 
Good 152 (27.1) 
Fair 52 (9.3) 
Poor 12 (2.1) 
Missing 50 (8.9) 
Total 560 (100.0) 
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Figure 6.2 General health - total responses 
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When all responses were analysed together, the majority of individuals reported 
having ‘excellent’, ‘very good’ or ‘good’ health (n=446; 79.6%). Only 12 respondents 
considered their general health to be ‘poor’ (2.1%). 50 survey participants did not 
answer the question, thus 8.9% of responses were missing. 
 
 203
Table 6.25 presents the responses to the question relating to general health in terms 
of treatment undergone. Table 6.26 presents the responses to the general health 
question dichotomising responses into ‘excellent’, ‘very good’ and ‘good’ and 
comparing this with ‘fair’ and ‘poor’. 
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Table 6.25 General health - categorised by treatment type 
 
General Health Colposcopy    Biopsy   Loop Excision 
 n (%) 
   
n (%)  n (%)  
Excellent 37  (16.1)  25  (18.1)  22  (15.5)  
Very Good 83  (36.1)  58  (42.0)  69  (48.6)  
Good 72  (31.3)  38  (27.5)  42  (29.6)  
Fair 28  (12.2)  15  (10.9)  9  (6.3)  
Poor 10  (4.3)  2  (1.4)  0 (0.0)  
Total 230  (100.0)  138  (100.0)  142  (100.0)  
 
 
It was not possible to undertake more sophisticated analyses of the responses to the 
question relating to general health when broken down by treatment type due to 
presence of zero values in response fields. However, across all treatment groups 
(colposcopy n=192; 83.5%, biopsy n=121; 87.6%, loop excision n=133; 93.7%), 
higher proportions of responders stated that their general health was ‘good’, ‘very 
good’ or ‘excellent’ than those stating that their general health was ‘fair’ or ‘poor’. To 
undertake more sophisticated analysis of the responses these were dichotomised 
between ‘excellent’, ‘very good’ and ‘good’ and compared with ‘fair’ and ‘poor’. 
Table 6.26 presents the dichotomised responses to these questions as outlined 
above. 
 
Table 6.26 General health dichotomised responses - categorised by treatment 
type 
 
 
General 
Health 
Colposcopy    Biopsy   Loop Excision  
 n (%) 
   
n (%)  n (%)   
Group 1 
(‘excellent’, 
‘very good’ or 
‘good’) 
192 (83.5) 121 (87.7) 133 (93.7)  X2 = 8.31 
p=0.0157 
Group 2 (‘fair’ 
‘poor’) 
38 (16.5) 17 (12.3) 9 (6.3)  
Total 230 (100) 138 (100) 142 (100)  
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The analysis shown in table 6.26 shows a significant difference in terms of treatment 
type and dichotomised responses to the question related to general health. Women 
who underwent colposcopy were more likely to rate their problems as ‘poor’ or ‘fair’ 
and women in the loop excision group were less likely to rate their general heath as 
‘poor’ or ‘fair’ (X2=8.31; p=0.0157). 
 
Table 6.27 presents the responses to the question relating to general health in terms 
of treatment undergone, with colposcopy being used as a proxy for a control group. 
 
 
Table 6.27 General health - responses categorised by undergoing colposcopy 
only, or biopsy/loop excision 
 
General Health Colposcopy    Biopsy/Loop   
   n                       (%)     n                       (%) 
 
Excellent 37  (16.1)  47 (16.8)  
Very Good 83  (36.1)  127 (45.3)  
Good 72  (31.3)  80 (28.6)  
Fair 28  (12.2)  24 (8.6)  
Poor 10  (4.3)  2 (0.70)  
Total 230  (100.0)  280 (100.00)    
 
 
 
 
 
 
Figure 6.3 General health - responses categorised by undergoing colposcopy 
only, or biopsy/loop excision 
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It was not possible to undertake formal statistical tests for association between 
variables to the question relating to general health and treatment type, due to some 
response fields including zero values. However, across both groups, as shown in 
Figure 6.3, a high proportion of responders stated that their general health was 
‘good’, ‘very good’ or ‘excellent’. Furthermore, 254 (90.7%) responders in the biopsy 
and loop excision group reported that their general health as ‘excellent’, ‘very good’ 
or ‘good’ was compared to the colposcopy group (n=192; 83.5%). Thus, there was 
very little difference in the responses given regarding general health between the 
colposcopy group and the combined biopsy/loop excision group.  
As per section above, to undertake more sophisticated analysis of the responses 
these were dichotomised between ‘excellent’, ‘very good’ and ‘good’ and compared 
with ‘fair’ and ‘poor’ and the responses are presented in table 6.28. 
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Table 6.28 General health dichotomised responses - categorised by treatment 
type (Colposcopy v biopsy and loop excision) 
 
 
General 
Health 
Colposcopy    Biopsy/Loop     
 n (%) 
   
n (%)   
Group 1 
(‘excellent’, 
‘very good’ or 
‘good’) 
192 (83.5) 254 (90.8) Pearson X2= 
6.02 
Group 2 (‘fair’ 
‘poor’) 
38 (16.5) 17 (926) p=0.0141 
Total 230 (100) 280 (100)  
 
 
When treatment groups were dichotomised between colposcopy compared with 
biopsy and loop excision, statistically more women in the colposcopy group likely to 
report their health as ‘poor’ or fair’ compared to the biopsy/loop excision group 
(Pearson X2=6.02; p=0.0141). 
 
Table 6.29 presents the responses to the question relating to general health in terms 
of deprivation quartile.
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Table 6.29 General health responses categorised by deprivation quartile  
 
General 
Health 
Most 
Affluent 
 
 
Less Affluent   Less 
Deprived 
 
 
Most 
Deprived 
 
 
   n               (%) 
 
  n                (%)   n              (%)   n              (%) 
Excellent 7  (21.9)  26  (23.2)  25  (15.8)  25  (12.6)  
V. Good 18  (56.3)  47  (42.0)  66  (41.8)  76  (38.4)  
Good 7  (21.9)  28  (25.0)  51  (32.3)  62  (31.3)  
Fair 0 (0.0)  8  (7.1)  16  (10.1)  26  (13.1)  
Poor 0 (0.0)  3  (2.7)  0 (0.0)  9  (4.5)  
Total 32  (100.0)  112 (100.0)  158 (100.0)  198  (100.0) 
 
 
 
 
Figure 6.4 General health responses categorised by deprivation quartile  
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All respondents in the most affluent quartile rated their general health as ‘excellent’, 
‘very good’ or ‘good’ (n=32; 100%). Around 90% of respondents in the less affluent 
and less deprived quartile rated their general health ‘excellent’, ‘very good’ or ‘good’. 
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Just over 80% of respondents in the most deprived quartile rated their general health 
in these terms. There were higher proportions of responders in the most deprived 
and less deprived groups stating that their general health was ‘fair’ or ‘poor’ as 
demonstrated in Figure 6.4.  
 
Table 6.30 presents the responses to the question relating to general health when 
deprivation quartiles were dichotomised into two groups representing ‘affluent’ and 
‘deprived’ (quartiles 1 and 2 combined to form the affluent group, and quartiles 3 and 
4 combined to form the deprived group).  
 
Table 6.30 General health responses categorised by ‘affluent’ or ‘deprived’ 
 
General Health Affluent   Deprived    
   n          (%)   n           (%) 
 
 
Excellent   33        (22.9)   50        (14.0)  
Very Good 65 (45.1)  142 (39.9)    X
2=11.54 
Good 35  (24.3)  113 (31.7)  p=0.0211 
Fair 8 (5.6)  42 (11.8)   
Poor 3 (2.1)  9 (2.5)   
Total 144 (100.0)  356 (100.0)   
 
 
 
Just over 90% of respondents in the ‘affluent’ group rated their general health as 
‘excellent’, ‘very good’ or ‘good’ (n=133) compared with respondents in the ‘deprived’ 
group (85.8%; n=305). This difference between groups was statistically significant 
(X2=11.54; p=0.0211).  
 
As demonstrated in figure 6.5, a higher proportion of respondents from the deprived 
group rated their heath as ‘good’ or ‘fair’ compared with the affluent group, with very 
similar proportions observed for respondents rating their health as ‘poor’. 
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Figure 6.5 General health responses categorised by ‘affluent’ or ‘deprived’ 
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Further analysis was undertaken using the dichotomised groups comparing general 
health rated as ‘excellent’, ‘very good’ or ‘good’ compared with ‘fair’ and ‘poor’. This 
was undertaken for the dichotomised quartiles only (presented in Table 6.31). It was 
not possible to undertaken more formal analysis using the four quartiles due to the 
presence of zero values. 
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Table 6.31 General health dichotomised responses - affluent/deprived 
 
 
General 
Health 
Affluent   Deprived     
 n (%) 
   
n (%)   
Group 1 
(‘excellent’, 
‘very good’ or 
‘good’) 
133 (92.4) 305 (85.7) PearsonX2= 
4.22 
Group 2 (‘fair’ 
‘poor’) 
11 (7.6) 51 (14.3) p=0.04 
Total 144 (100.0)) 356 (100.0)  
 
When the general health responses were dichotomised into two groups a significant 
result was observed with women in the deprived group being more likely to rate their 
general health as ‘fair’ or ‘poor’ compared to the affluent group (Pearson 6.02; 
p=0.04).  
 
Table 6.32 presents the responses to the question relating to general health in terms 
of respondent age group. 
 
Table 6.32 General health - responses categorised by age group 
 
 
 
 
 
 
 
 
 
 
 
General 
Health 
19-29   30-39   40-49   50+    
   n         (%)           n          (%)        n         (%)           n           (%)  
Excellent 19 (17.0)  34 (16.7) 22 (18.0)   7  (10.0)   
V. Good 59  (52.7)  88 (43.3) 42 (34.4)   20 (28.6)  X
2=37.07 
Good 24  (21.4)  67  (33.0) 38  (31.1)  23  (32.9)  p=0.0002
Fair 9 (8.0)  12 (5.9)  16 (13.1)  15 (21.4)   
Poor 1 (0.9)  2 (1.0)  4 (3.3)  5 (7.1)   
Total 112  (100.0)  203 (100.0) 122 (100.0) 70 (100.0)  
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Figure 6.6 General health - responses categorised by age group 
  
0
10
20
30
40
50
60
Excellent Very Good Good Fair Poor
Responses
%
 o
f r
es
po
nd
en
ts
19-29
30-39
40-49
50+
 
 
 
Just over 90% of responders in the 19 to 39 and 30 to 39 age groups rated their 
general health as ‘excellent’, ‘very good’ or ‘good’. The proportion of respondents 
rating their health in these terms decreased as the age group increased (40 to 49 
n=102; 83.5%, 50+ n= 50; 71.5%), (see Figure 6.6).  
 
Just over 7% (n=5) of respondents from the 50+ age group rated their general health 
as ‘poor’ compared to 3.3% (n=4) in the 40 to 49 group; 1% in the 30 to 39 age group 
(n=2) and just under 1% in the 19-29 group (n=1). A significant difference was 
observed across the four age groups in terms of responses to the question rating 
respondents’ perception of their general health. Respondents in the age groups 19 to 
29, 30-39 and 40 to 49 were significantly more likely to rate their general health as 
‘excellent’ or ‘very good’ than women in the 50 and over group (X2=37.07; p=0.0002). 
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6.5.3 Problems with social activities 
 
This section presents the analysis for the survey question relating to experiencing 
problems with social activities due to individuals’ physical and emotional health, 
presenting the total, aggregated responses, followed by analysis of the 
characteristics of responders in relation to these questions.  
 
Women were asked to consider the previous 12 months in terms of how much they 
perceived that their physical and emotional health had interfered with their social 
activities and choose from the following responses - ‘all of the time’, ‘most of the 
time’, ‘some of the time’, ‘a little of the time’ or ‘none of the time’. 
 
Table 6.33 presents the total responses to the question relating to problems with 
social activities. 
 
 
 
 
 
 
Table 6.33 Frequency of response (all respondents) to question relating to 
problems with social activities 
 
 
Problems with social activities   
 n % 
All the time 5 (0.9) 
Most of the time 37 (6.6) 
Some of the time 109 (19.5) 
A little of the time 135 (24.1) 
None of the time 262 (46.8) 
Missing 12 (2.1) 
Total 560 (100.0) 
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Figure 6.7 Problems with social activities - total responses 
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Almost half of the sample reported never experiencing problems with social activities 
(n=262; 46.8%). Fewer than 10% of the sample reported experiencing problems with 
social activities ‘all of the time’ and ‘most of the time’. Table 6.34 presents the 
responses to the question relating to problems with social activities broken down by 
treatment type.  
 
Table 6.34 Problems with social activities - categorised by treatment type 
 
 
Problems with Social 
Activities 
 
 
Colposcopy   
 
 
Biopsy   
 
 
Loop 
Excision 
   
 
 n (%) 
  
n (%)  n (%)  
All of the time 4  (1.6)  1  (0.7)  0 (0.0)  
Most of the time 23  (9.2)  8  (5.4)  6  (3.9)  
Some of the time 50  (20.1)  25  (17.0)  34  (22.4)  
A little of the time 56  (22.5)  40  (27.2)  39  (25.7)  
None of the time 116  (46.6)  73  (49.7)  73  (48.0)  
Total 249  (100.0)  147  (100.0)  152  (100.0)  
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Figure 6.8 Problems with social activities - treatment type  
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Similar proportions of responders across the three treatment types reported never 
experiencing problems relating to social activities due to their physical or emotional 
health (colposcopy n=116; 46.6%, biopsy n=73; 49.7%, loop excision n=73; 48.0%). 
As Figure 6.8 shows, no respondents from the loop excision group reported 
experiencing problems with social activities ‘all of the time’. 
To undertake more sophisticated analysis of the responses these were dichotomised 
between responders reporting problems with social activities ’all of the time’, ‘most of 
the time’ and ‘some of the time’ compared with the responses ‘a little of the time’ and 
‘none of the time’. 
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Table 6.35 presents the dichotomised responses to these questions as outlined 
above. 
 
Table 6.35 Problems with social activities dichotomised responses - 
categorised by treatment type 
 
 
Problems 
with social  
activities 
Colposcopy    Biopsy   Loop Excision  
 n (%) 
   
n (%)  n (%)   
Group 1 
(’none of the 
time, ‘a little of 
the time’) 
172  (69.1) 113 (76.9) 112 (73.7)  X2 = 2.97 
p=0.224 
Group 2 (‘all of 
the time’, most 
of the time’, 
‘some of the 
time 
77 (30.9) 34 (23.1) 40 (26.3)  
Total 249 (100.0) 147 (100.0) 152 (100.0)  
 
When responses were dichotomised between responders reporting problems with 
social activities ‘none of the time’, ‘a little of the time’ compared with responders 
reporting problems ‘all of the time’, ‘most of the time’ and ‘some of the time, in terms 
of treatment type, no statistically significant differences were observed between 
groups. 
 
Table 6.36 presents the results of the analysis relating to problems with social 
activities in terms of treatment type using colposcopy as a proxy for a ‘control’ group, 
compared to a combined biopsy/loop excision group. 
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Table 6.36 Problems with social activities - responses categorised by 
undergoing colposcopy only, or biopsy/loop excision 
 
 
 
Problems with Social 
Activities 
 
 
Colposcopy   
 
 
Biopsy/Loop 
excision 
 
 
 
  n        (%)   n         (%)  
All of the time 4  (1.6)  1 (0.3)   
Most of the time 23  (9.2)  14 (4.7)  X
2=7.59 
Some of the time 50  (20.1)  59 (20.0)  p=0.1078 
A little of the time 56  (22.5)  79 (26.0)   
None of the time 116  (46.6)  146 (49.0)   
Total 249  (100.0)  299 (100.0)   
 
 
When the colposcopy group was compared with the combined biopsy and loop 
excision groups with regard to respondents’ perceptions of their problems with social 
activities, higher proportions of respondents in the colposcopy group reported 
experiencing problems ‘all of the time’ and ‘most of the time’, although these findings 
were not statistically significant (X2=7.59; p=0.1078). 
 
However, as demonstrated by Figure 6.9, the differences between groups were, on 
the whole, very small. Only 1.6% of respondents in the colposcopy group (n=4) felt 
that their physical and emotional health impacted upon their social activities ‘all of the 
time’ and 0.3% (n=1) of responders in the biopsy and loop excision group noted this 
impact ‘all of the time’.  
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Figure 6.9 Problems with social activities - colposcopy vs. biopsy/loop excision 
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Table 6.37 presents the responses to the question relating to problems with social 
activities in terms of deprivation quartile. 
 
 
Table 6.37 Problems with social activities - responses categorised by 
deprivation quartile  
 
Problems with 
social activities 
Most 
Affluent  
 
 
Less 
Affluent 
 
 
Less 
Deprived 
 
 
Most 
Deprived 
 
 
  n      (%)   n        (%)  n      (%)   n      (%) 
All the time 0 (0.0)  1  (0.8)  0 (0.0)  4  (1.9)  
 
Most of the time 
 
0 (0.0)  
 
6  (5.0)  
 
5  (3.0)  
 
25  (11.7) 
 
Some of the time 
 
5  (14.7) 
 
20  (16.5)  
 
36 (21.3)  
 
45  (21.0) 
 
A little of the time 
 
11  (32.4) 
 
32  (26.4)  
 
45  (26.6)  
 
45  2(1.0) 
 
None of the time 
 
18  (52.9) 
 
62  (51.2)  
 
83  (49.1)  
 
95  (44.4) 
Total 34  (100.0) 121 (100.0) 169 (100.0)  214  (100.0) 
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Just under half of the sample in the ‘most deprived’ and ‘less deprived’ quartiles 
(44.4% and 49.1% respectively) had no problems with social activities due to their 
physical and emotional health and just over half the sample in the ‘most affluent’ and 
‘less affluent’ quartiles (52.9% and 51.2% respectively) also reported no problems in 
this area.  However, higher proportions of respondents in the ‘most deprived’ quartile 
reported experiencing problems with social activities ‘all of the time’ and ‘most of the 
time’ (n=4; 1.9% and n= 25; 11.7% respectively), although the absolute numbers of 
individuals with these issues was low. As Figure 6.10 demonstrates, the majority of 
responses tended towards the end of the scale, indicating few problems in the area 
of social activities. 
 
 
Figure 6.10 Problems with social activities - responses categorised by 
deprivation quartile  
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More formal analysis was undertaken dichotomising responses between 
experiencing problems with social activities ‘none of the time’, and ‘a little of a time’ 
and responses - ‘all of the time’, most of the time’ and ‘some of the time’. The results 
are presented in table 6.38. 
 
Table 6.38 Problems with social activities dichotomised responses - 
categorised by deprivation quartile  
 
Problems with 
social  
activities 
Most affluent   Less affluent   Less 
deprived 
Most 
deprived 
 
 n (%) 
   
n (%)  n (%)    
Group 1 (’none of 
the time, ‘a little of 
the time’) 
29 (85.3) 94 (77.7) 128 (75.7)  140 (65.4) X2=10.73 
Group 2 (‘all of the 
time’, most of the 
time’, ‘some of the 
time 
5 (14.7) 27 (22.3) 41 (24.3) 74 (34.6) p=0.0133 
Total 34 (100.0) 121 (100.0) 169 (100.0) 214 (100.0)  
 
Following analysis of the dichotomised responses, a significant result was observed 
with women in the most deprived quartile more likely to experience problems with 
social activities compared with all three other quartiles (X2=10.73; p=0.0133). 
 
 
Table 6.39 presents the responses to the question relating to problems related to 
social activities in terms of respondent age group. Table 6** presents the responses  
 
Table 6.39 Problems with social activities - categorised by age group 
 
Problems with 
social activities 
19-29   30-39   40-49   50+   
  n     (%)          n       (%)        n    (%)                 n     (%) 
 
All the time 0 (0.0)  0 (0.0)  3  (2.2)  2  (2.7)  
Most of the time 3  (2.8)  14  (6.5)  9  (6.6)  11 (14.9)  
Some of the time 19  (16.0)  46  (21.4)  31 (22.6)  12  (16.2)  
Little of the time 43  (36.1)  53  (24.7)  22 (16.1)  16  (21.6)  
None of the time 54  (45.4)  102 (47.4)  72 (52.6)  33  (44.6)  
Total 119 (100.0) 215 (100.0) 137 (100.0)  74 (100.0) 
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Almost half of the responders across all four age groups reported never experiencing 
problems with social activities. In the 40 to 49 age group, over half of the responders 
never experienced problems with social activities (52.6%; n=72). As shown in Figure 
6.11, in the younger age groups (19 to 29 and 30 to 39) no respondents reported 
having problems relating to social activities ‘all of the time’. In the older age range 
group (40 to 49 and 50+) less than 3% of the respondents reported having problems 
‘all of the time’ in the relation to social activities. 
 
 
 
Figure 6.11 Problems with social activities - responses categorised by age 
group 
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To undertake more sophisticated analysis of the responses these were dichotomised 
between responders reporting problems with social activities ’all of the time’, ‘most of 
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the time’ and ‘some of the time’ compared with the responses ‘a little of the time’ and 
‘none of the time’. The results are presented in table 6.40. 
Table 6.40 Problems with social activities - dichotomised responses - 
categorised by age group 
 
Problems with 
social activities 
19-29   30-39   40-49   50+    
  n     (%)          n       (%)       n    (%)            n     (%) 
 
 
Group 1 (’none of 
the time, ‘a little of 
the time’) 
97 (81.5) 155 (72.1) 94 (68.6) 49 (66.2) X2= 7.37 
Group 2 (‘all of the 
time’, most of the 
time’, ‘some of the 
time 
22 (18.5) 60 (27.9) 43 (31.4) 25 (33.8) p=0.061 
Total 119 (100.0) 215 (100.0) 137 (100.0) 74 (100.0)  
 
 
No significant differences were observed between responder age range and 
responses to the dichotomised question related to problems with social activities. 
 
6.5.4 Satisfaction with sex life 
 
This section presents the analysis for the question relating to respondents’ 
satisfaction with their sex life. It will present a summary of all responses aggregated 
together, followed by sub-group analyses of the characteristics of responders in 
relation to these questions. Women were asked to rank their satisfaction with their 
sex life on a Likert scale with one indicating ‘most dissatisfied’ and 10 indicating 
‘most satisfied’. Response five indicated that respondents were neither satisfied or 
dissatisfied. 
 
Table 6.41 shows the responses for all survey participants, with the data illustrated 
graphically in Figure 6.12. 
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Table 6.41 Frequency of responses (all respondents) to question relating to 
satisfaction with sex life 
 
Satisfaction with sex life   
 n (%) 
1 Most dissatisfied 27 (4.8) 
2 15 (2.7) 
3 21 (3.8) 
4 28 (5.0) 
5 106 (18.9) 
6 34 (6.1) 
7 62 (11.1) 
8 104 (18.6) 
9 49 (8.8) 
10 Most satisfied 91 (16.3) 
Missing 23 (4.1) 
Total 560 (100.0)
 
 
Just over 60% of respondents (n=340) rated their satisfaction between six and ten, 
which would indicate that a larger proportion of the respondents were on the satisfied 
side of the scale. 
Figure 6.12 Satisfaction with sex life - all responses 
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Table 6.42 presents the responses to the question relating to respondents’ 
satisfaction with their sex life in terms of treatment type, and this is graphically 
illustrated in Figure 6.13. 
 
 
Table 6.42 Satisfaction with sex life - responses categorised by treatment type 
 
Satisfaction with 
sex life 
Colposcopy  
 
n (%) 
Biopsy  
 
n (%) 
Loop 
Excision 
n (%) 
  
Total 
 
n (%) 
1 Most dissatisfied 13 (5.5)  7 (4.8)  7 (4.6)  27 (5.0) 
2 8 (3.4)  2 (1.4)  5 (3.3)  15 (2.8) 
3 6 (2.5)  7 (6.8)  8 (5.2)   21 (3.9) 
4 10 (4.2)  10 (6.8)  8 (5.2)   28 (5.2) 
5 43 (18.1)  30 (20.5)  33 (21.6)   106 (18.9) 
6 17 (7.1)  6 (4.1)  11 (7.2)   34 (6.3) 
7 27 (11.3)  17 (11.6)  18 (11.8)   62 (11.5) 
8 49 (20.6)  27 (18.5)  28 (18.3)   104 (19.4) 
9 18 (7.6)  20 (13.7)  11 (7.2)   49 (9.1) 
10 Most satisfied 47 (19.7)  20 (13.7)  24 (15.7)   91 (16.9) 
Total 238(100.0)   146(100.0)   153(100.0)  537(100.0)
Median  7 (IQR* 5 to 9) 7 (IQR 5 to 9) 7(IQR 5 to 8)  
* IQR = Inter quartile range 
 
Median scores for satisfaction with sex life were the same across all treatment 
groups (colposcopy: IQR = 5 to 9; biopsy: IQR = 5 to 9; loop excision: IQR = 5 to 8), 
indicating that there is likely to be no association between treatment type and scores 
on the satisfaction with sex life scale. The proportion of scores between six and 10 
(representing the satisfied end of the scale) was similar across all three treatment 
groups: colposcopy 66.3% (n=158); biopsy 61.6% (n=90); loop excision 60.2% 
(n=92). 
Following non-parametric testing (Kruskall-Wallis) no significant difference was 
observed across the treatment types (X2= 1.75; p=0.40) in response to this question. 
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Figure 6.13 Satisfaction with sex life - responses categorised by treatment type  
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Table 6.43 presents proportion of responses to the question relating to satisfaction 
with sex life, with colposcopy serving as a ‘control’ to compare with a combined 
biopsy and loop excision group. When colposcopy median scores were compared 
with biopsy and loop excision scores, both groups scored 7 for satisfaction with sex 
life (colposcopy IQR = 5 to 9; biopsy and loop excision IQR = 5 to 9). This again 
supports the theory that level of treatment alone is not associated with satisfaction 
with sex life. As illustrated by Figure 6.14, the majority of responses are on the 
‘satisfied’ section of the scale. 66.3% (n=158) of respondents undergoing colposcopy 
rated satisfaction with their sex life as between six and 10. 60.9% (n=182) of 
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respondents undergoing biopsy or loop excision rated satisfaction with their sex life 
between six and 10. 
 
Table 6.43 Satisfaction with sex life - responses categorised by undergoing 
colposcopy only, or biopsy/loop excision 
 
Satisfaction with 
sex life 
Colposcopy  Biopsy/Loop  Total 
   n(%)  n(%) n (%) 
1 Most dissatisfied 13 (5.5)  14 (4.7) 27 (5.0) 
2 8 (3.4)  7 (2.3) 15 (2.8) 
3 6 (2.5)   15 (5.0) 21 (3.9) 
4 10 (4.2)   18 (6.0) 28 (5.2) 
5 43 (18.1)   63 (21.1) 106 (18.9) 
6 17 (7.1)   17 (5.7) 34 (6.3) 
7 27 (11.3)   35 (11.7) 62 (11.5) 
8 49 (20.6)   55 (18.4) 104 (19.4) 
9 18 (7.6)   31 (10.4) 49 (9.1) 
10 Most satisfied 47 (19.7)   44 (14.7) 91 (16.9) 
Total 238 (100.0)   299 (100.0)   537 (100.0) 
Median  7 (IQR* 5 to 9)  7 (IQR 5 to 9)  
    
* IQR = Inter quartile range 
 
 
Figure 6.14 Satisfaction with sex life - responses categorised by undergoing 
colposcopy only, or biopsy/loop excision 
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Table 6.44 presents the responses to the question relating to respondents 
satisfaction with their sex life in terms of deprivation quartile, along with the median 
scores for satisfaction with sex life in terms of respondents’ deprivation quartile. 
 
 
Table 6.44 Satisfaction with sex life - responses by deprivation quartile  
 
Satisfaction 
with sex life 
Most 
Affluent   
Less 
Affluent  
Less Deprived  Most 
Deprived 
 
 
Total 
 n (%)  n (%)  n (%)  n (%) 
  
 
1 2 (6.1)   5 (4.3)   6 (3.6)  13 (6.2)  26 
2 1 (3.0)  4 (3.4)   5 (3.0)  5 (2.4)  15 
3 2 (6.1)   3 (2.6)   7 (4.2)  8 (3.8)  20 
4 0(0.0)  8 (6.8)   9 (5.4)  10 (4.7)  27 
5 4 (12.1)  22 (18.8)   30 (18.1)  49 (23.2)  105 
6 4 (12.1)  8 (6.8)   16 (9.6)  6 (2.8)  34 
7 6 (18.2)  15 (12.8)   16 (9.6)  23 (10.9)  60 
8 8 (24.2)  25 (21.4)   34 (20.5)  37 (17.5)  104 
9 4 (12.1)  9 (7.7)   17 (10.2)  17 (8.1)  47 
10 2 (6.1)  18 (15.4)   26 (15.7)  43 (20.4)  69 
Total 33 (100.0)  117 (100.0)   166 (100.0)  211 (100.0)   
Median; IQR* 7 (IQR 5 to 8) 7 (IQR 5 to 8) 7 (IQR 5 to 9) 7 (IQR 5 to 9)  
*IQR = Inter quartile range 
 
 
These scores were the same across the deprivation quartiles (7) indicating that level 
of deprivation does not influence scores on this scale (IQR most affluent 5 to 8; IQR 
less affluent 5 to 8; IQR less deprived 5 to 9; IQR most deprived 5 to 9). Figure 6.15 
illustrates the proportion of responses between one and 10 for each quartile. 
 
Following non-parametric testing (Kruskall-Wallis) no significant difference was 
observed across deprivation quartiles (X2= 1.84; p=0.98) in response to this question. 
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Figure 6.15 Satisfaction with sex life - categorised by deprivation quartile 
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Although across all quartiles over 50% of the proportion of responders scored 
between six and 10 on the scale, the proportion for each quartile was as follows: 
most affluent: 72.7% (n=24); less affluent: 64.1% (n=75); less deprived: 65.6% 
(n=109) and most deprived: 59.7% (n=126). Respondents in the most affluent group 
reported the highest degree of satisfaction with their sex life, with those in the most 
deprived group reporting a lower degree of satisfaction (although this disparity can be 
explained by the higher proportion of individuals in the most deprived group who 
reported being neither satisfied or dissatisfied).   
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Table 6.45 presents the responses to the question relating to respondents 
satisfaction with their sex life and age group and the median scores for satisfaction 
with sex life across the age groups. 
 
 
Table 6.45 Satisfaction with sex life - responses categorised by age group 
 
Satisfaction 
with sex life 
19 to 29   30 to 39   40 to 49   50+   Total 
   n (%)   n (%)   n (%)   n (%)  
 
1 2 (1.7)  3 (1.4)     12 (9.0)     10 (15.6)   27 
2 5 (4.2)  4 (1.9)   5 (3.7)   1 (1.6)   15 
3 5 (4.2)   10 (4.6)   3 (2.2)   3 (4.7)   21 
4 6 (5.0)  13 (6.0)   8 (6.0)   1 (1.6)   28 
5 19 (15.8)  40 (18.5)   27 (20.1)   20 (31.3)   106 
6 3 (2.5)  21 (9.7)   9 (6.7)   1 (1.6)   34 
7 21 (17.5)  19 (8.8)   12 (9.0)   10 (15.6)   62 
8 25 (20.8)  47 (21.8)   26 (19.4)   6 (9.4)   104 
9 12 (10.0)  26 (12.0)   9 (6.7)   1 (1.6)   48 
10 22 (18.3)  33 (15.3)   23 (17.2)   11 (17.2)   89 
Total 120   216    134    64     
Median    7(IQR 5 to 7)  7 (IQR 5 to 9)   7 (IQR 5 to 9)   5 (IQR 5 to 8)  
* IQR = Inter quartile range 
 
 
These scores were the same for the 19 to 29, 30 to 39 and 40 to 49 groups (7 IQR 
19 to 20: 5 to 7; IQR 30 to 39: 5 to 9; IQR 40 to 49: 5 to 9) although the median score 
for the 50+ group was lower (5) suggesting that older women were more likely to be 
neither satisfied or dissatisfied with their sex lives.  
Following non-parametric testing (Kruskall-Wallis) a significant difference was 
observed across the age range (X2= 10.4; p=0.015) in response to this question, with 
older women more likely to have a lower mean score on this measure. 
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Figure 6.16 Satisfaction with sex life - responses categorised by age group 
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6.5.5 Satisfaction with relationship 
 
This section presents the analysis for the question relating to respondents’ 
satisfaction with their relationships. It will present the total responses followed by 
analysis of the characteristics of responders in relation to this questions. Women 
were asked to rank their satisfaction with their relationship on a Likert scale with one 
indicating ‘most dissatisfied’ and 10 indicating ‘most satisfied’. 
 
Table 6.46 presents the total responses for the question related to satisfaction with 
relationships. 
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Table 6.46 Frequency of responses (all respondents) to question relating to 
satisfaction with relationships 
 
 
Satisfaction with relationship   
 n (%) 
1 Most dissatisfied 14 (2.5) 
2 4 (0.7) 
3 12 (2.1) 
4 15 (2.7) 
5 83 (14.8) 
6 22 (3.9) 
7 50 (8.9) 
8 77 (13.8) 
9 77 (13.8) 
10 Most satisfied 171 (30.5) 
Missing 35 (6.3) 
Total 560 (100.0)
 
 
Figure 6.17 illustrates the proportion of respondents whose response linked to each 
Likert scale point.   
 
Figure 6.17 Satisfaction with relationship - all respondents 
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The data show that the greater proportion of the total responders could be 
categorised at the ‘satisfied’ part of the scale. Just over 70% of responders (n=397) 
scored between six and 10 on the scale. Just under a third of responders (30.5%; 
n=171) were ‘most satisfied’ with their partner relationships. 
 
Table 6.47 presents the responses to the question relating to satisfaction with 
relationships in terms of treatment type followed by Figure 6.18 which presents this 
information graphically. 
 
Table 6.47 Satisfaction with relationship - responses categorised by treatment 
type 
 
 
Satisfaction with 
relationship 
Colposcopy  
 
 
Biopsy  
 
 
Loop  
Excision 
 
 
 
Total 
 n (%) 
 
n (%) n (%) n (%) 
1 Most dissatisfied 9 (3.9)   2(1.4)  3 (2.0)  14 (2.7) 
2 2 (0.9)  0(0.0)  2 (1.3)  4 (0.8) 
3 4 (1.7)  6 (4.2)  2 (1.3)  12 (2.3) 
4 7 (3.0)  5 (3.5)   3 (2.0)  15 (2.9) 
5 44 (19.0)  19 (13.4)  20 (13.2)  83 (15.8) 
6 14 (6.1)  2 (1.4)  6 (3.9)  22 (4.2) 
7 16 (6.9)  21 (14.8)  13 (8.6)  50 (9.5) 
8 26 (1.3)  24 (16.9)  27 (17.8)  77 (14.7) 
9 29 (12.6)  21 (14.8)  27 (17.8)  77 (14.7) 
10 Most satisfied 80 (34.6)  42 (29.6)  49 (32.2)  171 (32.6) 
Total 231 (100.0)  142 (100.0)  152 (100.0)  525 (100.0) 
 
Median 8 (IQR* 5-10) 8 (IQR 7-10) 8.50 (IQR 7-10)  
     
* IQR = Inter quartile range 
 
 
The median scores for satisfaction with relationship were the same across the 
treatment groups although women in the loop excision group scored 8.5 when 
compared to colposcopy and biopsy (median score 8; IQR colposcopy: 5 to 10; IQR 
biopsy: 7 to 10; IQR loop excision: 7 to 10). The majority of respondents across all 
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three treatment groups scored between 6 and 10 on the satisfaction scale, indicating 
a high level of satisfaction with their relationships.  
Following non-parametric testing (Kruskall-Wallis) no significant difference was 
observed across the treatment types (X2= 1.75; p=0.40) in response to this question. 
 
 
 
Figure 6.18 Satisfaction with relationship - treatment type  
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Table 6.48 presents the responses to the question relating to satisfaction with 
relationships comparing colposcopy only with a combined biopsy and loop excision 
group. 
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Table 6.48 Satisfaction with relationship - responses categorised by 
undergoing colposcopy only, or biopsy/loop excision 
 
Satisfaction with 
relationship 
Colposcopy   Biopsy/Loop   Total 
   n (%) n(%) n (%) 
1 Most dissatisfied 9 (3.9)   5(1.7) 14 (2.7) 
2 2 (0.9)   2(0.7) 4 (0.8) 
3 4 (1.7)   8(2.7) 12 (2.3) 
4 7 (3.0)   8(2.7) 15 (2.9) 
5 44 (19.0)   39(13.3) 83 (15.8) 
6 14 (6.1)   8(2.7) 22 (4.2) 
7 16 (6.9)   34(11.6) 50 (9.5) 
8 26 (1.3)   51(17.3) 77 (14.7) 
9 29 (12.6)   48(16.3) 77 (14.7) 
10 Most satisfied 80 (34.6)   91(31.0) 171(32.6) 
Total 231 (100.0)   294(100) 525(100.0) 
Median  8 (IQR* 5 to 10) 8 (IQR 7 to 10)  
    
* IQR = Inter quartile range 
 
 
The median score was the same between both groups (median score 8; colposcopy 
IQR: 7 to 10; biopsy and loop excision IQR: 7 to 10). 
 
Figure 6.19 Satisfaction with relationship - responses categorised by 
undergoing colposcopy only, or biopsy/loop excision 
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Again, as shown in Figure 6.19, the weighting of scores was overwhelmingly 
towards the ‘satisfied’ end of the scale. The proportion of respondents scoring 
between six and 10 for each group were as follows: colposcopy 61.5% 
(n=165); biopsy and loop excision 78.9% (n=232). 
 
Table 6.49 presents the responses to the question relating to satisfaction with 
relationships in terms of respondents’ deprivation quartile. 
 
Table 6.49 Satisfaction with relationship - categorised by deprivation 
quartile  
 
* IQR = Inter quartile range 
 
 
Median scores for satisfaction with relationship were the same across for 
most affluent and less affluent groups (median 8.5; IQR 7 to 10) although 
women in the less deprived group scored higher median scores (9; IQR 7 to 
10) and the most deprived scored a slightly lower median score (8; IQR 5 to 
10). Figure 6.20 illustrates the proportion of scores weighted on the ‘satisfied’ 
end of the scale. Over 80% respondents in the less deprived and less affluent 
quartiles scored between six and 10 on the scale. For the most affluent and 
Satisfaction 
with 
relationship 
Most Affluent    Less Affluent   Less Deprived   Most Deprived   Total 
 n (%)  n (%)  n (%)  n (%)   
 
1 0 (0.0)   1 (0.9)   4 (2.5)   8 (3.8)   13 
2 0 (0.0)    0 (0.0)   1 (0.6)   3 (1.4)   4 
3 1 (2.9)    3 (2.7)    2 (1.2)   5 (2.4)   11 
4 1 (3.1)   3 (2.7)   4 (2.5)   7 (3.4)   15 
5 4 (12.5)   13 (11.6)   21 (12.9)   44 (21.2)   82 
6 1 (3.1)   3 (2.7)    7 (4.2)    11 (5.3)   22 
7 2 (6.3)   16 (14.3)   13 (8.0)   18 (8.7)   49 
8 7 (20.6)   17 (15.2)   27 (16.6)   24 (11.5)   55 
9 7 (20.6)   20 (17.9)   25 (15.3)   24 (11.5)   76 
10 9 (28.1)   36 (32.1)   59 (36.2)   64 (30.8)   168 
Total 32 (100.0)   112 (100.0)   163 (100.0)   208 (100.0)    
Median  8.50 (IQR* 7 to 10) 8.50 (IQR 7 to 10) 9 (IQR 7 to 10) 8 (IQR 5 to 10)  
      
 236
most deprived groups respectively, the proportions were 78.7% (n=26) and 
67.8% (n=141). 
 
Following non-parametric testing (Kruskall-Wallis) no significant difference 
was observed across deprivation quartile (X2=6.90; p=0.75) in response to 
this question. 
 
Figure 6.20 Satisfaction with relationship - categorised by deprivation 
quartile 
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Table 6.50 presents the responses to the question relating to the respondents 
satisfaction with their relationship in terms of their age group. 
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Table 6.50 Satisfaction with relationship - responses categorised by age 
group 
 
Satisfaction 
with 
relationship 
19-29   30-39   40-49   50+   Tota
l 
   n (%)   n (%)   n (%)           n (%)  
1 2 (1.7)     2 (0.9)      7 (5.4)   3 (4.8)   14 
2 0 (0.0)   3 (1.4)   0 (0.0)   1 (1.6)   4 
3 1 (0.9)    5 (2.3)    4 (3.1)   2 (3.2)   12
4 3 (2.6)   5 (2.3)   5 (3.9)   2 (3.2)   15
5 11 (9.4)   30 (14.1)   22 (17.1)   20 (31.7)   83 
6 3 (2.6)   9 (4.2)    8 (6.2)   2 (3.2)   22
7 8 (6.8)   25 (11.7)   13 (10.1)   4 (6.3)   50
8 15 (12.8)   32 (15.0)   21 (16.3)   8 (12.7)   76
9 26 (22.2)   36 (16.9)   11 (8.5)   4 (6.3)   77
10 48 (41.0)   66 (31.0)   38 (29.5)   17 (27.0)   169 
Total 117 (100.0)   213 (100.0)  129 (100.0)   63 (100.0)    
Median  9 (IQR* 8 to 10)   8 (IQR 6 to 
10) 
  8 (IQR 5 to 
10) 
 7 (IQR 5 to 
10) 
 
* IQR =Inter quartile range 
 
The median scores for satisfaction with relationships ranged from 9 (IQR 8 to 
10) in the 19 to 29 group, to 8 in the 30 to 39 (IQR 6 to 10) and 40 to 49 
groups (IQR 5 to 10) and 7 in the 50+ group (IQR 5 to 10). This would seem 
to indicate that younger were women were more satisfied in their partner 
relationship. Figure 6.21 shows the weighting of scores towards the ‘satisfied 
end of the scale. Whilst 85.4% (n=100) and 78.8% (n=168) of respondents in 
the 19 to 29 and 30 to 39 age group scored between six and 10 on the scale, 
the proportions in the 40 to 49 and 50+ age groups were lower (70.6%; and 
55.5% respectively). 
Following non-parametric testing (Kruskall-Wallis) a significant difference was 
observed across age ranges (X2= 20.09; p=>0.001) in response to this 
question with younger women scoring significantly higher on this scale. 
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Figure 6.21 Satisfaction with relationship - responses categorised by 
age group 
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6.6 Summary of findings - questionnaire one (Q1) 
 
This chapter has reported the analysis undertaken and outlined the results of 
the first stage of the study (questionnaire 1). Before these results were 
presented, the study recruitment and responder bias for both phases of the 
study were outlined. The characteristics of responders to Q1 were presented, 
followed by an outline of the factors studied and potential predictors of the 
study outcomes. Where possible, Chi2 tests were performed to investigate 
relationships between variables and outcomes. Where it was not possible to 
undertake more sophisticated analysis, the proportions of responses were 
reported. Median results and the inter quartile ranges (IQR) were reported for 
responses measured on a Likert scale. 
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Section 6.5.1 presented the analysis of responses to survey questions related 
to physical, emotional and sexual health. The total responses were presented 
prior to sub-group analyses of the association between the frequency of 
responses given for each question and potential predictor variables 
(deprivation quartile, age group and treatment type). This process was 
repeated for questions relating to general health, problems with social 
activities, satisfaction with sex life and relationship satisfaction. The question 
related to general health was further analysed by dichotomising the categories 
of responses into ‘excellent’, ‘good’ or ‘very good’ compared with ‘fair’ or 
‘poor’. The question relating to problems with social activities were analysed 
after dichotomising responses between ‘all of the time’, ‘most of the time’ or 
‘some of the time’ compared with ‘a little of the time’ and ‘none of the time’. 
This enabled more sophisticated analysis to be undertaken for these 
questions given the presence of zero responses in the data. 
 
In terms of physical health, less than a fifth of the total sample reported that 
their physical health impeded their ability to carry out normal tasks or limited 
the kind of activities normally undertaken. Just under one third of individuals 
when all responses were analysed together reported that their emotional 
health meant that they accomplished less than they would like and a quarter 
reported that their emotional health impacted upon work or other activities. In 
terms of questions relating to sexual health, around one third of the total 
sample reported lacking interest in sex, or experiencing pain during 
intercourse. 
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When responses to the questions related to physical, emotional and sexual 
health were analysed after being broken down by treatment type, no 
significant differences were observed across groups. Where problems were 
reported, the proportion of responders noting such problems was similar 
across treatment groups.  
 
As a second stage of analysis of treatment type, the colposcopy group was 
compared to a combined group comprised of women in the biopsy and loop 
excision groups. The rationale for this comparison was based on the 
hypothesis that colposcopy alone may be considered as a less ‘invasive’ 
procedure than either biopsy or loop excision, and thus in the absence of a 
general population control group, the colposcopy only patients could serve as 
a proxy for controls. This stage of analysis did not show any significant 
differences between the groups, suggesting that treatment type was not 
associated in statistical terms with responses to the questions relating to 
physical, emotional and sexual health. 
 
Responses were then analysed in terms of deprivation quartile. No significant 
differences were noted for responses to questions relating to physical health, 
although a lower proportion of responders in the most affluent group reported 
problems with their physical health impacting upon their ability to carry out 
normal tasks: 8.8% (n=3), compared with 23.3% (n=28) in the less affluent 
group; 18.9% (n=32) in the less deprived group and 20.5% (n=44) in the most 
deprived group. Statistically significant differences were observed between 
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deprivation quartiles in terms of response to the question relating to the 
impact of emotional health upon the ability to accomplish what respondents 
would like (X2=8.31; p=0.04).  
 
Deprivation quartiles were not significantly associated with responses to any 
of the questions relating to sexual health, with similar proportions of 
responders reporting problems across all questions aside from questions 
relating to experiencing pain during intercourse. 26.5% (n=9) responders in 
the most affluent group reported problems in this area compared to 38.8% 
(n=45) in the less affluent group; 41.0% (n=66) in the less deprived group and 
32.7% (n=67) in the most deprived group. 
 
In terms of age, significant differences were observed between responses to 
questions relating to physical health impacting upon an ability to carry out 
normal tasks, with responders in the 50+ group more likely to report problems 
in this area (X2=30.54, p=<0.001). Similarly, in responses to the question 
related to the impact of physical health limiting the kind of work undertaken, 
the older age group (50+) was significantly more likely to report problems in 
this area (X2=25.95, p=<0.0001). Age was also significantly associated with 
responses to the question relating to the impact of emotional health upon 
individuals’ ability to perform work or other activities, with the 50+ group more 
likely to report problems in this area (X2=10.59, p=0.0142). 
 
In terms of age and responses to questions related to sexual health, no 
significant differences were observed between the age groups. In responses 
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to the question related to ‘lacking interest in sex’, a higher proportion of 
responders in the 50+ group reported problems in this area than those in the 
other age groups (47% compared with 36.6% (n=40) in the 19 to 29 group; 
35.0% (n=75) in the 30 to 39 group and 39.3% (n=53) in the 40 to 49 group).  
Similarly, a higher proportion of responders in the 50+ group reported 
problems lubricating 38.5% (n=25) compared with 24.6% (n=29) in the 19 to 
29 group; 25.2% (n=54) in the 30 to 39 group and 28.2% (n=35) in the 40 to 
49 group. In contrast, just under half of responders in the 19 to 29 group 
reported pain during intercourse, compared with just over a quarter of women 
in the 50+ group experiencing painful intercourse. 
Following bivariate analysis utilising the three predictors on interest, no 
significant results were observed on any of the questions except in relation to 
experiencing pain during intercourse and experiencing problems lubricating. 
Women aged 19-29 were over twice as likely to report experiencing pain 
during intercourse (OR: 2.24; CI 1.1 to 4.3). Women aged 19-29 were also 
half as likely to report problems with lubrication (OR: 0.52; 0.2 to 1.0) 
compared to women over 50. Following multivariate analysis of all domain 
questions a significant result was observed in relation to experiencing pain 
during sex. After controlling for all factors the three significant predictors of 
problems in this domain were age (19-29), treatment type (undergoing loop 
excision) and socioeconomic status (less deprived quartile). However, the 
model only explained around 3% of the variance, so caution is advised in 
interpreting this result. 
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Section 6.5.2 presented the analysis of the responses to the question relating 
to general health, including total responses and responses by characteristic. 
In terms of overall responses, the majority of responders rated their general 
health to be ‘excellent’, ‘very good’ or ‘good’ (79.6%; n=446).  
 
When results were analysed in terms of treatment type, again, the majority of 
responders across all the groups rated their general health as ‘excellent’, 
‘good’ or ‘very good’.  The highest proportion was observed in the loop 
excision group (93.7%; n=133). Combining the biopsy and loop excision group 
with the colposcopy group also demonstrated similar findings. However, once 
the response categories were dichotomised women in the colposcopy group 
were significantly more likely to rate their general health as ‘poor’ or ‘fair’ 
when compared with the biopsy or the loop excision group. 
 
In terms of deprivation quartile, no respondents in the ‘most affluent’ quartile 
rated their general health as ‘poor’ or ‘fair’ compared to the other three 
quartiles. When the four quartiles were combined and dichotomised into two 
groups (‘affluent’ and ‘deprived’) significantly higher proportions of responders 
in the affluent group described their general health as ‘excellent’, ‘very good’ 
or ‘good’ (X2=11.54; p=0.0211).  
 
Analysis of the association between age group and responses to the question 
relating to general health showed that the proportion of respondents rating 
their general health as ‘excellent’, ‘very good’ or ‘good’ decreased with age.  
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Women in the 19 to 29, 30 to 39 and 40 to 49 groups were significantly more 
likely to rate their general health as ‘excellent’, ‘very good’ or ‘good, compared 
with women in the 50+ age group (X2=37.07; p=0.0002). 
 
Section 6.5.3 presented the analysis undertaken on responses to the question 
exploring whether or not respondents had experienced problems with social 
activities due to their physical or emotional health. When all responses were 
analysed together, just under half of the sample reported never experiencing 
problems in this area and similar proportions were observed when the data 
was categorised by treatment, deprivation and age. 
 
Analysis of the results in terms of treatment type reported similar findings, with 
just under half the responders across all treatment groups never experiencing 
problems with social activities. No responders from the loop excision group 
experienced problems ‘all of the time’. 
 
In terms of deprivation quartile, just under half of respondents from the ‘most 
deprived’ and less deprived’ quartiles reported no problems with social 
activities, whilst just over half the respondents in the ‘most affluent’ and ‘less 
affluent’ quartiles reported problems in this area. Overall, the majority of 
responses across all deprivation quartiles tended towards the positive end of 
the scale, indicating few problems with social activities. However, following 
formal analysis dichotomising responses to this question, women in the most 
deprived quartile reported significantly higher problems with social activities 
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when compared with the three other quartiles (X2=10.73; p=0.0133). Age was 
not found to be statistically associated with problems with social activities. 
Section 6.5.4 presented the analysis for the question related to respondents’ 
satisfaction with their sex life and in terms of total responses, just over 60% of 
the sample rated their satisfaction levels between six and 10 - i.e. on the more 
satisfied end of the scale.  
 
The median score for satisfaction with sex life was seven across all treatment 
groups, with similar proportions of responders from each group scoring 
between six and 10 on the scale. The same median score was observed on 
the basis of deprivation quartile, although a higher proportion of respondents 
in the ‘most affluent’ quartile scored between six and 10 on the scale 72.7% 
(n=24) compared with ‘less affluent’ quartile 64.1% (n=75), the less deprived 
quartile 65.6% (n=109) and the most deprived quartile 59.7% (n=126). 
 
In terms of age, responders in the 50+ age group had a lower median score 
(5) compared with responders in the other age groups (median score = 7) and 
following formal analysis a significant result was observed with older women 
scoring lower on this scale (x2=10.4; p=0.015). 
 
The final section of analysis (Section 6.5) reported the responses to the 
question relating to respondents’ satisfaction with their relationship. Just over 
70% of responders scored between six and ten on this scale, indicating that 
on the whole, they were satisfied with their relationship. With regard to 
treatment type, the median score for responders in the loop excision group 
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was slightly higher (8.5) than for the colposcopy and biopsy groups (8) 
although this difference was not statistically significant. The proportion of 
responders scoring between six and ten on this scale was higher for those in 
the loop excision group (80.6%) when compared with colposcopy (61.5%) and 
biopsy groups (77.5%). 
 
In terms of deprivation, responders in the most deprived quartile had the 
lowest median score (8), with responders in the most affluent and less affluent 
groups scoring 8.5. Women in the less deprived quartile had the highest 
median score (9). Despite this difference, all median scores tended towards 
the more satisfied end of the scale. 
 
Older women scored the lowest median score on this scale (7) compared to a 
score of eight in the 30 to 39 and 40 to 49 age groups, and nine in the 19 to 
29 age group. Similarly, responders in the 50+ age group had a lower 
proportion of responders scoring between six and 10 on the relationship 
satisfaction scale compared with the highest proportion in the 19 to 29 age 
group with 85.4% of responders scoring between six and 10 on the scale. 
Following formal analysis, older women were observed to score significantly 
lower on this measure (X2=20.09; p=>0.005). 
 
 
Overall, the findings from this stage of the study seem to indicate that 
treatment had no significant association with any of the responses to the 
questions posed in questionnaire 1 aside from the question relating to painful 
 247
sex, where women in the colposcopy group were half as likely to report 
problems in the area compared with women in the loop excision group.  For 
the questions relating to general health, a statistically significant difference 
was observed in terms of age and dichotomised socioeconomic status. In the 
affluent group, a higher proportion of women described their general health as 
‘excellent’ or ‘very good’ and a higher proportion of women in the deprived 
group described their general health as ‘fair’ or ‘poor’. Age was found to have 
a stronger association with the kinds of responses women gave to questions 
relating to physical and emotional well-being, although it had little association 
with responses to questions relating to sexual health. For the question relating 
to general health, women aged under 50 years were less likely to rate their 
health as ‘excellent’ or ‘very good’ 
 
The results from the responses to the questions relating to sexual health 
suggest that problems of a sexual nature are not necessarily a facet of being 
‘younger’ or ‘older’. Older women may feel more at ease with their sexuality 
than younger women, despite the fact they may experience more 
physiological problems related to their sex life (menopause, vaginal dryness). 
Conversely, younger women may feel greater pressure to ‘perform’ sexually 
and feel less sexually confident than older women. Having multiple partners or 
shorter term relationships may also impact upon sexual well-being. A higher 
proportion of younger women reported problems related to pain during 
intercourse when compared with older women and following bivariate and 
multivariate analysis, this proportion was significantly higher. However, 
although not statistically significant, the results from the questions relating to 
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satisfaction with sex life and relationships would appear to indicate that 
younger women were more satisfied with both these areas of their lives when 
compared to women in the older age groups. As is shown in the analysis of 
questionnaire 2 (Chapter 7), it appears that sexual problems increase with 
age. 
 
Analysis of responses to the question relating to ‘general health’ and 
problems with social activities due to physical and emotional health, indicated 
that overall, respondents to the questionnaire experienced few problems in 
these areas. However, women in the older age group (50+) were significantly 
less likely to score ‘excellent’, ‘very good’ or ‘good’ when rating their general 
health.  
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CHAPTER 7: RESULTS - QUESTIONNAIRE TWO (Q2) 
7.1 Introduction 
 
This chapter reports the analysis and results of the second stage of the study, 
questionnaire two. Q2 was designed to collect a wider range of demographic 
data and health and lifestyle related factors, and incorporates three validated 
measures relating to sexual functioning, depression and anxiety and four 
other domains pertaining to physical, psychological, social and emotional 
factors. The demographic data collected were as follows: age, ethnicity, 
education and socioeconomic status. Other factors were: treatment type; 
smoking status; alcohol use and number of units drunk per week; problems 
with drugs or alcohol; partner status; whether respondents were currently 
sexually active and sexually active prior to the colposcopy (no specified time 
scale of sexual activity was given); sexual orientation; use of contraception; 
having children; ever having had a miscarriage premature birth or still birth; 
having gynaecological problems; having had a sexually transmitted infection; 
experiencing long term health problems, and the number of visits made to the 
GP over the previous 12 months.  
 
This chapter will begin by presenting a description of the demographic and 
health and lifestyle details of the population responding to Q2, including data 
collected relating to potential predictors of outcomes (Section 7.1). Section 7.2 
presents the characteristics of responders to Q2 and Section 7.3 presents the 
results from the analysis of treatment type and all outcome variables. Section 
7.4 presents an introduction to the analyses of the validated measures, 
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outlining a table of the three potential predictors of interest. Section 7.5 
presents the results pertaining to the presence of Female Sexual Dysfunction 
(FSD) in terms of the results for all respondents and the association between 
presence of FSD and treatment type, deprivation quartiles and age.  
 
Section 7.5.3 presents the results from bivariate analysis of 
presence/absence of FSD and the three potential predictor variables of 
interest. Section 7.5.4 presents the multivariate analysis for predictors of FSD. 
Section 7.6 presents the results for all respondents in terms of HADS anxiety 
and depression rating. Section 7.6.1 presents the mean scores for HADS 
anxiety and depression. Sections 7.7.1 to 7.7.3 include the analysis of the 
associations between HADS anxiety, treatment, deprivation quartile and age. 
Section 7.7.4 presents the bivariate analysis for HADS anxiety and predictors 
of scoring ‘normal’ or ‘mild and above’. Section 7.7.5 presents the multivariate 
analysis of predictors of scoring ‘normal’ or ‘mild and above’ on the anxiety 
scale. Section 7.8.1 to 7.8.3 includes the analysis of the associations between 
HADS depression, treatment, deprivation quartile and age. Section 7.8.4 
presents the bivariate analysis for HADS depression and predictors of scoring 
‘normal’ or ‘mild and above’ and Section 7.8.5 presents the multivariate 
analysis for this measure.  
 
Section 7.9.1 presents the scores from all respondents on the WHOQOL-
BREF physical, psychological, social and environmental domains and section 
7.9.2 presents the median scores for all four domains. Section 7.9.3 presents 
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the mean scores of these four domains. The overall results from this Chapter 
are summarised in section 7*. 
 
7.2 Characteristics of responders Q2 
 
Table 7.1 presents the sociodemographic and health and lifestyle 
characteristics of responders to Q2.  
 
 
Table 7.1 Characteristics of all responders to Q2 
 
Respondent Characteristic  n (%)* 
Colposcopy unit Women’s Hospital 167 (59.9) 
 City Hospital 36 (12.9) 
 Solihull Hospital 38 (13.6) 
 Heartlands Hospital 13 (4.7) 
 Good Hope Hospital 
Total 
25 (9.0) 
279 (100.0) 
Treatment type Colposcopy 119 (42.7) 
 Biopsy 76 (27.2) 
 Loop excision 84 (30.1) 
 Total 279 (100.0) 
Deprivation quartile Most Affluent (Q1) 28 (10.0) 
 Less Affluent (Q2) 51 (18.3) 
 Less Deprived (Q3) 78 (28.0) 
 Most Deprived (Q4) 114 (40.9) 
 Total 271 (97.1) 
Age group 19 to 29 80 (28.7) 
 30 to 39 98 (35.1) 
 40 to 49 70 (25.1) 
 50+ 31 (11.1) 
 Total 279 (100.0) 
Ethnicity White British 219 (78.5) 
 Other 60 (21.5) 
 Total 279 (100.0) 
Education Up to GCSE 99 (35.5) 
 Post GCSE 179 (64.2) 
 Total 278 (99.6) 
Smoking status Non-smoker 131 (47.0) 
 Smoker 79 (28.3) 
 Ex-smoker 69 (24.7) 
 Total 279 (100.0) 
Alcohol use Do not drink alcohol 49 (17.6) 
 Drinks alcohol 224 (80.3) 
 Total 273 (97.8) 
Alcohol units per week 1-7 145 (52.0) 
 8-13 40 (14.3) 
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Respondent Characteristic  n (%)* 
 14+ 36 (12.9) 
 Total 221 (79.2) 
Problems with 
drugs/alcohol 
Yes 10 (3.6) 
 No 261 (93.5) 
 Total 271 (97.1) 
Partner  Yes 227 (81.4) 
 No 48 (17.2) 
 Total 275 (98.6) 
Sexually active Yes 227 (81.4) 
 No 45 (16.1) 
 Total 272 (97.5) 
Sexually active before  Yes 253 (90.7) 
colposcopy No 16 (5.7) 
 Total 269 (96.4) 
Sexual orientation Straight 268 (96.1) 
 Gay 4 (1.4) 
 Bi-sexual 2 (0.7) 
 Total 274 (98.2) 
Contraception use Yes 156 (55.9) 
 No 114 (40.9) 
 Total 270 (96.8) 
Children Yes 183 (65.6) 
 No 94 (33.7) 
 Total 277 (99.3) 
Miscarriage Yes 52 (18.6) 
 No 215 (77.1) 
 Total 267 (95.7)  
Premature birth Yes 26 (9.3) 
 No 234 (83.9) 
 Total 260 (93.2) 
Still birth Yes 5 (1.8) 
 No 253 (90.7) 
 Total 258 (92.5) 
Gynaecological problems Yes 141 (50.5) 
 No 129 (46.2) 
 Total 270 (96.8) 
Sexually transmitted 
infection 
Yes 79 (28.3) 
 No 198 (71.0) 
 Total 277 (99.3) 
Long term health problems Yes 73 (26.2) 
 No 200 (71.7) 
 Total 273 (97.8) 
Visits to GP in last 12 
months 
0 14 (5.0) 
 1-5 190 (68.1) 
 6-9 34 (12.2) 
 10+ 24 (8.6) 
 Total 262 (93.9) 
* Percentages may not total 100 due to missing data 
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Responders from the Women’s hospital accounted for 59.9% (n=167) of the 
sample, with participants from Solihull hospital comprising 13.6% (n=38) of 
the sample. City hospital accounted for 12.9% (n=36); Good Hope hospital 
9.0% (n= 25), and Heartlands accounted for 4.7% (n=13) of the sample. In 
terms of age group, 35.1% of the sample (n=98) were in the 30 to 39 age 
group. The smallest number of responses was obtained from the 50+ age 
group, with women over 50 accounting for 11.1% of the sample (n=31). With 
regard to deprivation, the largest group of respondents came from the most 
deprived quartile (Q4), accounting for 40.9% (n=114) of the sample. The most 
affluent deprivation quartile (Q1) was the smallest group (10.0%; n=28). Index 
of Multiple Deprivation (IMD) quartile could not be assigned to 8 individuals 
within the sample (2.9%). In terms of treatment type, just under half of the 
sample was comprised of women who had undergone colposcopy only 
(42.7%; n=119), with similar proportions of women having had loop excision 
or biopsy (30.1%, n=84 vs. 27.2%, n=76 respectively).  
 
Data on ethnicity was collected, but due to the small sub-group sizes for 
ethnicity, and given that 78.5% of the sample were white British, ethnicity was 
dichotomised into ‘white’ vs. ‘non-white’ for the purposes of analysis. Non-
white British ethnicities were comprised of 20.0% Asian/Asian British (n=12); 
7.2% Black/Black British (n=20); 5.0% White non-British; 2.5% Mixed race (n= 
2.5); 2.2% other ethnicities (n=2.2) and 1% Chinese/Chinese British (n=1).  
 
Data related to level of education were also collected, and again, due to small 
sub-group sizes, the seven categories for which data were collected were 
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dichotomised for the purposes of analyses (up to GCSE and post GCSE). The 
original categories were as follows: 26.2% of the sample had GCSE or 
equivalent qualifications (n=73); 19.7% had non-degree qualifications (n=55); 
19.0% had a degree (n=53); 16.1% had post graduate qualifications (n=45); 
9.3% had been trained through work with formal qualifications; 8.6% had no 
formal qualifications (n=24); and 0.7% had never attended school (n=2). 
There was missing data for one respondent.  
 
For those responding to the question relating to smoking status, smokers 
accounted for under a third of the sample (n= 79; 28.3%) and almost half the 
sample were non-smokers (n= 131; 47.0%). 
 
Although 80.3% of responders to the question relating to alcohol reported 
drinking alcohol, only 12.9% (n=36) reported drinking 14 or more units per 
week. 14 units per week is the recommended ‘safe’ limit for women. For the 
purposes of analysis (, weekly alcohol intake was dichotomised into zero to 14 
and 14 and over. The majority of the responders to the question relating to 
problem alcohol/drug use (n= 261; 93.5%) reported having no substance 
misuse related problems. 
 
A high proportion of the responders to question regarding partnership status 
had a partner (n= 227; 81.4%), compared with 17.2 % (n=48) who did not. A 
large proportion of the responders to questions relating to current sexual 
activity were sexually active (n= 227; 81.4%), compared with 16.1% (n=45) 
who were not. Ninety nine point seven percent (n= 253) of the responders 
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reported being sexually active prior to colposcopy, although it is not possible 
to infer that any observed difference between current sexual activity and 
reported activity prior to colposcopy was due to the colposcopy itself. 
 
Ninety six point one percent (n= 268) of the responders to the question 
relating to sexual orientation identified themselves as straight, with only small 
proportions identifying as gay (1.4%) or bi-sexual (0.7%). 
 
Over half the responders to the question relating to contraception use used 
contraception (n=156; 55.9%) compared to 40.9% (n=114) who did not.  
65.6% (n=183) of responders had children. Just under one fifth of responders 
had had a miscarriage (n=52; 18.6%). Lower proportions of responders had 
had a premature birth (n=26; 9.3%) and a yet smaller proportion of 
responders to the question relating to still birth had experienced a stillbirth 
(n=5; 1.8%). Around half of the responders reported having had 
gynaecological problems (n=141; 50.5%) and 28.3% (n=79) of responders 
had had a sexually transmitted disease. 
 
Just over a quarter of responders reported having long-term health problems 
(n=73; 26.2%). The highest proportion of responders to the question relating 
to visits to the GP in the last 12 months attended their GP between one and 
five times (n=190; 68.1%). 
 
Section 7.3 will outline the results for analysis of treatment type as a predictor 
variable. Table 7.2 presents the factors and potential predictors of interest, 
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and Table 7.3 presents the validated measure outcomes investigated along 
with the potential predictors of these outcomes.  
 
Table 7.2 Factors studied and potential predictors in terms of treatment 
type (Q2)  
 
Factor Potential Predictors 
 
Demographic/health/lifestyle 
factors 
 
Deprivation  
Age  
Ethnicity  
Education  
Smoking status  
Alcohol use  
Alcohol units per week  
Problems with drugs/alcohol  
Partner status Treatment type 
Sexual activity  
Sexual activity prior to colposcopy  
Sexual orientation  
Contraception use  
Having children  
Miscarriage  
Premature birth  
Still birth  
Gynaecological problems  
Sexually transmitted infection  
Long term health problem  
Number of visits to GP in last 12 
months 
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Table 7.3 Validated outcome measures and potential predictors (Q2) 
 
 
Validated measure outcomes 
 
 
Potential predictors 
Presence/absence of FSD 
Variation in FSFI score 
HADS anxiety score ‘normal’ or ‘mild 
and above’ 
Variation in HADS anxiety score 
HADS depression score ‘normal’ or 
‘mild and above’ 
Variation in HADS depression score 
WHO-QOL BREF physical domain 
median score 
Variation in WHO-QOL BREF 
physical domain score 
WHO-QOL BREF psychological 
domain median score 
Variation in WHO-QOL BREF 
psychological domain score 
WHO-QOL BREF social domain 
median score 
Variation in WHO-QOL BREF social 
domain score 
WHO-QOL BREF environmental 
domain median score 
Variation in WHO-QOL BREF 
environmental domain score 
Treatment type 
Deprivation 
Age 
 
 
 
7.3 Analysis of treatment type and all outcome variables 
 
This section will present the findings from analysis of treatment type as a 
potential predictor of all outcome variables. One of the aims of the study was 
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to ascertain if treatment type in particular was significantly associated with any 
of the outcomes investigated.  
 
 
 
Table 7.4 presents the analysis of treatment type and its association with 
socioeconomic deprivation. Treatment type is included in two forms – with the 
three treatment groups considered separately, and secondly with colposcopy 
used as a proxy for a control group by being compared to the biopsy and loop 
excision groups combined.  
 
 
Table 7.4 Treatment type and deprivation 
 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
n %) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colpscopy 
vs. biopsy 
& loop 
 
Deprivation 
quartile 
      
Q1 Most 
affluent 
6 (5.2) 9 (12.2) 13 
(16.0) 
22 (14.2)   
Q2 Less 
affluent 
19 (16.4) 19 (25.7) 13 
(16.0) 
32 (20.6) X2=13.76 
p=0.0324 
X2=7.61 
p=0.0548 
Q3 Less 
deprived 
38 (32.8) 23 (31.1) 17 
(21.0) 
40 (25.8)   
Q4 Most 
deprived 
53 (45.7) 23 (31.1) 38 
(46.9) 
61 (39.4)   
Affluent/ 
deprived 
      
Affluent 25 (21.6) 28 (37.8) 26 
(32.1) 
54 (34.8) X2=6.29 Pearson 
X2=5.67 
Deprived 91 (78.4) 46 (62.2) 55 
(67.9) 
101 (65.2) p=0.0431 p=0.0173 
       
 
 
In the colposcopy and loop excision groups, the largest proportion of 
responders was concentrated within the most deprived quartile (Q4) (45.7%; 
n=53 and 46.9%; n=38 respectively). In the biopsy group, the same proportion 
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of responders was found in the most deprived (Q4) and less deprived 
quartiles (Q3) (31.1%; n=23).  
 
Significant differences were found with regard to level of deprivation across 
the three treatment groups when divided into the four IMD quartiles 
(X2=13.76; p=0.0324); although this significant result disappeared when 
colposcopy was compared with a combined biopsy/loop excision group 
(X2=7.61; p=0.0548). A higher than expected proportion of women had 
undergone colposcopy in the most (Q4) deprived and less deprived (Q3) 
quartile and a lower proportion in the biopsy and loop excision group. 
 
When the deprivation quartiles were combined into dichotomous variables 
(Q1+Q2 denoting ‘affluent’ patients; Q3+Q4 denoting ‘deprived’ patients), 
significant differences were found when comparing proportions across the 
three treatment groups (X2=6.29; p=0.0431). Higher than expected numbers 
of colposcopy patients were found in the deprived group and fewer than 
expected in the affluent group. Higher than expected numbers of women from 
the affluent group were found in the biopsy and loop excision group and lower 
than expected numbers of deprived women were found in both these 
treatment groups. Similar patterns were found when comparing colposcopy 
with biopsy and loop excision combined (X2=5.67; p=0.0173).  
 
Table 7.5 presents the findings from analysis in terms of age group vs. 
treatment type. 
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Table 7.5 Treatment type and age group 
 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Age group 
      
       
19 to 29 30 (25.2) 24 
(31.6) 
26 
(31.0) 
50 (31.3)   
30 to 39 39 (32.8) 27 
(35.5) 
32 
(38.1) 
59 (36.9) X2=7.18 X2=5.67 
40 to 49 31 (26.1) 17 
(22.4) 
22 
(26.2) 
39 (24.2) p=0.3045 p=0.1288 
50 + 19 (16.0) 8 (10.5) 4 (4.8) 12 (7.5)   
       
 
 
A similar proportion of responders were observed across all age ranges and 
all treatment groups, except in the 50+ group. For example, only 4.8% (n=4) 
of responders from the 50+ age group had undergone loop excision compared 
with 26.2% (n=22) in the 40 to 49 group; 38.1% (n=32) in the 30 to 39 group 
and 31.0% (n=26) in the 19 to 29 group. No statistically significant differences 
were observed across the age groups in terms of treatment undergone. 
 
Table 7.6 presents the findings of analyses relating to ethnicity and treatment 
type.   
 
 
 
Table 7.6 Treatment type and ethnicity 
 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Ethnicity 
      
       
White 
British 
89 (74.8) 64 
(84.2) 
66 
(78.6) 
130 (81.3) Pearson 
X2=1.69 
Other 30 (25.2) 12 
(15.8)  
18 
(21.4) 
30 (18.8) 
X2=2.44 
p=0.2952 p=0.1936 
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The majority of respondents across all groups were white British (colposcopy 
74.8%; n=89, biopsy 84.2%; n=68, loop excision 81.3%; n=66). No significant 
differences were observed between white British and other ethnicities across 
treatment groups. 
 
Table 7.7 outlines the findings regarding an analysis of treatment type vs. 
education attainment for respondents to Q2.  
 
Table 7.7 Treatment type and educational attainment 
 
 Colposcop
y 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
n (%) 
Biopsy/L
oop 
Excision 
n (%) 
 
Colposcop
y vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy & 
loop 
 
Education 
      
       
To GCSE 
or  
equivalent 
40 (33.6) 25 (33.3) 34 
(40.50) 
59 (37.1) Pearson 
X2=0.36 
Post GCSE 79 (66.4) 50 (66.7) 50 (59.5) 100 
(62.9) 
X2=1.24 
p=0.5379 p=0.5485 
 
 
No significant differences were observed between the treatment groups in 
terms of educational attainment. A larger proportion of responders across all 
treatment groups were educated to a post GCSE level (colposcopy 66.4%; 
n=79, biopsy 66.7%; n=50; loop excision 59.5%; n=50). 
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Table 7.8 Treatment type and smoking status 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Smoking 
status 
      
       
Smoker 29 (24.2) 23 
(30.3) 
27 
(32.1) 
50 (31.3) 
Non smoker 65 (54.6) 29 
(38.2) 
37 
(44.0) 
66 (41.3) 
Ex-smoker 25 (21.0) 24 
(31.6) 
20 
(23.8) 
44 (27.5) 
X2=6.22 
p=0.1833 
X2=4.9 
p=0.0863 
 
 
As shown in Table 7.8, over half of the responders in the colposcopy group 
were non-smokers (54.6%; n=65). In the biopsy and loop excision group, the 
proportion of non-smokers was lower (38.2%; n=29 and 44.0%; n=37 
respectively). No significant differences were observed between treatment 
type and smoking status.  
 
Table 7.9 presents the results in terms of whether respondents used alcohol, 
and if so, at what level (Table 7.10).  
 
 
Table 7.9 Treatment type and alcohol use 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Alcohol use 
      
       
Yes 91 (79.8) 65 
(85.5) 
68 
(81.9) 
133 (83.6) Pearson 
X2=0.66 
No 23 (20.2) 11 
(14.5) 
15 
(18.1) 
26 (16.4) 
X2=1.01 
p=0.6035 p=0.4166 
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Table 7.10 Treatment type and alcohol units (2 categories) 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Alcohol 
units per 
week 
      
       
1-13 75 (81.5) 54 (83.1) 
56 
(87.5) 110 (85.3) 
Pearson 
X2=0.55 
14+ 17 (18.5) 11 
(16.9) 
8 (12.5) 19 (14.7) 
X2=1.02 
p=0.6005 p=0.4583 
 
 
 
Around 80% of responders across all treatment groups drank alcohol 
(colposcopy n=91; 79.8, biopsy n=65; 85.5 and loop excision n=68; 81.9%). 
In terms of alcohol use and units consumed per week, no significant 
differences were observed between treatment groups. Higher numbers of 
responders in the colposcopy group drank alcohol (79.8%; n= 91) compared 
to the biopsy and loop excision groups (85.5%; n=65, 81.9%; n=68 
respectively), although this was not statistically significant. In terms of number 
of units consumed per week, relatively small proportions of responders drank 
14+ units per week (colposcopy 18.5%; biopsy 16.9% and loop excision 
14.7%).  
 
Table 7.11 presents the proportion of responders across all treatment groups 
reporting having problems with drugs or alcohol. 
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Table 7.11 Treatment type and problems with drugs or alcohol 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Problems 
with alcohol 
      
       
Yes 5 (4.1) 4 (5.3) 1 (1.2) 5 (3.2) 
No 108 (95.6) 72 
(94.7) 
81 
(98.8) 
153 (96.8) 
Fisher 
exact 
p=0.3952 
Two tail 
p=0.7460 
 
 
 
These proportions were small (colposcopy 4.1%, n=5; biopsy 5.3%, n=4; and 
loop excision 1.2%, n=1). There were no significant differences between 
groups in terms of problem drug or alcohol use. 
 
Table 7.12 shows the relationship between treatment type and respondents’ 
partner status. 
 
 
 
 
Table 7.12 Treatment type and partner status 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Partner 
      
       
Yes 89 (76.6) 65 
(85.5) 
73 
(88.0) 
138 (86.8) Pearson 
X2=4.7 
No 27 (23.3) 11 
(14.5) 
10 
(12.0) 
21 (13.2) 
X2=4.88 
p=0.0872 p=0.0298 
 
 
 
The proportion of responders who reported having a partner were relatively 
high, with the highest proportion found in the loop excision group (n=73; 
88.0%). 85.5% (n=65) in the biopsy group had a partner, and the lowest 
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proportion was found in the colposcopy group (n=89; 76.6%). As shown in 
Table 7.12, no significant differences were found between the three groups in 
terms of their partnership status, although a significant difference was 
observed when biopsy and loop excision groups were combined and 
compared with colposcopy patients (Pearson X2=4.7; p=0.0298). Here, larger 
than anticipated numbers in the colposcopy group did not have a partner and 
larger than anticipated number in the combined biopsy and loop excision 
group had a partner. 
 
In terms of sexual orientation, 97.4% (n=113) of responders in the colposcopy 
group identified as straight. In the biopsy and loop excision groups, 98.7% 
(n=74) and 97.6% (n=81) of responders respectively identified as straight. 
Due to small numbers of responders identifying as gay or bi-sexual, sub-
group analysis was not possible across all the variables studied. 
 
Table 7.13 presents the data on the association between treatment type and 
current reported sexual activity. 
 
 
Table 7.13 Treatment type and sexual activity 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Sexually 
active 
      
       
Yes 93 (82.3) 63 (82.9) 71 
(85.5) 
134 (84.3) Pearson 
X2=0.14 
No 20 (17.7) 13 (17.1) 12 
(14.5) 
25 (15.7) 
X2=0.39 
p=0.822 p=0.6629 
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82.3% (n=93) of women in the colposcopy group reported being sexually 
active compared with 82.9% (n=63) and 85.5% (n=71) in the biopsy and loop 
excision groups respectively. No significant differences were observed in 
terms of treatment type and sexual activity. Table 7.14 shows the proportion 
of women across the treatment groups who were sexually active prior to 
colposcopy. 
 
 
Table 7.14 Treatment type and sexual activity prior to colposcopy 
 
 
 
Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Sexually 
activity 
prior to 
colposcopy 
      
       
Yes 107 (95.5) 71 
(95.9) 
71 
(85.5) 
134 (83.3) Pearson 
X2=8.46 
No 5 (4.5) 3 (4.1) 12 
(14.5) 
25 (15.7) 
X2=8.61 
p=0.0135 p=0.0036 
 
 
Almost all women in the colposcopy and biopsy groups were sexually active 
prior to colposcopy (n=107; 95.5% and n=107; 95.9%) with slightly fewer 
women observed in the loop excision group (n=71; 85.5). There were 
significant differences observed across the groups in terms of sexual activity 
prior to colposcopy and type of treatment. Higher than anticipated numbers of 
women in the colposcopy and biopsy group were sexually active prior to 
colposcopy compared to the loop excision group. (X2=8.61; p=0.0135). When 
biopsy and loop excision groups were combined and compared with 
colposcopy, significantly higher proportions of women in the colposcopy group 
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indicated that they were sexually active prior to colposcopy (Pearson X2=8.46; 
p=0.0036). 
 
 
Table 7.15 Treatment type and contraception use 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Contraception 
use 
      
       
Yes 60 (53.1) 45 
(60.0) 
51 
(62.2) 
96 (61.1) Pearson 
X2=1.75 
No 53 (46.9) 30 
(40.0) 
31 
(37.8) 
61 (38.9) 
X2=1.82 
p=0.0821 p=0.1859 
 
 
 
As shown in Table 7.15, just over half of responders in the colposcopy group 
used contraception (53.1%; n=60) and 60.0% (n=45) and 62.2% (n=51) of 
responders in the biopsy and loop excision groups respectively used 
contraception. There were no statistically significant differences between 
groups in terms of contraception use. 
 
 
 
 
Table 7.16 Treatment type and children 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Children 
      
       
Yes 79 (66.4) 50 (66.7) 54 (65.1) 104 (65.8) Pearson 
X2=0.01 
No 40 (33.6) 25 (33.3) 29 (34.9) 54 (34.2) 
X2=0.05 
p=0.9753 p=0.9205 
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In the colposcopy group, 66.4% (n=79) of responders had children. In the 
biopsy and loop excision groups 66.7% (n=50) and 65.1% (n=54) of 
respondents, respectively, had children. As shown in Table 7.16, no 
significant differences were observed between treatment groups and the 
number of responders with children. 
 
 
Table 7.17 Treatment type and miscarriage 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy & 
loop 
 
Ever had  
Miscarriage 
      
       
Yes 25 (21.9) 15 
(20.8) 
12 
(14.8) 
27 (17.6) Pearson 
X2=0.76 
No 89 (78.1) 57 
(79.2) 
69 
(85.2) 
126 (82.4) 
X2=1.64 
p=0.4404 p=0.3833 
 
 
Table 7.17 shows the proportion of women who had had a miscarriage, 
broken down by treatment type. In the colposcopy group, 21.9% (n=25) of 
responders had a miscarriage. In the biopsy and loop excision groups 20.8% 
(n=15) and 14.8% (n=12) of responders respectively, had had a miscarriage. 
No statistically significant differences in these proportions were observed 
between treatment groups. 
 
Table 7.18 compares the proportions of respondents to Q2 who had given 
birth prematurely across treatment groups.  
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Table 7.18 Treatment type and premature birth 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Premature 
birth 
      
       
Yes 15 (13.4) 6 (8.5) 5 (6.5) 11 (7.4) Pearson 
X2=0.76 
No 97 (86.6) 65 
(91.5) 
72 
(93.5) 
137 (92.6) 
X2=1.64 
p=0.4404 p=0.3833 
 
 
Just under a quarter of women in the colposcopy group had had a premature 
birth (n=15). In the biopsy and loop excision groups 8.5% (n=6) and 6.5% 
(n=5) of responders respectively had had a premature birth. No statistically 
significant differences were observed between treatment groups. In terms of 
women having had a still birth, due to small numbers of responders 
experiencing this (colposcopy 1.8%, n=2; biopsy 2.8%, n=2; loop excision 
1.3%, n=1), sub-group analysis was not possible. 
 
 
Table 7.19 Treatment type and gynaecological problems 
 
 Colposcop
y 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loo
p Excision 
n (%) 
 
Colposcop
y vs. 
biopsy vs. 
loop 
Colposcop
y vs. 
biopsy & 
loop 
 
Ever had  
gynaecologica
l problems 
      
       
Yes 64 (56.1) 42 (56.0) 35 
(43.2) 
77 (49.4) Pearson 
X2=1.21 
No 50 (43.9) 33 (44.0) 46 
(56.8) 
79 (50.6) 
X2=3.77 
p=0.1182 p=0.2713 
 
 
The proportion of women across treatment groups experiencing 
gynaecological problems is shown in Table 7.19. Just over half of women in 
the colposcopy and biopsy groups reported having had gynaecological 
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problems (colposcopy 56.1%; n=64, biopsy 56.0%; n=42). Lower proportions 
of women in the loop excision group had experienced gynaecological 
problems. However, no significant differences were observed between 
treatment groups. 
 
Table 7.20 compares treatment groups with respondents reporting a history of 
sexually transmitted infections.  
 
 
Table 7.20 Treatment type and history of sexually transmitted infections 
(STIs) 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Ever had 
an STI 
      
       
Yes 30 (25.4) 25 
(32.9) 
24 
(28.9) 
49 (30.8) Pearson 
X2=0.97 
No 88 (74.6) 51 
(67.1) 
59 
(71.1) 
110 (69.2) 
X2=1.27 
p=0.5299 p=0.3247 
 
 
Around a quarter of responders from the colposcopy group had a history of 
STI’s (n= 30; 25.4%). Slightly higher proportions were observed in the biopsy 
and loop excision groups, where 32.9% (n=25) and 28.9% (n=24) of 
respondents respectively had a history of STIs. However, there were no 
significant differences in these proportions across treatment groups.  
 
Table 7.21 shows the proportions of women who reported having long term 
health problems. 
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Table 7.21 Treatment type and long term health problems 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Long term 
health 
problems 
      
       
Yes 42 (35.6) 61 
(21.3) 
15 
(18.8) 
31 (20.0) Pearson 
X2=8.32 
No 76 (64.4) 59 
(78.7) 
65 
(81.3) 
124 (80.0) 
X2=21.36 
p=<0.001 p=0.0039 
 
 
The highest proportion of responders with long term health conditions was 
observed in the colposcopy group with around a third of responders reporting 
such problems (n=42). This was compared with 21.3% (n=61) in the biopsy 
group and 18.8% (n=15) in the loop excision group and this result was 
statistically significant. When biopsy and loop excision groups were combined 
and compared with colposcopy patients, higher than expected numbers in the 
colposcopy group had long term health problems with lower numbers in the 
biopsy/loop excision group (Pearson X2=8.32; p=0.0039). 
 
 
 
Table 7.22 Treatment type and number of visits to the GP in last 12 
months 
 
 Colposcopy 
 
n (%)  
Biopsy 
 
n (%) 
Loop 
Excision 
 n (%) 
Biopsy/Loop 
Excision 
n (%) 
 
Colposcopy 
vs. biopsy 
vs. loop 
Colposcopy 
vs. biopsy 
& loop 
 
Number of 
visits to GP 
      
       
0 1 (0.9) 6 (8.8) 7 (8.6) 13 (8.7) 
1 to 5 84 (74.3) 46 
(67.6) 
60 
(74.1) 
106 (71.1) 
6 to 9 16 (14.2) 7 (10.3) 11 
(13.6) 
18 (12.1) 
10+ 12 (10.1) 9 (13.2) 3 (3.7) 12 (8.1) 
X2=12.34 
p=0.0548 
X2=9.33 
p=0.0252 
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With regard to the number of times respondents had visited their GP in the 12 
months prior to receiving the questionnaire (Table 7.22), 74.3% (n=84) of 
responders in the colposcopy group reported having visited their GP on 
between one and five occasions. In the biopsy and loop excision groups 
67.6% (n=46) and 74.1% (n=60) of responders respectively visited their GP 
on between one and five occasions in the previous 12 months. In the 
colposcopy group, 10.1% (n=12) of respondents visited their GP on ten or 
more occasions, compared with 13.2% (n=9) in the biopsy group and 3.7% 
(n=3) in the loop excision group. When the colposcopy group was compared 
with the combined biopsy and loop excision group, a higher proportion of 
responders from the biopsy and loop excision group had not visited their GP 
at all when compared with the same proportion in the colposcopy group. 
Similarly, a higher proportion of responders in the colposcopy group visited 
their GP on 10 or more occasions when compared with the biopsy and loop 
excision group combined (X2=9.33; p=0.0252). 
 
 
7.4 Analysis of responses to validated measures 
 
The following sections will present the analyses for the responses to the 
validated measures included in Q2: the Female Sexual Function Index (FSFI), 
HADS depression and HADS anxiety measures, and the WHOQOL-BREF 
scale.  
 
The results for each validated measure will be presented in a separate 
section. 
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Section 7.5 - pertaining to female sexual dysfunction - will present the results 
for the presence or absence of FSD for in terms of the three potential 
predictors of interest (treatment type, deprivation quartile and age).  It will 
assess if there are any statistically significant associations between the 
presence of FSD and these predictors using Chi2 tests for association. 
Following this, odds ratios derived from binary logistic regression modelling 
will be presented, in order to demonstrate which of the factors investigated in 
Q2 (see Table 7.3) may be considered predictors of FSD for responders to 
Q2. The same process will then be undertaken for the HADS anxiety and 
HADS depression measures, looking at responders in the ‘normal’ range 
compared to the ‘mild and above range of depression and anxiety scores. 
Finally, results will presented for the four WHOQOL-BREF domains 
(psychological, social, environmental and physical), including the median and 
mean scores for each domain.  
 
 
7.5 Female Sexual Dysfunction 
 
This section will present the results for the presence or absence of FSD for 
the potential predictor - treatment type, deprivation quartile and age. It will 
assess if there are any statistically significant associations between the 
presence of FSD and these predictors using Chi2 tests for association. As 
discussed in chapter five, a sensitivity analysis will be performed removing 
women who had reported not being ‘sexually active’ as a response across all 
the FSFI domains. Following this, odds ratios derived from binary logistic 
regression modelling will be presented, in order to demonstrate which of the 
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factors investigated in Q2 may be considered predictors of FSD in responders 
to Q2.  
 
 7.5.1 Female Sexual Dysfunction results for all respondents 
 
To ascertain the presence or absence of female sexual dysfunction for study 
participants, the Female Sexual Function Index (FSFI) was administered. 
More detail about how scores were derived is presented in Chapter 5 (Section 
5.6.2). The results for all respondents are presented in Table 7.23.  
 
Table 7.23 Proportion of respondents to Q2 calculated as having female 
sexual dysfunction 
 
Presence of FSD n (%) 
  
Yes 153 (54.8) 
No 126 (45.2) 
Total 279 (100.0) 
 
 
In the sample responding to Q2, over 50% of respondents were found to have 
FSD, with 153 (54.7%) of responders scoring < 26.55 on the FSFI scale. 
Similar proportions were observed after removal of women who were not 
sexually active (table 7.24). 
 
Table 7.24 Proportion of respondents to Q2 calculated as having female 
sexual dysfunction (removing non-sexually active from analysis) 
 
Presence of FSD n (%) 
  
Yes 136(52.0) 
No 126 (48.0) 
Total 262 (100.0) 
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7.5.2 FSFI - Female Sexual Dysfunction proportion of responses by 
treatment type, deprivation and age group 
 
Table 7.25 presents the proportion of women with FSD by treatment type, age 
and deprivation quartile. For all potential predictors, more than half of the 
women responding had FSD and in the 50+ age group, close to three quarters 
of women who responded had FSD (71.0%), although the absolute numbers 
were quite small (n=22). In terms of treatment, the highest proportion of 
women with FSD was observed in the loop excision group (n=49; 58.3%) and 
lowest in the biopsy group (n=36; 47.4%). Similar proportions of responders 
with FSD were observed in the less affluent and most deprived groups (n=26; 
51.0% and n=59; 51.8% respectively). 
 
Table 7.25 Presence of FSD - proportion of responses by treatment type, 
deprivation and age 
 
Predictors Participants with FSD (n) Proportion with FSD % 
 
Treatment type 
  
Colposcopy 68 57.1 
Biopsy 36 47.4 
Loop Excision 
Total 
49 
153 
58.3 
 
Biopsy/Loop Excision 
 
85 53.1 
Deprivation Quartile   
Most Affluent (Q1) 16 57.1 
Less Affluent (Q2) 26 51.0 
Less Deprived (Q3) 48 61.5 
Most Deprived (Q4) 59 51.8 
Total 
 
149  
Affluent/Deprived   
Affluent 42 53.2 
Deprived 
Total 
107 
149 
55.7 
 
   
Age   
19-29 43 53.8 
30-39 50 51.0 
40-49 38 54.3 
50+ 
Total 
22 
153 
71.0 
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The next three sections present the results for the associations between 
treatment type, deprivation quartile and age group and the presence of FSD 
using Chi2 tests. 
 
 
Association between treatment type and FSD 
 
Table 7.26 presents a comparison of the proportion of responders who had 
FSD between treatment groups. The highest proportion of responders with 
FSD was observed in the loop excision group (n=49; 58.3%) closely followed 
by the colposcopy group (n=68; 57.1%). No significant differences were 
observed in terms of the presence of FSD and level of treatment. This was the 
case both when the three treatment groups were compared to each other 
separately, and when the colposcopy group was compared to a combined 
biopsy/loop excision group.   
Following sensitivity analysis (table 7.27), removing women who had recorded 
no sexual activity from the analysis, no significant differences were observed 
in terms of treatment type and presence of FSD. 
 
 
Table 7.26 Association between treatment type and FSD - all responses 
 
 FSD Yes 
n (%) 
FSD No 
 n (%) 
Colposcopy vs. 
biopsy vs. loop 
excision  
Colposcopy vs. 
biopsy & loop 
excision 
 
 
Treatment type 
    
   
Colposcopy 68 (57.1) 51 (42.9) 
Biopsy 36 (47.4) 40 (52.6) 
Loop Excision 49 (58.3) 35 (41.7) 
Biopsy/Loop 85 (53.1) 75 (46.9) 
   
X2=2.8 
p=0.30 
Pearson X2=0.44 
p=0.50 
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Table 7.27 Association between treatment type and FSD - sensitivity 
analysis 
 
 FSD Yes 
n (%) 
FSD No 
 n (%) 
Colposcopy vs. 
biopsy vs. loop 
excision  
Colposcopy vs. 
biopsy & loop 
excision 
 
 
Treatment type 
    
   
Colposcopy 64 (56.6) 49 (43.4) 
Biopsy 33 (47.9) 37 (52.1) 
Loop Excision 45 (57.7) 33 (42.3) 
Biopsy/Loop 70 (47.0) 79 (53.0) 
   
X2=1.78 
p=0.41 
Pearson X2=0.34 
p=0.55 
 
 
 
Association between deprivation quartile and FSD 
 
The highest proportion of responders with FSD was observed in the less 
deprived quartile (Q3) (n=48; 61.5%) with the lowest proportion observed in 
the less affluent (Q2) and most deprived quartile (Q4). Here, around 50% of 
responders had FSD (n=26 and n=59 respectively). As shown in Table 7.28, 
no statistically significant differences were observed in terms of the presence 
of FSD and level of deprivation across the four deprivation quartiles. Following 
sensitivity analysis, presented in table 7.29 no significant differences were 
observed between in terms of presence of FSD and deprivation quartile. 
 
Table 7.28 Association between deprivation quartile and FSD 
 
 FSD Yes 
n (%) 
FSD No 
n %) 
p value 
 
Deprivation quartile 
   
    
Q1 (Most Affluent) 16 (57.1) 12 (42.9)  
Q2 (Less Affluent) 26 (51.0) 25 (49.0) X2=2.22 
Q3 (Less Deprived) 48 (61.5) 30 (38.5) p=0.528 
Q4 (Most Deprived) 59 (51.8) 55 (48.2)  
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Table 7.29 Association between deprivation quartile and FSD - 
sensitivity analysis 
 
 
 FSD Yes 
n (%) 
FSD No 
n %) 
p value 
 
Deprivation quartile 
   
    
Q1 (Most Affluent) 16 (57.1) 12 (42.9)  
Q2 (Less Affluent) 26 (51.0) 25 (49.0) X2=1.49 
Q3 (Less Deprived) 42 (60.0) 28 (40.0) p=0.68 
Q4 (Most Deprived) 55 (50.9) 53 (49.1)  
 
 
 
Association between age group and FSD 
 
Table 7.30 shows the proportion of women with FSD between age groups. 
The highest proportion of FSD was observed in the 50+ group (n=22; 71.0%) 
compared with proportions of around 50% for the other three age groups. 
Despite these differences in proportions, there was no statistically significant 
difference observed across age groups with regard to the prevalence of FSD 
in the sample.  Similarly, no significant differences were noted following 
sensitivity analysis. 
 
 
Table 7.30 Association between age group and FSD 
 
 FSD Yes 
n(%) 
FSD No 
n(%) 
Significance 
Age range    
    
19 to 29 43 (53.8) 37 (46.3)  
30 to 39 50 (51.0) 48 (49.0) X2=3.84 
40 to 49 38 (54.3) 32 (45.7) p=0.27 
50+ 22 (71.0) 9 (29.9)  
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Table 7.31 Association between age group and FSD - sensitivity analysis 
 
 FSD Yes 
n(%) 
FSD No 
n(%) 
Significance 
Age range    
    
19 to 29 41 (53.9) 35 (46.1)  
30 to 39 50 (50.5) 48 (49.5) X2=3.85 
40 to 49 35 (53.8) 30 (46.2) p=0.27 
50+ 20 (71.4) 8 (28.6)  
 
7.5.3 Predictors of FSD - bivariate analysis 
 
The next section will outline the results from the bivariate analysis of FSD 
incidence across the three potential predictor variables of interest i.e. the 
Odds Ratios (OR) derived from a binary logistic regression analysis, to 
determine the predictors of the presence of FSD derived from responses to 
the FSFI measure.  
Table 7.32 presents the results from the analysis for presence of FSD for the 
three potential predictor variables of interest. 
 
Table 7.32 Results FSD bivariate analysis for potential predictors of 
interest 
 
Characteristic Presence of FSD  
n ( %) 
 
Bivariate OR 
(95% CI) 
p value * 
 Yes No 
   
  
    
Treatment type    
Colposcopy Only 68 (57.1) 51 (42.9)  0.9 (0.5 -1.7) 0.90 
Biopsy 36 (47.4) 40 (52.6)  0.6 (0.3 - 1.2) 0.16 
Loop Excision 49 (58.3) 35 (41.7)  Reference Reference 
    
Deprivation quartile    
Most Affluent (Q1) 16 (57.1) 12 (42.9)  1.2 (0.5 - 2.9) 0.60 
Less Affluent (Q2) 26 (51.0) 25 (49.0)  0.9 (0.5 - 1.8) 0.92 
Less Deprived (Q3) 
Most Deprived (Q4) 
48 (61.5) 30 (38.5) 
59 (51.8) 55 (48.2)  
1.5 (0.8 - 2.6) 
Reference 
0.18 
Reference 
    
Age group    
19 to 29 43 (53.8) 37 (46.3)  0.5 (0.2 - 1.1) 0.10 
30 to 39 50 (51.0) 48 (49.0)  0.4 (0.2 - 1.0) 0.06 
40 to 49 
50+ 
38 (54.3) 32 (45.7) 
22 (71.0) 9 (29.9)  
0.5 (0.2 - 1.2) 
Reference 
0.12 
Reference 
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None of the potential predictor variables was found to be significantly 
associated with presence/absence of FSD in the bivariate analysis. 
7.5.4 Predictors of FSD - multivariate analysis 
 
This section will present the results from the multivariate regression where the 
effects of each variable were controlled for by all other variables within the 
model. Thus, the remaining variables which are retained in the model can be 
considered independent predictors of the presence of FSD when the effect of 
all other variables are accounted for. A logistic regression (using the Enter 
method) was performed using all three variables and each of the dichotomous 
outcome variables in order to ascertain potentially significant predictors of 
FSD. The results are presented in Table 7.33. 
Table 7.33 Results of FSD multivariate analysis for predictors of interest 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
-0.061 (0.303) 
 
0.84 
 
0.941 
 
(0.5 - 1.7) 
 
Treatment type 2 
(biopsy) 
 
-0.410 (0.331) 
 
0.21 
 
0.216 (0.3 - 1.2) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
0.289 (0.440) 
 
0.51 
 
1.335 (0.5 - 3.1) 
 
IMD 2 (Q2) 
 
0.041 (0.344) 
 
0.90 
 
1.042 (0.5 - 2.0) 
 
IMD 3 (Q3) 
 
0.420 (0.305) 
 
0.16 
 
1.522 (0.8 - 2.7) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
-0.700 (0.464) 
 
0.13 
 
0.496 (0.2 - 1.2) 
 
Age 2 (29-39) 
 
-0.863 (0.453) 
 
0.06 
 
0.422 (0.7 - 1.2) 
 
Age 3 (40-49) 
 
-0.699 (0.197) 
 
0.13 
 
0.497 
 
(0.9 - 1.2) 
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Model X2 = 7.943 (p=0.439); Hosmer and Lemeshow = 4.033 (p=0.854); Cox & Snell R2= 
0.029; Nagelkerke R2 = 0.39 
 
 
 
Following multivariate analysis, no significant results were observed in terms 
of predictors for the presence of FSD. 
 
7.6 Anxiety and Depression Scale (HADS) results for all 
respondents 
 
HADS is a short measure of anxiety and depression that is appropriate for use 
in a general population. It is a fourteen item scale, with seven questions 
relating to anxiety and seven relating to depression. The outcomes indicate 
anxiety/depression levels with a range of ‘normal’, ‘mild’, ‘moderate’ and 
‘severe.’ The results for all responses considered together are presented in 
Table 7.34. In the main results section, the results are presented for the four 
ranges of anxiety levels as well as scores dichotomised between ‘normal’ and 
‘mild and above’. Chapter 5 (Section 5.6.2) provides more detail for how the 
scores on this scale were calculated. 
 
 
Table 7.34 HADS Anxiety/Depression results for all respondents 
 
HADS anxiety score n (%) HADS Depression 
Score (%) 
   
Normal 58 (20.8) 126 (45.2) 
Mild 67 (24.0) 59 (21.1) 
Moderate 96 (34.4) 77 (27.6) 
Severe 
Missing 
56 (20.1) 
2 (0.7) 
15 (5.4) 
2 (0.7) 
Total 279 (100.0) 279 (100.0) 
 
 
Just under half of the sample (n=126; 45.2%) scored within the ‘normal’ range 
on the depression scale. 66.3% (n=185) of the sample scored either ‘normal’ 
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or ‘mild’ on the depression scale. 33% of respondents (n=92) scored within 
the ‘moderate’ or ‘severe’ range of the depression scale. In terms of anxiety, 
one fifth of the sample (n=58; 20.8%) scored within the ‘normal’ range of the 
scale and just under half scored either ‘normal’ or ‘mild’ on the anxiety scale 
(n=125; 44.8%). Over half of the sample scored within the ‘moderate’ or 
‘severe’ end of the scale (n=153; 54.4%). Data were missing for 0.7% of the 
sample (n=2).  
 
7.6.1 HADS Anxiety/Depression mean scores 
 
Table 7.35 presents the mean scores for anxiety and depression across the 
three primary predictor variables (treatment type, deprivation and age).  
 
Table 7.35 Mean Scores - HADS Anxiety/Depression 
 
Predictor variable Anxiety Mean Score 
(SD)* 
Depression Mean Score 
(SD) 
   
Treatment type   
Colposcopy 10.88 (4.421) 8.44 (4.515) 
Biopsy 11.75 (4.262) 8.70 (4.262) 
Loop Excision 10.99 (4.110) 8.22 (3.829) 
Biopsy/Loop Excision 11.35 (4.187) 8.45 (3.926) 
   
Deprivation quartile   
Most Affluent (Q1) 10.96 (4.678) 7.36 (4.556) 
Less Affluent (Q2) 11.04 (4.463) 7.53 (4.258) 
Less Deprived (Q3) 11.47 (4.394) 8.49 (3.889) 
Most Deprived (Q4) 11.08 (4.113) 9.00 (4.158) 
   
Affluent/Deprived   
Affluent (Q1+Q2) 11.01 (4.511) 7.49 (4.338) 
Deprived (Q3+Q4) 11.24 (4.222) 8.79 (4.048) 
   
Age group   
19 to 29 11.90 (4.224) 8.40 (4.301) 
30 to 39 10.59 (4.375) 7.88 (4.116) 
40 to 49 11.04 (4.364) 8.62 (4.336) 
50+ 11.23 (3.888) 9.94 (3.425) 
* SD = Standard Deviation 
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Overall, mean depression scores on the HADS scale were lower than the 
anxiety scores. Women in the biopsy treatment group scored marginally 
higher on the anxiety and depression scale (11.75; SD = 8.70) than 
respondents in the colposcopy and loop excision groups. In terms of 
deprivation quartile, responders in the less deprived group (quartile 3) scored 
highest on the anxiety scale (11.47) and the most affluent group (quartile 1) 
scored the lowest on this scale (10.96). The most deprived group scored 
highest on the depression scale (9.00) and the most affluent group scored 
lowest on this scale (7.36). In terms of age, the 19 to 29 group scored highest 
on the anxiety scale (11.90) and lowest on the depression scale (8.40). The 
50+ group scored highest on the depression scale (9.94).  
 
Section 7.7 presents the proportion of participants with anxiety levels rated as 
either ‘normal’, ‘mild’, ‘moderate’ or ‘severe’ and tests for association between 
anxiety level and treatment type, deprivation and age. Further analysis was 
undertaken dichotomising anxiety levels into ‘normal’ or ‘mild and above’. 
 
7.7 HADS anxiety results 
 
7.7.1 Association between treatment type and HADS anxiety level 
 
Table 7.36 presents the proportion of responders rated on each level of the 
anxiety scale in terms of treatment type; both taken separately, and with 
colposcopy compared to a combined biopsy/loop excision group. Around a 
quarter of responders in the loop excision group had anxiety levels rated as 
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‘normal’ (n=20). This group had the highest proportion of responders in the 
normal range. 23.7% (n=18) of responders in the biopsy group were rated as 
having ‘severe’ anxiety. The lowest proportion of responders rated as having 
‘severe’ anxiety were observed in the loop excision group (n=15; 18.1%). As 
shown in Table 7.37, similar proportions were observed when the HADS scale 
was dichotomised into ‘normal’ or ‘mild and above’. However, no statistically 
significant differences were observed in term of anxiety levels and treatment 
type using the four levels of anxiety or when scores were dichotomised into 
two groups. 
 
 
 
 
 
 
 
Table 7.36 Association between treatment type and HADS anxiety level 
 
HADS Anxiety Normal 
n (%) 
Mild 
n (%) 
Moderate 
n ( %) 
Severe 
n (%) 
Colposcopy 
vs. biopsy 
vs. loop 
excision  
Colposcopy 
vs. biopsy 
& loop 
excision 
Treatment type       
Colposcopy 27 (22.9) 31 (26.3) 37 (31.4) 23 (19.5)   
Biopsy 11 (14.5) 17 (22.4) 30 (39.5) 18 (23.7) X2=4.05 X2=1.44 
Loop Excision 20 (24.1) 19 (22.9) 29 (34.9) 15 (18.1) p=0.6699 p=0.6962 
Biopsy/Loop 31 (19.5) 36 (22.6) 59 (37.1) 33 (20.8)   
 
 
Table 7.37 Association between treatment type and HADS anxiety level 
(normal vs. mild and above) 
 
HADS Anxiety Normal 
n (%) 
Mild and 
above 
n (%) 
Colposcopy 
vs. biopsy vs. 
loop excision  
Colposcopy 
vs. biopsy & 
loop excision 
 
Treatment type 
    
     
Colposcopy 27 (22.9) 91 (77.1)   
Biopsy 11 (14.5) 65 (85.5) Pearson 
X2=0.47 
Loop Excision 20 (24.1) 63 (75.9) 
X2=2.69 
p=0.2605 p=0.493 
     
Biopsy/Loop 31 (19.5) 128 (80.5)   
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7.7.2 Association between deprivation quartile and HADS anxiety 
level 
 
Table 7.38 presents the proportions of responders rated as ‘normal’, ‘mild’, 
‘moderate’ and ‘severe’ on the anxiety scale when responses are categorised 
by deprivation quartile. The highest proportion of responders rated as ‘normal’ 
on the scale were from the less affluent quartile (Q2) (n=13; 25.5%). The 
lowest proportion of responders on the ‘normal’ range were in the most 
affluent quartile (Q1) (n=5; 17.9%).The less affluent group (Q2) had the 
highest proportion of responders with anxiety rated as ‘severe’ (n=13; 25.5%). 
The most deprived group (Q4) had the lowest proportion of responders rated 
as ‘severe’ (n=17; 15%). There were no statistically significant differences 
observed in terms of anxiety levels and deprivation level using the four levels 
of anxiety scores on the HADS scale. 
 
As shown in Table 7.39, when anxiety scores were dichotomised into ‘normal’ 
and ‘mild and above’, a significant difference was observed (X2=60.87; 
p=0.001) with lower than anticipated numbers of patients rated as ‘normal’ in 
the ‘most affluent’ (Q1) and ‘less affluent’ (Q2) groups and higher than 
anticipated numbers rated as ‘normal’ in the ‘less deprived’ (Q3) and ‘most 
deprived’ (Q4) groups. These findings suggest that more affluent participants 
were more likely to experience more pronounced levels of anxiety when 
compared with more socioeconomically deprived respondents. 
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Table 7.38 Association between deprivation quartile and HADS anxiety 
level 
 
HADS Anxiety Normal 
n (%) 
Mild 
n (%) 
Moderate 
n (%) 
Severe 
n (%) 
p value 
      
Deprivation 
quartile 
     
Q1 (Most Affluent) 5 (17.9) 10 (35.7) 7 (25.0) 6 (21.4) 
Q2 (Less Affluent) 13 (25.5) 11 (21.6) 14 (27.5) 13 (25.5) 
Q3 (Less 
Deprived) 
15 (19.5) 18 (23.4) 25 (32.5) 19 (24.7) 
Q4 (Most 
Deprived) 
23 (20.4) 27 (23.9) 46 (40.7) 17 (15.0) 
X2=8.17 
p=0.5171 
 
 
 
Table 7.39 Association age group and HADS anxiety level (normal v mild 
and above) 
 
HADS Anxiety Normal 
n (%) 
Mild and above 
n (%) 
p value  
 
Deprivation quartile 
   
    
Q1 (Most Affluent) 5 (17.9) 23 (82.1) 
Q2 (Less Affluent) 13 (25.5) 38 (74.5) 
Q3 (Less Deprived) 56 (74.7) 19 (25.3) 
Q4 (Most Deprived) 78 (74.3) 27 (25.7) 
X2=60.87 
p=<0.001 
 
 
 
 
 
7.7.3 Association between age group and HADS anxiety level 
 
Table 7.40 presents the proportion of responders rated on the anxiety scale in 
terms of age. The lowest proportion of responders rated in the ‘normal’ range 
were from the 50+ age group (n=3; 9.7%). The 30 to 39 and 40 to 49 age 
groups both had around a quarter of respondents rated as having ‘normal’ 
anxiety levels (n=26; n=17 respectively). In terms of ‘severe’ anxiety, the 
group with the highest proportion of responders was from the 19 to 29 age 
group (n=19; 23.8%).   As shown in Table 7.41, when the anxiety scores were 
dichotomised into ‘normal’ or ‘mild and above’, the highest proportion of 
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responders scoring ‘mild or above’ on the HADS anxiety scale was in the 50+ 
age group.  No statistically significant differences were observed between 
levels of anxiety and age group. 
 
 
 
Table 7.40 Association between age group and HADS anxiety level 
 
HADS Anxiety Normal 
n (%) 
Mild 
n (%) 
Moderate 
n (%) 
Severe 
n (%) 
p value  
      
Age group      
19 to 29 12 (15.0) 18 (22.5) 31 (38.8) 19 (23.8)  
30 to 39 26 (26.8) 24 (24.7) 27 (27.8) 20 (20.6) X2=12.02 
40 to 49 17 (24.6) 13 (18.8) 27 (39.1) 12 (17.4) p=0.2122 
50+ 3 (9.7) 12 (38.7) 11 (35.5) 5 (16.1)  
 
 
 
 
Table 7.41 Association between age group and HADS anxiety level 
(normal vs. mild and above) 
 
HADS Anxiety Normal 
n (%) 
Mild or above 
n (%) 
p value  
    
Age group    
19 to 29 12 (15.0) 68 (85.0)  
30 to 39 26 (26.8) 71 (73.2) X2=6.67 
40 to 49 17 (24.6) 52 (75.4) p=0.0832 
50+ 3 (9.7) 28 (90.3)  
7.7.4 Predictors of scoring ‘normal’ or ‘mild and above’ on the HADS 
anxiety scale - bivariate analyses  
 
Section 7.7.4 will outline the results from the bivariate analysis i.e. the Odds 
Ratios (OR) derived from a binary logistic regression analysis, to determine 
the predictors of respondents rating either ‘normal’ or ‘mild and above’ on the 
HADS anxiety scale. Table 7.42 presents the results from this analysis for the 
three potential predictor variables of interest. 
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Table 7.42 Predictors of scoring ‘normal’ or ‘mild and above’ on the 
HADS anxiety scale - Bivariate analyses for all predictors 
 
 
Characteristic HADS Anxiety Score  
n (%) 
 
Bivariate OR 
(95% CI) 
p value* 
 Normal Mild or above   
 
Treatment type 
   
Colposcopy only 27 (22.9) 91 (77.1)  1.0 (0.5 - 2.0) 0.84 
Biopsy 
Loop excision 
11 (14.5) 
20 (24.1) 
65 (85.5) 
63 (75.9)  
1.9 (0.8 - 4.2) 
Reference 
0.12 
Reference 
    
Deprivation quartile    
Most Affluent (Q1) 5 (17.9) 23 (82.1)  1.1 (0.4 - 3.4) 0.76 
Less Affluent (Q2) 13 (25.5) 38 (74.5)  0.7 (0.3 - 1.6) 0.43 
Less Deprived (Q3) 
Most Deprived (Q4) 
56 (74.7) 
78 (74.3) 
19 (25.3) 
27 (25.7)  
0.9 (0.5 - 2.1) 
Reference 
0.88 
Reference 
    
Age group    
19 to 29 12 (15.0) 68 (85.0)  0.6 (0.1 - 2.3) 0.46 
30 to 39 26 (26.8) 71 (73.2)  0.3 (0.8 - 1.0) 0.58 
40 to 49 
50+ 
17 (24.6) 
3 (9.7) 
52 (75.4) 
28 (90.3)  
0.3 (0.8 - 1.2) 
Reference 
0.95 
Reference 
    
 
Following bivariate analysis, none of the potential predictors of interest were 
significantly associated with scoring ‘normal’ or mild and above’ on the HADS 
anxiety scale. 
 
7.7.5 Predictors of scoring ‘normal’ or ‘mild and above’ on the HADS 
scale - multivariate analysis 
 
This section will present the results from the multivariate regression 
undertaken to establish which factors might be significant predictors of anxiety 
on the HADS scale when all other factors are controlled for in the model. A 
logistic regression (using the enter method) was performed using all variables. 
The results are presented in Table 7.43. 
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Table 7.43 Results scoring ‘normal’ or ‘mild and above’ on the HADS 
anxiety scale - multivariate analysis for all predictors 
 
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
-0.038 (0.356) 
 
0.91 
 
0.963 
 
(0.4 - 1.9) 
 
Treatment type 2 
(biopsy) 
 
0.700 (0.438) 
 
0.11 
 
2.014 (0.8 - 4.7) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
0.218 (0.564) 
 
0.69 
 
1.243 (0.4 - 3.7) 
 
IMD 2 (Q2) 
 
-0.392 (0.410) 
 
0.33 
 
0.676 (0.3 - 1.5) 
 
IMD 3 (Q3) 
 
-0.047 (0.379) 
 
0.90 
 
 
0.954 (0.4 - 2.0) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
-0.528 (0.693) 
 
0.44 
 
0.590 (0.1 - 2.2) 
 
Age 2 (29-39) 
 
-1.263 (0.661) 
 
0.06 
 
0.283 (0.7-1.0) 
 
Age 3 (40-49) 
 
-1.125 (0.679) 
 
0.09 
 
0.325 (0.8 - 1.2) 
 
Note: Model X2 =11.716 (p=0.164); Hosmer and Lemeshow = 4.160 (p=0.761); Cox & Snell 
R2=0.043; Nagelkerke R2 = 0.067 
 
 
Following multivariate regression, none of the potential predictors entered into 
the model were significant predictors of scoring ‘normal’ or ‘mild and above’ 
on the HADS anxiety scale. 
7.8 HADS Depression results 
7.8.1 Association between treatment type and HADS depression level 
 
Table 7.44 presents the responses on the HADS depression scale 
disaggregated by treatment type. It shows the proportions of responders 
scoring ‘normal’, ‘mild’, ‘moderate’ or ‘severe’ on the HADS depression scale. 
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Similar proportions of responders across all treatment groups were rated as 
having ‘normal’ scores on the depression scale (colposcopy n=56; 47.1%, 
biopsy n=17; 44.7% and loop excision n=36; 43.4%). Relatively small 
proportions of women were rated as having ‘severe’ depression’ between all 
groups, although the loop excision group had the lowest proportion (n=3; 
4.4%). As shown in Table 7.45, similar proportions were observed across 
treatment groups when the depression scale was dichotomised into ‘normal’ 
and ‘mild and above’. Just over half of the sample were rated as having ‘mild 
or above’ depression. However, no statistically significant differences were 
observed in terms of depression levels and treatment type using the four 
levels of depression or when scores were dichotomised into ‘normal’ or ‘mild 
and above’, nor was there a difference when considering the three treatment 
types separately or comparing the colposcopy group to a combined 
biopsy/loop excision group.  
 
 
Table 7.44 Association between treatment type and HADS depression 
level 
 
HADS 
Depression 
Normal 
n (%) 
Mild 
n (%) 
Moderate 
n (%) 
Severe 
n (%) 
Colposcopy 
vs. biopsy 
vs. loop 
excision  
 
Colposcopy 
vs. biopsy & 
loop 
excision 
 
 
Treatment type 
      
       
Colposcopy 56 (47.1) 17 (14.4) 37 (31.4) 8 (6.8)   
Biopsy 34 (44.7) 18 (23.7) 20 (26.3) 4 (5.3) X2=7.2 X2=6.4 
Loop Excision 36 (43.4) 24 (28.9) 20 (24.1) 3 (3.6) p=0.3027 p=0.0937 
Biopsy/Loop 70 (44.0) 42 (26.4) 40 (25.2) 7 (4.4)   
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Table 7.45 Association between treatment type and HADS anxiety 
depression (normal vs. mild and above) 
 
HADS Depression Normal 
n (%) 
Mild and 
above 
n (%) 
Colposcopy vs. 
biopsy vs. loop 
excision 
Colposcopy vs. 
biopsy & loop 
excision 
 
Treatment type 
    
     
Colposcopy 56 (47.5) 62 (52.5)   
Biopsy 34 (44.7) 42 (55.3) X2=0.35 Pearson X2=0.32 
Loop Excision 36 (43.4) 47 (56.6) p=0.8395 p=0.5716 
Biopsy/Loop 70 (44.0) 89 (56.0)   
     
 
 
 
 
7.8.2 Association between deprivation quartile and HADS 
depression level 
 
Table 7.46 presents the proportion of responders rated as having ‘normal’, 
‘mild’, ‘moderate’ or ‘severe’ depression when responses were considered on 
the basis of deprivation quartile.  
 
A higher proportion of women in the less affluent quartile (Q2) scored ‘normal’ 
on the depression scale (n=29; 56.9%), compared with 50.0% (n=14) in the 
most affluent quartile (n=14; 50.0%), 42.9% (n=33) in the less deprived 
quartile (Q3). The lowest proportion of responders scoring ‘normal’ on this 
scale was observed in the most deprived quartile (Q4) (n=47; 41.6%). Similar 
proportions of respondents scoring ‘severe’ on the depression scale were 
observed in the most affluent (Q1), less affluent (Q2), and less deprived 
quartiles (Q3) with the highest proportion observed in the most deprived 
quartile (n=8; 7.1%). When scores were dichotomised into ‘normal’ or ‘mild 
and above’, higher proportions of responders scored ‘mild or above’ in the 
less deprived (Q3) and most deprived quartile (Q4) (n=44; 57.1% and n=66; 
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58.4% respectively). However, no statistically significant differences were 
observed between depression scores and the four deprivation quartiles. 
 
 
 
 
 
Table 7.46 Association between deprivation and HADS depression level 
 
HADS Depression Normal 
n (%) 
Mild 
n (%) 
Moderate 
n (%) 
Severe 
n (%) 
p value 
      
Deprivation quartile      
Most Affluent (Q1) 14 (50.0) 7 (25.0) 6 (21.4) 1 (3.6) 
Less Affluent (Q2) 29 (56.9) 10 (19.6) 10 (19.6) 2 (3.9) 
Less Deprived (Q3) 33 (42.9) 18 (23.4) 23 (29.9) 3 (3.9) 
Most Deprived (Q4) 47 (41.6) 23 (20.4) 35 (31.0) 8 (7.1) 
X2=6 
p=0.7399 
 
 
 
Table 7.47 Association between deprivation quartile and HADS 
depression (normal vs. mild and above) 
 
 
HADS Depression Normal 
n (%) 
Mild and above 
n (%) 
p value 
 
Deprivation quartile 
   
    
Most Affluent (Q1) 14 (50.0) 14 (50.0) 
Less Affluent (Q2) 29 (56.9) 22 (43.1) 
Less Deprived (Q3) 33 (42.9) 44 (57.1) 
Most Deprived (Q4) 47 (41.6) 66 (58.4) 
X2=3.79 
p= 0.2851 
 
 
 
7.8.3 Association between age group and HADS depression level 
 
Table 7.48 shows the proportion of responders scoring ‘normal’, ‘mild’, 
‘moderate’ or ‘severe’ in terms of age group. Around half of responders in the 
30 to 39 and 40 to 49 age group were observed in the ‘normal range’, with the 
lowest proportion in the ‘normal’ range observed in the 50+ range (n=7; 
22.6%). Due to insufficient numbers of responses, it was not possible to 
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perform more sophisticated statistical analysis and tests for association 
across age groups and the four levels of depression responses for the HADS 
measure.  
 
When depression scores were dichotomised into two groups representing 
‘normal’ and ‘mild and above’, (Table 7.49) a significant difference was 
observed with lower proportions of patients from the 19 to 29 and 50+ groups 
in the ‘normal’ range and higher proportions of patients from the 30 to 39 and 
40 to 49 groups in the normal range (X2=8.41; p=0.0383). 
 
Table 7.48 Association between age group and HADS depression level 
 
 
HADS 
Depression 
Normal 
n (%) 
Mild 
n (%) 
Moderate 
n (%) 
Severe 
n (%) 
p value 
      
Age group 
 
     
19 to 29 35 (43.8) 17 (21.3) 24 (30.0) 4 (5.0)  
30 to 39 49 (50.5) 20 (20.6) 24 (24.7) 4 (4.1) Cannot 
40 to 49 35 (50.7) 14 (20.3) 13 (18.8) 7 (10.1) calculate 
50+ 7 (22.6) 8 (25.8) 16 (51.6) 0 (0.0)  
 
 
Table 7.49 Association between age quartile and HADS depression 
(normal v mild and above) 
 
HADS Depression Normal 
n (%) 
Mild or above 
n (%) 
p value 
    
Age group    
 
19 to 29 
 
35 (43.8) 
 
45 (56.3) 
 
30 to 39 49 (50.5) 48 (49.5) X2=8.41 
40 to 49 35 (50.7) 34 (49.3) p=0.0383 
50+ 7 (22.6) 24 (77.4)  
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7.8.4 Predictors of scoring ‘normal’ or ‘mild and above’ on the HADS 
depression scale - bivariate analyses  
 
Section 7.8.4 will outline the results from the bivariate analysis undertaken to 
determine the predictors of rating either ‘normal’ or ‘mild and above’ on the 
HADS depression scale. Table 7.50 presents the results from this analysis for 
the three potential predictor variables of interest. 
 
Table 7.50 Predictors of scoring ‘normal’ or ‘mild and above’ on the 
HADS depression scale - bivariate analyses for potential predictors of 
interest 
 
Characteristic HADS Depression Score 
n (%) 
 
Bivariate OR 
(95% CI) 
p value 
 Normal Mild or 
above  
  
Treatment type    
Colposcopy Only 56 (52.5) 62 (52.5)  0.8 (0.5 - 1.5) 0.56 
Biopsy 
Loop Excision 
34 (44.7) 
36 (43.4) 
42 (55.3) 
47 (56.6) 
  
0.9 (0.5 - 1.8) 
Reference 
0.86 
Reference 
Deprivation quartile    
Most Affluent (Q1) 14 (50.0) 14 (50.0)  0.7 (0.3 - 1.6) 0.42 
Less Affluent (Q2) 29 (56.9) 22 (43.1)  0.5 (0.3 - 1.0) 0.07 
Less Deprived (Q3) 
Most Deprived (Q4) 
33 (42.9) 
47 (41.6) 
44 (57.1) 
66 (58.4) 
  
0.9 (0.5 - 1.7) 
Reference 
0.86 
Reference 
Age group    
19-29 35 (43.8) 45 (56.3)  0.4 (0.1 - 0.9) 0.04 
30-39 49 (50.5) 48 (49.5)  0.3 (0.1 - 0.7) 0.008 
40-49 
50+ 
35 (50.7) 
7 (22.6) 
34 (49.3) 
24 (77.4)  
0.3 (0.1 - 0.7) 
Reference 
0.01 
Reference 
    
 
 
 
In terms of HADS depression scores, age was the most prominent predictor of 
higher depression scores. Women aged 50+ were significantly more likely to 
score mild or above on the depression scale than those in the 19-29, 30-39 
and 40-49 groups (OR: 0.4; CI 0.1 to 0.9 vs. OR: 0.3; CI 0.3 to 1.0 and OR: 
0.3; CI 0.1 to 0.7 respectively).  
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7.8.5 Predictors of scoring ‘normal’ or ‘mild and above’ on the HADS 
scale - multivariate analysis 
 
As outlined in Section 7.6, a logistic regression (forward LR) was performed 
using all variables (whether significant or not) and each of the dichotomous 
outcome variables in order to ascertain potentially significant predictors of 
scoring mild or above on the depression scale. The results are outlined in 
Table 7.51. 
 
Table 7.51 Results scoring ‘normal’ or ‘mild and above’ on the HADS 
depression scale - multivariate analysis for predictors of interest  
 
Included  
Variables 
B(SE) p value Exp b CI for Exp b (95% CI) 
Model 
 
    
Treatment type     
 
Treatment type 1 
(colposcopy) 
 
-0.265 (0.307) 
 
0.37 
 
0.767 
 
(0.4 - 1.3) 
 
Treatment type 2 
(biopsy) 
 
0.069 (0.336) 
 
0.83 
 
1.071 (0.5 - 2.0) 
 
IMD 
   
 
 
IMD 1 (Q1) 
 
-0.369 (0.441) 
 
0.40 
 
0.692 (0.2 - 1.6) 
 
IMD 2 (Q2) 
 
-0.671 (0.352) 
 
0.06 
 
0.511 (0.2 - 1.0) 
 
IMD 3 (Q3) 
 
-0.116 (0.307) 
 
0.70 
 
0.891 (0.4 - 1.6) 
 
Age range 
   
 
 
Age 1 (19-29) 
 
-1.026 (0.495) 
 
0.03 
 
0.359 (0.1 - 0.9) 
 
Age 2 (29-39) 
 
-1.326 (0.486) 
 
0.006 
 
0.266 (0.1 - 0.6) 
 
Age 3 (40-49) 
 
-1.375 (0.503) 
 
0.006 
 
0.253 (0.1 - 0.6) 
 
 
Note: Model X2 =14.500 (p=0.070); Hosmer and Lemeshow = 4.099 (p=0.848); Cox & Snell 
R2=0.052; Nagelkerke R2 = 0.070 
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Addition of all the potential predictor variables for whether women scored 
normal or mild and above on the HADS scale score indicated that a woman’s 
age was the only significant predictor of scoring mild or above on the 
depression scale. Women aged 19-29, 30-39 and 40-49 were significantly 
less likely to score mild or above on the HADS depression scale (OR: 0.359, 
95% CI: 0.1 to 0.9; OR: 0.266, 95% CI: 0.1 to 0.6 and OR: 0.253, 95% CI: 0.1 
- 0.6 respectively). 
However, the proportion of variability explained by the multivariate model was 
low (5-7%). 
 
 
7.9 Results - WHOQOL-BREF 
 
The following sections will present the results from the responses to the 
WHOQOL-BREF measure. Section 7.9.1 presents the total scores for each of 
the four domains that comprise the WHOQOL-BREF measure for all 
respondents. This is followed by presentation of the median scores for each 
domain in terms of treatment type, deprivation quartile and age. The mean 
scores are then presented for each domain in terms of the main predictors of 
interest.  
 
 
7.9.1 WHOQOL-BREF scores for all respondents 
 
The WHOQOL-BREF assesses quality of life across four domains - physical 
health, psychological health, social relationships and environmental factors. 
The detail of how the scores were calculated is provided in Chapter 5, Section 
5.6.2. 
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Table 7.52 presents the distribution of scores for the WHOQOL-BREF 
physical domain, for all respondents to questionnaire 2.  
 
 
 
 
 
Table 7.52 WHOQOL-BREF - all respondents’ physical domain 
distribution of scores 
 
Total physical score n (%) 
  
3.57 1 (0.4) 
17.86 2 (0.7) 
21.43 1 (0.4) 
28.57 1 (0.4) 
32.14 4 (1.1) 
35.71 3 (1.1) 
39.29 2 (0.7) 
42.86 5 (1.8) 
46.43 1 (0.4) 
50.00 7 (2.5) 
53.57 7 (2.5) 
57.14 7 (2.5) 
60.71 14 (5.0) 
64.29 12 (4.3) 
67.86 15 (5.4) 
71.43 18 (6.8) 
75.00 25 (9.4) 
78.57 26 (9.8) 
82.14 18 (6.8) 
85.71 27 (10.2) 
89.29 28 (10.5) 
92.86 20 (7.5) 
96.43 13 (4.9) 
100.0 
Missing 
9 (3.4) 
13 (4.7) 
Total 279 (100.0) 
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In the WHOQOL-BREF measure, higher scores indicate better physical 
health. Around 10% of the sample scored between 3.57 and 50.00 (n=20). 
The remaining 85.8% of the sample scored greater than 50, indicating good 
physical health. 4.7% (n=13) of data items were missing.  
 
Table 7.53 presents the distribution of scores for the WHOQOL-BREF 
psychological domain, when all respondents were taken together. 
 
 
 
Table 7.53 WHOQOL-BREF all respondents psychological domain total 
 
Total psychological score n (%) 
  
4.17 1 (0.4) 
8.33 3 (1.1) 
20.83 1 (0.4) 
25.00 2 (0.7) 
29.17 11 (3.9) 
33.33 6 (2.2) 
37.50 7 (2.5) 
41.67 11 (3.9) 
45.83 10 (3.6) 
50.00 11 (3.9) 
54.17 18 (6.5) 
58.33 22 (7.9) 
62.50 22 (7.9) 
66.67 17 (6.1) 
70.83 39 (14.0) 
75.00 27 (9.7) 
79.17 19 (6.8) 
83.33 18 (6.5) 
87.50 2 (0.7) 
91.67 7 (2.5) 
95.83 
Missing 
9 (3.2) 
16 (5.7) 
Total 279 (100.0) 
 
 
As with the physical domain, higher scores in the psychological domain 
indicate better psychological health. Around one fifth of the sample scored 
between 4.17 and 50.00 (n=63). The remaining 71.7% of the sample scored 
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greater than 50 (n=200). 5.7% (n=16) of data were missing, thus 
psychological domain scores could not be calculated for these individuals. 
 
 
Table 7.54 presents the total response scores for the WHOQOL-BREF social 
domain. Again, higher scores indicate better wellbeing within this domain. 
 
 
 
 
 
Table 7.54 WHOQOL-BREF all respondents social domain total 
 
Total social domain score n (%) 
  
0.00 2 (0.7) 
8.33 1 (0.4) 
16.67 3 (1.1) 
25.00 4 (1.4) 
33.33 10 (3.6) 
41.67 14 (5.0) 
50.00 26 (9.3) 
58.33 30 (10.8) 
66.67 53 (19.0) 
75.00 48 (17.2) 
83.33 28 (10.0) 
91.67 25 (9.0) 
100.00 
Missing 
25 (9.0) 
10 (3.6) 
Total 279 (100.0) 
 
 
Around one fifth of the sample scored between 0.00 and 50.00 (n=60; 12.2%). 
The remaining 74.9% of the sample scored higher than 50 for the social 
domain score (n=209). Data for 10 individuals (3.6%) were missing.  
 
Finally, Table 7.55 presents the distribution of scores on the WHOQOL-BREF 
environmental domain for all respondents combined. Just under one fifth of 
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the sample scored between 12.50 and 50.00 (n=50). The remaining 78.7% of 
the sample scored greater than 50 (n=220). 3.2% (n=9) of data were missing.  
 
 
 
 
 
 
Table 7.55 WHOQOL-BREF all respondents environmental domain total 
 
Total environmental score n (%) 
12.50 1 (0.4) 
15.63 1 (0.4) 
21.88 2 (0.7) 
25.00 1 (0.4) 
28.13 1 (0.4) 
31.25 2 (0.7) 
34.38 2 (0.7) 
37.50 6 (2.2) 
40.63 5 (1.8) 
43.75 8 (2.9) 
46.88 14 (5.0) 
50.00 7 (2.5) 
53.13 4 (1.4) 
56.25 15 (5.4) 
59.38 15 (5.4) 
62.50 18 (6.5) 
65.63 15 (5.4) 
68.75 20 (7.2) 
71.88 31 (11.1) 
75.00 21 (7.5) 
78.13 17 (6.1) 
81.25 16 (5.7) 
84.38 19 (6.8) 
87.50 10 (3.6) 
90.63 6 (2.2) 
93.75 5 (1.8) 
96.88 7 (2.5) 
100 
Missing 
1 (0.4) 
9 (3.2) 
Total 279 (100.0) 
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7.9.2 WHOQOL-BREF median scores 
 
There are no currently available UK normative data for this measure. 
Comparisons were drawn between the groups studied in this cohort. 
WHOQOL-BREF domain scores were not normally distributed across any of 
the comparison groups therefore all analyses undertaken with these data 
utilised non-parametric tests (Kruskal Wallis). The median scores and inter-
quartile range (IQR) for each domain are presented in the following three 
tables categorised by treatment type (Table 7.56), deprivation quartile (Table 
7.57), and age group (Table 7.58). 
 
Table 7.56 WHOQOL-BREF median scores categorised by treatment type 
 
Treatment 
Type 
Physical 
domain 
Psychological 
domain 
Social domain Environmental 
domain 
Colposcopy 78.6  
(IQR 60.7- 
85.7) 
66.7 
(IQR 54.2-75.0) 
66.7 
(IQR 56.3-85.3) 
68.8 
(IQR 59.4-78.1) 
Biopsy 78.6 
(IQR 64.3-
89.3) 
66.7 
(IQR 50.0-75.0) 
66.7 
(IQR 58.3-83.3) 
68.8 
(IQR 59.4-78.1) 
Loop Excision 78.6 
(IQR 67.9-
89.3) 
62.5 
(IQR 54.2-75.0) 
66.7 
(IQR 58.3-83.3) 
68.8 
(IQR 53.9-81.3) 
Biopsy/Loop 
Excision 
78.6 
(IQR 67.9-
89.3) 
64.6 
(IQR 50.0-75.0) 
66.7 
(IQR 58.3-83.3) 
68.8 
(IQR 56.3-79.7) 
 
 
Table 7.57 WHOQOL-BREF median scores categorised by deprivation 
quartile 
 
Deprivation 
quartile 
Physical 
domain 
Psychological 
domain 
Social 
domain 
Environmental 
domain 
Most Affluent (Q1) 82.1 
(IQR 75.9-92.9) 
66.7 
(IQR 58.3-79.2) 
75.0 
(IQR 60.4-
83.3) 
73.4 
(IQR 63.3-81.3) 
Less Affluent (Q2) 82.1 
(IQR 66.1-89.3) 
70.8 
(IQR 56.3-79.2) 
75.0 
(IQR 66.7-
91.7) 
75.0 
(IQR 67.2-84.4) 
Less Deprived 
(Q3) 
78.6 
(IQR 67.9-89.3) 
66.7 
(IQR 51.0-75.0) 
66.7 
(IQR 58.3-
83.3) 
68.8 
(IQR 59.4-81.3) 
Most Deprived 
(Q4) 
75.0 
(IQR 60.7-85.7) 
62.50 
(IQR 50.0-75.0) 
66.7 
(IQR 50.0-
83.3) 
65.6 
(IQR 52.3-75.0) 
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Table 7.58 WHOQOL-BREF median scores categorised by age group 
 
Age group Physical 
domain 
Psychological 
domain 
Social domain Environmental 
domain 
19-29 78.6 
(IQR 71.4-89.3) 
62.5 
(IQR 50.0-70.8) 
66.7 
(IQR 58.3-83.3) 
65.6 
(IQR 50.0-77.3) 
30-39 80.4 
(IQR 67.9-89.3) 
66.7 
(IQR 58.3-79.2) 
66.7 
(IQR 58.3-83.3) 
71.9 
(IQR 52.5-78.1) 
40-49 75.0 
(IQR 62.5-89.3) 
66.7 
(IQR 50.0-79.2) 
66.7 
(IQR 58.3-83.3) 
71.9 
(IQR 56.2-82.8) 
50+ 66.0 
(IQR 54.5-78.6) 
60.4 
(IQR 46.9-74.0) 
66.7 
(IQR 41.7-81.3) 
68.8 
(IQR 56.3-79.7) 
 
 
Non-parametric tests (Kruskall-Wallis) were performed to investigate whether 
there were any statistically significant differences in WHOQOL-BREF scores 
across variables. The findings of these tests are summarised below: 
 
Treatment type 
The distribution of the physical, psychological, social and environmental 
domain scores were the same across treatment groups (physical p=0.480; 
psychological, p=0.663; social, p=0.899; environmental p=0.923). 
 
Deprivation quartile 
The distribution of the psychological and social domain scores was the same 
across deprivation quartiles (psychological, p=0.445; social p=0.122). 
However, the distribution of physical and environmental domain scores were 
not the same across deprivation quartiles, with women from the most deprived 
group (Q4) scoring comparatively lower than those in the more affluent 
deprivation quartiles, indicating the presence of more pronounced physical 
health and environmental related problems in the more deprived group 
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(physical score=75.0; p=0.039; environmental score=65.6; p=0.001 
respectively). 
 
When the four IMD quartiles were amalgamated and dichotomised into two 
‘affluent’ and ‘deprived’ groups, the distribution of scores differed across the 
physical, social and environmental domains (physical, p=0.026; social, 
p=0.0026; environmental, p=<0.001), with the deprived group scoring 
comparatively lower in these three domains, indicating more pronounced 
problems in these areas than their more affluent counterparts. The distribution 
of psychological domain scores was the same across both deprived and 
affluent groups (psychological, p=0.151). 
 
Age group 
The distribution of the psychological, social and environmental domain scores 
was the same across age groups (psychological, p=0.142; social, p=0.408, 
environmental, p=0.074). However, the distribution of physical domain scores 
was not the same across all age groups, with women in the 50+ group scoring 
comparatively lower than those in other groups, indicating the presence of 
more pronounced physical health related problems amongst these 
respondents (physical, p=0.031). 
 
These results would be expected as social, physical and environmental 
factors may all be influenced by age and level of deprivation. The lack of 
difference in the distribution of psychological scores across all variables is 
supported by the results of the HADS measure where no differences were 
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found between groups on the basis of treatment type or deprivation quartile, 
except when the scale scores were amalgamated into larger groups. When 
HADS depression scores were dichotomised into ‘normal’ and ‘mild and 
above’ some differences were shown in terms of age. 
 
7.9.3 WHOQOL-BREF mean scores for all domains 
This section presents the analyses undertaken of the comparison of mean 
scores for each of the four WHOQOL-BREF domains using ANOVA one-way 
and post-hoc analyses (using Tukey’s HSD test) for each of the groups of 
interest. Tables 7.59 and 7.60 summarise the WHOQOL-BREF mean scores 
for each domain, categorised by treatment type, and present the findings of 
ANOVA tests undertaken on these data. 
 
 
Table 7.59 WHOQOL - BREF mean scores for responses categorised by 
treatment type 
 
Treatment Type Physical 
domain 
Psychological 
domain 
Social domain Environmental 
domain 
Colposcopy 73.81 64.34 67.84 67.98 
Biopsy 73.92 61.50 69.10 66.34 
Loop Excision 77.39 62.71 68.37 67.19 
Biopsy/Loop 
excision 
75.76 62.14 68.71 66.82 
 
 
Table 7.60 Anova (one way) WHOQOL-BREF treatment type 
 
 Sum of squares df Mean square F p 
value 
Physical Total  
Between Groups 
Within Groups 
Total  
 
711.653 
79542.682 
80254.335 
 
 
2 
263 
265 
 
355.826 
302.444 
 
 
1.177 
 
0.310 
      
Psychological Total  
Between Groups 
Within Groups 
Total 
 
364.077 
86425.372 
86789.449 
 
2 
260 
262 
 
182.038 
332.405 
 
0.548 
 
0.579 
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Social Total  
Between Groups 
Within Groups 
Total 
 
70.305 
109593.573 
109663.879 
 
2 
266 
268 
 
35.153 
412.006 
 
0.085 
 
 
0.918 
      
Environmental Total  
Between Groups 
Within Groups 
Total 
 
112.364 
73687.730 
73800.094 
 
2 
267 
269 
 
56.182 
275.984 
 
0.204 
 
0.816 
 
 
No significant differences were observed across any of the four WHOQOL-
BREF domains with regard to treatment type. 
 
These analyses were repeated for deprivation quartile (Tables 7.61 and 7.62). 
 
 
 
Table 7.61 WHOQOL - BREF mean scores for responses categorised by 
deprivation quartile 
 
Deprivation 
quartile 
Physical 
domain 
Psychological 
domain 
Social 
domain 
Environmental 
domain 
Most Affluent (Q1) 79.97 64.51 72.92 71.87 
Less Affluent (Q2) 76.68 65.65 72.83 74.55 
Less Deprived (Q3) 76.37 63.83 68.51 67.33 
Most Deprived (Q4) 72.18 61.56 65.49 63.52 
 
 
Table 7.62 ANOVA (one way) WHOQOL-BREF deprivation quartile 
 
 Sum of squares df Mean square F p 
value* 
Physical Total  
Between Groups 
Within Groups 
Total  
 
1832.251 
74799.614 
76631.865 
 
3 
255 
258 
 
610.750 
293.332 
 
2.082 
 
 
0.103 
      
Psychological Total  
Between Groups 
Within Groups 
Total 
 
651.263 
81598.465 
82249.728 
 
3 
251 
254 
 
217.088 
325.093 
 
0.668 
 
0.573 
      
Social Total  
Between Groups 
Within Groups 
Total 
 
2445.332 
99374.591 
101819.923 
 
3 
257 
260 
 
815.111 
386.672 
 
 
2.108 
 
0.100 
      
Environmental Total  
Between Groups 
Within Groups 
Total 
 
4714.714 
65222.704 
69937.418 
 
3 
258 
261 
 
1571.571 
252.801 
 
6.217 
 
<0.001 
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Following ANOVA testing, a significant difference was observed in terms of 
the median score for the WHOQOL-BREF environmental domain in relation to 
deprivation quartile (F=6.217; p=<0.001). However, although two 
homogenous sub-sets of responses were identified in post-hoc analysis 
(Table 7.63); with women from the more deprived quartiles and those from 
more affluent quartiles tending to give similar responses on this domain, there 
were no statistically significant differences between these subsets. 
 
 
 
Table 7.63 Tukey HSD for environmental domain total score 
 
Deprivation quartile n 1 2 
    
Most deprived (Q4) 110 63.5227  
Less deprived (Q3) 75 67.3333 67.333 
Most affluent (Q1) 28  71.8750 
Less affluent (Q2) 49  74.5539 
Significance  0.621 0.103 
 
 
Table 7.64 presents the WHOQOL-BREF mean scores for responses broken 
down by deprivation quartile dichotomised between ‘affluent’ and ‘deprived’ 
groups, followed by Table 7.65 showing the results of the ANOVA tests for 
these responses. 
  
Table 7.64 WHOQOL-BREF mean scores for responses categorised by 
deprivation when dichotomised between ‘affluent’ and ‘deprived’ 
 
Deprivation  Physical 
domain 
Psychological 
domain 
Social 
domain 
Environmental 
domain 
Affluent 77.88 65.24 72.86 73.58 
Deprived 73.87 62.48 66.76 65.07 
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Table 7.65 ANOVA (one way) WHOQOL-BREF ‘affluent’ and ‘deprived’ 
 
 Sum of squares df Mean square F p 
value* 
Physical Total  
Between Groups 
Within Groups 
Total  
 
871.732 
75760.133 
76631.865 
 
1 
257 
258 
 
871.732 
294.787 
 
2.957 
 
0.87 
      
Psychological Total  
Between Groups 
Within Groups 
Total 
 
407.719 
81842.008 
82249.728 
 
1 
253 
254 
 
407.719 
323.486 
 
 
1.260 
 
0.263 
      
Social Total  
Between Groups 
Within Groups 
Total 
 
2038.678 
99781.246 
101819.923 
 
1 
259 
260 
 
2038.678 
385.256 
 
 
5.292 
 
0.022 
      
Environmental Total  
Between Groups 
Within Groups 
Total 
 
3939.328 
65998.090 
69937.418 
 
1 
260 
261 
 
3939.328 
253.839 
 
15.519 
 
<0.001 
*Statistically significant results are indicated in bold text 
 
These results indicate that significant differences were observed between 
affluent and deprived groups in terms of the WHOQOL-BREF social and 
environmental domain median scores (F=5.292; p=0.022; F=15.519; 
p=<0.001 respectively). Post-hoc analysis to investigate homogeneous 
subsets of responses was not required as there were only two groups in the 
analysis.  
 
Finally, Table 7.66 shows the results of the mean scores for responses 
broken down by respondent age group, followed by Table 7.67 which 
presents the ANOVA analysis undertaken for this group. 
 
Table 7.66 WHOQOL-BREF mean scores for responses categorised by 
age group 
 
 
Age Group Physical 
domain 
Psychological 
domain 
Social domain Environmental 
domain 
19-29 77.21 60.77 69.23 63.55 
30-39 77.24 66.53 70.61 70.40 
40-49 72.80 62.25 66.42 68.02 
50+ 65.82 60.12 62.80 65.96 
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Table 7.67 ANOVA (one way) WHOQOL-BREF age group 
 
 Sum of squares df Mean square F p 
value 
Physical Total  
Between Groups 
Within Groups 
Total  
 
3534.725 
76719.610 
80254.335 
 
3 
262 
265 
 
1178.242 
292.823 
 
4.024 
 
 
0.008 
      
Psychological Total  
Between Groups 
Within Groups 
Total 
 
1785.616 
85003.832 
86789.449 
 
3 
259 
262 
 
595.205 
328.200 
 
 
1.814 
 
0.145 
      
Social Total  
Between Groups 
Within Groups 
Total 
 
1663.527 
108000.351 
109663.879 
 
3 
265 
268 
 
554.509 
407.548 
 
1.361 
 
0.255 
      
Environmental Total  
Between Groups 
Within Groups 
Total 
 
2100.497 
71699.597 
73800.094 
 
3 
266 
269 
 
700.166 
269.547 
 
2.598 
 
0.053 
 
The ANOVA tests indicated a statistically significant difference in the mean 
score for the WHOQOL-BREF physical domain in terms of age group (F= 
4.024; p=0.008). Post hoc testing was undertaken to investigate whether there 
were statistically significant homogeneous subsets of responses within the 
physical domain (Table 7.68). This table shows that although two 
homogeneous subsets were identified, with the 19 to 29 and 50+ age groups 
responding in a similar fashion, and the 19 to 29, 30 to 39 and 40 to 49 year 
age groups also being similar to each other, there were no statistically 
significant differences between these groups. 
Table 7.68 Tukey HSD for physical domain total score 
 
Deprivation quartile n 1 2 
    
50+ 28 65.8163  
19 to 29 65 72.8022 72.8022 
40 to 49 79  77.2152 
30-39 94  77.2416 
Significance  0.150 0.535 
 309
 
7.10 Summary of findings - Q2 
This Chapter has reported the findings from questionnaire two (Q2). It 
described the demographic characteristics of the population responding to Q2 
and reported the proportion of responses to each question relating to 
demographic details, lifestyle, health status, partner status, gynaecological 
and sexual issues. Analysis of the influence of treatment type upon all 
responses was also presented.  
 
The proportion of responses to the validated measures relating to FSD, HADS 
anxiety, HADS depression and WHOQOL-BREF domains were presented. 
The predictors of each measure were investigated separately. The results 
from the findings for the presence or absence of FSD were reported. 
Presence of FSD was explored in terms of the three main predictors of 
interest - treatment type, deprivation and age. Bivariate analysis of the 
presence of FSD was undertaken for all potential predictors. A logistic 
regression was performed to ascertain the significant predictors of the 
presence or absence of FSD. This process was undertaken for HADS anxiety 
and HADS depression dichotomising responses into ‘normal’ and ‘mild and 
above’. Comparison of means was undertaken for the results from WHOQOL-
BREF (physical, psychological, social and environmental domains). 
 
Characteristics of responders 
The largest proportion of responders were from the Women’s hospital (around 
60%) and the lowest proportion were from Heartlands hospital (just under 
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5%). In terms of treatment, a greater proportion of women had undergone 
colposcopy (n=119; 42.7%) and the lowest proportion was found in the biopsy 
group (n=76; 27.2%). The most deprived quartile (Q4) had the highest number 
of responders (n=114; 40.9%) and the lowest proportion was observed in the 
most affluent quartile (Q1) (n=28; 10.0%). The age groups of responders were 
fairly evenly spread between the 19 to 29, 30 to 39 and 40 to 49 groups, 
although women in the 50+ group only accounted for around 10% of the 
sample.  
 
Associations between treatment type and other variables 
All variables were explored against treatment type to investigate associations 
between treatment type undergone and all variables of interest. In terms of 
demographic data, significant differences were observed in terms of 
deprivation quartile with higher than expected responders from the 
colposcopy group in the most deprived and less deprived quartiles. Higher 
than expected numbers of responders from the biopsy group were observed 
in the most affluent and less affluent quartiles, and higher than expected 
proportions of respondents from the most affluent and most deprived group 
were observed in the loop excision group (p=0.0324). No significant 
differences were observed in terms of ethnicity and level of education and 
treatment type. 
 
In terms of variables relating to lifestyle factors, no significant differences were 
observed in terms of smoking status, alcohol use, or problems with drugs or 
alcohol. 
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In terms of the variables relating to partner and sexual status, no significant 
differences were observed in terms of partnership status when comparing 
between the three groups. When the colposcopy group was compared with 
the biopsy and loop excision combined, a significant difference was observed 
with larger than anticipated numbers in the biopsy and loop excision group 
having a partner (p=0.0298). A significantly higher proportion of women 
reported not being currently sexually active in the loop excision group 
(p=0.0379). Similarly, significantly higher than anticipated numbers of women 
from the loop excision group were not sexually active prior to colposcopy 
(p=0.0135).  
 
No significant differences were observed in terms of treatment type and 
having children; having a miscarriage, premature birth or still birth; 
gynaecological problems or history of STIs. In terms of long term health 
problems, significant differences were observed, with greater proportions of 
women in the biopsy group reporting long term health problems when 
compared with colposcopy or loop excision (p=<0.001). No significant 
differences were observed in terms of treatment type and number of visits to 
the GP in the last 12 months. Presented below are the results from all 
analyses for each of the validated measures utilised in questionnaire 2. 
 
FSD presence/absence  
Analysis of the associations between the variables studied and presence of 
FSD found that there were no significant differences between the type of 
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treatment undergone and the presence/absence of FSD. There were also no 
significant differences observed in terms of presence/absence of FSD and 
levels of deprivation or age.  Following multivariate analysis of the presence 
or absence of FSD, no significant results were observed after the three 
outcomes of interest were added into the model.  
 
HADS anxiety ‘normal’ and ‘mild or above’ and HADS anxiety total score 
No differences were observed in terms of associations between treatment 
type or age group and whether respondents scored ‘normal’ or ‘mild and 
above’ on the HADS anxiety scale. However, a significant association was 
observed between deprivation quartile and scoring ‘normal’ or ‘mild or above’ 
on this scale (p=<0.0001) with higher than anticipated numbers of 
respondents scoring ‘mild or above’ in the more affluent groups (Q1 and Q2).  
No significant results were observed following multivariate analysis of the 
potential predictors of scoring ‘normal’ or ‘mild and above’ on the anxiety 
scale 
 
HADS depression ‘normal’ and ‘mild or above’ and HADS depression total 
score 
No differences were observed in terms of treatment type or deprivation 
quartile and scoring ‘normal’ or ‘mild and above’ on the HADS depression 
scale. However, a significant difference was noted between age and whether 
women scored ‘normal’ or ‘mild or above’ on the HADS depression scale. 
Older women were significantly more likely to score ‘mild or above’ on this 
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measure, suggesting that older respondents were more likely to experience 
depressive problems (p=0.0383). 
These finding was replicated following multivariate analysis with older women 
significantly more likely to score ‘mild or above’ on the scale compared with 
younger women in the cohort. However the model R2 was low. 
 
WHOQOL-BREF physical/psychological/social/environmental domains 
There were no significant differences observed in terms of the distribution of 
scores across the four WHOQOL-BREF domains and treatment type. 
 
However, women in the most deprived quartiles had lower scores on the 
WHOQOL-BREF physical and environmental domains suggesting that 
deprivation levels impact negatively upon both these factors. In terms of age, 
on the WHOQOL-BREF physical domain, older women had lower scores 
indicating that increasing age is negatively correlated with physical health and 
well-being. 
 
Following comparison of means tests (ANOVA), no significant differences 
were observed for any of the four WHOQOL-BREF domains on the basis of 
treatment type. In terms of deprivation, a significant difference was observed 
between mean scores on the environmental domain. However, following post 
hoc analysis, no significant differences were observed between the two 
homogenous sub-sets. Similarly, significant differences were observed 
between the mean score on the physical domain and age group. Again 
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following post hoc analysis, there were no significant differences observed 
between the two homogeneous groups. 
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CHAPTER 8: ANALYSIS - QUALITATIVE DATA 
 
8.1 Introduction 
 
Qualitative data are most commonly gathered via face to face interviews with 
participants, having the advantage of being able to elicit in-depth data on 
participants views and experiences.152 As the opportunity to interview 
participants about their experiences was outside the scope of the study, 
questionnaire one provided participants with an A4 sized space to note any 
specific comments relating to their colposcopy experience. 
 
The advantages of using an open text option in a survey are well 
described.153,154 They can be used to corroborate responses to closed 
questions and there is evidence that they can increase response rates.155 
There are inherent limitations in using this method, for example, there is no 
avenue for checking the status of the responses.154 In the context of a 
quantitative study, it is possible that those who choose to respond to an open 
question are not necessarily representative of the sample. 
 
Despite these limitations, it was deemed important that participants were 
given the opportunity to elaborate and add context to issues raised in the 
questionnaire.  
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The aim of adding this qualitative aspect to questionnaire one was to present 
the breadth of experience and opinion to complement the findings from the 
quantitative data.  
8.2 Methods 
 
Participant responses were analysed using a conventional content analysis 
approach which essentially assigns codes to the data, enabling further 
categorisation and development of broader themes as they emerge. This 
approach is often referred to as the constant comparative method.156 This 
approach is widely utilised in qualitative data analysis, as it enables the 
researcher to fully immerse themselves in the data. 
 
The full text was copied verbatim from each of the completed sections to 
facilitate familiarity with the scripts and to aid thematic analysis. Reading 
through the scripts enabled greater immersion in the data and codes were 
applied manually to the scripts and were refined following discussions with 
study supervisors. The over arching themes were established and quotations 
were chosen that best represented the themes. The seven main themes are 
described in the results section using illustrative quotations and the discussion 
brings together the main findings in the light of the wider literature. 
 
 8.3 Results 
 
Of the 560 women who completed Q1, 198 completed the open text section - 
a response rate of 35%. Table 8.1 shows the demographic details, treatment 
type and where attended for treatment for responders and non-responders. 
The differences between responders/non-responders almost reached 
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significance in the treatment group (X2=5.9; p=0.0523), with a higher than 
expected number of responders in the loop excision group and lower than 
expected number of responders in the colposcopy and biopsy groups. 
Although not statistically significant, there were higher than anticipated 
number of responders in the first three deprivation quartiles (most affluent, 
less affluent, less deprived) than in the most deprived quartile (Q4) (X2=7.2; 
p=0.065). 
 
 
Table 8.1 Characteristic of responders/non-responders to open text 
 
Characteristic Responders 
(%) 
Non-
responders 
Significance 
    
Colposcopy unit    
Women’s 113 (57.1) 215 (59.4)  
City 26 (13.1) 48 (13.3)  
Solihull 36 (18.2) 51 (14.1) X2=2; p=0.738 
Heartlands 7 (3.5) 12 (3.3)  
Good Hope 16 (8.1) 36 (9.9)  
    
Age group    
19-29 46 (23.2) 76 (21.0)  
30-39 68 (34.3) 152 (42.0) X2=3.17; p=0.36 
40-49 55 (27.8) 87 (24.0)  
50+ 29 (14.6) 47 (13.0)  
    
Deprivation quartile *    
Most Affluent (Q1) 14 (7.1) 20 (5.5)  
Less Affluent (Q2) 48 (24.5) 76 (21.0) X2=7.2; p=0.006 
Less Deprived (Q3) 68 (34.7) 101 (27.9)  
Most Deprived (Q4) 64 (32.7) 159 (43.9)  
    
Treatment type    
Colposcopy only 79 (39.9) 172 (47.5)  
Biopsy 51 (25.8) 100 (27.6) X2=5.9; p=0.052 
Loop Excision 68 (34.3) 90 (24.9)  
    
* IMD derived from 2007 Index of Multiple Deprivation 
 
 
  
The seven broad themes identified and the range of codes applied across the 
data are shown in Table 8.2. 
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Table 8.2 Themes and codes 
 
Themes Codes 
  
Fear Fear of cancer 
Fear about future fertility 
Fear about recurrence 
Fear of effect upon sex life 
Procedure allayed fears 
Fear of looking stupid 
 
Physical effects Pain - at time of the procedure and post procedure. 
Bleeding 
Post operative effects 
Tiredness 
Soreness 
Stenosis 
Effect upon menstrual cycle 
Physical effects not attributable to procedure 
 
Psychological 
effects 
Fearfulness 
Low mood 
Depression 
Worry about the results 
Stress 
Embarrassment 
Trauma 
Feeling sick and exposed 
Feeling ‘out of control’ of own body 
Stigmatised 
Seeing procedure on monitor 
Insomnia 
 
Sex life and 
relationships 
Fear that won’t be able to have sex again 
Partner not understanding 
Partner very understanding 
Reduced sexual desire/interest 
No effect upon desire/interest 
Pain during intercourse 
Feeling unattractive 
Loss of woman-hood 
 
Experiences 
with health 
professionals 
Fear of looking stupid 
Positive experiences with staff - understanding, 
caring, good bedside manner, short waiting time to get 
results 
Negative experiences - Inexperienced staff, poor 
bedside manner, seeing someone different at each 
appointment, need for counselling 
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Knowledge 
deficit 
Needing more information 
Being worried about asking for more information 
  
Positive 
experiences 
Procedure allayed fears 
Colposcopy as a ‘life saver’ 
Reassurance 
Seeing procedure on monitor  
Partner understanding 
 
 
 
There is a certain degree of linkage between themes - fear and psychological 
outcomes; physical side effects and sexuality; sexuality and psychological 
effects. Although themes are not distinct, they are presented separately. 
 
Fear is a psychological reaction and one of the ‘fears’ identified by 
respondents was the possibility of having cervical cancer, and linked to this, 
the fear that abnormalities may recur and lead to further investigation. Due to 
the prominence of ‘fear’ as a theme in the data, it has been discussed as a 
standalone theme, despite its psychological basis. ‘Fear’ of cancer was 
alluded to on a number of occasions - not merely the fear in relation to the 
possible outcome of the treatment - ‘do I have cancer?’, and ‘will I get 
cancer?’, but also fear of the procedure itself. Fear of the procedure, rather 
than the procedure itself was on occasions the more prominent source of 
anxiety. 
 
The spectre of cervical cancer has become more prominent on the public 
radar in the last three years, partly due to the relatively recent and high profile 
death from cervical cancer of a young celebrity - Jade Goody. Furthermore, 
the ‘pressure’ put upon women to attend for regular cervical screening, it 
could be argued, may elevate disproportionately the worries that women have 
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about getting cervical cancer. There are national screening targets for cervical 
screening targets and the QOF arrangements in place reward general 
practitioners for screening eligible patients.157 
 
The fear and preoccupation with the recurrence of abnormalities or cells 
changes was mentioned by a number of participants. One woman stated 
(110005) that due to her fears of cancer, she felt she needed reassurance 
that any infections had cleared. The colposcopy would be seen to represent 
on the one hand the ‘spectre’ of cancer, whilst also being the very procedure 
that could also help to allay or dispel any fears: 
 
‘ I have become worried and anxious about getting cancer, I worry that 
one day I will develop cancer, not just cervical, but elsewhere… I 
understand that some procedures have to be done for prevention and 
this is a good thing.’ (Respondent 210339) 
 
 
This sentiment was echoed by another respondent who stated: 
 
‘You worry in case you get cancer of the cervix so I think it is a great 
idea having check ups’ (Respondent 320089) 
 
 
One respondent seemed to have a more fatalistic approach, worrying that re-
referrals and regular follow-ups may eventually lead to a diagnosis of cancer:  
 
‘It is quite stressful to know that someday, I may develop cervical 
cancer’. There is a sense of the inevitability that once any 
abnormalities are found then it is just a ‘matter of time’. (Respondent 
110055) 
 
‘I felt shocked that there could potentially be something life threatening 
when I felt so well. It was constantly on my mind and I kept asking 
myself - what if?. It made me re-evaluate relationships and life 
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generally despite being told on the day that it was unlikely to be 
anything sinister.’ (Respondent 110677)  
 
 
The sense of feeling ‘well’ whilst being ‘ill’ is a theme that Hounsgaard et al98 
identified in the qualitative study discussed in chapter three. The notion of 
‘body betrayal’ would seem to be a particular characteristic for patients 
diagnosed with cervical cancer, which to a large extent is asymptomatic in its 
early stages: 
 
‘I feel that the more times you attend the colposcopy clinic the greater 
the effect of the issues mentioned. On my first visit, although a little 
nervous about the procedure it did not affect my emotional well being 
or sexual health. However each time I attend I seem to get more 
concerned and nervous for longer periods of time. I spent over a week 
in the lead up to my most recent appt becoming very stressed, anxious 
and nervous about the results and therefore disinterested in sex 
because I worry about the result. After the appointment, whilst waiting 
for results I am also same. As the more prolonged the period of 
monitoring is the more you convince yourself that the term ‘pre-
cancerous cells’ will turn into ‘cancerous cell’. (Respondent 110740) 
 
 
This respondent’s concerns seem to reflect those found more widely in the 
literature - the sense that it is the process of waiting for results rather than the 
procedure itself that can cause distress. Some respondents also explained 
that they had worries and fears about how the procedure would affect their 
current or future fertility and obstetric health. This is particularly prescient in 
light of the fact that women under the age of 35 are the group most likely to 
get cancer of the cervix and these women may be more likely to be 
considering having children. Respondent 110419 who was pregnant at the 
time of completing the survey reported that she was worried about the effect 
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of the loop excision upon her cervical health and the effect it may have upon 
the pregnancy. She stated: 
 
‘I think all women who have the procedure worry about the effect on 
their ability to carry a pregnancy to term.’ (Respondent 110419) 
 
 
Another respondent (330035) said that as she was getting ready to start a 
family she was worried about the long term effects of the colposcopy upon her 
ability to conceive and carry a child. Conception worries were mentioned 
again (respondent 210027) as the respondent felt that women’s health usually 
relates to older women, but felt that younger women needed support as well 
especially in terms of any potential side-effects that the treatment may have 
had. Conceptions of self-identity and femininity will be discussed later in this 
chapter but it would seem that concerns about fertility are inextricably linked 
to the idea of woman-hood and perceptions that an inability to conceive is 
somehow a deficit of femininity. One respondent stated: 
 
 ‘I have been advised that I cannot conceive naturally, so as a sexual 
women I feel redundant and useless.’ (Respondent 110376) 
 
 
 
Iatrogenic effects - physical and psychological 
 
Some women’s responses indicated the breadth of physical and emotional 
experience of undergoing a colposcopy, with many finding it an extremely 
uncomfortable, painful and distressing ordeal. One respondent had 
experienced heavy bleeding and pain following the procedure and was later 
diagnosed with a post-operative infection, meaning she had to take time off 
work: 
 323
 
 ‘it seems unfair that a small procedure can cause such an infection.’ 
(Respondent 110137) 
 
‘A colposcopy is very embarrassing, uncomfortable and it stings. It was 
very frightening at the time.’ (Respondent 110168) 
 
 
One respondent described the ‘stress and nerves’ associated with colposcopy 
and cervical screening tests. Both made her feel ‘sick and exposed’ and she 
found the experience mentally traumatic. She described feeling ‘out of control’ 
of her own body.’ (Respondent 110172) 
 
One respondent felt she would feel more comfortable if she could have 
medication, or even be ‘put out’, so she was unaware of what was going on 
during treatment. (110339).  
 
For some women, changes in menstruation and associated pain had had a 
negative impact upon their sex life:  
 
‘Since having a colposcopy, intercourse has been much worse. I have 
pain in the stomach three to four times per month and suffer with 
sleeplessness and menstrual pain.’ (Respondent 110449) 
 
‘The blood loss was quite thick and brown and lasted a few weeks. I 
felt very put off from having intercourse even after the bleeding had 
stopped.’ (Respondent 330110) 
 
 
Prolonged menstruation was also problematic for one respondent: 
 
‘My periods have definitely changed since the procedure - they are 
longer. I ‘show’ for a few days before the usual heavy couple of days 
then the period lasts for nine rather than 5 days.’ (Respondent 330131) 
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It seemed that for some women the opportunity to observe the procedure was 
in itself, a source of trauma: 
 
‘I found the initial exploration of the cervix rather traumatic as I didn’t 
know what to expect and wasn’t prepared for what I saw on the monitor 
as it looked horribly diseased. It kept haunting me for weeks 
afterwards.’ (Respondent 110465) 
 
 
Respondent 110508 found that although the doctor was keen to show her 
what was happening on the screen, she didn’t want to look.  
 
Another respondent describes the fact that ‘there was a me before colposcopy 
and a me after colposcopy.’ (310002) She noted that following colposcopy 
she suffered heavy and painful periods and felt unwell during menstruation, 
and this was very unlike her. She clearly experienced some radical 
physiological changes that she felt could only be attributed to the colposcopy. 
 
However, some respondents did not find the experience too onerous and 
welcomed the chance to observe how the procedure went:  
 
‘I was anxious about the initial test but was fascinated by the photos on 
the screen of my cervix - which the doctor talked me through - I’m not 
squeamish at all! The whole process was a little worse than a smear 
test, but the staff were very reassuring and comforting.’ (Respondent 
330285)  
 
 
 
Effect upon sex life and relationships  
 
As the questionnaire and patient information literature was explicit about the 
fact that this study was designed to investigate any potential sexual 
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dysfunction, it is maybe unsurprising that effects upon participants’ sex life 
feature prominently within the open-text responses. 
 
Several respondents discussed the fear of resuming sexual activity following 
the procedure; concerns that partners would not understand, or feel somehow 
different towards their partners; physiological sexual problems - painful 
intercourse, problems lubricating; loss of desire and interest in sex were all 
part of the narrative for a number of the participants. There was a sense for 
some women that they felt ‘less womanly’ either because of the nature of the 
procedure or because they felt that the procedure has led to reduced sexual 
desire. 
 
Respondent 110005 stated that she felt tentative about resuming her sex life 
with her husband despite having a supportive husband. One respondent 
(110134) alluded to the fact that the effect of the procedure upon her sex life 
had been a cause of anguish. She had felt ‘unable to perform’ for the last two 
years. This had left her tearful, but had not affected her relationship with her 
‘wonderful husband’, it had led to both her and her husband feeling ‘anxious 
and depressed’ about their sex life. She mentioned that she felt confused 
about the situation as she was still attracted to her husband and this had led 
her to feel ‘bad about myself.’ Respondent 110168 reported that although her 
sexual desire was undiminished, her lack of confidence had led to her avoid 
sexual situations.  
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Two respondents felt unable to answer questions related to sex due to their 
religious beliefs or said that they felt they were too personal. This was to be 
expected, given the intimate nature of some of the questions asked. 
 
A number of respondents raised the particular issue of the effect of the 
procedure upon their sexual life. It is plausible that this was prompted by the 
nature of the questions in questionnaire one (alluding to sexual function) and 
that without it, women may not have made reference to their sexual life. 
However, it was clear that for some women, given the nature of their 
descriptions, the impact upon their sex life was acute: 
 
The colposcopy caused ‘fears and anxieties before during and after 
sex’ (Respondent 110168) 
 
‘I felt unable to have sex despite wanting to’ (Respondent 110172) 
 
 
This response demonstrates the apparent disjuncture between the presence 
of sexual desire, but feelings that the colposcopy procedure had impeded the 
physical ability to engage in sexual activity: 
 
‘Before I went for a colposcopy, I was worried for myself and partner as 
I didn’t know what to expect from the procedure or result. This affected 
our sex life more before than after the colposcopy’ (Respondent 
110499) 
 
 
Respondent 110662 was referred for colposcopy at a young age and the 
doctor’s expression of surprise at seeing a woman 20 years of age magnified 
her worries. She felt there was something wrong given her young age and 
although she had a boyfriend of three years who was supportive, she couldn’t 
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help worrying about the impact upon their sex life. She felt ‘unattractive’ and 
‘unwomanly.’  
 
Similarly, one respondent attributed her ’sexual hang-ups’ and lack of sexual 
interest to the sense of guilt she felt about starting to have sex from a 
relatively young age:  
 
‘I feel that this has somehow contributed to my abnormal cells.’ 
(Respondent 330072) 
 
Although there is evidence that women who have their first experience of 
intercourse at a young age or who have had multiple partners are at 
increased risk of contracting HPV,158 the sense that getting cervical cancer is 
a punishment for promiscuity had a major impact upon respondent 330072. 
Certainly, early health  promotion materials from the 1960’s used to 
encourage attendance for cervical screening did have a moralistic and 
potentially stigmatising tone that may have attributed to feelings of guilt for 
women diagnosed with cervical abnormalities. 
 
‘After when I was all healed I didn’t feel like sex for month. When I did, 
it hurt a lot. I still don’t have much of a sex drive anymore and it still 
hurts during foreplay and sometimes during sex.’ (Respondent 330301) 
 
‘I have no desire for a partner because I no longer feel very sexual. I 
would have considered myself highly sexed before. It’s depressed me 
and left me feeling low.’ (Respondent 110738) 
 
‘Since having last colposcopy, I have neither had sex or want sex. I do 
not know why this problem of not wanting or having sex has come 
about. I do know that I find having sex a very painful ordeal. The same 
as when I have a colposcopy I do find it very painful. Every time I have 
one this is one of the reasons I do not attend my appointments and 
deep down I know that I should because it is for my own good. If I 
could have the choice to have everything taken away, I would. Then 
perhaps I would feel better about having sex. Perhaps it worries me in 
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case having sex could cause me harm. I do not really know.’ 
(Respondent 111026) 
 
 
These excepts reflect the complex nature of female sexuality and how 
different women with different histories and experiences can all tell a powerful 
story - Feelings of guilt, worries about attractiveness, despair at the loss of 
libido and concerns about how a partner may react to the situation. There is 
also a sense of bewilderment voiced in the last excerpt as the respondent is 
unable to understand her response to the colposcopy and it’s effect upon her. 
 
A number of respondents believed that there were other factors that explained 
their lack of sexual interest, emotional well-being or physical symptoms - sex 
drive diminishing with age and associated physical health problems 
(undergoing hysterectomy, being on HRT, being menopausal, weight gain); 
relationship breakdown; bereavement or becoming a parent. 
 
 ‘I do not feel the colposcopy has anything to do with my current sex life 
(or lack of). It is more to do with the fact that I am post menopausal and 
suffer with vaginal dryness… Anyway at 65 years of age I’m not that 
interested.’ (Respondent 110849) 
 
‘I have had abnormal smears for many years on and off and do not 
relate this to sexual experiences (not consciously). I think the 
dissatisfaction with my sex life is mostly related to lack of emotional 
satisfaction in my relationship.’ (Respondent 330311) 
 
 
These quotations capture the sense that female sexuality has emotional as 
well as physical attributes. Not feeling settled or content with a partner is just 
as likely to influence the perceived quality of sexual life as is physiological 
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‘functionality.’ The Natsal140 study found that the most common predictor of 
FSD was partner dissatisfaction and these excerpts give a sense of this. 
 
Conversely, there are also respondents who felt that the procedure had no 
effect upon their sex life, or others who felt that sex isn’t really an issue as 
they either don’t have a partner, or they have a low libido pre-dating the 
procedure. A number of respondents pointed out that there were other 
explanations as to why their sexual desire had diminished - going through the 
menopause; being on HRT; having recently had children or being currently 
pregnant; or just being too busy. One respondent offers an explanation that 
seems to crystallise some of these points: 
 
‘I think my lack of interest in sex is due to being tired due to having two 
boys and working full-time. I don’t think it is do with the procedure. I 
don’t have an issue with sex… just lost interest. I do enjoy it when we 
have sex. My relationship with my husband is very strong and we joke 
about sex a lot - anyway, how often should you have sex to be normal? 
Sometimes I feel all these emotions in this survey, but they are short 
lived and usually depend on the week I’ve had - there are a lot of 
pressures upon women these days!’ (Respondent 310180)   
 
 
A number of respondents indicated that the procedure had had minimal or no 
effect upon their sex life: 
 
 ‘I do not feel the colposcopy has anything to do with my current sex life 
(or lack of) - more to do with the fact I am post menopausal and suffer 
from vaginal dryness.’ (Respondent 110849)  
 
 
A number noted that abstinence for a period of 6-8 weeks had been advised 
by the health professional and following this period they had resumed normal 
sexual activity without any problems. 
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One respondent was nothing but positive about the experience as it meant 
that her quality of (sex) life improved following the procedure: 
 
‘I have a positive attitude to any of the medical treatments I have 
received and to sex in general. The colposcopy helped to clear up a 
long standing problem, which made me more confident.’ (Respondent 
330365) 
 
 
One respondent also felt the colposcopy had a minimal impact upon her sex 
life: 
 
‘I was advised to wait six weeks before sex. I tried again after five and 
it did bleed, but thereafter, everything was fine.’ (Respondent 110463) 
 
 
A number of respondents made the point that their responses to the questions 
had been influenced by a number of factors unrelated to the colposcopy, or at 
least they did not feel they could be directly related to the colposcopy itself. 
There is a sense that it is difficult to disentangle the possible effects of 
undergoing a colposcopy from the other 
physical/psychological/social/sexual/environmental factors that influence 
health status (self-perceived or otherwise). This difficulty may be compounded 
by the fact that women contacted to participate would have undergone 
colposcopy some time ago and therefore, attributing any possible adverse 
effects to the procedure could be misleading. 
 
Given the nature of the intimate questions being asked, the level of disclosure 
and openness of many of the participants who completed the open text 
 331
section was somewhat surprising. It could plausibly be argued that the 
responders to the survey were the kind of women who felt more comfortable 
in revealing aspects of their sexual, psychological and physical health. As 
there were more non-responders than responders to both surveys, it is also 
plausible that the nature of the questions asked dissuaded women from 
responding to the questionnaire, although the level of non-responses could 
also be explained by other factors - disinterest in the subject matter, lack of 
time or literacy problems.  
 
Responder bias results for this part of the study indicated that a higher 
proportion of women who underwent loop excision (the most invasive 
treatment group) responded to the open text invitation (p=0.0523). It is 
possible that as loop excision is the more invasive treatment, women 
experienced more pronounced effects and felt more inclined to share their 
experiences. Although not statistically significant, there was also a lower than 
expected number of responder in the most deprived quartile. 
  
Experiences with health professionals and patient knowledge deficit 
There was a breadth of opinion in terms of how women felt they were treated 
by medical staff, ranging from total satisfaction to anger about the way they 
had been treated. Lack of information provision was also raised as a factor 
that contributed to the overall quality of the experience. 
A number of respondents praised the staff at the colposcopy units in terms of 
how they felt they were treated:  
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‘the staff were sensitive and treated me with respect’ (Respondent 
110055) 
 
‘Staff were warm and positive.’ (Respondent 110477) 
 
‘Staff were very good and used lay language. This was very helpful as 
it allayed my fears’ (Respondent 110168) 
 
 
One respondent appeared aggrieved as she felt her GP had referred her 
inappropriately, as no abnormalities were found: 
 
‘If GPs paid more attention, it may lead to less unnecessary referrals 
for colposcopy.’ (Respondent 110099) 
 
 
Some women felt that their experience would have been improved had they 
had more information:  
 
‘the staff were friendly and professional although I feel that more 
reassurance and information would improve the experience.’ 
(Respondent 110094) 
 
‘I did not receive enough information about the link between HPV and 
abnormalities, despite trying to broach the subject. My lack of 
knowledge led to increased worries about having an STI. It was an 
extremely concerning time.’ (Respondent 110121) 
 
‘feelings of uncertainty and worry may have been eased with more 
information and statistics’ (Respondent 110188) 
 
 
Interestingly, these views are in contrast to the findings from Brooks et al91, 
who found an association between pre-colposcopy knowledge and increased 
anxiety at their first visit. The women who responded to this part of the study 
all felt that better information would have made the procedure less traumatic. 
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In this study, some women were dissatisfied with how they had been treated 
by staff, in terms of the lack of rapport with the doctors and for one woman, 
the lack of continuity in terms of who they were seen by at their visits: 
 
‘Some of the doctors are great, but others less so. It requires 
sensitivity. Even when the outcome is good, it always affects you 
emotionally due to how intrusive it is.  I never relished seeing the 
screen.’ (Respondent 210270) 
 
 
One participant felt dissatisfied with her treatment at the colposcopy unit, 
describing it as ‘very poor… both aftercare and support.’ (Respondent 
110191) 
 
‘I found it distressing as each time I was seen by a different person. 
You can’t build up a trusting relationship if you don’t see the same 
doctor or nurse.’ (Respondent 110227) 
 
‘I felt it took too long to get the results of the treatment - there should 
be shorter waiting time.’ (Respondent 110254) 
 
‘I was advised that there were no problems, but I had no explanation, 
even though I had initially been told I did have problems… no one 
explained the results.’ (Respondent 110376) 
 
 
One respondent stated that although staff were very supportive, lack of 
information made the visit particularly traumatic: 
 
‘I was totally unaware and unprepared when I turned up at the hospital. 
I had been given no information about what they were going to do or 
why they were doing it or how I might feel physically or emotionally 
afterwards. Although staff were lovely and even held my hand during 
the procedure and made me a cup of tea afterwards. I would have 
bought a friend if I had known as I had to drive home crying and 
shaking in pain. I was given a small leaflet to take home, but would 
have liked more information about what they did, why they did it and 
what might be the next step.’ (Respondent 330350) 
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One respondent explained that she was unaware that HPV can lead to cell 
abnormalities -  
 
‘ I feel colposcopy, abnormal smears and especially the HPV virus are 
not very well understood in my age group (18-25 and above). I have 
made my friends aware about it because of my experiences.’ 
(Respondent 110985) 
 
 
Positive effects of undergoing colposcopy  
As has been shown earlier in this section, a number of respondents reported 
various difficulties and problems following colposcopy, but a number 
expressed ambivalence or seem pleased that they had undergone the 
procedure which they attribute to improving their health status: 
 
 ‘Colposcopy has had no impact upon my life whatsoever. It was 
something that had to be done to protect my health’ (Respondent 
330262) 
 
Respondent 110503 found the experience of colposcopy on the whole to be 
positive as it ‘put paid to any greater anxieties’ and the care was ‘timely and 
efficient.’ Another respondent was quite strident in her view: 
 
 ‘colposcopy doesn’t have any medium or long term effect on emotional 
or physical health.’ (Respondent 110411) 
 
‘The test saved my health, because my cervical screening showed 
abnormal cells and as a result, I followed the right treatment… It can 
save lives.’ (Respondent 110695) 
 
 
At the other extreme end of this spectrum, one respondent stated: 
 
 ‘I feel no different than I did before the colposcopy. As far as I know, 
my health is fine and I am able to do all the things I used to do before. I 
have started going the gym.’ (Respondent 110779) 
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Such sentiments were rarely found in the participant responses, but it is 
entirely plausible that those women who chose not to leave any further 
comments did so because they felt they had had no problems relating to the 
procedure. 
 
Effect on participants of receiving the questionnaire 
One respondent apologised for the late return of her questionnaire, but 
explained that she had ‘wanted to forget all about the procedure’ (330006). At 
the inception of the study, it had been considered that this could have arisen 
due to the fact that women were being contacted some time after colposcopy. 
There is of course a potential that reminding someone of something that 
occurred in the past may cause distress, as we identified in our ethical 
approval application, although this is the only returned questionnaire that 
raised this issue. 
 
Another respondent indicated that although she had experienced sexual 
problems following the procedure, she had never considered the colposcopy 
to be the reason for this. Although the patient information sheet is clear that 
we are unsure of the potential adverse effects of undergoing colposcopy, the 
questions asked do relate to sexual well-being and this respondent had, not 
unsurprisingly, attributed her problems to the colposcopy. That said, she 
appeared to find this reassuring:  
 
‘I am happy to know why this is…’ (Respondent 110767) 
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One respondent appeared quite affronted by the nature of the questions being 
asked:  
 
‘It seems odd to me that Cancer Research UK is funding what seems 
to be a sex survey and I hope your findings justify the cost of all this. I 
just wish your brains were being put to better use finding cures for 
cancer. Oh, and in passing, why do you assume all women have sex 
lives anyway.’ (110909) 
 
 
8.4 Discussion 
 
The range of responses presented provided a diverse picture of how women 
undergoing colposcopy experience the procedure. The data generated 
provided an important perspective that will be considered in the light of the 
qualitative literature and the results from the quantitative data collection from 
this study. 
 
The quantitative findings from this study appeared to indicate that the 
treatment type undergone had little effect upon any adverse outcome 
experienced. Similarly, age and deprivation provided little to support the 
hypothesis that the age of women undergoing treatment or the level of 
deprivation experienced will influence the extent of any adverse outcome 
experienced.  
 
However, the aim of the qualitative data collection was to enable a more 
nuanced interpretation of women’s experience of the procedure. It was not 
concerned with how many women had good or bad experiences, rather the 
nature of these experiences and what kind of impact these had had upon their 
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emotional and physical health, relationship, social interactions and 
environment. 
 
The main broad themes arising from the analysis were feelings of fear, effects 
upon identity and femininity, partner relationships and sexual life, 
psychological and physical effects of the procedure, influence on their 
experience of how they felt treated by staff, influence of knowledge deficit and 
positive outcomes following the procedure. The influence of particular coping 
styles of the participants will also be considered as it adds a further dimension 
to the discussion. 
 
For women reporting a negative experience of undergoing colposcopy, the 
feelings of fear were pervasive. Beresford et al59 identified fear as a major 
emotion facing women having undergone colposcopy and the four main areas 
of concern were fear of cancer60 , fear of reproductive loss and sexual 
function, fear of the procedure itself and fear of being betrayed by ones own 
body. As we have seen above, our findings here support the notion that 
fertility, sexuality, identity and threat to life are experienced by some women 
undergoing colposcopy. Hounsgaard et al98 also raised the issue of ‘body 
betrayal’ for some women. The experience of feeling ‘well’ and relatively 
healthy whilst being diagnosed with a potentially life threatening disease can 
lead women to feel an unease and lead them to question the integrity of their 
own relationship with their body. 
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Furthermore, the authors raised the issue of the disjuncture between a patient 
or ‘lay’ interpretation of disease and that of the medical professional. The 
nature of the progression of CIN as well as the fact that such abnormalities 
can recede and cause no further harm may be a concept that patients find 
difficult to interpret in the context of their own disease status. For many 
women, as our data suggest, being diagnosed with abnormalities sets them 
upon the seemingly inevitable road to cancer.  
 
Juraskova et al103 again provided data that demonstrates the ‘pathway’ 
experienced by women undergoing investigation and treatment. The fear of 
the unknown and the shock and anxiety that may accompany a diagnosis of 
an abnormality can to some degree be more distressing than the treatment 
itself. Their findings explore the reactions that women have after treatment as 
their fears are replaced with a sense of relief. Following treatment there is a 
sense of empowerment and a feeling of reassurance that they are no longer 
ill. The authors also allude to the sense of loss of trust in their bodies that 
some women felt, which are also apparent in Beresford et al and 
Hounsgaard’s studies. 
 
 
The role of health beliefs - attributions - locus of control 
One aspect of health psychology - attribution theory159 could go some way 
towards explaining the responses of participating women. This theory looks at 
the ways that individuals explain the causes of certain events (e.g. of 
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becoming ill; or recovering from an illness). It can also be applied to the way 
individuals explain behaviours, whether their own or of others. 
Although attribution theory may be criticised for being too ‘reductionist’,  
compartmentalising people into specific ‘types’, it does offer a useful 
framework to understand participants’ responses to treatment: 
 
‘there seemed to be some confusion about the choice of treatment, 
whereas I would rather be ‘told’ by someone who knows, or at least 
strongly advised. I think this may come under ‘patient choice’ however 
if we knew what needed to be done… we’d be doing it - or we’d be 
doctors! (330164) 
 
 
This raised an interesting perspective on the perceived patient/professional 
role. ‘Patient choice’ is much lauded in the design and delivery of medical 
services and a priority for recent government intiatives.160,161  Many patients 
may perceive the role of medical science to direct and treat them as they see 
fit, viewing doctors in a rather paternalistic role.162 For this patient, 
relinquishing control over what should be the best treatment regimen was 
entirely appropriate, given that the doctor should know what is the ‘best’ 
course of action. 
 
In contrast, one respondent described her treatment by medical staff as ‘very 
professional’ for the reason that they accepted her right to ‘insist on no 
intervention’ following the result of her second colposcopy. Her belief in ‘the 
power of the body to heal itself’ was clearly very important to her and she 
appreciated the fact that this was respected. From a locus of control 
perspective163, it could be argued that the former respondent was 
demonstrating an ‘external locus of control’ and the latter an ‘internal locus of 
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control’. An ‘internal’ locus of control would imply that a person feels that 
events that may occur in their life are primarily due to the personal choices 
they make, as opposed to outside influences.   
 
As mentioned at the outset, it is important to be mindful of the psychological 
profile of the patient when considering the nature of their responses to 
colposcopy.115 No one woman will experience colposcopy in the same way 
that another does. It is the nature of being human to have a unique response 
to any event. It could be argued that events that threaten to undermine the 
notion of the self as a ‘healthy’ human being are likely to produce acute, 
existential doubts and lead to questioning many of the fundamental beliefs 
about the ‘self.’  
 
Chapter 9 will discuss of the findings from the systematic review and the 
quantitative and qualitative results of the study. 
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CHAPTER 9: DISCUSSION OF FINDINGS 
 
9.1 Main findings 
This chapter will discuss the principal findings from the study as a whole. 
Furthermore, the study limitations will be outlined, as will the implications for 
future services and future work.  
 
The primary aim of this study was to determine whether undergoing 
colposcopy and treatment for CIN has any long term adverse psychological or 
sexual impacts. 
 
The objectives of the study were as follows: 
 To undertake a systematic review of the available evidence of the 
psycho-sexual consequences of colposcopy and treatment for CIN 
 To investigate the long-term effects of colposcopy upon women’s 
quality of life 
 To establish whether there are any long-term effects of colposcopy 
upon sexual function in particular. 
 To characterise adverse sexual function by level of colposcopic 
intervention. 
 To determine the potential sociodemographic and/or clinical predictors 
of adverse outcomes following colposcopy (treatment type, 
socioeconomic status and age). 
 
This study sought to stratify women undergoing colposcopy in terms of level 
of intervention. It was hypothesised that women undergoing more extensive 
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and invasive treatment (biopsy and loop excision) would be more likely to 
experience an excess risk of adverse outcomes when compared with women 
undergoing colposcopy only. None of the findings from the quantitative stage 
of this study support this hypothesis. There were no significant differences 
observed between women undergoing colposcopy, biopsy or loop excision for 
any of the outcome measures across both stages of the study (questionnaire 
1 and questionnaire 2), aside from in terms of the response to the question 
(Q1) relating to experiencing pain during sex and problems with lubrication. 
Younger women were significantly more likely to report problems with painful 
sex, but less likely to report problems with lubrication. 
 
There appears to be a relationship between age and physical and emotional 
well-being, with older responders to Q1 experiencing more pronounced 
problems in these areas than their younger counterparts. These findings are 
supported by data from Q2 that demonstrated that older women had more 
pronounced problems with depression, physical health, social problems and 
psychological problems and sexual problems.   
 
One of the main outcomes of interest at the inception of the study was 
whether undergoing colposcopy would have an impact upon female sexual 
function. Although this study has established with some degree of confidence 
that level of treatment does not influence sexual outcomes, it would appear 
that women in this study cohort had higher levels of sexual dysfunction when 
compared with currently available data from the general population. As 
outlined previously, there is a paucity of data relating to female sexual 
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dysfunction in the UK population. It would have been useful if access to age 
and deprivation matched controls for this study had been possible, to increase 
the robustness of the study and its generalisability to the wider population. As 
described previously, this was not possible, and given the lack of robust 
normative data, caution is advised in drawing any firm conclusions about the 
levels of FSD found in the cohort recruited for this study. Normative data 
indicated that 15% of the general population experienced sexual dysfunction. 
In our cohort the figure is 55%, which would indicate a tripling of dysfunction.  
To put this in context, in this study, women were asked to report problems 
experienced in the previous four weeks. Mercer and colleagues, from whom 
the normative data cited were derived, asked participants to consider sexual 
problems experienced in the previous six months. Given the shorter time 
frame employed in the current study, it is plausible that participants reported 
short-term, transient problems. The figure of 15% for the general population is 
more likely to capture persistent sexual problems. As indicated previously, the 
higher figure in this cohort may be a product of responder bias, with those 
women with ‘more problems’ feeling more inclined to respond than those 
without problems, or with problems considered too minor to warrant reporting.  
 
The study findings indicate that sexual dysfunction increases with age, but 
these findings were not statistically significant, so we cannot be certain that 
age can definitely be attributed to this finding. Moreover, as discussed in 
Chapter 4, caution is needed when trying to ‘measure’ such nebulous and 
multi-factorial human characteristics like sexuality, or indeed assigning a label 
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such as ‘dysfunction’ to such a cluster of psycho-social and physiological 
factors relating to sexuality. 
 
Overall, it would appear that the factors influencing whether or not adverse 
outcomes are experienced can be attributed to factors other than undergoing 
colposcopy or colposcopically directed treatment. The possibility that 
colposcopy does have adverse consequences cannot be ruled out 
completely, but as the evidence from the systematic review demonstrates, 
many of the adverse outcomes experienced are relatively short-lived and 
transitory. The women in this cohort underwent colposcopy up to two years 
previously, so this may explain the fact that adverse outcomes did not seem 
to be directly linked to the procedure itself. However, as the nature of case 
identification meant that it was not possible to ascertain from patient data 
whether women have been subsequently recalled for colposcopy outside of 
the time period of interest (March 2008 - April 2009), this is a limitation to the 
findings.  
 
Despite the equivocal findings from the systematic review regarding the 
psycho-sexual outcomes of undergoing colposcopy, there are a number of 
indications from the findings of this study that would seem to partly support 
this. As we have seen where adverse outcomes had been experienced, these 
were very unlikely to be directly associated with the type of procedure 
undergone. The psychological profile of a patient is likely to influence how 
they experience the procedure. The findings from the review indicate that 
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sexual and psychological problems following colposcopy or treatment for CIN 
are transient in nature.  
 
This study found higher rates of FSD when compared with the Natsal data. 
However, as the FSFI asks women to rate any problems they have had in the 
last four weeks, this measure may pick up a range of transitory problems that 
do not persist in the long term. Furthermore, findings from the current study 
indicate that the ‘best’ predictor of experiencing FSD was whether a woman 
had gynaecological problems. It is plausible that the higher level of reported 
FSD compared with normative data can be explained by the presence of co-
morbid gynaecological problems rather than colposcopically directed 
treatment. This study was designed to follow women up after a relatively long 
period following colposcopy, and it is impossible to be able to attribute, with 
any certainty, that the colposcopy led to the outcomes observed. As 
discussed, in the context of the findings from Chapter 4, it is important to be 
mindful that there are inherent difficulties in trying to measure, or ascribe a 
label of ‘dysfunction’ to the complex, multi-faceted notion of human sexuality. 
 
 
The qualitative findings from this study appear to be supported by the 
qualitative findings from the systematic review. Fear of cancer and fear of the 
procedure feature prominently, as do the worries associated with feeling well, 
whilst simultaneously, being ‘ill.’ In this study, some respondents attribute 
colposcopy directly to their subsequent sexual and relationship problems and 
feelings of loss of womanhood and femininity. Of course it is entirely plausible 
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that these women did experience prolonged adverse outcomes in terms of 
their sexual life following colposcopy. However, as with any investigation of 
the adverse outcomes of an invasive procedure, there will always be some 
women who experience problems to a greater extent than others. Although 
not generalisable, the qualitative methodology employed generated data that 
was able to provide an important narrative account of how undergoing a 
colposcopy can impact adversely upon women. Using a mixed method 
approach enabled the study to capture both the epidemiological data relating 
to the prevalence of adverse outcomes as well as the essence of individual 
experiences which epidemiology alone cannot provide.  
 
 
9.2 Study limitations and strengths 
 
 
Limitations 
 
 
In the context of the study findings, this section will outline the limitations and 
strengths of the study.  
Study power 
The study was initially powered to detect a doubling of FSD from 15% to 30% 
(i.e. the difference between the prevalence of FSD assumed in the general 
population on the basis of NATSAL data, compared with the hypothesised 
prevalence of FSD in the study cohort who had undergone colposcopy). 
Despite mailing over and above the proposed numbers of potential 
participants required to detect a doubling of FSD, the response rate achieved 
in this study was lower than anticipated. In light of this, the study was only 
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powered to estimate a 2.6 fold risk of FSD after treatment for CIN. The lower 
than anticipated sample size meant that the study was not powered to detect 
small differences between the groups. Although the study did not find any 
differences on the basis of treatment type for any of the outcome measures 
assessed, it is plausible that there may be small differences between groups 
that this study was not powered to detect. 
Questionnaire design 
 
The findings from Q1 are limited by the fact that the measures used are 
adapted and therefore not validated for use with the particular population 
included in this study (i.e. women who had undergone colposcopy). Along 
with treatment type, only limited sociodemographic data for responders and 
non-responders were obtained (deprivation level and age) as potential 
predictors of problems with physical, emotional and sexual health, general 
health, problems with social activities and scores on the two satisfaction 
scales.  
Use of questionnaire as data collection tool 
The use of a questionnaire as the chosen methodology to answer the primary 
research question regarding adverse outcomes after colposcopy may have 
led to non-participation and therefore under-representation of people who are 
less well-educated or who do not read or write in English. There was a 
significant difference between the proportion of responders and non-
responders on the basis of the colposcopy units from which patients were 
invited (X2=29.43; p=<0.0001), with a higher than expected number of non-
responders from Good Hope, Heartlands, City and Solihull hospitals. Similar 
responder bias was found in the sample invited to participate in Q2. The level 
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of deprivation was found to be significantly associated with the likelihood of 
responding to Q1 (X2=54.85; p=<0.0001) with higher than expected numbers 
of responders from the less affluent and less deprived groups (deprivation 
quartiles 2 and 3), and higher than expected numbers of non-responders in 
the most affluent and most deprived groups (quartiles 1 and 4). 
 
Significant differences were observed in the proportion of women responding 
to Q2 in terms of age group, with higher than expected numbers of patients 
responding from the 19 to 29 and 40 to 49 groups (X2=11.85; p=0.0079). 
Lower than expected numbers of responses were received from women in the 
30 to 39 and 50+ groups. Significant differences between responders and 
non-responders were also found in the proportion of responders according to 
treatment type (X2=3.3; p=0.0192) with proportionally larger numbers in the 
colposcopy group responding to Q2 and significantly lower than expected 
responses from individuals in the biopsy or loop excision groups. 
 
Those who did take part, as noted above, were more likely to be better 
educated, and may have been more likely to take a particular interest in their 
own health and perceive greater value in participating in research projects in 
general. As no reimbursement for participation was available due to financial 
constraints, those who did participate would have largely done so for altruistic 
reasons. 
 
More extensive data were gathered for participants responding to Q2. The 
decision was made that the initial questionnaire should be short, to encourage 
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those who invested time in completing Q1 to agree to participate in the 
second stage of the research, for which the survey was longer and collected 
data on a wider range of validated measures and other participant 
characteristics. 
 
Piloting issues  
Issues related to questionnaire design, and in particular, aspects of specific 
wording used in both questionnaires may have had an impact on response 
rates. It was expected that piloting of both questionnaires would have resulted 
in any inconsistencies or omissions being noted, allowing them to be rectified 
before questionnaires were sent to potential study participants. Unfortunately, 
the process of piloting did not identify all of these inconsistencies, which have 
become clear in hindsight. For example, it would have been useful if Q1 had 
included a question relating to women’s sexual activity status (i.e. whether 
they were sexually active or not) given the inclusion of six questions related to 
specific aspects of sexual activity on this questionnaire. Unfortunately, despite 
piloting Q1 with colleagues and acquaintances, this omission was not noted 
by any of the individuals with whom Q1 was piloted. Although an explanation 
of what constituted ‘sexual activity’ was provided within Q2, it may have 
benefited participants if such an explanation was also included in Q1. 
Providing a wider definition of ‘sexual activity’ may have ensured that 
participants who described themselves as sexually active, although they were 
not, for example, engaged in intercourse, may have felt more able respond to 
these questions.  
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Furthermore, the question posed on questionnaire two relating to sexual 
activity prior to colposcopy omitted to define its terms of reference regarding 
the specific period of time before colposcopy that was of interest for the study. 
However, this question, along with a number of other health and demography-
related questions were excluded from formal analysis, thus any 
misinterpretation of the meaning of these questions on the part of participants 
(and thus any inconsistencies in their responses) would not have had any 
negative impact on the robustness of analyses presented.  
Lack of a control dataset 
At inception, the study proposed to recruit age and deprivation matched 
controls, to establish prevalence estimates for FSD and quality of life 
outcomes. This was not possible in light of the logistical issues outlined in 
Chapter 4 (Section 4.3.3).  
Chapter 5 (study methodology) outlines the problems encountered recruiting a 
practice whose patient list could provide study control participants. The 
practice approached felt that given other pressures, it would not be possible 
for practice staff to perform the thorough level of patient list checking 
perceived as necessary prior to mailing to ensure that questionnaires were 
not sent to women who had been the victim of sexual abuse. It is, of course, 
entirely plausible that in some cases, regardless of how thoroughly pre-
mailing screening checks were conducted, the practice would not have been 
aware that a specific patient may have been a victim of sexual abuse. Thus, 
having ‘extra’ checks in place would have been unlikely to have completely 
removed this potential problem.  
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The concern raised by this particular practice, in hindsight, may have been 
overcome had the patient information sheet contained a more explicit 
reference to the fact that the questionnaire contained questions of a sexual 
nature. It would have given women for whom such questions may have raised 
concern or worries the opportunity to discard the questionnaire.  
However, it is important to be mindful of the fact that because someone has 
experienced sexual abuse in the past does not mean that they would 
necessarily been unhappy to receive a questionnaire containing questions of 
a sexual nature. 
 
Having an age and deprivation matched control group would have enabled a 
more precise estimate of the prevalence of FSD in the case group. In the light 
of this, normative data were presented as a proxy for healthy control patients 
recruited from general practice. However, the limited range of normative data 
available for the validated measures utilised made interpretation of results in 
the wider context problematic. Consideration was given to accessing control 
patients via other means, such as recruiting control participants from the 
university student population. However, recruiting participants from this 
population would have made age-matching very difficult given the typical age 
profile of university students. It is unlikely that sufficient numbers of control 
participants could have been recruited via this method.  Furthermore, the 
majority of university students live in a relatively small geographical area, so 
would not have provided the range of deprivation scores required for case-
control deprivation matching. Interestingly, the residential postcodes (and 
therefore the assigned IMD quartile for each student) would not necessarily 
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have been representative of their ‘true’ socioecomonic status given the typical 
location of student accommodation in relatively ‘deprived’ areas.  
 
Outcome measures 
The decision to use the FSFI, HADS anxiety and depression scale and 
WHOQOL-BREF predated commencement of the PhD.  The HADS anxiety 
and depression scale, despite being a well validated and relatively brief 
measure that is easily understood by research participants is not without 
limitations. The HADS measure assesses the current anxiety and depression 
levels of a respondent. As this study was designed to investigate the long-
term impacts of colposcopy, it seems plausible that responses to the HADS 
questions primarily provide a measure of how the respondent felt at the time 
of receiving the questionnaire, which would have occurred at least 12 months 
after their procedure. This also assumes that participants had not undergone 
any further colposcopy related procedures subsequent to their ‘index’ 
procedure in the interim, which cannot be ruled out. 
 
Zigmond and Snaith133 (HADS) cite scores of 8-10 or above indicating mild 
depression, 11-15 for moderate cases and 16 and above for severe cases, 
although they recommend that using a threshold of 11 would include all 
probable cases and 8-10 all possible cases. This supports the notion that 
anxiety and depression should be regarded as ‘dimensional rather than 
categorical constructs’.149 Categorical tests use a ‘cut off’ score to indicate 
presence or absence of a problem, thus separating what is defined as 
‘normal’ from was could be considered ‘pathological’. This would suggest that 
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it is less efficacious to use HADS as a tool for ‘diagnosing’ anxiety and 
depression, rather than in demonstrating the extent or degree of an existing 
problem.  
Furthermore, one of the limitations in terms of the analysis of the categorical 
data collected from Q2 where HADS anxiety and depression were 
dichotomised into ‘normal’ or ‘mild and above’ was that the ‘mild and above’ 
category encompassed a wide range of scores, many of them at the ‘mild’ end 
of the spectrum, thus it is rather blunt instrument to use. It can be argued that 
dichotomising the scores did not provide a nuanced picture of the mental 
health of the respondents.  
Had the measures to be used in the doctoral research not been pre-specified 
as part of the study protocol and as a condition of PhD funding, the use of a 
measure that provided an overall picture of a participant’s anxiety and 
depression that did not require them to complete it in terms of how they were 
feeling on the day of receiving the questionnaire may have provided a more 
robust assessment of their general mental health rather than a ‘snap shot’ of 
how they were feeling on that day. The use of the State-Trait Anxiety 
Inventory168 may have yielded a more rounded picture of responders’ anxiety 
levels, as it asks that they consider their current state, but also poses 
statements that relate to their overall sense of self in terms of their anxiety. 
For example, questions such as ‘I am content. I am a steady person’ should 
elicit responses that pertain to overall mental well being. However, the 
majority of validated measures that are used to ascertain psychological well 
being ask respondents to report their current mental health. However, the 
focus of the STAI measure is upon anxiety rather than depressive symptoms. 
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In terms of use of the FSFI, chapter 4 outlines the ‘dysfunction’ bias that is 
inherent in the measure.169 The measure includes a response related to 
sexual activity in the past 4 weeks, whereby if the respondent has not been 
sexually active during this time, a zero score is assigned. When calculating 
the FSFI score (< 26.55 indicating presence of sexual dysfunction), the 
measure implies that women who are not sexually active are sexually 
dysfunctional, and thus it is possible that analyses based on this scoring 
convention may result in an over-estimation of the prevalence of FSD in a 
given population. To assess the extent to which such over-estimation may 
have been a feature of analyses performed in this study, a sensitivity analysis 
was undertaken in which all women who did not report being currently 
sexually active were removed from the dataset. Removal of these cases was 
shown to have no impact upon the overall prevalence rate of FSD in the 
cohort.  
 
Responder bias 
Responders may have been more inclined to participate in the study if either 
they had had a very positive experience, or a very negative experience of 
undergoing colposcopy which may have influenced the nature of the data 
obtained. Negative experiences may be partly ameliorated for a participant if 
they are able to report the kind of problems they experienced. It can provide 
an avenue to un-burden themselves of negative feelings. Similarly, having a 
positive experience may encourage participation as people see it as an 
opportunity to praise the particular unit they attended. Those who are more 
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ambivalent about the experience may see little value in participating in the 
study. It could be argued that the results will over-represent the good and the 
bad at the expense of the perfectly ‘normal’ or unremarkable experiences. 
Given the more pronounced levels of FSD in the study cohort compared with 
normative data, it is possible that responders experiencing problems were 
more inclined to participate. 
 
Older women may feel less compelled to answer questions of a sexual nature 
when compared with younger, arguably more sexually liberated women. In an 
increasingly libertarian and non-secular society there have been notable shifts 
in the ease with which sexuality is discussed in the media. Women today are 
more likely to engage in a variety of sexual relationships - multiple partners, 
fewer monogamous relationships, and more same-sex relationships. Younger 
women in particular may feel more sexually empowered, therefore there may 
be less stigma for them in answering questions that focus upon sexuality. 
Women in long-standing relationships may differ in how they view sex and its 
place within their relationships. They may place less emphasis upon the 
importance of sex in an otherwise contented and fulfilled relationship. 
 
Women who have had children may be comparatively less affected by the 
colposcopy procedure as they will have already have undergone the 
potentially traumatic and intimate experience of giving birth. For women who 
have never had children, they may be more likely to experience increased 
anxiety around any adverse effects upon their obstetric health and fertility. 
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The nature of the kinds of questions asked and the measures used to quantify 
psychological, physical or sexual health outcomes in the context of having 
undergone a colposcopy may, for some women, lead them to erroneously 
assume that any problems they may have are attributable to the procedure. 
The kinds of experiences of undergoing colposcopy are also likely to depend 
upon the health locus of control for the individual.  
 
The length of time elapsing between undergoing treatment and receiving the 
questionnaire makes it difficult to attribute, with certainty, that any adverse 
outcomes experienced were due to undergoing a colposcopy or 
colposcopically directed treatment. Furthermore, it is entirely plausible that 
women who had been recorded as undergoing colposcopy only during the 
study period (April 2008-March 2009), had subsequently undergone further, 
more invasive investigation or treatment. Without accessing the full medical 
records for each patient, which was unfeasible due to the resources available 
to support the study, this limitation was difficult to overcome.  
 
Multiple testing 
 
As this study’s main aim was to ascertain whether treatment type, age or 
deprivation were associated with, or could be considered ‘predictors’ of 
experiencing adverse impacts after colposcopy, analysis was undertaken 
assessing the association between these three predictors and all of the 
outcomes of interest. The greater the number of statistical comparisons 
performed on the same set of data, the greater the likelihood that spurious 
statistical associations between variables (type I errors) may be found simply 
by chance rather than as the result of ‘true’ statistical significance. To reduce 
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the likelihood of such spurious statistical significance being found, a number 
of statistical techniques have been developed (such as Bonferroni correction), 
which reduce the p value needed to denote a statistically significant result 
according to the number of tests being performed on the data. This reduction 
in the threshold for statistical significance thus compensates for the effects of 
multiple comparisons in requiring a stronger ‘level of evidence’ to be observed 
before statistical significance can be asserted.   
 
Multiple tests were performed on the data as part of this study, and there is a 
chance that spurious statistical significance may have been detected. 
However, while Bonferroni correction was considered as a means of guarding 
against the spurious assertion of statistical significance, the lack of statistically 
significant findings in the study data analysis suggested that the likelihood of 
type I error was extremely low, and that the effect of multiple testing is not 
likely to have had a significant impact on the study findings.  
 
 
 
 
 
Strengths 
 
Undertaking a large-scale systematic review of the current evidence base in 
terms of the adverse psycho-sexual outcomes of undergoing colposcopy 
provided an important context within which to place the findings from this 
study. It is also the first review to explore the psycho-sexual outcomes of 
undergoing colposcopy or CIN directed treatment, and to include both 
quantitative and qualitative research. 
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The questionnaire element of the study had a large sample size when viewed 
in the context of the studies included in the systematic review. Furthermore, in 
order to ascertain if there was any difference in outcome observed between 
treatment groups, the study stratified the cohort in terms of what kind of 
treatment respondents had undergone. It is the first larger scale study to do 
so. 
 
The mixed methodology approach employed enabled prevalence data in 
terms of the outcomes measured to be collected as well as data relating to 
individual experiences of undergoing colposcopy or treatment for CIN. 
Exploring psycho-sexual outcomes lends itself to this approach as, to some 
extent, issues of this nature can be more difficult to assess using purely 
quantitative methods. 
 
The sample is taken from a large urban, ethnically diverse population and so 
could be seen to be generalisable to the general population. Although a 
poorer responses rate may have been expected from black and minority 
ethnic (BME) groups, some of whom may have felt less comfortable 
answering questions related to their sexual life, in this study 21.5% of 
responders to Q2 were from BME groups which is largely representative of 
the UK population.167  
 
Sampling across five hospitals within the West Midlands minimised any 
potential bias in terms of the sample representing the experiences of 
undergoing colposcopy at one unit only. It would have been difficult to 
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extrapolate the findings from such a study and conclude that they were 
representative of the experiences of women undergoing colposcopy.  
 
Finally, the use of validated measures in Questionnaire 2 provided a robust 
measure of the outcomes of interest - sexual function; anxiety and 
depression; physical, psychological, social and environmental domains. 
 
 
 
9.3 Service Improvement 
 
Overall, it would appear that problems observed in this cohort in terms of 
psycho-sexual functioning are attributable to factors other than the colposcopy 
itself. This should provide some reassurance that there are unlikely to be 
long-term adverse consequences for women undergoing treatment and for the 
health care professionals providing treatment.  
 
However, it is worth noting that from the data generated by the qualitative 
stage of the research that there are some areas for service improvement that 
may benefit women undergoing colposcopy. Women’s poor experiences are 
accounted for, in part, by how they felt they were treated by staff at the units. 
Feeling that they had little information, or impersonal treatment impacted 
negatively upon some women’s experiences. It may also be useful to discuss 
with women the range of potential adverse consequences they may 
experience. However, this needs to be balanced with information about the 
effectiveness of treatment. That said, many women found that they were 
treated very well by all healthcare professional involved. As with any medical 
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intervention, especially treatment of an invasive and intimate nature, some 
after effects are unavoidable. Ensuring that women are informed and 
empowered to understand what is happening to them and that potential side 
effects are explained in language that is coherent to a lay person are 
important in minimising undue distress and trauma.  
 
The diversity of experiences women undergo during and after the colposcopy 
procedure may be as much a facet of the particular psychological profile of 
the individual as it is of the way the procedure is performed. It is accepted that 
undergoing colposcopy is an effective way to manage and treat CIN41,42 and is 
therefore a necessity for women who have cervical abnormalities. However, 
many women may benefit from being better informed by their GP as to what 
CIN is, what  causes it, what they can expect when they attend for 
colposcopic investigation, along with the potential side-effects of undergoing 
treatment. Poor communication skills amongst some clinicians may contribute 
to the poor experience for some women undergoing treatment. Regular 
assessment of the ability of health care professionals to communicate with 
patients in a sensitive and appropriate manner may increase the satisfaction 
levels for women undergoing treatment. 
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CHAPTER 10: CONCLUSIONS 
 
What can be concluded about the impacts of undergoing colposcopy and 
treatment for CIN? 
 
This Chapter outlines the conclusions of this study, and will reflect upon the 
original aims and objectives of the study. It will recap the findings from each 
stage of the study and will conclude with a summary of the project and 
suggestions for future research to develop the field of research further. 
 
10.1 Main conclusions 
 
This study aimed to determine whether undergoing colposcopy and treatment 
for CIN had any long terms adverse psycho-sexual impacts. After outlining the 
aims and objectives, the background to the study was outlined including the 
prevalence and aetiology of cervical cancer and an overview of the National 
Health Service Cervical Screening Programme (NHSCSP). Current 
colposcopy service provision was detailed including the current treatments 
available for CIN. A literature review was undertaken of the current evidence 
base relating to the more general adverse outcomes after colposcopy 
including the physical and obstetric consequences of undergoing treatment. A 
systematic review of the current evidence relating, more specifically, to the 
adverse psycho-sexual consequences of colposcopy and treatment for CIN 
was presented. The overarching conclusions from the review suggest that 
although women may experience adverse psycho-sexual sequelae following 
colposcopy, these are generally short lived. The higher quality studies in the 
review, focusing upon long term consequences indicated that any problems 
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tend to be transitory in nature. The heterogeneity of studies included in terms 
of design, setting, population, follow-up timescales and quality provided 
further justification for undertaking this study. 
 
Prior to reporting the analysis and results of the empirical stage of the study, a 
discussion was presented of the notion of female sexual dysfunction. As an 
investigation of the prevalence of FSD in women undergoing colposcopy was 
a main objective of this study, highlighting the debates around the efficacy of 
using FSD as a diagnostic label for sexual problems in women was deemed 
an important element in the study. The discussion highlights the fact that there 
remains a lack of consensus in terms of how best to ‘measure’ sexuality. 
These findings informed the discussion of the results from this study. 
 
The study methodology was outlined along with a justification for the methods 
employed to answer the research questions. The presentation of the results of 
the analysis also included the details of recruitment and non-responder bias. 
The main results of the analysis of both stages of the study were presented 
along with a summary of these findings in the context of the study aims. 
 
The original hypothesis that treatment type would influence the prevalence of 
FSD was rejected. The three potential predictors of interest in terms of sexual 
dysfunction, depression, anxiety, physical, psychological, social and 
environmental factors were studied to ascertain both the prevalence of 
problems in these areas in the context of normative data, as well as the ‘best’ 
predictors of experiencing problems in this cohort. Analysis of the qualitative 
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stage of the study was also presented and  the findings from empirical work 
were discussed in the context of the conclusions from the systematic review. 
 
The presence of FSD in this cohort was greater than rates observed in the 
normative data. However, the problems inherent in using normative data as a 
proxy for age and deprivation matches controls were outlined. Furthermore, 
the FSFI asks women to rate their sexual ‘function’ in the previous four weeks. 
The normative data used to compare prevalence rates (NATSAL) uses a six 
month time frame, and therefore is more likely to pick up persistent sexual 
problems. It is plausible that the FSFI, with its shorter time-frame, will pick up 
sexual problems that are transitory in nature and our findings may be 
interpreted as an over-estimation of FSD in this cohort.  
 
Findings from the HADS anxiety and depression scale indicated higher levels 
of these problems compared to normative data. Again, there is a lack of 
robust normative data available for these measures, so caution is advised 
when interpreting these findings. Furthermore this scale asks responders to 
rate the responses on the day of completing the measure. There is a 
possibility that the rates observed include more transient problems. The lack 
of normative data available for the WHOQOL-BREF makes if difficult to draw 
any firm conclusions about the findings for this study in the light of population 
norms. 
 
Examining the associations between the variables for all measures concluded 
the following: 
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FSD 
No significant differences were observed between type of treatment, age or 
deprivation in terms of the presence of FSD.  
 
HADS anxiety 
Treatment type, deprivation or age were not significantly associated with 
scoring ‘normal’ or ‘mild and above’ on the anxiety scale.  
 
HADS depression 
Treatment and deprivation were not significantly associated with scoring 
‘normal’ or ‘mild and above’ on the depression scale. Age, however, showed a 
significant association with older women more likely to score ‘mild and above’. 
 
WHOQOL-BREF (physical, psychological, social, environmental domains) 
Across all four domains, treatment type was not associated with any 
differences in the score distribution. Associations were observed in terms of 
age and physical health outcomes, with older women reporting more 
problems in this area.  Deprivation was also found to be associated with 
experiencing physical and environmental problems. Women in the most 
deprived quartile reported more problems in these areas. 
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In conjunction with the epidemiological data generated, the qualitative data 
collected provided a more individualised account of women’s experiences of 
undergoing colposcopy. The findings from this stage of the study support the 
findings from the systematic review of the qualitative data pertaining to 
women’s experiences, especially the fear associated with the procedure and 
impact of the procedure upon some of the respondents’ sense of femininity 
and sexuality. 
 
Overall, from the findings from the study, it is possible to assert with some 
certainty that the type of colposcopically directed intervention undergone was 
not associated with, nor a predictor of any problems observed in terms of 
sexual function or anxiety and depression levels. Similarly, treatment type was 
not associated with the variance observed in terms of the physical, 
psychological, social or environmental domains scores observed. The findings 
from the systematic review, whilst acknowledging that colposcopy can have 
an impact upon psycho-sexual function that maybe more pronounced in some 
women more than others, would appear to indicate that in general these 
impacts are likely to transitory in nature. This study concludes that other 
factors unrelated to treatment were likely to best explain any problems 
observed. 
 
Older women may be more likely to experience problems associated with 
sexual function. However, these problems cannot necessarily be attributed to 
colposcopy. Similarly, the higher levels of depression and physical health 
problems experienced by older women are just as likely to be a facet of 
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problems relating to getting older. Women living in areas of higher deprivation 
were more likely to experience environmental problems than women in more 
affluent areas. Again, this is likely to be due to the kind of problems these 
women have in terms of poorer housing and access to services, than 
colposcopy itself. 
 
10.2 Summary and suggestions for future research 
 
This study initially sought to compare colposcopy ‘cases’ with age and 
deprivation matched ‘controls’. This would have provided more robust 
comparative data, and the problems inherent in comparing outcomes with 
normative data would have been minimised. It would be useful to attempt to 
undertake this as a secondary part of this study. However, the problems 
encountered in attempting to recruit general practitioners willing for their 
patients to be sent questionnaires asking questions of a sexual nature would 
need to be overcome. Understandably, many general practitioners feel 
‘protective’ of their patients and may be concerned that receiving such a 
questionnaire may have a negative impact upon some patients who had 
experienced sexual trauma. Different approaches to recruitment of control 
patients when seeking responses about sensitive issues needs exploration. 
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Appendix 1 - Systematic Review Search Strategy  
 
 
 
1. CIN  
2. cervical intraepithelial neoplasia  
3. cervical dysplasia  
4. cervix uteri surgery.  
5. uterine cervical dysplasia.  
6. colposcopy 
7. cone biopsy  
8. coni?ation  
9. laser coni?ation  
10. LLETZ 
11. loop electrosurgical excisional procedure 
12. LEEP 
13. large loop excision 
14. punch biopsy 
15. cone biopsy 
16. sexual dysfunction 
17. sexual function 
18. sexual well-being 
19. female sexual dysfunction 
20. libido 
21. desire 
22. dyspareunia 
23. vaginal dryness 
24. vaginal lubrication 
25. body image 
26. orgasm 
27. painful intercourse 
28. psycho-sexual 
29. psychological 
30. anxiety 
31. depression 
32. emotional 
33. fear of cancer 
34. libido 
35. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 
36. 
37. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 
or 29 or 30 or 31 or 32 or 33 or 34  
38. 
39. 36 and 38 
40. 
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Appendix 2 - Data Extraction Form 
 
 
General Information 
 
Date of data extraction 
Identification features of the study 
 Author 
 Article title 
 Source (eg Journal, Conference) Year/Volume/Pages/Country of origin 
 Institutional Affiliation (first author) and/or contact address 
Identification of the reviewer 
Notes 
 
Specific Information 
 
Study characteristics 
Verification of study eligibility 
 Correct population, interventions, outcomes, and study design 
Population characteristics and care setting 
1. Target population (describe/size of population) 
2. Inclusion/exclusion criteria 
3. Recruitment procedures used (if available) 
4. Demographic characteristics of women undergoing colposcopy if 
available 
5. Is there a comparator population? 
 
Methodological quality of the study 
 1. Design of study 
a.) RCT 
b.) Cohort study  
c.) Systematic review 
d.) Qualitative study 
e.) Case study 
 
 2. Quality assessment 
 
Intervention 
1. Focus of intervention (describe) Colposcopy 
 
Outcomes, outcome measures 
 
1. What outcomes (adverse or otherwise) were measured? 
2. Who carried out the measurement? 
3. What was the measurement tool? 
4. How many experienced adverse or otherwise outcomes? 
5. Was/were the tool(s) validated? 
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Analysis 
 
1. Statistical techniques used (if quantitative study) 
2. Does technique adjust for confounding? 
3. Unit of analysis 
 
Results 
 
1. Quantitative results (estimate of effect size) 
2. Effect of intervention upon outcome measures 
3. Qualitative results 
 
 
[Adapted from NHS CRD Report 4 (2nd Edition), University of York, March 
2001] 
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Appendix 4 Quality Assessment Scores For Systematic Review Studies 
 
Studies comparing two or more treatment modalities 
 
 
 Clear research 
aims 
Quantitative 
Appropriate 
method 
Design 
appropriate 
Recruitment 
strategy 
appropriate 
Appropriate/
clear data 
collection 
Researcher/participant 
Appropriate 
relationship 
Ethical 
issues 
considered 
Data 
analysis 
rigourous 
Results 
explicit 
Contribution 
to 
knowledge 
base 
Total 
Balasubramani 
2007 86 
 
1 1 1 1 1 1 1 0 1 1 9 
Baldaro 2003 87 
 
1 1 1 0 0 0 0 0 1 1 5 
Ferris 2003 93 
 
1 1 1 0 1 0 0 1 1 1 7 
Freeman-Wang 
94 
 
1 1 1 0 0 0 0 0 0 0 3 
Hellsten 2008 95 
 
1 1 1 0.5 1 0 0.5 1 1 1 8 
Hellsten 2008 96 
 
1 1 1 0.5 1 0 0.5 1 1 1 8 
Hellsten et al 
2009 97 
 
1 1 1 0.5 1 0 0.5 1 1 1 8 
Jones 1996 102 
 
1 1 1 0 0 0 0 0 0 0 3 
Kitchener 
2004105 
 
1 1 1 1 1 0 0 1 1 1 8 
Kola 2009 106 
 
1 1 0 0 1 0 0 1 1 1 6 
 374
Le 2006 109 
 
1 1 1 0 1 0 0 1 1 1 7 
 Clear 
research 
aims 
Quantitative 
Appropriate 
method 
Design 
appropriate 
Recruitment 
strategy 
appropriate 
Appropriate/
clear data 
collection 
Researcher/participant 
Appropriate 
relationship 
Ethical 
issues 
considered 
Data 
analysis 
rigourous 
Results 
explicit 
Contribution 
to 
knowledge 
base 
Total 
Little (Tombola 
Group) 2009 111 
 
1 1 1 1 1 1 1 1 1 1 10 
Naik 2001 114 
 
1 1 1 0 0 0 0 0 1 1 5 
Orbell 2004 115 
 
1 1 1 1 1 0 1 1 0 1 8 
Sharp 2010 119 
 
1 1 1 1 1 1 1 1 1 1 10 
Tamburini 1991 
120 
 
1 1 1 0 0 0 0 0 0 0 3 
 
 
One cohort 
 
 Clear research 
aims 
Quantitative 
Appropriate 
method 
Design 
appropriate 
Recruitment 
strategy 
appropriate 
Appropriate/
clear data 
collection 
Researcher/participant 
Appropriate 
relationship 
Ethical 
issues 
considered 
Data 
analysis 
rigourous 
Results 
explicit 
Contribution 
to 
knowledge 
base 
Total 
Boneveski 1998 
 
1 1 0 0 1 0 0 1 0 0 4 
Brooks 2002 91 
 
1 1 1 0 0 0 0 0 1 1 5 
Gath et al 
1995 61 
 
1 1 1 0 1 0 0 0 1 1 6 
Howells 1999 99 
 
1 1 1 0 0 0 0 1 1 1 6 
Idestrom 2003 0 1 0 0 1 1 0 0 1 1 5 
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100 
 
 Clear 
research 
aims 
Quantitative 
Appropriate 
method 
Design 
appropriate 
Recruitment 
strategy 
appropriate 
Appropriate/
clear data 
collection 
Researcher/participant 
Appropriate 
relationship 
Ethical 
issues 
considered 
Data 
analysis 
rigourous 
Results 
explicit 
Contribution 
to 
knowledge 
base 
Total 
Inna 2010 101 
 
1 1 1 1 1 0 0 1 1 0 7 
Kilkku 1982 104 
 
0 1 0 0 0 0 0 0 0 0 1 
Lauver 1999 107 
 
1 0 0 1 1 0 0 0 0 1 4 
Lauver 1999 108 
 
0 1 1 1 0 0 0 1 1 1 6 
Marteau 1990 112 
 
0 1 0 0 0 0 0 0 0 0 1 
McDonald 1989 
60 
 
1 1 1 0 0 0 0 0 1 1 5 
Richardson 
1996 116 
 
1 0.5 0.5 0 1 1 0 1 0 1 6 
Rubin 2010 117 
 
0.5 0.5 1 0 0 0 0 1 1 1 5 
Serati  
2010 118 
 
1 1 1 0 1 0 0 0 1 1 6 
Tahseen 2008 
121 
 
1 0 1 0 0 0 1 0 0 1 4 
Valdini 2004 122 
 
0 1 1 0 0 0 0 0 0 1 3 
Zeisler 1997 123 
 
1 1 0 0 0 0 0 0 0 1  
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Disease status 
 
 Clear research 
aims 
Quantitative 
Appropriate 
method 
Design 
appropriate 
Recruitment 
strategy 
appropriate 
Appropriate/
clear data 
collection 
Researcher/participant 
Appropriate 
relationship 
Ethical 
issues 
considered 
Data 
analysis 
rigourous 
Results 
explicit 
Contribution 
to 
knowledge 
base 
Total 
Bell et al 33 
 
 
1 1 1 0 1 0 0 0 1 1 6 
Cairns 2008 92 
 
1 1 0 1 1 0 1 0 1 1 7 
Campion et al 
1988 57 
 
0 1 0 0 1 0 0 0 1 1 4 
Lerman 1991 110 
 
1 1 1 0 0 0 0 1 1 0 5 
Palmer et al 
1993 54 
0 1 1 1 1 0 1 0 1 1 6 
 
 
 
Questionnaire development 
 
 Clear research 
aims 
Quantitative 
Appropriate 
method 
Design 
appropriate 
Recruitment 
strategy 
appropriate 
Appropriate/
clear data 
collection 
Researcher/participant 
Appropriate 
relationship 
Ethical 
issues 
considered 
Data 
analysis 
rigourous 
Results 
explicit 
Contribution 
to 
knowledge 
base 
Total 
Bennetts 1995 89 
 
1 1 1 1 0 1 0 1 1 1 8 
Doherty 1991 58 0 1 0 0 0 0 0 0 1 1 3 
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Qualitative studies 
 
 Clear research 
aims 
Qualitative 
Appropriate 
method 
Design 
appropriate 
Recruitment 
strategy 
appropriate 
Appropriate/
clear data 
collection 
Researcher/participant 
Appropriate 
relationship 
Ethical 
issues 
considered 
Data 
analysis 
rigourous 
Results 
explicit 
Contribution 
to 
knowledge 
base 
Total 
Beresford 1986 
59 
0 1 1 0 0 0 0 0 0 0 2 
Hounsgaard 
2007 98 
1 1 1 0 1 0 1 0 1 1 6 
Juraskova 2007 
103 
1 1 1 0 1 0 0 0 1 1 6 
Mortensen 2010 
113 
1 1 1 1 1 0 0 1 1 1 8 
Posner & Vesey 
34 
1 0 0 1 0 1 1 0 0 1 5 
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Appendix 5 Glossary Of Acronyms 
 
ST  - See and Treat 
DT  - Defer and Treat 
DD  - Diagnose and Defer 
CS  - Cytological Surveillance 
LLETZ - Large Loop Excision of the Transformation Zone 
LEEP   - Loop Electrical Excisional Procedure 
CC   - Cervical Cancer 
STI   - Sexually Transmitted Infection 
CIN   - Cervical Intraepithelial Neoplasia 
SF   - Sexual Function 
SQ   - Symptom Questionnaire 
CES-D  - Centre for Epidemiological Studies 
MBSS  - Miller Behavioural Style Score 
STAI   - Spielberger State Trait Inventory 
MADRS-S  - Montgomery-Asbery Depression Rating Scale 
QOL   - Quality Of Life 
GHQ   - General Health Questionnaire 
HADS  - Hospital Anxiety and Depression Scale 
IES   - Impact of Event Scale 
POSM  - Process Outcome Specific Measure 
MMPI   - Minnesota Multiphasic Personality Inventory 
ASQ   - Abnormal Smear Questionnaire 
POMS  - Profile Of Mood Status 
PSE   - Present State Examiniation 
FSFI   - Female Sexual Function Index 
PEAPS - Q  - Psychological Effects of having an Abnormal Pap Smear Questionnaire 
FG   - Focus Group 
 379
Appendix 6 Excel Proforma For Patient Identification 
 
 
Uni ID Postcode Date 
of 
birth 
Level of 
intervention 
Referral 
date 
Appt 
date 
Referral 
source 
Treatment 
method (if 
applicable) 
Any 
comments 
When 
pack 
sent  
When 
reminder 
sent 
110001           
110002           
110003           
110004           
110005           
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Appendix 7 - Participant Invitation Letter 
 
 
         INSERT TRUST  
Title First Name Last Name     LOGO 
Address line 1 
Address line 2 
Address line 3 
Address line 4 
Postcode 
         Date 
 
Dear (personalised) 
 
 
  Understanding Women’s Experiences of Colposcopy 
 
I am writing to you to ask if you can help us find out more about women’s 
experiences of having a colposcopy. 
 
Women are usually referred for a colposcopy when they have had an abnormal 
smear test. 
As you may know, colposcopy is an examination of the cervix (neck of the womb) 
and is performed by a doctor or nurse in a hospital outpatient clinic. Although it is a 
common procedure, we know very little about whether this has an effect upon 
women’s sex life, or other aspects of their health. 
To look at the long term effects we will compare how women who have never had a 
colposcopy feel, with women who have had a colposcopy. 
 
If you have received this letter, you have been selected from records at a colposcopy 
unit. 
 
We have enclosed with this letter, an information sheet about this research and a 
short questionnaire. This questionnaire should take no more that 10 minutes to 
complete and we would be grateful if you could take the time to fill it in. 
Your response will be treated in strict confidence. 
 
Many thanks 
 
Yours sincerely 
 
 
INSERT CONSULTANT ELECTRONIC SIGNATURE 
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Appendix 8 - Participant Information Sheet 
 
         
Participant Information Sheet         
 
 
Understanding Women’s Experiences of Colposcopy 
Information about the research 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take 
time to read the following information carefully. Talk to others about the study if you wish. 
The study is to find out what kind of experiences women have had following colposcopy and 
to see if it has had any effects upon their sex life, health and well-being.  
Why is this study needed? 
Colposcopy is a detailed examination of the cervix (neck of the womb) and is performed by a 
doctor or nurse colposcopist. Although a lot of women have experienced colposcopy, not 
much is known about what it is like for them and if it has any effects upon their health and 
well-being. In order to find out more about this we are asking women to complete a 
questionnaire.  
We will compare the experiences of women who have, and have not, had a 
colposcopy. 
Why have I been invited to take part? 
You’re being asked to take part in the study because you had a colposcopy. 
Do I have to take part? 
It is entirely up to you whether to take part or not. You are free to withdraw or change your 
mind at any time without giving a reason. Even if you don’t want to take part, we would be 
grateful if you could return the reply slip in the FREEPOST envelope provided. 
What happens if I take part? 
At the end of this questionnaire we have left a space for you to add any further comments or 
raise any other issues that you think may be relevant. It also asks if you would be happy to 
complete a follow-up questionnaire. If you agree to do so, we will send you a second, more 
detailed questionnaire. This will take a little longer to complete.  
What are the possible disadvantages and risks of taking part? 
This study doesn’t involve any treatment or tests, so there is no physical risk involved. Some 
of the questions relate to psychological and sexual issues which are personal but we would 
appreciate your honesty when answering these questions. 
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What are the possible benefits of taking part? 
You’ll have the satisfaction of knowing that others may be helped by this research in the 
future.  
What happens when the research study stops? 
When all the questionnaires have been returned and analysed, a report will be prepared and 
the findings will be published in medical journals and at conferences. It will be several 
months before this happens. Once published, a summary report will be published on the 
University of Birmingham’s website. All reports and publications will use the information 
collected in a way that makes sure you cannot be identified. 
If you would like to receive a summary of the results, you can tick a box at the end of the 
second questionnaire and we will send you a copy of this summary. 
What if there’s a problem? 
If you have any complaint about the way you are dealt with during the study, please contact 
Professor Sue Wilson at the University of Birmingham on 0121 414 7397. If you remain 
unhappy and wish to complain formally, you can do this by contacting Birmingham and Black 
Country Comprehensive Local Research Network (Tel 0121 627 2160). 
What will happen if you don’t want to carry on with this study? 
You can decide to leave the study at any time without giving a reason. 
Will my taking part in this study be kept confidential? 
All information you provide will be kept strictly confidential by the research team. This 
means that we will never pass on any information about you, your involvement in the 
study, or the answers you give to anyone, for any reason. When we publish our results, 
these will be summaries of what a number of people have told us – you will not be able to be 
identified. All information will be kept in accordance with the Data Protection Act.  
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people called a Research 
Ethics Committee, to protect your safety, rights, well-being and dignity. This study has been 
reviewed and given a favourable opinion by Black Country Research Ethics Committee. 
How can I find out more? 
If you’d like more information about the study before you make up your mind, you can 
contact    
 
 
Who is organising and funding the research? 
The research is being carried out by a team from the Department of Primary Care Clinical 
Sciences at the University of Birmingham (contact details can be found above). The study is 
funded by a national cancer charity, Cancer Research UK. 
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Appendix 9 - Questionnaire One 
 
              
Colposcopy Follow-up Study   
 
 
We are interested in hearing from you, even if you haven’t had a 
colposcopy 
 
Please fill in all sections. 
 
Some women find that having a colposcopy or a smear test affects their sex life and other aspects of 
their life. These possible effects have not been fully explored and we believe it is important that we 
know more about them, so that the services that are provided take women’s experiences into account. 
 
All information you provide will be kept strictly confidential by the research team. This means that 
we will never pass on any information about you, your involvement in the study, or the 
answers you give to anyone, for any reason. 
 
 
SECTION 1: 
 
THIS SECTION ASKS YOU GENERAL QUESTIONS ABOUT YOUR HEALTH. 
 
1.  In general, would you say that your health is (Please circle one option) 
 
Excellent 
 
Very Good Good Fair Poor 
 
 
2.  In the past 12 months, have you had any of the following problems with your work or other regular 
daily activities as a result of your physical health? (Please tick one box) 
 
Felt less able to carry out normal tasks  Yes             No  
  
Were limited in the kind of work or other activities you have 
undertaken 
 
Yes             No  
 
 
 
3.  During the past 12 months, have you had any of the following problems with your regular activities 
as a result of any emotional problems (such as feeling depressed or anxious)? (Please tick one 
box)  
 
Accomplished less than you would like Yes              No  
  
Didn’t do work or other activities as you usually would do Yes              No  
ID: 
 384
 
 
 
 
4.  During the past 12 months, how much of the time have your physical OR emotional problems 
interfered with your social activities (like visiting friends, relatives, etc.)? (Please circle one option) 
 
All of the time 
 
Most of the time Some of the time A little of the time None of the time 
 
 
 
 
 
SECTION 2: SEXUAL HEALTH 
 
We want to find out the kind effects having a colposcopy may have upon women.  
You may find some of the following questions a little personal but please try to answer as honestly as 
you can.  ‘Sex’ and ‘Sexual activity’ can include caressing, foreplay, masturbation and vaginal 
intercourse. 
 
 
5.  Have you ever had a colposcopy? Yes             No  
                             IF NO, please go to question 
8 
 
 
 
 
6.  When did you first go for a colposcopy? Month/Year 
 
 
 
 
7.  How many times have you been for a 
colposcopy? 
 
 
 
 
8.  In the past year have you experienced any of the following for three months or longer? 
(Please tick the box that applies most to you) 
 Yes No 
Lacked interest in having sex? 
 
  
Felt anxious just before having sex about your ability to perform 
sexually? 
 
  
Were unable to come to a climax (experience an orgasm)? 
 
  
Have come to a climax (experienced an orgasm) too quickly? 
 
  
Experienced physical pain during intercourse or sexual activity? 
 
  
Have had trouble lubricating? 
 
  
 
 
 385
9.  On a scale of one to ten, with 1 being most dissatisfied and 10 being most satisfied, how would 
you rate your satisfaction with your sexual life?  (Please circle the number that applies most to 
you) 
 
1 2 3 4 5 6 7 8 9 10 
 
Most 
dissatisfied 
    
Neither 
satisfied nor 
dissatisfied 
     
Most 
satisfied 
 
 
 
10.  On a scale of one to ten, with 1 being most dissatisfied and 10 being most satisfied, how would 
you rate your satisfaction with your relationship?  (Please circle the number that applies most to 
you) 
 
1 2 3 4 5 6 7 8 9 10 
 
Most 
dissatisfied 
    
Neither 
satisfied nor 
dissatisfied 
     
Most 
satisfied 
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SECTION 3 
 
The space below has been left blank as we are interested in knowing if there are any other 
experiences or comments you would like to tell us about related to the issues discussed in the 
questionnaire. 
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SECTION 4 
 
We’d be grateful if you would consider taking part in a follow-up. If you agree we will send you a 
questionnaire which will ask you some more questions related to your general and sexual health.  We 
hope it will tell us more about the things that are important to women who experience colposcopy. 
 
 
 
I wish to participate in the next stage of the study   
 
 
I do not wish to participate in the next stage of the study   
 
 
Name: 
……………………………………….………………………………..………. 
 
Address: 
………………………………………………………………………………………….. 
 
………………………………………………………………………………………….. 
 
 
 
Date of birth:   __ __/ __ __ / __ __ __ __ 
 
 
Thank you for your time. 
We greatly appreciate your participation.  Study results will help us to better 
understand women’s experiences of colposcopy.  Please return your completed 
survey in the enclosed FREEPOST envelope. 
 
 
 
 
 
 
If you have any concerns or questions about the study, please contact: 
 
 
 
 
 
 
 
  
Please note: 
All information provided will be held in accordance with the Data Protection Act 
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Appendix 10 - Questionnaire Two 
 
 
 
 
 
 330149    
 
Colposcopy Follow-up Study - Part Two 
 
We are interested in hearing from you, even if you haven’t had a 
colposcopy 
 
Please fill in all sections 
 
You have already helped us complete the initial part of our research study and agreed to participate in 
this second stage. There are some areas that we have already asked you about that we would like to 
explore in more detail and we would be grateful if you could complete the following questionnaire.   
 
All information you provide will be kept strictly confidential by the research team. This means that 
we will never pass on any information about you, your involvement in the study, or the 
answers you give to anyone, for any reason. 
 
SECTION 1:  THIS SECTION ASKS YOU FOR GENERAL BACKGROUND INFORMATION 
 
(Please answer every question by filling one circle or writing in an answer) 
 
1. What is your age?  
  
 
2. How would you describe your ethnicity? (Please fill one circle) 
White – British    Mixed   
White – non-British    Chinese/Chinese British    
Asian/Asian British    Other ethnicity (please specify below)   
Black/Black British    ………………………………   
 
3. At what stage did you finish your full-time education?  (Please fill one circle)    
 
Never attended school    Qualification other than a degree 
from college/university 
  
No formal qualifications    Degree   
GCSE or ‘O’ level equivalent    Post- Graduate qualification   
Training through work with formal 
qualification 
      
 
ID:  
       Yrs 
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4a. Do you smoke cigarettes at all nowadays? (including 
hand rolled cigarettes) 
 
Yes                No             
Ex-smoker                                     
 
 
4b. How many do/did you smoke per day?  
 
 
4c. If you are an ex-smoker, when did you give up? Year 
 
 
5a. Do you drink alcohol? Yes                   No       
 
 
5b. If you drink alcohol, how many units per week?   
 
                                                          Units 
 
 
6a. In the last 12 months have you used drugs or alcohol 
in a way that has caused you problems in your daily 
life? 
 
6b. IF YES, please can you describe these problems in 
the space below? 
 
Yes         No  
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Do you have a partner?  Yes              No  
 
 
8. Are you sexually active? Yes               No  
 
 
 
9. Do you identify as                       Straight                Gay        Bi-Sexual
  
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10a. Have you had a colposcopy? Yes               No  
 
10b. If so, were you sexually active prior to colposcopy? Yes               No  
 
 
11a. Do you use contraception? Yes             No  
 
 
 
11b. If so, which method do you use?  
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SECTION 2: 
 
THIS SECTION WILL ASK YOU FOR SOME MORE DETAIL ABOUT YOUR MEDICAL HISTORY: 
 
(Please answer every question by filling one circle or writing in an answer) 
 
12a. Have you ever had any children? 
 
Yes         No  
                          
 
 
12b. If yes, how many children do you have? 
 
 
 
 
Have you ever had any of the following?  
 
13. A miscarriage? 
 
14. A baby born early (premature)? 
 
15. A still birth? 
 
 
Yes  No  
 
Yes  No  
 
Yes  No  
 
 
 
16. Have you ever had any gynaecological problems (e.g. 
women’s problems such as bad period pains, or 
problems requiring treatment or surgery)?  
IF YES, please describe these problems in the space 
below? 
 
Yes  No    
 
 
 
 
 
 
 
 
 
17. Have you ever had a sexually transmitted 
infections (for example Chlamydia, Herpes, Genital 
warts, HPV, HIV/AIDS, Hepatitis B, Gonorrhoea)? 
IF YES, can you describe these problems in the space 
below? 
 
Yes  No   
 
 
 
 
 
 
 
 
 
18. Have you got any serious long term health problems 
which require ongoing medical advice (for example 
asthma, diabetes, heart disease)? 
IF YES, can you please describe these problems in the 
space below? 
Yes  No  
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19. How many times have you seen your GP in the last 
12 months?  
 
 
 
SECTION 3: 
 
THIS SECTION WILL ASK YOU ABOUT YOUR EMOTIONS AND FEELINGS: 
 
Please consider the following statements and fill in the circle which most applies to you. There are no 
right or wrong answers. Do not spend too much time on any one statement but give the answer which 
best describes your present feeling. (Please fill one circle only for each question) 
 
 All of 
the time 
Most of 
the time 
Some of 
the time 
Hardly 
ever 
Never 
20. I feel tense and wound up      
  
21. I still enjoy the things I used to enjoy      
  
22. I get a sort of frightened feeling as if 
something awful is about to happen      
  
23. I can laugh and see the funny side of 
things      
  
24. Worrying thoughts go through my mind       
  
25. I feel cheerful      
  
26. I can sit at ease and feel relaxed      
  
27. I feel as if I am slowed down      
  
28. I get a sort of frightened feeling like 
butterflies in the stomach      
  
29. I have lost interest in my appearance      
  
30. I feel restless as if I have to be on the 
move      
  
31. I look forward with enjoyment to things      
  
32. I get sudden feelings of panic      
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33. I can enjoy a good book or radio or TV 
programme      
 
SECTION 4: 
 
In the first questionnaire we asked you some questions relating to your sexual feelings and responses 
during the last 3 months. We would like to ask some more questions that are a little more detailed. We 
realise that this is a particularly sensitive and private matter. Your responses will be treated in the 
strictest confidence.  
 
In answering these questions the following definitions apply: 
Sexual activity can include caressing, foreplay, masturbation and vaginal intercourse. 
Sexual intercourse is defined as penile penetration (entry) of the vagina. 
Sexual stimulation includes situations like foreplay with a partner, self-stimulation (masturbation), or 
sexual fantasy. 
Sexual desire or interest is a feeling that includes wanting to have a sexual experience, feeling 
receptive to a partner's sexual initiation, and thinking or fantasizing about having sex. 
Sexual arousal is a feeling that includes both physical and mental aspects of sexual excitement. It 
may include feelings of warmth or tingling in the genitals, lubrication (wetness), or muscle contractions. 
 
 
Over the past 4 weeks, (Please fill one circle for each question) 
 
 
 
38.  How confident were you about becoming sexually aroused during sexual activity or intercourse? 
No sexual 
activity 
Very high 
confidence  
High 
confidence 
Moderate 
confidence 
Low confidence 
 
Very low or no 
confidence 
      
34. How often did you feel sexual desire or interest?
 Almost always or always 
Most times 
(more than half 
the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never or 
never 
      
 
35. How would you rate your level (degree) of sexual desire or interest? 
 Very high High Moderate Low Very low or none at all 
      
36.  How often did you feel sexually aroused ("turned on") during sexual activity or intercourse?
No sexual 
activity 
Almost always 
or always 
Most times 
(more than half 
the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never or 
never 
      
 
37.  How would you rate your level of sexual arousal ("turn on") during sexual activity or intercourse? 
No sexual 
activity Very high High Moderate Low 
Very low or 
none at all 
      
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39. How often have you been satisfied with your arousal (excitement) during sexual activity or intercourse?
No sexual 
activity 
Almost always 
or always 
Most times 
(more than half 
the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never or 
never 
      
40.  How often did you become lubricated ("wet") during sexual activity or intercourse? 
 
No sexual 
Activity 
 
 
Almost always 
or always 
 
 
Most times 
(more than half 
the time) 
 
Sometimes 
(about half the 
time) 
 
A few times 
(less than half 
the time) 
 
Almost never or 
never 
 
 
 
41.  How difficult was it to become lubricated ("wet") during sexual activity or intercourse? 
No sexual 
activity 
 
Extremely 
difficult or 
impossible 
Very difficult 
 
 
Difficult 
 
 
Slightly difficult 
 
 
Not difficult 
 
 
      
42. How often did you maintain your lubrication ("wetness") until completion of sexual activity or 
intercourse? 
No sexual 
activity 
Almost always 
or always 
Most times 
(more than half 
the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never or 
never 
      
43.  How difficult was it to maintain your lubrication ("wetness") until completion of sexual activity or 
intercourse? 
No sexual 
activity 
Extremely 
difficult or 
impossible 
Very difficult Difficult Slightly difficult Not difficult 
      
44. When you had sexual stimulation or intercourse, how often did you reach orgasm (climax)? 
No sexual 
activity 
Almost always 
or always 
Most times 
(more than half 
the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never or 
never 
      
45.  When you had sexual stimulation or intercourse, how difficult was it for you to reach orgasm (climax)? 
No sexual 
activity 
Extremely 
difficult or 
impossible 
Very difficult Difficult Slightly difficult Not difficult 
      
46. How satisfied were you with your ability to reach orgasm (climax) during sexual activity or intercourse? 
No sexual 
activity Very satisfied 
Moderately 
satisfied 
About equally 
satisfied and 
Moderately 
dissatisfied 
Very 
dissatisfied 
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dissatisfied 
      
47.  How satisfied have you been with the amount of emotional closeness during sexual activity between 
you and your partner? 
No sexual 
activity Very satisfied 
Moderately 
satisfied 
About equally 
satisfied and 
dissatisfied 
Moderately 
dissatisfied 
Very 
dissatisfied 
      
   
48. How satisfied have you been with your sexual relationship with your partner? 
 
No sexual 
activity Very satisfied 
Moderately 
satisfied 
About equally 
satisfied and 
dissatisfied 
Moderately 
dissatisfied 
Very 
dissatisfied 
      
 
48.  How satisfied have you been with your overall sexual life? 
 
No sexual 
activity Very satisfied 
Moderately 
satisfied 
About equally 
satisfied and 
dissatisfied 
Moderately 
dissatisfied 
Very 
dissatisfied 
      
50. How often did you experience discomfort or pain during vaginal penetration? 
 
Did not attempt 
intercourse 
Almost always 
or always 
Most times 
(more than half 
the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never or 
never 
      
51.  How often did you experience discomfort or pain following vaginal penetration? 
Did not attempt 
intercourse 
Almost always 
or always 
Most times 
(more than half 
the time) 
Sometimes 
(about half the 
time) 
A few times 
(less than half 
the time) 
Almost never or 
never 
      
52.  How would you rate your level (degree) of discomfort or pain during or following vaginal penetration? 
Did not attempt 
intercourse Very high High Moderate Low 
Very low or 
none at all 
      
 
SECTION 5: 
 
THESE QUESTIONS ASK YOU HOW YOU FEEL ABOUT YOUR QUALITY OF LIFE, HEALTH AND 
OTHER AREAS OF YOUR LIFE.  
Please choose the answer that appears the most appropriate. If you are unsure about which response 
to give to a question, the first one you give is usually the best one. (Please fill one circle for each 
question) 
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We ask you to think about your life in the last four weeks. 
 
53. How would you rate your 
quality of life? Very Poor 
 
 
 
 
 
Poor 
 
 
 
 
 
Neither 
 poor nor 
 good 
 
 
Good 
 
 
 
 
Very Good 
 
 
 
 
  
54. How satisfied are you with 
your health? 
 
 
 
 
Very 
dissatisfied 
 
 
Dissatisfied 
 
 
 
Neither 
satisfied nor 
dissatisfied 
 
 
 
Satisfied 
 
 
Very 
Satisfied 
 
 
 
The following questions ask about how much you have experienced certain things in the last four 
weeks. 
 
  Not at all A little A moderate 
amount 
Very much An extreme 
amount 
 
55. To what extent do you feel 
that physical pain prevents you 
from doing what you need to do? 
     
  
56. How much do you need any 
medical treatment to function in 
your daily life? 
     
  
57. How much do you enjoy your 
life?      
 
58. To what extent do you feel 
your life to be meaningful?      
  
59. How well are you able to 
concentrate?      
      
60. How safe do you feel in your 
daily life?      
      
61. How healthy is your physical 
environment?      
 
The following questions ask about how completely you experienced or were able to do certain things 
in the last four weeks. 
 
  Not at all A little Moderately Mostly Completely 
 
 
62. Do you have enough energy 
for everyday life?      
      
63. Are you able to accept your 
bodily appearance?      
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64. Do you have enough money 
to meet your needs?      
      
65. How available to you is the 
information that you need in your 
day-to-day life? 
     
      
 
66. To what extent do you have 
the opportunity for leisure 
activity? 
     
      
67. How well are you able to get 
around?      
 
 
 
 
 
 
Very 
dissatisfied 
 
 
 
Dissatisfied 
 
 
 
 
Neither 
satisfied nor 
dissatisfied 
 
 
 
Satisfied 
 
 
 
Very 
Satisfied 
 
 
68. How satisfied are you with 
your sleep? 
 
     
      
  
Very 
dissatisfied 
 
 
 
Dissatisfied 
 
 
 
 
Neither 
satisfied nor 
dissatisfied 
 
 
 
Satisfied 
 
 
 
Very 
Satisfied 
 
 
69. How satisfied are you with 
your ability to perform your daily 
living activities? 
     
      
70. How satisfied are you with 
your capacity for work?      
      
71. How satisfied are you with 
yourself?      
      
72. How satisfied are you with 
your personal relationships?      
      
73. How satisfied are you with 
your sex life?      
      
74. How satisfied are you with the 
support you get from your 
friends? 
     
 
75. How satisfied are you with 
the conditions of your living 
place? 
     
      
76. How satisfied are you with 
your access to health services?      
      
77. How satisfied are you with 
your transport?      
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The following question refers to how often you have felt or experienced certain things in the last four 
weeks. 
 
Never 
 
 
Seldom 
 
 
 
Quite often 
 
 
 
Very often 
 
 
 
Always 
 
 
78. How often do you have 
negative feelings such as low 
mood, despair, anxiety, 
depression? 
  
 
 
 
 
 
 
 
 
 
 
 
 
Please fill in the tick box below if you would like to receive a summary of the 
results of this study, once they are available. 
 
I would like to receive a summary of the study  Yes         No  
                            
 
 
Thank you for your time. 
We greatly appreciate your participation.  Study results will help us to better 
understand women’s experiences of colposcopy.  Please return your completed 
survey in the enclosed FREEPOST envelope. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If you have any concerns or questions about the study, please contact: 
 
 
 
 
 
 
 
  
Please note: 
All information provided will be held in accordance with the Data Protection Act 
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